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Abstract 
 
The genus Salvia belongs to the family Lamiaceae and encompasses 900 species 
worldwide of which 26 are found in southern Africa and many of them are used in local 
traditional medicine.  However, the phytochemistry and pharmacological activities of the 
South African species have not been extensively investigated.   
 
The leaf trichome morphology that may be used to distinguish species was investigated 
with the scanning electron and light microscopy.  Both glandular (capitate or peltate) and 
non-glandular trichomes were identified in all species.   
 
The essential oils were isolated by hydro-distillation and analysed by GC and GC-MS 
methods.  The oil yield was relatively low and ranged from 0.004 (S. radula) to 0.50% (S. 
muirii) (w/w).  Major components identified include α-pinene, 1,8-cineole, linalool, 
limonene, myrcene, β-caryophyllene, spathulenol, β-caryophyllene oxide, viridiflorol, δ-3-
carene and α-bisabolol.  High performance liquid chromatography analysis was used to 
identify phenolic compounds in 17 solvent extracts.  Betulafolientriol oxide was detected 
in all species.  Rosmarinic acid was only absent in S. verbenaca, while S. garipensis and S. 
radula were the only species which lacked oleanolic acid/ursolic acid.   
 
Various in vitro biological activities were investigated.  Nearly all the solvent extracts 
displayed anti-oxidant activity with IC50 values ranging from 1.61 to 74.50 μg/ml using the 
DPPH· radical, while the IC50 values ranged from 11.88 to 69.26 μg/ml with the ABTS·+ 
radical.  The solvent extract of S. schlechteri was three times more active than vitamin C.  
Total phenolic content based on gallic acid equivalents (GAE) revealed the presence of 
total soluble phenolics in the extract at 45 to 211 mg of GAE dry sample.  Almost all the 
essential oils exhibited promising anti-inflammatory activity (5-lipoxygenase assay) with 
IC50 values ranging from 22.81 to 77.32 µg/ml.  The antimalarial activity was determined 
using [3H]-hypoxanthine method on the Plasmodium falciparum (FCR-3) strain.  The IC50 
values of the essential oils ranged from 1.20 to 13.50 µg/ml and were low compared to the 
solvent extracts (IC50 values ranging from 3.91 to 26.01 µg/ml).  Betulafolientriol oxide 
and salvigenin isolated from S. radula inhibited the growth of malaria parasites with IC50 
values of 4.95 and 24.60 µg/ml, respectively.  With the exception of S. radula, all the 
solvent extracts displayed moderate to good activity against Staphylococcus aureus, 
 vii
Bacillus cereus, Klebsiella pneumoniae, Escherichia coli and Mycobacterium tuberculosis 
with the MIC values ranging from 0.03 to 8.00 mg/ml.  Four compounds, namely carnosol, 
7-O-methylepirosmanol, oleanolic acid and its isomer ursolic acid were isolated from S. 
chamelaeagnea as the active principles against S. aureus.  The solvent extracts of Salvia 
species were tested for in vitro anticancer activity against human breast adenocarcinoma 
(MCF-7), colon adenocarcinoma (HT-29) and glioblastoma (SF-268) using the 
sulforhodamine B assay.  The extracts inhibited cell proliferation of all three cell lines to 
varying degrees, with the IC50 values ranging between 9.69 and 43.65 µg/ml and 8.72 and 
59.12 μg/ml against the MCF-7 and SF-268 cell lines, respectively.  The IC50 values 
against the HT-29 cell line ranged from 17.05 to 57.00 μg/ml.  The in vitro toxicity profile 
of 28 samples (17 solvent extracts and 11 essential oils) was evaluated on human kidney 
epithelial cells using the 3-(4,5-dimethylthiazol-2-yl)-2,5 dimethyl tetrazolium bromide 
method.  The samples displayed some degree of toxicity with IC50 values ranging from 
1.79 to 22.9 µg/ml for the essential oils and from 12.12 to 53.34 μg/ml for the solvent 
extracts.  The essential oil composition of S. africana-caerulea, S. africana-lutea and S. 
lanceolata, collected at the same locality throughout the 2004/2005 growing season, was 
compared in terms of essential oil yields, chemical composition and biological activities.  
Mostly quantitative, rather than qualitative variation was observed.  Major seasonal 
fluctuations of certain essential oil compounds were observed in all three species.  
Variations in biological activities of the solvent extracts over seasons were noted.  The 
biological activities of the solvent extracts of three Salvia species (Salvia africana-
caerulea, S. africana-lutea and S. lanceolata) were evaluated in the presence and absence 
of essential oils.  The solvent extract of S. africana-caerulea without essential oil exhibited 
the best activity against Gram-positive bacteria (MIC value: 0.1 mg/ml), while the solvent 
extract containing essential oil of S. africana-lutea was the most active against Gram-
negative bacteria.  The toxicity profile of all three species was significantly higher (P < 
0.05) with the solvent extracts containing essential oils.  The in vitro biological activities 
add scientific support to the use of Salvia species in traditional medicine.  
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Chapter 1:  General Introduction 
 
1.1 Introduction 
 
Traditional medicine is widely practiced in many Third World countries.  The WHO 
estimated that about 80% of populations in developing countries rely on traditional 
medicine for their primary health care needs (Jäger and van Staden, 2000; Matu and van 
Staden, 2003).  In rural areas, reliance on traditional medicine is high and can be attributed 
to both economic and cultural factors.  From an economic point of view, the high cost of 
imported, conventional drugs and/or inaccessibility to western health care facilities implies 
that the traditional mode of health care is the only form that is affordable to them (Matu 
and van Staden, 2003).  Even when western health care facilities are available, they usually 
exist side by side with traditional medicine (Sindiga, 1994).  The use and preparation of 
medicinal plants is conveyed verbally from one generation to the next, a process that 
involves the risk of losing essential details (Atindehou et al., 2004).  Furthermore, plant 
species that form the basis of traditional medicine are disappearing at an alarming rate in 
many countries of the world.  It is therefore imperative to study medicinal plants and to 
determine and evaluate their potential biological activities and efficacy.  
 
Secondary metabolites from a vast array of plants are used in numerous fields such as 
phytotherapy, perfumes, cosmetics, aromatherapy and spices.  Aromatherapy has attracted 
the attention of many scientists and the screening of plants to study their biological 
activities has increased (Lahlou, 2004).  For thousands of years, medicine and natural 
products have been closely linked with traditional medicines and chemical studies of these 
predominantly plant-derived traditional medicines were the basis of most early medicine 
such as aspirin and quinine (Butler, 2004).  More recently, essential oils and various other 
extracts have stimulated a growing interest in natural product research and many have been 
screened for their potential use as alternative remedies for the treatment of various ailments 
(Buchbauer, 2000). 
 
Species of the genus Salvia (Lamiaceae) are well known throughout the world for their 
medicinal properties which have made it an attractive choice for many researchers.  
Although some Salvia species have been scientifically studied in many parts of the world 
and are reported to have various biological activities including antibacterial (Ulubelen et 
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al., 2001), anti-oxidant (Couladis et al., 2003), anti-inflammatory (Perry et al., 2003, 
anticancer (Liu et al., 2000) and anticholinesterase (Perry et al., 2003), not much is known 
about the South African species.  Therefore, there is little scientific basis to validate the 
claims by traditional medicine practitioners about the effectiveness of local indigenous 
Salvia species. 
 
1.2 The role of secondary metabolites in plants 
 
Plants are essential for all life on Earth since they provide oxygen.  In addition, they 
provide non-nutritional compounds or secondary metabolites which are not necessarily 
involved in cell metabolism (e.g. essential oils).  These natural compounds are formed 
from diverse precursors such as acetyl-CoA or amino acids, through enzymatic reactions 
(Harbone, 1993). 
 
Plants are sessile organisms and can be attacked easily by snails, insects or vertebrate 
herbivores.  Some authors have suggested that natural compounds might have evolved to 
provide protection to the plant against attack by herbivores and/or to challenge hostile 
environments.  Experimental evidence supports the view that many alkaloids, cyanogenics, 
glycosides, glucosinolates, terpenoids and tannins are allochemicals (Wink, 2003).  
However, plants often need animals to assist in pollination or seed dispersal and in these 
cases, secondary metabolites serve to attract the animals to the plant.  Some secondary 
metabolites concomitantly carry out physiological functions.  For instance, peptides 
(protease inhibitors) can serve as mobile and toxic nitrogen transport (Harbone, 1993).  
The observed multiple functions are typical and do not contradict the main role of many 
secondary metabolites as chemical defense and signal compounds (Wink, 2003). 
 
Secondary metabolites are present in all higher plants and display immense structural 
diversity (Table 1.1).  As a rule, a single group of secondary metabolites dominate within a 
given taxon (Wink, 2003) although few major compounds are often accompanied by 
several derivatives and minor compounds.  Typical secondary metabolites of the 
Lamiaceae include various terpenoids, especially monoterpenes, sesquiterpenes, as well as 
various phenolic acids (Wink, 2003).  The secondary metabolites are generally 
concentrated in one particular region of a plant such as the leaves, roots, bark, fruits or 
glandular hairs.  In cases where they occur in various organs of the same plant, they 
frequently have different chemical profiles (Araújo et al., 2003). 
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Table 1.1 Structural diversity and number of secondary plant metabolites (Wink, 2003). 
 
Natural products Number 
Alkaloidsa 12,000 
Alkamidesa 150 
Aminesa 100 
Carbohydratesb > 200 
Cyanogenic glycosidesa 60 
Diterpenesb 2,500 
Flavonoidsb 4,000 
Glucosinolatesa 100 
Monoterpenesb 2,500 
Non-protein amino acidsa 700 
Phenylpropanoids, coumarins, lignansb 2,000 
Polyacetylenes, fatty acids, waxesb 1,000 
Polyketidesb 750 
Sesquiterpenesb 5,000 
Tetraterpenesb 500 
Triterpenes, saponins, steroidsb 5,000 
                                                   a with nitrogen       b without nitrogen 
 
The essential oils of plants are important not only because they possess biologically active 
compounds, but their chemical compositions have been used to resolve some taxonomic 
problems and discrepancies, especially in the Lamiaceae (Wink, 2003).  It is thought that 
trichomes are structures responsible for the secretion of essential oils.  These structures are 
also important in plant taxonomy, as they have been used to determine the degree of 
similarities among many species of the Lamiaceae.  Considering the difficulties often 
encountered in distinguishing Salvia species, the study of their chemical composition and 
the morphology of the leaf trichome types can be an important tool in clarifying this issue. 
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1.3 Natural compounds and chemotherapeutic agents 
 
Despite competition from synthetic drugs, natural compounds still occupy a commanding 
position among drugs that are now used against infective organisms and diseases.  Table 
1.2 lists a few isolated compounds from plants which are currently in clinical use.  Drugs 
derived from natural compounds are well represented in the top 35 worldwide ethical drug 
sales between 2000 and 2002 with 40% being derived from natural compounds in the year 
2000 (Butler, 2004).   
 
Table 1.2 Natural compounds or naturally derived drugs from plants that are currently 
used clinically (Iwu, 1994; Butler, 2004). 
 
Compounds / drugs Plant Disease 
Artemisinin Atermisia annua      Malaria 
Aspirin Salix species      Inflammation, pain 
Physostigmine Physostigma venonosum      Glaucoma 
Quinine Cinchona pubescens      Malaria 
Reserpine Rauvolfia serpentia      Hypertension 
Taxol Taxus brevifolia      Ovarian and breast cancer   
Vinblastine and vincristine Catharanthus roseus      Lung cancer 
 
Natural compounds often have complex chemical structures making them difficult, if not 
impossible, to synthesize.  Medicinal plants which form the backbone of traditional 
medicine have in the last few decades been subjected to intense pharmacological 
investigations.  This has been catalysed by the acknowledgement of the value of medicinal 
plants as a potential source for new compounds with therapeutic value and as valuable 
sources for drug discoveries and development (Matu and van Staden, 2003).  The common 
practice of phytochemists to isolate, characterize and publish phytocompounds without 
exploring the bioactivity is no longer attractive to academic journals and funding 
companies (Fatope et al., 2000).  Therefore, it is important to isolate and identify the active 
compounds which show good biological activity from plants.   
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1.4 Approach to plant-based research 
 
In the approach of searching for new drugs, no decision is taken by the researcher about 
the specific plant or organisms to be examined.  Based, for example, on the impressive 
quantity and quality of information derived by indigenous cultures that have used these 
medicinal plants, plants are ethnobotanically selected with the aim of searching for 
compounds with desirable biological activities.   
 
Drug discovery is often refered as a ‘number-game’.  There are an estimated 250,000 to 
plant species that inhabit our planet and only a very small percentage of these have been 
evaluated for potential bioactivities (Clark, 1996).  Based on this approach, it would take 
many years of a systematic and concerted effort to evaluate the Earth’s plants for a specific 
biological activity.  Furthermore, it is a difficult task in terms of financial demands.  
Another problem that might arise from this approach is that extracts might contain more 
than one substance, which can obfuscate the assay.  Results obtained from the early 1980’s 
by random screening have been disappointing.  Valeriote et al. (1990) estimated that only 
1% of randomly selected agents tested for anticancer activity demonstrated sufficient solid 
tumour selectivity to proceed to in vivo experiments.  Corbett et al. (1990) screened more 
than 15,000 agents against various cancer cell lines and found that only about 5% were 
selective in vitro.  To date, this approach constitutes the only effective way to obtain new 
and unique classes of agents with novel mechanisms of action (Corbett et al., 1990).  It is 
estimated that approximately 77% of the medicinal agents worldwide were obtained from 
ethnobotanical surveys (Corbett et al., 1990). 
 
1.5 Future of natural products research 
 
Although plants have, up to now, supplied man with a large number of excellent drugs and 
templates for further developments, some people have expressed concern feeling that 
research in this field is languishing.  In the 1980’s, there was a lack of emphasis on plant 
drug research in some developed countries because the available programmes did not 
successfully yield any new marketable medicines.  After testing approximately 40,000 
plants, the National Cancer Institute (USA) was unable to identify a single new agent to be 
used in the treatment of human cancer (Tyler et al., 1988).  During the same period in 
Germany, drugs made from plants and even new plant constituents were continually 
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introduced into the market.  The discovery of new drugs is a question of hard work and 
perseverance, as was shown by the National Cancer Institute when in the late 1980’s it 
developed an exciting new drug (Taxol®) because of its continued efforts (Clark, 1996).  
Since the end of the twentieth century, there has been a resurgence of interest in the 
investigation of natural materials as sources of potential new chemotherapeutic agents 
(Cragg et al., 1997, Cragg and Newman, 2005).  Research activity is stronger now than 
perhaps at any other time and this renewed interest can be attributed to several factors: 
 
(i) unmet therapeutic needs,  
(ii) remarkable diversity of both chemical structure and biological activity of 
naturally occurring secondary metabolites,  
(iii) utility of novel bioactive natural products,  
(iv) development of novel and sensitive techniques to detect biologically active 
natural products, and  
(v) improved techniques to isolate, purify and structurally characterize these 
active constituents. 
 
By coupling the technological capabilities with the creativity and innovation of nature, the 
future of natural product based research is more promising than ever before.  Natural 
products are still a potential source of new drugs, especially in the anticancer and 
antihypertensive therapeutic areas.  The natural products discovered to date have played a 
vital role in improving the human condition and this role will continue as long as there are 
unexplored sources of novel natural products (Clark, 1996). 
 
1.6 The genus Salvia: description, history and traditional uses in South 
Africa  
 
1.6.1 Morphological description 
 
Salvia species are easily recognized by their square stems and opposite, simple pairs of 
leaves that are usually velvety or hairy.  Leaves are often rugose, entire, toothed and lobed.  
Flowers are clustered in racemes, spike-like racemes, spikes and panicles are usually large 
and brightly coloured, depending on species.  Flowers and stems are key diagnostic 
characteristics for identification of the genus (Hedge, 1974; Codd, 1985).  There are four 
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stamens, but only two bear anthers.  Seeds, stem cuttings and divisions are the common 
mode of propagation.  Salvia grows optimally in full sun and needs well-drained soil.  In 
waterlogged soil, the roots may rot. 
 
1.6.2 History 
 
Salvia species (sage) belong to the mint family Lamiaceae (formerly Labiatae).  The genus 
name Salvia L. is derived from the Latin salvare meaning ‘to heal or to be safe and 
unharmed’ referring to the medicinal properties of some of the species (Blumenthal et al., 
2000).  It has been used for centuries, especially by the Chinese as a herb for longetivity or 
in Roman ceremonies as a sacred herb.  This name was translated to sauge (sage) in French 
and sawge in Old English.  Sage encompasses about 900 species, widespread throughout 
the world (Codd, 1985; Paton, 1991; Gali-Muhtasib et al., 2000) and includes several 
ornamental, culinary and medicinal species.  Because they readily cross-pollinate, 
innumerable hybrids, both natural and manmade, are also found.  The genus has a sub-
cosmopolitan distribution, but is largely absent in the North and most of the low-lying 
tropical areas of the world such as the Amazon basin and central and west Africa (Paton, 
1991).  Most of South African species are found in the Cape region (Codd, 1985). 
 
Although Mexico has the highest number of species (about 250), the center of origin of the 
genus has been reported to probably be Afghanistan and Soviet Central Asia where there 
are a larger range of primitive morphological types (Paton, 1991).  In Africa, the greatest 
number of species is in the north-west and in the southern parts (Hedge, 1974).  The genus 
is absent from most of western and central tropical Africa (Jäger and van Staden, 2000).  
The distribution of the genus extends all over northern Africa from west to east and 
southwards to the east African highlands.  Although the species in the north-west are either 
common or affiliated to others species, most southern Africa species are endemic and only 
display a certain degree of similarity with other African species (Paton, 1991). 
 
Southern africa is home to more than 24,000 higher plant taxa (Arnold and De Wet, 1993) 
and a large proportion of them are endemic in character (Mulholland and Drewes, 2004).  
In this part of the world, as in many Third World countries, traditional medicine still plays 
an important role with Salvia species being widely used alone or in combinations with 
other plants.  About 26 species have been identified in South Africa (Codd, 1985; Paton, 
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1991) but species such as S. coccinea, S. officinalis, S. reflexa, S. sclare, S. verbenaca and 
S. tillifolia have been introduced and are thus not indigenous to the region.  
 
1.6.3 Traditional uses of Salvia species 
 
S. officinalis is native to the Mediterranean rim, especially around the Adriatic Sea and 
cultivated in South Africa and has one of the longest histories of use as a medicinal plant.  
Salvia has been used throughout the world and the famous proverb ‘why should he die who 
has sage in his garden’ was used to describe the medicinal properties of the plant (Gali-
Muhtasib et al., 2000).  A few centuries ago, it was nearly always at the top of the list of 
household remedies for the relief of many diseases.  Herbalists in Jordan, Syria and 
Lebanon consider Salvia as a ‘panacea’ i.e. a universal drug (Gali-Muhtasib et al., 2000).  
The therapeutic value of Salvia was also recognized by the king of France, Louis XIV, 
who trusted Salvia more than his doctor (Gali-Muhtasib et al., 2000).  The traditional uses 
of Salvia in South Africa are summarized in Table 1.3.  Despite the fact that an important 
local ethnobotanical bibliographic description of the most commonly used plants in the 
treatment of various diseases exits (Watt and Breyer-Brandwijk, 1962; van Wyk et al., 
2000), there are few experimental studies which validate the therapeutic properties of these 
plants locally. 
 
1.7 Chemical constituents of Salvia species 
 
1.7.1 Volatile compounds (essential oils) 
 
Limited phytochemical work has been carried out on indigenous Salvia species.  The 
essential oil of S. stenophylla collected on the “highveld” of the Free State revealed the 
presence of monoterpenes.  The oxygenated monoterpenoids constituted 5% of the oil and 
the sesquiterpene hydrocarbons 35.5%.  S. stenophylla was found to contain very low 
amounts of 1,8-cineole and camphor, and lacked α- and β-thujene (Jequier et al., 1980).  
Brunke and Hammerschmidt (1985) also analyzed the essential oil of S. stenophylla and 
reported the predominance of α-bisabolol (29.8%). 
 
For the exotic Salvia species, the essential oil composition varies between species and 1,8-
cineole, α-thujene, β-thujene, camphor, (E)-caryophyllene, linalool and linalyl acetate were 
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found to be the most predominant compounds in the majority of species investigated 
(Topcu et al., 1997; Gali-Muhtasib et al., 2000; Kalemba and Kunicka, 2003; Pitarokili et 
al., 2003; Pavela, 2004). Azcan et al. (2004) investigated the fatty acid seed oil 
composition of twelve Salvia species growing in Turkey and the main fatty acids found 
were oleic, linoleic, linolenic acids and palmitic acids. 
 
Table 1.3 Medicinal uses of South African Salvia species (Watt and Breyer-Brandwijk, 
1962). 
 
Species Part used Mode of uses Ailments 
S. africana-caerulea Twig Infusion mixed with Epson salt and 
lemon 
Colic, diarrhoea, indigestion, 
abdominal trouble 
S. africana-lutea Whole plant Infusion, decoction Colds, cough 
S. chamelaeagnea Leaves Decoction, infusion Colds, cough 
S. triangularis Whole plant Decoction with Helichrysum latifolium 
and Commelina africana 
Liver sickness, barrenness 
S. repens Roots, leaves, 
whole plant 
Decoction, added to bath 
Sores on the body, stomach 
problems, diarrhoea 
S. runcinata Whole plant, 
leaves, stems 
and roots 
Burned, decoction 
Disinfect dwelling sickness, 
urticaria 
S. scabra Leaf Decoction Purgative 
Salvia species Roots, whole 
plants 
Decoction Biliousness, cold, febrile attacks 
Salvia species Whole plant Infusion in combination with Leonotis 
leonurus 
Tuberculosis, cough, influenza, 
bacterial infections, cold 
S. stenophylla Whole plant Infusion, decoction Disinfect dwelling sickness 
 
 
1.7.2 Non-volatile compounds (phenolic compounds) 
 
Salvia species are a rich source of polyphenolics and flavonoids.  The polar phenolic acids 
constitute the major part of the Salvia decoction.  Caffeic acid plays a central role in the 
biochemistry of Lamiaceae and occurs predominantly in the dimer form as rosmarinic acid 
(Gerhardt and Schroeter, 1983).  In Salvia species, caffeic acid is the building block of a 
variety of the plant metabolites from the simple monomers to multiple condensation 
products that give rise to a variety of oligomers (Lu and Foo, 2002).  Phenolic acids such 
as rosmarinic, caffeic and salvimanolic acids have been isolated (Lu and Foo, 2002). 
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The phenolic glycosides are not very common in Salvia.  The rosmarinic acid 3'-glucoside 
and its methyl ester, as well as the cis- and trans-p-coumaric acid 4-O-(2-O-apyiosyl) 
glucosides, are the only examples of the glycosylated phenolic acids (Lu and Foo, 2002).  
In contrast, flavonoids are widely distributed in Salvia species (Ulubelen and Tuzlaci, 
1990) and they are mostly present as flavones, flavonols and their glycosides (Lu and Foo, 
2002).  The majority of O-flavonoids are the flavones, apigenin and luteolin.  The 6-
hydroxyflavones are the flavonoids that characterise the species of Salvia and they include 
a variety of 6-hydroxylated apigenin and luteolin derivatives with cirsimaritin.  Flavonols 
are mostly those of kaempferol and quercetin.  Flavonone O-glycosides are apparently 
common in Salvia and most of them are flavone 7-glucosides represented by cosmosiin 
and cinaroside (Lu and Foo, 2002). 
 
A solvent extract of S. stenophylla collected in the Eastern Cape was investigated for 
flavonoids.  Apigenin-7-methyl ether, luteolin and 6-hydroxyluteolin-6,7-dimethyl ether 
were identified (Wollenweber et al., 1992).  A large study on the occurrence of alkaloids in 
plants included a number of the southern African Salvia species, with S. chamelaeagnea, S. 
namaensis and S. runcinata testing positive for alkaloids, while in S. africana-caerulea, S. 
africana-lutea, S. coccinea, S. dolomitica, S. reflexa, S. tillifolia and S. triangularis, no 
alkaloids were detected (Raffauf, 1996). 
 
1.8 Biological activities of Salvia species 
 
A literature search indicated that the genus Salvia has been a popular topic in 
phytochemical and ethnobotanical research.  The solvent extracts, essential oils and 
compounds isolated from Salvia species revealed that they displayed a broad range of 
pharmacological properties, both in vitro and in vivo.  Table 1.4 lists some examples of 
biological properties of Salvia including two indigenous species. 
 
1.9 Rationale and motivation of the study 
 
Salvia was chosen as the basis of this study because of its long history of traditional use in 
South Africa and the rest of the world.  Despite many reports on the medicinal properties 
of Salvia, few studies have been carried out on indigenous species (Table 1.4).   
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Table 1.4 Some examples of biological activities of Salvia species. 
  
 
Species 
Plant parts 
used 
Bioactive  
fraction/compound 
Activity 
Methodology used/ 
organisms used 
S. aethiopis Roots Aethiopinone Anti-inflammatory  5-Lipoxygenase a, b 
S. africana-lutea Leaves Solvent extract Anti-analgesic  Acetic acid writhing in mice c 
S. fruticosa Whole plant Rosmarinic acid Anti-oxidant Free radical assay d 
S. hypargeia Roots Crude extracts, taxodione Antibacterial Mycobacterium tuberculosis e 
S. lavandulaefolia Aerial parts Essential oils Anticholinesterase Microtitre plate assay f 
S. miltiorrhiza Roots Tanshionones Anticancer Human tumour cells g, h 
S. officinalis Leaves Ursolic acid Anti-inflammatory Oedema induced in mice i 
S. paleastina Leaves Cirsimaritin Antibacterial Gram-positive bacteria j 
S. prionitis Leaves 
3-Keto-4-hydroxysa- 
prothorquinone 
Anticancer Stomach cancer cell lines k 
S. repens Whole plant 
Dichloromethane:methanol 
extract 
Antimalarial Parasite lactate dehydrogenase l 
S. viridis Roots 1-Oxoferrunol Antibacterial S. aureus, B. cereus, B. subtilis m 
           a Hernandez-Perez et al., 1995; b Benrezzouk et al., 2001; c Amabeoku et al., 2001; d Exarchou et al., 2002; e Ulubelen et al., 1988; f Savelev et al., 2003; g Liu  et al., 2000; 
       h Ryu et al., 1997; i Baricevic et al., 2001; j Miski et al., 1983; k Chen et al., 2002; l Clarkson et al., 2004;  m Ulubelen et al., 2000.
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From a literature survey on biological activities of the South African Salvia species, only 
two publications reported the pharmacological properties in S. africana-lutea and S. repens 
(Amabeoku et al., 2001; Clarkson et al., 2004) in addition to the composition of S. 
stenophylla essential oil (Jequier et al., 1980; Brunke and Hammerschmidt, 1985). 
 
The reported traditional medicinal uses and the lack of phytochemical and pharmacological 
studies on indigenous Salvia species prompted this investigation into the phytochemistry 
and the biological activities of various Salvia species from South Africa. 
 
1.10 Aim of the study 
 
The aim of this study was to screen seventeen South African Salvia species in order to 
evaluate their biological activity, to isolate and identify compounds responsible for the 
selected biological activities and to assess a chemotaxonomic relationships amongst South 
African representatives of the genus Salvia. 
 
1.11 Objectives of the study 
 
The objectives of this study were to: 
(i) examine the morphology of leaf trichome types of Salvia species and to 
assess the taxonomic value of these epidermal structures,  
(ii) investigate the chemical composition of the essential oils and to assess 
variation in their chemical composition across the seasons using gas 
chromatography (GC) and gas chromatography coupled to mass 
spectrometry (GC-MS) analysis and to identify various groups that may be 
used in the flavourant and cosmetic industries,  
(iii) identify the presence of phenolic compounds previously identified in exotic 
Salvia  in the solvent extract of indigenous species using high performance 
liquid chromatography, 
(iv)  investigate the anti-oxidant activity of the crude extracts and essential oils 
of indigenous Salvia species using two radicals,  
(v) evaluate the ability of crude extracts and essential oils to inhibit the 5-
lipoxygenase enzyme which is one of the enzymes involved in the 
inflammatory process,  
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(vi) investigate the effect of the essential oils and solvent extracts on 
Plasmodium falciparum, the protozoan responsible for malaria by the [3H]-
hypoxanthine radiometric assay and isolate the active compound(s) from the 
most active solvent plant,  
(vii) evaluate the inhibitory effects of the essential oils and solvent extracts on 
the growth of selected bacteria and the common tuberculosis pathogen as 
well as to isolate the active compound(s) from the plant showing the best 
antibacterial activity,  
(viii) evaluate the inhibitory effects of the solvent extracts against the growth of 
breast, neuronal and colon cancer cell lines using a protein detection 
colorimetric method,  
(ix) determine the toxicity profile of the essential oils and solvent extracts 
against a transformed human kidney epithelium cell line using the 
tetrazolium cell proliferative method, 
(x) study the seasonal variation in biological activities of selected Salvia 
species, and  
(xi) evaluate the influence of the essential oils on the biological activities of 
solvent extracts. 
 
1.12 Outline of the thesis  
 
The rest of the thesis consists of 13 Chapters.  Reprints of publications, abstracts for 
conferences and the monographs are included in the Appendices.  Apart from Chapters 2 
and 14 which describe the localities and the general conclusions, respectively, each 
Chapter consists of an abstract, an introduction, materials and methods, results, discussion 
and conclusion.  
 
Chapter 2:  The extraction procedures for volatile (essential oils) and non-volatile (solvent 
extracts) fractions are described.  The localities where the plants were collected are also 
listed. 
 
Chapter 3:  The variety of trichomes found in various plant organs have been a valuable 
tool for comparative systematic studies of Angiosperms.  In this Chapter, the morphology 
of the leaf trichome types is examined. 
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Chapter 4:  The essential oils have a broad range of applications, including the cosmetic 
industry, food industry and in aromatherapy.  GC and GC-MS were used to analyse the 
chemical composition of the essential oils isolated by hydrodistillation.  The relationship 
among different species could thus be more clearly established. 
 
Chapter 5:  Salvia is known to possess various phenolic compounds which contribute to 
biological activities.  Some of the most common compounds in Salvia extracts as well as 
those isolated from two Salvia species are identified in the investigated species. 
 
Chapter 6:  There is increasing evidence to suggest that many degenerative diseases such 
as inflammation, brain dysfunction, immune system suppression and cancer could be the 
result of cellular damage caused by free radicals.  The free radical scavenging activity 
(anti-oxidant activity) of the solvent extracts and essential oils is evaluated and the 
phenolic content determined. 
 
Chapter 7:  The 5-lipoxygenase enzyme is one of the key enzymes involved in the 
inflammation process.  The potential of the solvent extracts and essential oils to inhibit this 
enzyme is evaluated. 
 
Chapter 8:  The increasing prevalence of malaria has been attributed to a number of 
factors, one of them being the emergence and spread of drug resistant parasites.  In this 
Chapter, the essential oils and solvent extracts were tested for their potential to inhibit the 
growth of Plasmodium falciparum and two compounds from the most active solvent 
extract were isolated, characterised and tested. 
 
Chapter 9:  Despite the progress in understanding the life cycle and control of many 
pathogens, nearly all diseases, affecting millions of people in developing countries, are still 
caused by micro-organisms.  The essential oils and solvent extracts were investigated in 
order to evaluate their potential to inhibit the growth of common bacterial pathogens.  
Furthermore, the active compounds were isolated and characterised from the most 
promising plant. 
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Chapter 10:  A major problem with present day cancer chemotherapy is the serious 
deficiency of active drugs for the curative therapy and their adverse effects on the patient.  
The anticancer activity of solvent extracts is investigated on three different cell lines and 
their potential selectivity noted. 
 
Chapter 11:  There is a common notion among people who frequently use Salvia species 
to treat different ailments that ‘if it does not benefit, it would not harm’ and many people 
are not aware of any side effects or toxic symptoms that may be associated with excessive 
use of Salvia species.  In this Chapter, the toxicity of essential oils and the solvent extracts 
is explored.  
 
Chapter 12:  The composition of the essential oils and solvent extracts may vary 
depending on environmental conditions and season which may, inevitably, affect the 
biological activities.  Seasonal variation in essential oil composition and biological 
activities of the solvent extracts across seasons are evaluated for three species.   
 
Chapter 13:  Aromatic plants such as Salvia species possess both the volatile and non-
volatile fractions.  The contribution of the volatile fractions on the biological activities of 
the non-volatile fraction is discussed.    
 
Chapter 14:  General conclusions of the study and recommendations are presented.  The 
reference documents employed for this research are cited subsequent to Chapter 14. 
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Chapter 2:  Plant Collection, Isolation of Volatiles and 
Extraction of Non-Volatiles  
 
2.1 Species selection 
 
Species investigated in this study were selected according to their reported traditional uses 
in South Africa. 
 
2.2 Collection of plant materials 
 
Codd (1985) described 26 Salvia species in southern Africa, 17 of 22 species occurring 
naturally in southern Africa were included in this study.  The aerial parts of the selected 
species were harvested at different localities in South Africa between December 2003 and 
December 2005.  Possible variation between populations was not taken into account and 
only one representative per species was considered.  The taxonomic identification of all 
species collected was confirmed at the herbarium at the South African National 
Biodiversity Institute (Pretoria) and voucher specimens were deposited in the Department 
of Pharmacy and Pharmacology, University of the Witwatersrand, Johannesburg, South 
Africa.  Table 2.1 lists the species investigated and a concise description and photographs 
of each species are shown in the monographs in Appendix C.  The traditional uses of each 
plant are also included in Appendix C. 
 
2.3 Preparation of samples 
 
2.3.1 Preparation of the essential oils (volatile fractions) 
 
The essential oils of the fresh aerial parts were isolated by hydrodistillation using a 
Clevenger type apparatus for three hours at 100 °C (Figure 2.1).  The oil yield was 
recorded before being sealed in glass vials with silica septa, protected from light and kept 
refrigerated until used. 
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Table 2.1 Species studied, localities of collection, accession and voucher numbers.  
 
Species Locality 
Date of 
collection 
Accession number 
(KBG1) 
Voucher 
number  
S. africana-caerulea SWC2 01-12-2003 0554/82 AV 875 
S. africana-lutea SWC2 01-12-2003 1185/71 AV 873 
S. albicaulis KBG1 06-01-2004 0050/79 AV  894 
S. aurita KBG1 01-12-2003 0244/01 AV 1066 
S. chamelaeagnea KBG1 06-01-2004 0725/93 AV 848 
S. disermas KBG1 31-03-2005 0574/74 AV 1194 
S. dolomitica ex Manning 26-09-2003 0038/79 AV 838 
S. garipensis KBG1 27-03-2004 0689/91 AV 1193 
S. lanceolata SWC2 01-12-2003 0919/96 AV 877 
S. muirii KBG1 27-03-2004 189/82 AV 874 
S. namaensis* Swartberg  11-07-2002 n.g3 AV 497  
S. radula Road to 
Derby 
13-12-2003 n.g3 AV 880 
S. repens KBG1 06-01-2004 0609/95 AV 615 
S. runcinata Klerkskraal 
Dam 
13-12-2003 n.g3 AV 679 
S. schlechteri KBG1 27-03-2004 0173/02 AV 1068 
S. stenophylla East of 
Clarens 
06-01-2004 n.g3 AV 893 
S. verbenaca De Rust 02-12-2003 n.g3 AV 631 
1 KBG: Kirstenbosch Botanical Garden 
2SWC: South Western Cape 
3 n.g: Accession number not given because the plants were not collected at the KBG 
* Plant material used was collected in 2002    
 
2.3.2 Preparation of the solvent extracts (non-volatile fractions) 
 
Aerial parts of each plant were air dried at room temperature for seven days and pulverised 
into a fine powder, using a coffee grinder.  The pulverised aerial parts were then extracted 
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with methanol:chloroform (1:1, v/v) in a water bath for three hours at 36-40 °C and filtered 
using Whatman® No 1 filter paper (pore size: 20-25 µm).  
 
The filtrate was evaporated to dryness under reduced pressure and kept refrigerated until 
used.  It is important to note that various solvent systems (acetone, methanol, 
dichloromethane, chloroform) were assayed before the methanol:chloroform mixture was 
finally selected because this mixture extracted compounds over a range of polarities.  
             
                      
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1 Clevenger apparatus used for the isolation of the essential oils. 
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Chapter 3:  Leaf Trichome Types  
 
Abstract 
 
Trichomes are outgrowths of the epidermis found on various plant organs.  Leaf trichome 
morphology is described here for the first time for 12 species of Salvia collected at the 
Kirstenbosch Botanical Garden.  Leaf surfaces were examined by scanning electron 
microscopy while transverse sections of leaves were studied by light microscopy.  All 
species investigated contain both glandular and non-glandular trichomes.  The non-
glandular trichomes are multicellular, unbranched and consist mainly of elongated cells, 
while the glandular trichomes are either capitate or peltate.  The capitate type, present in all 
species, has a unicellular or multicellular head, one to four short or long stalk cells and one 
epidermal basal cell.  The peltate type, also found in all species, is relatively large with 
multicellular head cells (up to sixteen), one or two stalk cell(s) and one epidermal basal 
cell.  The non-glandular hairs are abundant in S. africana-lutea, S. lanceolata and S. muirii, 
while many glandular trichomes are observed in S. africana-caerulea, S. chamelaeagnea, 
S. disermas, S. garipensis and S. repens.  Few glandular trichomes were found in S. 
albicaulis, S. dolomitica, S. lanceolata and S. muirii.  The non-glandular trichomes as well 
as the types of glandular trichomes observed are taxonomically informative to 
distinguishing between groups of species.  
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3.1 Introduction 
 
Trichomes are hair-like outgrowths derived from specialised epidermal cells on leaf, root 
or stem surfaces.  Scientific interest in plant trichomes is based on their taxonomic 
importance and on the economic benefit of some trichome-generated products (Davis and 
Heywood, 1973; Theobald et al., 1979).  
 
The great diversity of trichomes and the composition of exudates produced by them are 
used in plant taxonomy to distinguish between closely related species in some families 
(Spring, 2000).  There is a great range in coverage for both glandular and non-glandular 
trichomes, and various proportions of types between species, and between the abaxial and 
adaxial sides of organs such as leaves.  Hairs may be present on one side or both sides 
equally or unequally, sometimes along the margins and/or veins or restricted to intercostal 
regions in clefts (Werker, 2000).  When non-glandular trichomes form a dense 
indumentum, they may serve as a mechanical barrier against various external factors such 
as excessive water loss, pathogens and herbivores (Werker, 2000). 
 
Although the role of glandular trichomes is not clearly elucidated, they are considered as 
storage sites of secondary metabolites.  Glandular trichomes which secrete lipophilic 
substances may provide chemical or physiochemical protection against various types of 
herbivores and pathogens by entrapping, deterring, poisoning them or attract them for 
pollination or seed dispersal (Wagner, 1991).  
 
Glandular trichomes vary in the chemical composition of substances they secrete, mode of 
production, location and function (Hanlidou et al., 1991; Ascensâo et al., 1995).  
Secretions include sugars, salts, lipids, essential oils, resins and proteins.  Suggestions have 
been made to classify glandular trichomes according to the nature of their secretion 
products (Fahn, 2001).  However, there are some limitations to this type of classification 
since some glandular hairs may secrete more than one type of substance (Werker, 2000).  
 
The study of trichomes is a valuable tool in the resolution of many taxonomic problems in 
the Lamiaceae and may be used to determine the relationship between species (Davis and 
Heywood, 1973; Theobald et al., 1979).  Although the indumentum is characteristic in 
many members of the Lamiaceae, little is known on the structural diversity of the 
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trichomes of South African Salvia species which might facilitate accurate identification.  
Salvia species are frequently used in traditional medicine and their scarcity makes them 
highly susceptible to adulteration and substitution.  Thus, the wrong plant could easily be 
used in many herbal preparations with potentially dangerous consequences.  
 
The objectives of this chapter were to: 
(i) investigate the structure of trichomes using scanning electron microscopy 
(SEM) and light microscopy (LM) in order to determine the leaf trichome 
types in twelve South African species of Salvia, and 
(ii) evaluate the structural characteristics of leaf trichomes for their potential in 
identifying species. 
 
3.2 Materials and methods 
 
3.2.1 Plant material 
 
Fresh leaves of all 12 species, namely; S. africana-caerulea, S. africana-lutea, S. 
albicaulis, S. aurita, S. chamelaeagnea, S. disermas, S. dolomitica, S. garipensis, S. 
lanceolata, S. muirii, S. repens and S. schlechteri, were collected at the Kirstenbosch 
Botanical Garden (South Africa) in August 2005.  For each species, some leaves were air-
dried and others directly preserved in a formaldehyde, alcohol and acetic acid solution 
(FAA) basically according to Johansen (1940), but the proportions were modified as 
follows; distilled water:95% ethanol:formaldehyde:glacial acetic acid (28:17:6:2).  Only 
one collection per species was considered. 
 
3.2.2 Preparation of solutions and stain 
 
3.2.2.1 Preparation of glycol methacrylate  
The glycol methacrylate (GMA) monomer mixture was prepared using 188 ml of glycol 
methacrylate, 12 ml of polyethylene glycol 200 and 1 g of benzoyl peroxide.  The mixture 
was stirred slowly for one hour and the solution filtered with Whatman® No 1 filter paper.  
The filtrate was placed in a desiccator and the air removed with a vacuum pump before 
being stored in the dark at 4 °C. 
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3.2.2.2 Preparation of toluidine blue 
The buffer used to prepare the 0.05% (w/v) toluidine blue was made with 0.25 g benzoic 
acid and 0.3 g sodium benzoate dissolved by heating in 200 ml of distilled water.  The pH 
was adjusted to 4.4 with NaOH and the solution was filtered through Whatman® No 1 filter 
paper and stored in the dark at room temperature.  
 
3.2.3 Morphological and anatomical studies of leaf trichomes 
 
3.2.3.1 Morphology of leaf trichomes: scanning electron microscopy  
Leaves preserved in FAA were cut with a razor blade and rinsed with 50% ethanol five 
times for 30 minutes.  The leaf was then dehydrated successively once in 70%, once in 
90% and three times in 100% ethanol for 30 minutes followed by critical point drying in 
liquid carbon dioxide.  For dried material, small pieces were obtained.  Each leaf portion 
was then mounted on an aluminium stub by securing it with double-sided adhesive tape, 
coated with gold and examined.  A standard location on each leaf (Figure 3.1) was chosen 
so that similar positions were examined.  Each sample was scanned at a low magnification 
to reveal the general surface morphology and at higher magnification (where necessary) to 
show details.  Both the abaxial and adaxial surfaces were studied.  Samples were examined 
with a JEOL-5600 scanning electron microscope operating at an acceleration voltage of 6 
kV.  The trichome types were scored as absent (–) or present (+) and the relative 
abundance of glandular and non-glandular trichomes noted.   
 
 
 
Figure 3.1 Leaf area selected for the study of trichome morphology. 
 
3.2.3.2 Microscopic structure of trichomes: light microscopy  
Small portions (≈ 3 mm2) of leaves preserved in FAA were cut with a razor blade and 
prepared according to the method of Feder and O’Brien (1968).  The material was 
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dehydrated by passing it through a graded alcohol series (2 x 50% ethanol, 2 x 100% 
ethanol; 2 x 100% propanol and 2 x 100% butanol).  Specimens were left in each alcohol 
concentration for six hours to ensure that alcohol penetration was complete after which the 
material was infiltrated with the GMA monomer mixture.  Each piece was then placed in a 
gelatin capsule containing GMA and incubated at 60 °C for 24 hours to polymerise prior to 
orienting and sectioning.  Several transverse sections (3-5 µm thick) were cut using a 
Porter Blüm ultramicrotome and placed on slides with a drop of distilled water.  Slides 
were placed on a slide warmer for the sections to adhere and then stained with undiluted 
Schiff’s reagent and toluidine blue (as described in Section 3.2.2.2) (Feder and O’Brien, 
1968).  The slides were finally mounted with Entallen® and observations were made on a 
light microscope (Leitz Wetzlar) equipped with a digital camera (KY-F1030, JVC) 
connected to a computer with the Acquis Digital Imaging syncroscopy version 4.0.0.7.  
The relative abundance of trichomes was determined by counting the number of trichomes 
under the light microscope.  At least 10 fileds were counted to obtain an average number. 
 
3.3 Results 
 
3.3.1 Scanning electron microscopy observations 
 
Representative portions of leaf surfaces are shown in Figures 3.2 to 3.7.  Two glandular 
trichome types, namely peltate and capitate could be observed and are present in all the 
investigated species.  There is no difference in trichome type, between adaxial and abaxial 
surfaces in all taxa.  Although the abundance of trichomes differs among the species with 
either glandular or non-glandular trichomes predominating.  In order words, where the 
glandular trichomes are less dense, the non-glandular trichomes form a dense covering that 
completely obscures the epidermal surface and this was particularly evident in S. africana-
lutea (Figure 3.2C),  S. dolomitica (Figure 3.5A), S. lanceolata (Figure 3.6A) and S. muirii 
(Figure 3.6D).  The non-glandular hairs are multicellular, unbranched and consist of long 
cells and are also present in all the species (Figures 3.2 to 3.7).  While most non-glandular 
trichomes bear one basal cell, S. aurita (Figure 3.3D), S. chamelaeagnea (Figure 3.4A) and 
S. repens (Figure 3.7A) bore multiple cells at the base.  Micropapillae were visible on the 
non-glandular trichomes of some species such as S. chamelaeagnea (Figure 3.4C), S. 
lanceolata (Figure 3.6C) and S. muirii (Figure 3.6E).  In some species such as S. africana-
lutea (Figure 3.2D), S. albicaulis (Figure 3.3B), S. aurita (Figure 3.3F) and S. 
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chamelaeagnea (Figure 3.4B), the rupture of the cuticle revealed that there are up to 
sixteen secretory cells present in the peltate trichomes, whereas the capitate trichomes are 
composed of up to four head cells and this can clearly be seen in S. garipensis (Figure 
3.5F) and S. muirii (Figure 3.6E).  
 
 
Figure 3.2 SEM micrographs of Salvia africana-caerulea (A and B) and S. africana-lutea 
(C, D and E).  (A): Stalked capitate trichomes, sessile peltate trichomes and non-glandular 
trichomes on the lower leaf surface, bar = 100 µm; (B): sessile peltate trichomes on lower 
leaf surface covered by turgid and intact cuticle and non-glandular multicellular trichomes 
unbranched, bar = 10 µm;  (C): leaf surfaces showing a glandular trichome (arrow) and 
dense covering of non-glandular trichomes, bar = 100 µm; (D): details of the lower leaf 
surface showing sessile glandular trichome and non-glandular trichomes, bar = 100 µm; 
(E): high density of non-glandular trichomes on the lower leaf surface, bar = 100 µm. 
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Figure 3.3 SEM micrographs of Salvia albicaulis (A, B and C) and S. aurita (D, E and F).  
(A): lower leaf surface showing a capitate (short arrow) and peltate (long arrow) 
trichomes, bar = 100 µm; (B): sessile peltate trichome on lower surface with a ruptured 
cuticle revealing individual secretory cells, bar = 10 µm;  (C): non-glandular unbranched 
trichome on the upper leaf surface, bar = 10 µm; (D): peltate and capitate trichomes, the 
arrow indicates the base of a non-glandular trichome with multiple cells, bar = 100 µm; 
(E): peltate trichome on lower surface with intact cuticle, bar = 100 µm; (F): a 
multicellular peltate trichome with a ruptured cuticle, bar = 100 µm.  
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Figure 3.4 SEM micrographs of Salvia chamelaeagnea (A, B and C) and S. disermas (D, 
E and F).  (A): lower leaf surface showing glandular trichomes; the black arrow indicates a 
stoma and the white arrow the base of a non-glandular trichome with many cells, bar = 100 
µm; (B): sessile peltate trichomes on the lower surface with a ruptured cuticle revealing 
individual secretory cells and neigbbouring stomata; the arrow indicates a capitate 
trichome of two cells, bar = 100 μm; (C): non-glandular trichome, the white arrow 
indicates a capitate trichome composed of four cells, bar = 100 μm; (D): upper surface 
showing peltate (long arrow) and capitate (short arrows) trichomes, bar = 100 μm; (E): 
capitate trichomes with long and short multicellular stalk cells, rupture of the cuticle 
visible, bar = 100 μm; (F): capitate,  non-glandular (arrow) and peltate trichomes with 
intact cuticles, bar = 100 μm.  
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Figure 3.5 SEM micrographs of Salvia dolomitica (A, B and C) and S. garipensis (D, E 
and F).  (A): upper leaf surface showing a peltate trichome (long arrow), a capitate 
trichome (short arrow) and a dense covering of non-glandular trichomes, bar = 100 μm; 
(B): detail of upper surface of sessile peltate and non-glandular trichomes, bar = 10 μm; 
(C): a capitate trichome with a short stalk, bar = 10 μm; (D): lower surface showing 
relatively long multicellular non-glandular trichomes (mainly on the vein), peltate and 
capitate trichomes with short and long multicellular stalk cells, bar = 100 μm; (E):  
numerous peltate and capitate trichomes, bar = 10 μm; (F): capitate trichomes, arrow 
indicates the four cells revealed by the ruptured cuticle, bar = 100 μm.   
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Figure 3.6 SEM micrographs of Salvia lanceolata (A, B and C) and S. muirii (D, E and 
F).  (A): upper leaf surface showing capitate (short arrow) and peltate (long arrow) 
trichomes and relatively dense point shaped multicellular non-glandular trichomes, bar = 
100 μm; (B): sessile peltate trichome covered by turgid and intact cuticle, bar = 10 μm; 
(C): peltate trichome and non-glandular trichomes with micropapillae (black arrow), bar = 
10 μm; (D): upper surface with glandular and non-glandular trichomes, bar = 100 μm; (E): 
multicellular capitate trichome and multicellular non-glandular trichomes with 
micropapillae (black arrow), bar = 10 μm; (F): multicellular peltate trichomes with an 
intact cuticle, bar = 100 μm. 
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Figure 3.7 SEM micrographs showing the types of trichomes found on the adaxial leaf 
surface of Salvia repens (A, B and C) and S. schlechteri (D, E and F).  (A): capitate (short 
white arrow) and peltate (long white arrow) trichomes, the black arrow indicates a 
multicellular non-glandular trichome with many cells at the base, bar = 100 μm; (B): 
capitate trichome with stalk cells and peltate trichome covered by an intact cuticle, bar = 
10 μm; (C): a capitate trichome with two stalk cells, bar = 10 μm; (D): glandular and very 
sparse multicellular non-glandular trichomes mainly at the vein, stomata visible (black 
arrows), bar = 100 μm; (E): capitate trichome with two secretory cells imbedded in a 
cavity, bar = 10 μm; (F):  peltate trichome with intact cuticle imbedded in a cavity, bar = 
10 μm. 
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3.3.2 Light microscopy observations 
 
The presence of glandular and non-glandular trichomes was confirmed using light 
microscopy (LM).  The general leaf structure in transverse section of each taxon is shown 
in Figures 3.8 to 3.13, while the various types of trichomes found in all species are 
illustrated in Figure 3.14.  Micro-ornamentation was not evident.  No variation in trichome 
types was found on leaves at different stages of development (mature and immature 
leaves).  The trichome types of the species investigated are summarised in Table 3.1. 
 
 
 
Figure 3.8 LM micrographs showing transverse sections of Salvia africana-caerulea (A 
and B) and S. africana-lutea (C and D).  (A): capitate trichomes of mature leaf, bar = 0.2 
mm; (B): mature leaf revealing the presence of glandular and non-glandular trichomes, bar 
= 0.1 mm; (C): young leaf showing non-glandular trichomes, bar = 0.2 mm; (D): young 
leaf showing glandular trichomes, bar = 0.1 mm. CGT: capitate trichome with head 
composed of one or more than one cell; CUT: cuticle of a peltate trichome; NGT: non-
glandular trichome; PGT: peltate trichome (multicellular head). 
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Figure 3.9 LM micrographs showing transverse sections of Salvia albicaulis (A and B) 
and S. aurita C and D).  (A): mature leaf with peltate trichomes, bar = 0.2 mm; (B): mature 
leaf with glandular and non-glandular trichomes, bar = 0.1 mm; (C): mature leaf showing 
capitate and non-glandular trichomes, bar = 0.2 mm; (D): mature leaf revealing peltate 
trichomes and the cuticle, bar = 0.1 mm. CGT: capitate trichome with head composed of 
one or more than one cell; CUT: cuticle of a peltate trichome; NGT: non-glandular 
trichome; PGT: peltate trichome (multicellular head). 
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Figure 3.10 LM micrographs showing transverse sections of Salvia chamelaeagnea (A and 
B) and S. disermas (C and D).  (A): mature leaf showing the general morphology, bar = 
0.2 mm; (B): young leaf with peltate trichomes, bar = 0.1 mm; (C): mature leaf revealing 
non-glandular trichomes, bar = 0.2 mm and (D): young leaf with glandular trichomes, bar 
= 0.1 mm. CGT: capitate trichome with head composed of one or more than one cell; CUT: 
cuticle of a peltate trichome; NGT: non-glandular trichome; PGT: peltate trichome 
(multicellular head). 
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Figure 3.11 LM micrographs of transverse sections of Salvia dolomitica (A and B) and S. 
garipensis (C and D).  (A): mature leaf showing a peltate trichome, bar  0.2 mm; (B): 
young leaf showing non-glandular and glandular trichomes, bar = 0.1 mm; (C): mature leaf 
revealing the  capitate and non-glandular trichomes, bar = 0.2 mm; (D): mature leaf 
revealing  a peltate trichome, bar = 0.1 mm. CGT: capitate trichome with head composed 
of one or more than one cell; CUT: cuticle of a peltate trichome; NGT: non-glandular 
trichome; PGT: peltate trichome (multicellular head). 
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Figure 3.12 LM micrographs of transverse sections of Salvia lanceolata (A and B) and S. 
muirii (C and D).  (A): mature leaf showing an abundance of non-glandular trichomes, bar  
= 0.2 mm;  (B): young leaf showing glandular trichomes, bar = 0.1 mm; (C): mature leaf 
revealing non-glandular trichomes, bar = 0.2 mm; (D): mature leaf showing various 
glandular trichomes, bar = 0.1 mm. CGT: capitate trichome with head composed of one or 
more than one cell; CUT: cuticle of a peltate trichome; NGT: non-glandular trichome; 
PGT: peltate trichome (multicellular head). 
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Figure 3.13 LM micrographs of transverse sections of Salvia repens (A and B) and S. 
schlechteri (C and D).  (A): mature leaf showing non-glandular trichomes, bar 0.2 mm; 
(B): capitate and peltate trichomes on a mature leaf, bar = 0.1 mm; (C): mature leaf 
revealing capitate trichomes, bar = 0.2 mm; (D): mature leaf showing glandular trichomes, 
bar = 0.1 mm. CGT: capitate trichome with head composed of one or more than one cell; 
CUT: cuticle of a peltate trichome; NGT: non-glandular trichome; PGT: peltate trichome 
(multicellular head). 
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Figure 3.14 Various types of glandular and non-glandular trichomes found in Salvia 
species.  (A): type I capitate trichomes of S. africana-caerulea, with unicellular head and 
short stalks, bar = 10 µm; (B): capitate trichome type II of S. africana-lutea, with head 
composed of more than one cell and short stalk, bar = 10 µm; (C): capitate type III 
trichome of S. garipensis, with unicellular head and long stalks, bar = 10 µm; (D): capitate 
trichome type IV of S. garipensis,  with head  composed of more than one cell and long 
stalk, bar = 10 µm; (E): peltate trichome of S. africana-caerulea with up to sixteen 
secretory head cells and short stalk, bar = 10 µm.  
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Figure 3.14 Contd. Various types of glandular and non-glandular trichomes found in 
Salvia species: (F): non-glandular trichome with round top (S. aurita), bar = 10 µm; (G): 
short non-glandular trichome composed of two cells (S. dolomitica), bar = 10 µm; (H): 
sharply-pointed non-glandular trichome (S. africana-caerulea) composed of three cells, bar 
= 10 µm.  
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Table 3.1 Distribution of trichomes on the leaves of Salvia species: absence (–) and 
presence (+) based on trichome type observations in 3.14.  
 
Species Accession number (KBG A B C D E F G H 
S. africana-caerulea 0554/82 + – – – + – – + 
S. africana-lutea 1185/71 + + – – + – – + 
S. albicaulis 0050/79 + + – – + – – + 
S. aurita 0244/01 + + – – + + – – 
S. chamelaeagnea 0725/93 – + – – + – – + 
S. disermas 0574/74 + + + – + – – + 
S. dolomitica 0038/79 + – – – + – + – 
S. garipensis 0689/91 + + + + + – – + 
S. lanceolata 0919/96 + + – – + – – + 
S. muirii 189/82 – + – – + – + – 
S. repens 0609/95 + – + – + + – – 
S. schlechteri 0173/02 – + – – + + – – 
(A): Capitate trichomes: single-celled head, two or three short stalk cells, (B): capitate trichome: two-celled 
head, two or three short stalk cells, (C): capitate trichomes: single-celled head, two or three long stalk cells,  
(D): capitate trichomes: two celled-head, two or three long stalk cells, (E): peltate trichomes: four to sixteen 
cells in the head, one or two stalk cells, (F): non-glandular trichome with round top, (G): short non-glandular 
trichome composed of two cells, (H): sharply-pointed non-glandular trichome composed of three cells. 
 
The capitate trichome type varies in the number of secretory cells (up to four cells) with 
one to four stalk cell(s) and one basal epidermal cell.  To accommodate differences in the 
number of cells comprising the head and the length of the stalk cells, capitate trichomes 
were classified into four types.  Capitate trichome type I refers to a structure composed of a 
unicellular head, a short stalk cell and one basal epidermal cell.  The head of the capitate 
trichome type II is composed of more than one cell with short stalk cell(s) and one basal 
epidermal cell.  Type III capitate trichome is composed of a unicellular head, a long stalk 
cell(s) and one basal epidermal cell and type IV capitate trichome comprises a head with 
more than one cell, a long stalk cell(s) and one basal epidermal cell (Figure 3.14A-D).  In 
general, the head of a capitate trichome has a slightly greater diameter than that of the stalk 
cells.  The types of capitate trichomes found in different species are recorded in Table 3.2.  
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Table 3.2 Various types of capitate trichomes observed in Salvia species. 
 
Trichome 
type 
Characteristics Salvia species 
I Unicellular head, short stalk,  
one basal epidermal cell 
S. africana-caerulea, S. africana-
lutea, S. albicaulis, S. aurita,  S. 
dolomitica, S. disermas, S. 
garipensis, S. lanceolata, S. repens 
II Head with more than one cell,  
short stalk, one basal epidermal 
cell 
S. africana-lutea, S. albicaulis, S. 
aurita,  S. chamelaeagnea, S. 
disermas,  S. lanceolata, S. 
garipensis, S. muirii,S. schelchteri 
III Unicellular head, long stalk, one 
basal epidermal cell 
S. disermas, S. garipensis, S. repens
IV Head with more than one cell, long 
stalk, one basal epidermal cell 
S. garipensis 
  
Peltate glandular trichomes consist of a round broad multicellular head with up to sixteen 
cells, a short stalk cell(s) with cutinized outer walls and a basal epidermal cell (Figure 
3.14E).  In the species examined here, the secretory cells of the head are arranged in one 
(Figure 3.3B) or two (Figure 3.3F) concentric circles.  The number of cells in the central 
circle is usually four, while in the periphery the cell number varies according to the species 
[e.g. 10 peripheric cell in S. aurita (Figures 3.3F) and 12 peripheric cells in S. 
chamelaeagnea (Figure 3.4B)].  The stalk cell(s) of the peltate trichomes are often sunken 
to various degrees into grooves in the epidermis (Figures 3.4A, 3.6F and 3.7F).  
 
The non-glandular trichomes are uniseriate, unbranched and multicellular and may vary in 
shape and number of cells (up to seven) among species.  However, a stalk composed of 4 
or 5 cells is the most common type and was found in the majority of species (Table 3.1).  
For most species, the base of the non-glandular trichomes is composed of one cell, 
however, multiple cells at the base of the non-glandular trichomes could be seen in S. 
albicaulis, S. aurita and S. repens.  The various groups of non-glandular trichomes are 
illustrated in Figure 3.14F-H.  
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The distribution (presence/absence) of the various trichome types found in each 
investigated species is listed in Table 3.1.  Based on SEM and LM observations, the 
species studied can be arranged into six groups (Table 3.2). 
 
The relative abundance of glandular trichomes follows the increasing order: S. disermas > 
S. garipensis > S. africana-caerulea > S. chamelaeagnea > S. aurita > S. schlechteri > S. 
repens > S. africana-lutea, while S. dolomitica, S. albicaulis, S. muirii and S. lanceolata 
have a lower concentration of glandular trichomes. 
 
Although the trichome types found vary between species, the use of trichomes alone could 
not be used to delimit one species from another.  Other characters should also be 
considered. 
 
3.4 Discussion 
 
In the Lamiaceae (Labiatae), many species are densely covered with both glandular and 
non-glandular hairs (Metcalfe and Chalk, 1950; Serrato-Valenti et al., 1997; Bisio et al., 
1999).  Two types of glandular trichomes generally occur together in a single leaf, viz. 
capitate and peltate, the latter being the most characteristic of the family (Metcalfe and 
Chalk, 1950).  The capitate trichomes of Salvia species investigated varied and were 
designated type I, II, III or IV (Figure 3.14A-D).  An SEM study of the Salvia stenophylla 
complex indigenous to southern Africa, similarly revealed the presence of non-glandular 
and glandular trichomes with the latter being capitate or peltate (Gono-Bwalya, 2003).  
Investigation of the various organs of S. glutinosa L. revealed that glandular and non-
glandular trichomes were present (Kaya et al., 2003).  In this study, the SEM and LM 
observations revealed the presence of both these trichome types on the adaxial and abaxial 
surfaces of each species (Figures 3.2 to 3.7 and 3.14A-E).  Similar glandular trichome 
types were found in most species studied.  However, taking into account the variation that 
exists in the nature of the stalk (long or short) and in the number of secretory cells in the 
head, the species investigated could be divided into four distinct groups (Table 3.2).  
 
The taxonomic significance of the morphology of glandular hairs in members of the 
Lamiaceae is not yet determined and it is still being debated in the literature (Falciani et 
al., 1995; Fahn, 2001).  Generally in this family, capitate trichomes are unicellular or 
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multicelullar with short or long stalk cells and one basal epidermal cell.  The peltate 
trichomes are composed of one to sixteen cells and a short stalk cell(s) and one basal 
epidermal cell (Metcalfe and Chalk, 1950; Hallahan, 2000).  The cells of the heads of 
peltate trichomes are usually arranged in two concentric circles and the number of cells in 
the central circle is usually four.  Werker et al. (1985) investigated the glandular hairs of 
eight species of the Lamiaceae and found that the central circle was composed of four 
cells, while the number of cells on the periphery varied from 6 to 14 cells.  In the current 
study, the peltate trichomes are composed of one or two circles, the central circle being 
composed of four cells, while the number of cells in the periphery varied from 6 to 12 cells 
(Figures 3.3F and 3.4B) which concurs with previous studies of the Lamiaceae.  
 
There is a discrepancy in the literature regarding the type of glandular trichomes which are 
widespread in the Lamiaceae, in particular, the genus Salvia.  Some authors regard the 
peltate trichome type as the most common in Salvia species (Metcalfe and Chalk, 1950; 
Werker et al., 1985) while others consider, a peltate trichome with a single-celled stalk and 
the capitate trichome with a unicellular head to be the most common (Hanlidou et al., 
1991).  Metcalfe and Chalk (1950) also state that heads with one or two cells are present in 
capitate trichomes of Salvia.  However, Werker et al. (1985) pointed out that the bicellular 
head was rather rare.  Bourett et al. (1994) also observed small capitate glandular 
trichomes with two secretory cells, which were similar to those found in the current study 
(Figure 3.14B).  In this study, unicellular, bicellular or even four-celled heads (with short 
or long stalk cells) were present in all 12 species (Table 3.1).  On the basis of external 
morphology, the glandular trichomes of the species studied are similar to those previously 
described in the Lamiaceae, namely S. glutinosa L. and S. africana-lutea (Serrato-Valenti 
et al., 1997; Kaya et al., 2003). 
 
Non-glandular trichomes in Lamiaceae may be unicellular or multicelullar with up to seven 
cells in Salvia species (Werker et al., 1985).  This is consistent with the observations 
recorded here, with up to six cells being observed in some species (Figure 3.7A).  
Trichome types reported in this study have been identified in exotic species such as S. 
glutinosa and S. officinalis.   
 
It is important to note that trichome morphology can vary between the plant organs (leaf, 
stem or calyx) studied in addition to the stage of development.  However, in this 
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investigation, no variation could be observed between the mature and the immature plant 
material regarding the trichome types.  It was shown in S. glutinosa that the presence or 
absence of various trichome types, as well as their density varied for different plant organs 
(Kaya et al., 2003).  Changwe (2002) also observed that glandular trichomes, like non-
glandular ones on the leaves, stems and calyces, are unevenly distributed in Thorncroftia 
species.  An investigation of other organs in the investigated species may well reveal 
similar variation, but was beyond the scope of this study.  
 
Studies have shown that the short-stalked glands with up to sixteen or more secretory cells 
in the head secrete pleasantly scented oils such as those of Salvia and other aromatic plants 
e.g. Rosmarinus officinalis and Thymus vulgaris (Metcalfe and Chalk, 1950).  Prasium 
majus (Lamiaceae) which is not aromatic only possesses capitate trichomes (Werker et al., 
1985).  It is possible to isolate an individual gland from the leaf surface and analyse its 
contents for chemical composition and presence of specific oils or enzymes (Svoboda and 
Svoboda, 2000).  This study was however not extensive enough to determine whether the 
glandular hairs produce the fragrance of sage would be interesting to determine.  Glandular 
trichomes contain essential oils as well as other secretions that can cover the surrounding 
surface of the leaves.  Some trichomes have specifically evolved to act as defense 
mechanisms.  Trichomes that occur in large numbers may protect a plant by making its 
tissue less edible or inhospitable to feeding and breeding insects (Harbone, 1993).  
 
Observations made in this study suggest that the secreted material in Salvia species can be 
released by breaking the cuticle or via pores in the cuticular structures (Figure 3.4B and 
3.14A) (Serrato-Valenti et al., 1997; Bisio et al., 1999).  While the first mode is common 
to many aromatic species, the second has only been described for capitate trichomes in the 
members of the Lamiaceae (Figure 3.14A) (Werker et al., 1985).  
 
The outer surface of the non-glandular trichomes sometimes exhibits micro-ornamentation, 
which may show great diversity causing it to appear micropapillate (Werker, 2000).  
Micro-ornamentations were not evident in this study.  However, micropapillae were only 
visible under high magnification in the SEM study on the non-glandular trichomes of some 
species including S. chamelaeagnea, S. lanceolata and S. muirii (Figure 3.4A, 3.6A and 
3.6E, respectively).  An expanded cuticle of the peltate trichomes at maturity has been 
reported in other studies in the Lamiaceae (Hallahan, 2000).  This cuticle could be seen in 
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all species investigated (e.g. Figure 3.3 B, 3.3F and 3.4B).  It is probably through the 
rupture of the cuticle that secondary metabolites such as essential oils contained in the 
heads are released. 
 
Non-glandular trichomes are also frequent in the Lamiaceae, and may be uniseriate, tufted 
or branched (Metcalfe and Chalk, 1950; Werker et al., 1985; Kaya et al., 2003).  In this 
study, they were found to be uniseriate and unbranched (Figure 3.14F-H) and the major 
difference was the number of cells at the base rather than the number of cells forming the 
stalk.  The basal cells of the non-glandular hairs can be used to distinguish S. aurita, S. 
chamelaeagnea and S. repens from other species.  While glandular hairs act as a chemical 
defense against herbivores or insects, non-glandular hairs constitute a physical defense of 
the plant (Werker et al., 1985).  The distribution of non-glandular trichomes is variable.  
For some species (S. africana-lutea, S. dolomitica and S. muirii), they might form a dense 
cover; while in S. aurita, S. chamelaeagnea and S. schlechteri, they are sparse (Figure 
3.2C, 3.3D, 3.4A, 3.5A, 3.6D and 3.7D). 
 
The reliability of trichomes as taxonomic characters varies from one group of plants to 
another and may be influenced by many factors such as the plant parts studied and the 
stage of development of the plant.  Trichome characteristics are regarded as being under 
strong genetic control and less little affected by the environment (Mueller, 1966; Cutler 
and Brandham, 1977).  But, Stace (1965) and Dilcher (1974) suggest that the 
characteristics might vary according to environmental factors such as soil type and climate.  
Furthermore, some attributes of the leaf may have arisen in response to evolutionary 
pressures.  The question has often been posed whether the density of the glandular hairs is 
fixed during the life span of the leaf or increases with age.  Some authors have suggested 
that the number is established early during the leaf differentiation (Ascensâo and Pais, 
1987), while others have concluded that it increases throughout all stages of leaf 
development (Maffei et al., 1989).  Taking into consideration these observations, the 
density of trichomes should be recorded carefully.  This is also true with the number of 
cells in capitate or peltate trichomes, since the number of cells present at a particular stage 
may increase during a later stage of development (Ascensâo and Pais, 1987). 
 
Substances such as polysaccharides, essential oils, salts, sugars and proteins are secreted 
by glandular trichomes in species of the Lamiaceae (Werker et al., 1985; Karousou et al., 
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1992; Ascensâo et al., 1995).  The study of trichomes demonstrated that the species 
investigated could be divided into groups, but distinction between species was not possible.  
The composition of the essential oils (Chapter 4) in addition to leaf trichome types 
observed in Salvia species may facilitate the identification of Salvia species. 
 
3.5 Conclusions 
 
• Two types of glandular trichomes (peltate and capitate) were observed to be present 
in all 12 species. 
• The peltate trichome type is present in all species but varies in the number of head 
cells (four to sixteen). 
• Similarly, the capitate trichomes vary in the number of head cells and the length of 
the stalk cells.  
• As with other members of the Lamiaceae, species of the genus Salvia showed some 
degree of diversity in leaf trichome types, but not sufficient to distinguish between 
the investigated species.  
• Salvia aurita, S. chamelaeagnea and S. repens have multiple cells at the base of the 
non-glandular trichomes, unlike the rest of species only one basal cell. 
• Based on the type of capitate trichomes, the species investigated could be divided 
into four distinct groups.  
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Chapter 4:  Essential Oil Composition  
 
 
Abstract 
 
Eleven of the seventeen species under investigation are pungently aromatic which 
prompted a study of their essential oils.  The essential oils were isolated by 
hydrodistillation and analyzed by GC and GC-MS.  The oil yield was relatively low and 
ranged between 0.004 (S. radula) to 0.50% (S. muirii) (w/w).  Ninety-three components 
were identified representing 72.9 to 97.5% of the oils.  Quantitative and qualitative 
variations in oil composition were observed among species.  The essential oils were 
dominated by monoterpene hydrocarbons in S. muirii (53.0%), S. stenophylla (41.5%), S. 
africana-lutea (35.6%) and S. repens (32.6%).  Oxygen-containing monoterpenes 
dominated in S. dolomitica (71.8%) and S. chamelaeagnea (42.8%), while oxygen- 
containing sesquiterpenes were dominant in the remaining samples.  Major components 
identified include α-pinene, 1,8-cineole, linalool, limonene, myrcene, β-caryophyllene, 
spathulenol, β-caryophyllene oxide, viridiflorol, δ-3-carene and α-bisabolol.  Quantitative 
and qualitative heterogeneity in the oils was supported by the essential oil cluster analysis.  
Only S. africana-caerulea and S. lanceolata showed a very high correlation (Scorr > 0.9).  
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4.1 Introduction 
 
Essential oils are odorous, volatile products of an aromatic plant’s secondary metabolism 
normally formed in special cells, or groups of cells, such as trichomes (Metcalfe and 
Chalk, 1950; Werker et al., 1985).  They are generally concentrated in one particular 
region of a plant such as leaves, stems, fruits, barks or roots and when they occur in 
different organs in the same plant, they frequently have different composition profiles 
(Araújo et al., 2003).  
 
Despite the strong competition from synthetic products, essential oils currently still occupy 
an important place in the perfume, fragrance and therapeutic (mainly aromatherapy) 
industries (Lis-Balchin et al., 1998).  Many aromatic plants are also used in traditional 
medicine for various purposes (Cimanga et al., 2002).  The total value of the essential oil 
industry worldwide was estimated at about 10 billion US dollars with production from the 
developing countries representing about 55% of world production (IDRC, 2006).  
Aromatherapy is the therapeutic use of fragrances, or at least volatiles, to cure, mitigate or 
prevent disease, infection and indisposition by means of inhalation (Buchbauer, 2000).  
Essential oils from aromatic and medicinal plants have been known to possess biological 
activity since time immemorial.  There are many reports describing the pharmacological 
properties of essential oils (Baratta et al., 1998; De Feo et al., 2003).  This has recently 
attracted the attention of many scientists and encouraged them to screen plants for the 
pharmacological properties of their oils.  With the growing interest in the use of essential 
oils in perfume and pharmaceutical industries, a systematic examination of plants for these 
properties has become increasingly important.  
 
Studies on the chemical composition of essential oils have proven to be a valuable tool in 
the resolution of some taxonomic problems and can help in determining the relationship 
between different species in the genus.  The study of essential oils is important not only 
from a taxonomic view point, but also from the pharmacological aspect, as plants with 
similar chemical compositions may theoretically have very few differences in their 
biological properties.  
 
The objectives of this study were to: 
(i) determine the chemical composition of 11 essential oils using GC and GC-
MS analysis, and 
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(ii) determine any possible chemotaxonomic relationship between the 
investigated species. 
 
4.2 Materials and methods 
 
The essential oils were isolated by hydrodistillation as explained in Section 2.3.1 (Figure 
2.1) and were analyzed using gas chromatography (Figure 4.1a) and gas chromatography 
coupled to mass spectrometry (Figure 4.1B) (Pedro et al., 2001). 
 
4.2.1 Gas chromatography  
 
GC analyses were performed using a Perkin Elmer 8700 gas chromatograph equipped with 
two FIDs, a data handling system and a vaporizing injector port into which two columns of 
different polarities were installed: a DB-1 fused-silica column (30 m  x  0.25 mm i.d., 
film thickness 0.25 µm; J & W Scientific Inc., Rancho Cordova, CA, USA) and a DB-17 
HT fused-silica column (30 m  x  0.25 mm i.d., film thickness 0.15 µm; J & W Scientific 
Inc.).   
 
 
Figure 4.1 Gas chromatography (A) and gas chromatography coupled to mass 
spectrometry (B) apparatus. 
 
The oven temperature was programmed to run from 45-175 °C, at 3 °C/min, then to 
increase in temperature by 15 °C/min up to 300 °C, where it was maintained for 10 min; 
injector and detector temperatures, 280 °C and 290 °C, respectively; carrier gas, 
hydrogen, adjusted to a linear velocity of 30 cm/s.  The samples were injected using the 
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split sampling technique, ratio 1:50.  The percentage composition of each oil sample was 
computed from the GC peak areas using the normalization method; the data were 
calculated as mean values of two injections from each oil sample without using response 
factors. 
 
4.2.2 Gas chromatography coupled to mass spectrometry  
 
The gas chromatography coupled to mass spectrometry (GC-MS) unit (Figure 4.1B) 
consisted of a Perkin Elmer Autosystem XL gas chromatograph, equipped with DB-1 
fused-silica column (30 m x 0.25 mm i.d., film thickness 0.25 μm; J & W Scientific, 
Inc.), and interfaced with Perkin-Elmer Turbomass mass spectrometer (software version 
4.1).  Oven temperature was as above; transfer line temperature, 280 °C; ion trap 
temperature, 220 °C; carrier gas, helium, adjusted to a linear velocity of 30 cm/s; split 
ratio, 1:40; ionization energy, 70 eV; ionization current, 60 µA; scan range, 40-300 u; 
scan time, 1 s. 
 
4.3 Data analysis and chemotaxonomic relationship among species 
 
The identity of the components was assigned by comparison of their retention indices 
relative to C8-C17 n-alkanes and GC-MS spectra with corresponding data of components 
of reference oils, laboratory-synthesized components and commercially available standards 
from a home-made library from the Departamento de Biologia Vegetal, Universidade de 
Lisboa (Portugal).  The percentage composition of the essential oil samples was used to 
determine the relationship between the different samples of Salvia species by cluster 
analysis using the NTSYS software (Rohlf, 1992).  Correlation was selected as a measure 
of similarity and the unweighted pair-group method with arithmetic average was used for 
cluster definition.  The degree of correlation was evaluated according to Pestana and 
Gageiro (2000) where a very high correlation ranged between 0.90 and 1.00, high between 
0.70 and 0.89, moderate between 0.40 and 0.69, low between 0.20 and 0.30 and very low if 
less than 0.20. 
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4.4 Results 
 
4.4.1 Percentage yield 
 
The essential oil yields among the 11 species ranged from 0.004 to 0.50% (w/w) wet 
biomass (Figure 4.2).  The highest yield was obtained for S. muirii, while S. radula gave 
the lowest yield. 
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Figure 4.2 Percentage essential oil yields (w/w, wet biomass) obtained for eleven 
indigenous Salvia species. 
 
4.4.2 Essential oil composition 
 
The essential oil compositions determined by GC and GC-MS revealed 93 identified 
components present in the 11 species representing from 72.9% to 97.5% of the total oil 
composition.  The components identified, together with their respective percentage 
composition in each species, are shown in Table 4.1, in order of their elution in a DB-1 
column.  The essential oils with high levels of monoterpene hydrocarbons include; S. 
muirii (53.0%), S. stenophylla (41.5%), S. africana-lutea (35.6%) and S. repens (32.6%) 
(Table 4.1).  Oxygen-containing monoterpenes dominated in S. dolomitica (71.8%) and S. 
chamelaeagnea (41.8%), while the oils of the remaining species are dominated by oxygen-
containing sesquiterpenes and include S. africana-caerulea, S. albicaulis, S. lanceolata, S. 
radula and S. runcinata (Table 4.1).   
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Table 4.1 Percentage of the components identified in the essential oils of 11 South African 
Salvia species.  
  
Components RI Sac Sal Sab Sch Sdo Sla Smu Sra Sre Sru Sst 
Tricyclene 921 -  tr -  -  tr -  0.1 -  -  -  0.1 
α-Thujene 924 0.1 0.6 tr 0.2 -  0.5 0.3 -  4.7 -  0.1 
Benzaldehyde 927 -  -  -  -  -  -  -  -  -  tr tr 
α-Pinene 930 4.1 6.0 1.9 10.4 tr 2.6 22.3 -  tr tr 1.3 
Camphene 938 0.1 tr tr 0.2 -  tr 7.6 -  3.3 tr 2.0 
Sabinene 958 tr 0.9 tr 0.1 0.1 1.4 0.1 -  2.4 tr 0.4 
6-Methylhept-5-en-2-one 960 -  -  -  -  -  -  -  -  -  -  tr 
1-Octen-3-ol 961 tr 0.9 tr  0.1 0.1 1.4 tr 0.2 tr tr -  
β-Pinene 963 1.3 0.2 tr 1.9 tr 1.0 6.7 0.2 tr 0.1 0.2 
2-Octanone 967 -  -  -  -  -  -  -  0.8 -  -  -  
3-Octanol 974 -  -  -  -  -  - -  -  -  0.1 -  
Myrcene 975 0.2 11.5 tr 1.6 0.6 0.6 1.9 -  1.0 0.1 3.9 
δ-2-Carene 983 -  -  tr -  -  -  -  -  0.9 -  -  
α-Phellandrene 995 -  -  -  -  -  -  -  -  -  -  0.1 
δ-3-Carene 1000 -  -  tr -  -  -  -  -  1.4 -  22.6 
o-Ocimene 1000 -  -  -  -  -  -  -  -  -  -  0.3 
p-Cymene 1003 1.5 7.6 2.5 0.9 0.2 1.1 1.6 0.2 9.5 tr 0.6 
1,8-Cineole 1005 0.5 1.9 9.4 40.5 tr 1.8 23.2 0.2 12.8 tr -  
β-Phellandrene 1005 -  -  - -  -  -  -  -  -  tr 3.7 
Limonene 1009 1.5 1.6 9.4 9.7 0.6 1.8 11.6 -  9.4 0.5 4.8 
cis-β-Ocimene 1017 tr 5.4 -  0.3 0.6 tr 0.5 -  -  0.1 -  
trans-β-Ocimene 1027 tr 1.8 -  0.4 -  tr 0.1 -  -  -  0.2 
γ-Terpinene 1035 -  -  -  -  tr -  0.1 -  -  -  0.2 
trans-Sabinene 
  hydrate 
1037 tr tr -  0.1 -  tr -  -  -  - 0.5 
cis-Linalool oxide 1045 -  -  - -  0.2 -  -  -  -  -  -  
n-Octanol 1045 -  -  -  -  -  -  -  -  -  0.1 -  
trans-Linalool oxide 1059 -  -  -  -  0.2 -   - -  -  -  -  
Terpinolene 1064 -  -  -  -  0.2 -  0.1 -  -  -  1.0 
cis-Sabinene hydrate 1066 0.1 tr -  0.1 -  tr -  -  -  -  -  
Linalool 1074 0.3 0.8 tr 0.6 16.6 1.3 -  -  tr 0.2 0.4 
trans-p-2-Menthen-1- ol 1074 0.6 0.2 tr 0.3 -  0.2 -  -  -  -  -  
α-Campholenal 1088  - -  tr -  -  -  -  -  -  -  -  
Camphor 1095 -  -  2.3 -  -  -  8.3 0.3 5.3 0.9 3.2 
neo-iso-Thujanol 1101  - -  tr -  -  -  -  -  -  -  -  
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Components RI Sac Sal Sab Sch Sdo Sla Smu Sra Sre Sru Sst 
trans-Pinocarveol 1106 -  -  -  -  -  -  0.2 -  -  -  -  
cis-p-2-Menthen-1-ol 1110 -  -  -  -  -  -  -  -  -  -  tr 
allo-Ocimene 1110  - -  -  -  0.8 -  -  -   - -  -  
trans-Verbenol 1114 -  -  -   - -  -  0.1 -  -  -  -  
Pinocarvone 1121 -  -  -  -  -  -  0.1 -  -  -  -  
Nerol oxide 1127 -  -  -   - 0.1 -  -  -  -  -  -  
δ-Terpineol 1134 tr 0.2 -  0.2 -  0.5 -  -  -  -  -  
Borneol 1134 -  -  tr -  -  -  0.6 -  1.0 1.2 2.2 
Terpinen-4-ol 1148 0.5 0.6 -  0.4 0.8 1.0 0.9 7.1 -  0.7 0.8 
α-Terpineol 1159 0.7 0.8 2.7 0.5 6.2 1.3 0.7 0.7 tr 0.6 0.8 
Myrtenol 1168 -  -  1.5 -  -  -  0.2 -  tr 0.8 3.5 
trans-Carveol 1189 tr tr tr tr -  0.1 -  -  tr -  -  
Cuminaldehyde 1200 -  -  tr -  -  -  -  -  tr - -  
Carvone 1206 0.3 tr tr 0.1 -  tr -  -  -  -  -  
Citronellol 1210 -  -  -  -  0.4 -  -  -  -  -  -  
Geraniol 1236 -  -  -  -  19.6 -  -  -  -  -  -  
Linalyl acetate 1245 -  -  -  -  19.6 -  -  -  -  -  -  
Cumin alcohol 1260 -  -  -  -  -  -  -  -  tr -  -  
Bornyl acetate 1265 -  -  tr -   - -  1.8  - 1.3 0.1 -  
Neryl acetate 1275 -  -  -  -  4.0 -  -  -  -  -  -  
cis-Jasmone 1372 tr tr -  tr -  tr 0.1 0.4 -  0.1 -  
Geranyl acetate 1370 -  -  -  -  2.3 -  -  -  -  -  -  
α-Gurjunene 1400 tr 1.1 -  0.6 tr 0.2 -  -  1.6 -  -  
Isocaryophyllene 1406 -  -   - -  -  -  tr 8.6 -  0.2 -  
β-Caryophyllene 1414 1.9 3.4 2.1 1.7 0.3 5.7 2.2 tr 8.0 10.5 2.1 
β-Gurjunene* 1426 0.7 0.3 -  0.2 -  0.1 -  -  1.4 -  -  
Aromadendrene 1428 0.9 2.7 2.0 2.1 -  0.8 0.4 tr -  tr - 
α-trans-Bergamotene 1434 -  -  -  -  -  -  0.3 tr -  0.7 1.1 
Eudesmadiene* 1435 0.8 tr -  0.4 -  tr -  -  -  -  tr 
α-Humulene 1447 1.2 1.9 tr 1.0 0.2 4.7 0.2 1.6 2.8 2.3 -  
trans-β-Farnesene 1455 -  -  -  - 0.2 -  0.1 -  -  0.4 0.5 
allo-Aromadendrene 1456 tr 1.3 tr 1.0 -  2.4 -  -  0.9 -  -  
Geranyl-2-butylether 1466 -  -  -  -  1.8 -  -  -  -  -  -  
ar-Curcumene 1475 -  -  -  -  -  -  -  -  -  0.1 -  
β-Selinene 1476 -  -  -  -  - -  tr -  -  0.1 -  
Viridiflorene 1487 0.2 1.3 -  0.7 0.8 0.2 -  -  1.8 -  -  
UI-C 1492 -  -  -  -  1.4 - -  -  -  -  -  
UI-A 1494 -  -  -   - 3.5 -  -  -  -  - -  
β-Bisabolene 1495 -  -  -  -  -  -  0.1 -  -  0.6 3.0 
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Components RI Sac Sal Sab Sch Sdo Sla Smu Sra Sre Sru Sst 
γ-Cadinene 1500 1.5 4.7 -  0.6 -  2.5 -  -  0.8 -  -  
trans-Calamenene 1505 0.3 0.9 -  tr -  tr -  -  -  -  -  
β-Sesquiphellandrene 1508 -  -  - -  -  -  -  -  -  0.2 -  
trans-Nerolidol 1549 1.4 3.5 2.1 1.6 -  2.2 1.8 -  -  0.7 -  
β-Caryophyllene 
  alcohol 1550 1.4 2.0 -  1.6 -  2.2 -  -  -  - -  
UI-D 1550 -  -  -  -  2.8 -  -  -  -  -  -  
Spathulenol 1551 29.1 2.0 2.0 tr 1.5 18.3 -  7.7 2.6 tr -  
β-Caryophyllene  
  oxide 1561 14.6 1.9 5.6 0.6 -  14.3 0.6 22.6 4.9 1.3 -  
Globulol 1566 tr 0.8 2.2 0.5 -  0.6 -  -  -  -  - 
Viridiflorol 1569 0.0 3.3 24.5 9.3 -  0.9 1.9 1.3 5.3 tr -  
UI-B 1569 -  -  -  -  2.8 -  -   - -  -  -  
Humulene epoxide* 1579 -  -  -  -  -  -  0.4 12.6 -  0.8 -  
Ledol 1580 6.5 0.0 6.6 1.4 -  5.2 -  -  4.6 -  -  
epi-Cubenol 1600 0.0 1.8 -  0.4 -  0.6 -  -  -  -  -  
T- Cadinol 1616 3.0 1.9 2.0 2.3 -  1.9 -  -  1.1 -  tr 
δ-Cadinol 1618 -  -  -  -  0.6 -  -  1.8 1.1 tr -  
β-Eudesmol 1620 0.7 1.7 tr 0.1 -  1.3 -  -  -  -  -  
Cubenol 1624 -  -  -  -  -  -  -  1.4 -  tr -  
α-Cadinol 1626  - -  tr -  -  -  -  -  3.1 -  -  
α-Eudesmol 1634 2.0 tr -  1.1 -  0.4 -  -  -  -  -  
α-Bisabolol 1656  - - -  -  -  -  0.2 3.8 -  65.5 26.1 
epi-α-Bisabolol 1658 -  -  2.0 -  -  -  -  -  1.4 -  -  
(Z)- Lanceol 1692 -  -  - -  -  -  -   -  - 0.2 1.3 
α-Bisabolol oxide A* 1702 -  -  -  -  -  -  0.1 1.4 -  0.8 1.0 
% Identification   78.0 77.5 80.8 95.8 78.6 81.1 97.5 72.9 94.4 90.0 88.0 
Monoterpenes hydrocarbons 8.8 35.6 13.8 25.7 2.3 9.0 53.0 0.4 32.6 0.8 41.5 
Oxygen containing monoterpenes 3.0 4.5 15.9 42.8 71.8 6.2 36.2 8.7 20.4 4.6 11.4 
Sesquiterpene hydrocarbons 7.5 17.6 4.1 8.3 1.5 16.6 3.3 10.2 17.3 15.1 6.7 
Oxygen containing sesquiterpenes 58.7 18.9 47.0 18.9 2.1 47.9 5.0 52.6 24.1 69.3 28.4 
Others   0.0 0.9 0.0 0.1 0.1 1.4 0.0 1.0 0.0 0.2 0.0 
Monoterpenes   11.8 40.1 29.7 68.5 74.1 15.2 89.2 9.1 53.0 5.4 52.9 
Sesquiterpenes   66.2 36.5 51.1 27.2 3.6 64.5 8.3 62.8 41.4 84.4 35.1 
RI: Relative retention indices calculated against n-alkanes. Sac: Salvia africana-caerulea; Sal: S. africana-
lutea; Sab: S. albicaulis; Sch: S. chamelaeagnea; Sdo: S. dolomitica; Smu: S. muirii; Sla: S. lanceolata; Sra: 
S. radula; Sre: S. repens; Sru: S. runcinata; Sst: S. stenophylla. UI-A: unidentified compound A; UI-B: 
unidentified compound B; UI-C: unidentified compound C; UI-D: unidentified compound D; - : not present, 
tr: trace (< 0.05 %); *: determined by mass spectra only. 
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The components of essential oils identified in high amounts (> 10%) include α-pinene, 1,8-
cineole, linalool, limonene, myrcene, β-caryophyllene, spathulenol, β-caryophyllene oxide, 
viridiflorol, δ-3-carene and α-bisabolol.  The components identified in all 11 species 
include β-pinene, p-cymene, α-terpineol and β-caryophyllene.  The essential oil 
composition of each species is described briefly below. 
 
Salvia africana-caerulea: Forty-three components representing 78.0% of the total oil were 
identified.  The oil was dominated by oxygen-containing sesquiterpenes (58.7%).  The 
percentage of monoterpenes, both monoterpene hydrocarbons and oxygen-containing 
monoterpenes, represent only 11.8% of identified oil components (Table 4.1).  Major 
components of this oil include spathulenol (29.1%), β-caryophyllene oxide (14.6%) 
followed by ledol (6.5%) and α-pinene (4.1%).  These four compounds represent up to 
70% of the total oil (Figure 4.3). 
 
Salvia africana-lutea: Forty-three components representing 77.5% of the total oil 
composition were characterized.  Monoterpene hydrocarbons (35.6%) and sesquiterpenes 
(36.5%), both oxygen-containing sesquiterpenes and sesquiterpene hydrocarbons, are the 
major identified groups of components with myrcene (11.5%), p-cymene (7.6%), α-pinene 
(6.0%) and cis-β-ocimene (5.4%) being the major components.  They constitute about 39% 
of the total oil identified in this species (Figure 4.3). 
 
Salvia albicaulis: Thirty-eight components were identified in S. albicaulis essential oil and 
account for 80.8% of the total oil.  This oil was characterized by the predominance of 
oxygen-containing sesquiterpenes (47.0%) compared to monoterpenes (29.7%) (Table 4.1).  
Viridiflorol (24.5%), 1,8-cineole (9.4%) and limonene (9.4%) were the most prominent 
components followed by ledol (6.6%) and  β-caryophyllene oxide (5.6%).  All these 
compounds represent 69% of the total oil (Figure 4.3). 
 
Salvia chamelaeagnea: Forty-three components were identified in this species 
representing 95.8% of the total oil composition.  Oxygen-containing monoterpenes and 
oxygen-containing sesquiterpenes represent 42.8% and 18.9% of the identified groups of 
components, respectively.  This oil is characterized by high levels of 1,8-cineole (40.5%) 
followed by α-pinene (10.4%), limonene (9.7%)  and viridiflorol (9.3%) (Table 4.1).  
These four compounds constitute 73% of the total oil of S. chamelaeagnea (Figure 4.3). 
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Figure 4.3 Variation in relative amounts of common and major components of the 
essential oils of eleven indigenous Salvia species: Sac: Salvia africana-caerulea; Sal: S. 
africana-lutea; Sab: S. albicaulis; Sch: S. chamelaeagnea; Sdo: S. dolomitica; Smu: S. 
muirii; Sla: S. lanceolata; Sra: S. radula; Sre: S. repens; Sru: S. runcinata; Sst: S. 
stenophylla. 
 
Salvia dolomitica: Thirty-six components representing 78.6% of the total oil were 
identified in S. dolomitica.  The oil of this species is characterized by a high level of 
oxygen-containing monoterpenes (71.8 %), while the sesquiterpenes represent only 3.6% 
of the identified components.  The major components identified include geraniol (19.6%), 
linalyl acetate (19.6%), linalool (16.6%) and α-terpineol (6.2%) (Table 4.1).  They 
represent 79% of the compounds identified in S. dolomitica oil (Figure 4.3).  In S. 
dolomitica, four compounds amounting 11% of the total oil were detected at RIs 1494,  
1569, 1492 and 1550 but remained unidentified (UI) and were assigned as UA-A, UI-B, 
UI-C and UI-D, respectively.  The mass spectra of these four compounds previously 
detected in species belonging to the family Umbelliferae are shown in Figure 4.4. 
  
Salvia lanceolata:   Forty-three components accounting for 81.1% of the total oil were 
identified.  The oil had a predominance of oxygen-containing sesquiterpenes (47.9%), 
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while the monoterpenes represented only 15.2% of the identified components.  Major 
components were spathulenol (18.3%), β-caryophyllene oxide (14.3%) followed by β-
caryophyllene (5.7%) and ledol (5.2%) (Table 4.1).  The four compounds constitute 54% 
of the total oil of this species (Figure 4.3).  
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Figure 4.4 Mass spectra of the unidentified compounds [RIs 1494 (UI-A), 1569 (UI-B), 
1492 (UI-C) and 1550 (UI-D)] present in Salvia dolomitica oil. 
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Salvia muirii: Thirty-nine components representing 97.5% of the oil were identified and 
this oil was dominated by the monoterpene hydrocarbons (53.0%) and oxygen-containing 
monoterpenes (36.2%) as the major classes of components, while sesquiterpenes 
represented only 8.3% of the identified components (Table 4.1).  The major components of 
this oil include 1,8-cineole (23.2%), α-pinene (22.3%) followed by limonene (11.6%), 
camphor (8.6%), camphene (7.6%) and β-pinene (6.7%).  They represent 82% of the 
identified compounds in S. muirii oil (Figure 4.3). 
 
Salvia radula: As shown in Table 4.1, GC and GC-MS analysis of the oil resulted in the 
identification of only 22 components representing 72.9% of the oil.  The major class of 
components was the oxygen-containing sesquiterpenes (52.6%), while sesquiterpene 
hydrocarbons and monoterpenes represented only 10.2% and 9.1% of the identified 
components, respectively (Table 4.1).  β-Caryophyllene oxide (22.6%) and humulene 
epoxide (12.6%) were the most prominent components followed by isocaryophyllene 
(8.6%), spathulenol (7.7%) and terpineol-4-ol (7.1%).  They represent 80% of the total oil 
(Figure 4.3).   
 
Salvia repens: Analysis of the essential oil resulted in the characterization of thirty-six 
components representing 94.4% of the oil.  Monoterpene hydrocarbons (32.6%) and 
oxygen-containing sesquiterpenes (24.1%) were the major structural groups of compounds 
in this oil.  The oil has a predominance of 1,8-cineole (12.8%), p-cymene (9.5%) and 
limonene (9.4%), followed by β-caryophyllene (8.0 %), camphor (5.3%) and viridiflorol 
(5.3%) (Table 4.1).  They amount to 53% of the total oil (Figure 4.3).   
 
Salvia runcinata: Forty-two components representing 90.0% of the total oil were 
identified and the major structural class of compound was oxygen-containing 
sesquiterpenes (69.3%), while monoterpenes represented only 5.4% of the identified 
components (Table 4.1).  This oil was dominated by α-bisabolol (65.5%) and β-
caryophyllene (10.5%).  These two compounds represent 84% of S. runcinata oil (Figure 
4.3). 
 
Salvia stenophylla: The results of the GC and GC-MS showed that 36 components 
representing 88.0 % of the oil could be identified.  This oil was dominated by monoterpene 
hydrocarbons (41.5%) and oxygen-containing sesquiterpenes (28.4%) with α-bisabolol 
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(26.1%) and δ-3-carene (22.6%) being the most prominent components followed by 
limonene (4.8%) (Table 4.3).  These compounds contribute to 61% of the total oil 
composition (Figure 4.3).  
 
4.4.3 Cluster analysis 
 
The cluster analysis was constructed using the 93 essential oil components identified in the 
11 Salvia species and UI-A, UI-B, UI-C and UI-D and interpreted according to Pestana and 
Gageiro (2000).  Two major clusters (A and B) could be observed (Figure 4.5).  One 
cluster consists of S. dolomitica alone, while the remaining species constitute another 
cluster.  A very high correlation was observed between the essential oil of S. africana-
caerulea and S. lanceolata (Scorr ≈ 0.92) (Figure 4.5).  This strong correlation is based on 
the abundance of spathulenol and β-caryophyllene oxide present in the two plants (Table 
4.1).  
 
Figure 4.5 Cluster analysis of eleven Salvia species constructed using the essential oil 
composition data.  
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A high correlation was obtained between S. chamelaeagnea and S. muirii (Scorr ≈ 0.77) 
(Figure 4.5) due to the presence of α-pinene, 1,8-cineole and limonene in relatively high 
amounts.  A high correlation was also observed between S. runcinata and S. stenophylla 
(Scorr ≈ 0.71) with both containing high amounts of α-bisabolol (Table 4.1).  Moderate 
correlation was observed between S. albicaulis, S. chamelaeagnea, S. muirii and S. repens 
and also between S. radula, S. africana-caerulea and S. lanceolata (Figure 4.5).  S. 
africana-lutea and S. dolomitica have a low correlation with the nine other species as 
indicated by the low correlation coefficient (Scorr < 0.30). 
 
 
4.5 Discussion 
 
This investigation showed variability in yield of essential oils of the species studied with S. 
muirii having the highest yield and S. radula the lowest.  The yield obtained in this study 
was relatively low compared to those reported in literature for other Salvia species.  
Bellomaria et al. (1992) reported the yield of S. pomifera, S. willeana and S. fruticosa to be 
1.3, 2.8 and 5.3%, respectively.  Pitarevic et al. (1984) found that the yield of S. officinalis 
collected at various seasons throughout the year varied from 1.8 to 3.1%.  The difference 
obtained in yield may be explained by the fact that in the current study, the yield was 
expressed based on wet biomass, while in other studies, the dry biomass was used.  
Furthermore, difference in yield varies with soil types, plant part used, climate, season and 
stage of plant development (Putievsky et al., 1986; Bellomaria et al., 1992).  The relatively 
high yield obtained in S. muirii and S. chamelaeagnea may be attributed to high density of 
glandular trichomes as it has been reported that these trichomes are responsible for the 
secretion of the essential oils (Werker et al., 1985; Karousou et al., 1992).  
 
The essential oils are qualitatively and quantitatively heterogeneous (Figure 4.4).  
Constituents of essential oils such as α-pinene, 1,8-cineole, linalool, limonene, myrcene, β-
caryophyllene, spathulenol, β-caryophyllene oxide, viridiflorol, δ-3-carene and α-bisabolol 
were identified in greater amounts (Table 4.1).  Components identified in all the 11 species 
include β-pinene, myrcene, p-cymene, α-terpineol and β-caryophyllene.  Many components 
identified in the current study have been previously identified in non-indigenous Salvia 
species and these include 1,8-cineole, myrcene, β-caryophyllene, borneol, camphene, 
limonene and spathulenol (Pitarevic et al., 1984; Bellomaria et al., 1992; Ahmed et al., 
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1994; Carta et al., 1996; Foray et al., 1999; Kaya et al., 2003).  However, in this study, 
high levels of geraniol and linalyl acetate were detected in S. dolomitica (Table 4.1) in this 
study, which have rarely been identified in exotic Salvia species (Bellomaria et al., 1992; 
Farhat et al., 2001).  It is important to note that α-thujene and β-thujene, which are major 
components of the essential oil of S. offinalis (Pitarevic et al., 1984), were detected in 
relatively low amounts (Table 4.1).  Many factors may explain variation in essential oil 
composition between different species.  In addition to the genetic make up of each species 
and factors listed above which affect the essential oil yield, the mode of harvest and 
isolation procedure may also influence the essential oil composition (Pitarevic et al., 1984; 
Bellomaria et al., 1992).  Ahmed et al. (1994) investigated the essential oil of S. hispanica 
L. collected from three geographical areas and found major variations in their essential oil 
composition.  Brunke and Hammerschmidt (1985) analysed the essential oil of S. 
stenophylla and found that δ-carene (20.0%) and α-bisabolol (29.8%) were the dominant 
components.  In the current study, the two components represent 22.6 and 26.1%, 
respectively (Table 4.1).  Jequier et al. (1980) found that oxygen-containing monoterpenes 
represent 5% of the oil and the sesquiterpene hydrocarbons 35% in S. stenophylla.  The 
amount of oxygen-containing monoterpenes and sesquiterpene hydrocarbons is this 
investigation was 11.4% and 6.7%, respectively (Table 4.1).  
 
There are many components that were identified in one plant but were absent in others 
(Table 4.1 and Figure 4.4) and this confirms the heterogeneity of the oils investigated.  
Based on Cabo et al. (1987) classification, the essential oils of Salvia species can be 
classified into three groups: Group I is composed of species with a predominance of α-
thujene, β-thujene and 1,8-cineole; group II is composed of essential oils rich in linalool 
and linalyl acetate;  and group III comprises species rich in 1,8-cineole and camphor.  The 
oils examined in this study do not fall into any of the groups as described by Cabo et al. 
(1987).  Apparently, these findings display new groups (Table 4.1).   S. runcinata may be a 
potential natural source α-bisabolol since it constitutes more than 65% of the total oil.  
Components of the essential oil present in only one species and absent in others with an 
amount greater than 1% include geraniol (19.6%), linalyl acetate (19.6%), neryl acetate 
(4.0%), geranyl-2-butylether (1.8%), cubenol (1.4%) and  unidentified components (UI-A, 
UI-B, UI-C and UI-D) with 1.4%, 2.8%, 1.4% and 2.8%, respectivel (Table 4.1).  Eight 
components, including the unidentified (UI) UI-A, UI-B, UI-C and UI-D, representing 
55.5% of the total oil, were found only in S. dolomitica and were absent in other species.  
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The presence of these components can explain the very low correlation coefficient found 
between the essential oil of S. dolomitica and the rest of the species (Figure 4.4).  The 
unidentified components of the oils namely UI-A, UI-B, UI-C and UI-D were previously 
detected in species of the family Umbelliferae (Figueiredo, pers comm), but have not yet 
been characterised.  Their presence in S. dolomitica differentiates this species from others 
indigenous Salvia species to date. The oil composition of S. africana-caerulea resembles 
that of S. lanceolata (Table 4.1) and this is supported by the cluster analysis (Figure 4.5).  
Codd (1985) placed S. africana-caerulea, S. africana-lutea, S. chamelaeagnea and S. 
lanceolata within the same group based on morphological characters and SEM 
observations (Chapter 3).   
 
The essential oil of S. chamelaeagnea in this study resembles that of S. muirii as shown by 
the high correlation coefficient found between the two species (Figure 4.5).  On the other 
hand, low similarity was found in essential oil composition of S. africana-lutea and other 
species within the complex.  In the current study a very high correlation was found 
between S. africana-caerulea and S. lanceolata and provides chemotaxonomic support for 
the affinity as described by Codd (1985).   Similarly, S. repens, S. runcinata and S. 
stenophylla were also placed in the same group and a high correlation was found between 
the essential oil of S. runcinata and S. stenophylla (Figure 4.5).  The essential oil 
composition data has provided additional information in order to better understand the the 
chemistry of the investigated species which will in turn help to understand the biological 
activities of the essential oils studied in the next Chapters. 
 
 4.6 Conclusions 
 
• The essential oil yield varied between species, with S. muirii giving the highest 
yield and S. radula the lowest yield. 
• Quantitative and qualitative variations were observed between the essential oils of 
the investigated species.   
• S. runcinata is the only species where one compound (α-bisabolol) represents more 
than 65% of the total oil. 
• A very high correlation was found between the essential oil of S. africana-caerulea 
and S. lanceolata due to their high amount of spathulenol and β-caryophyllene 
oxide. 
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• The correlation between the essential oil of S. dolomitica and the rest of the species 
was very low due to the presence of geraniol, linalyl acetate and four other 
unidentified components. 
• The essential oil data provides chemotaxonomical confirmation previously 
suggested relationships between taxa based on morphological evidence alone. 
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Chapter 5: HPLC-UV-MS Analysis of the Solvent Extracts  
 
Abstract 
 
Salvia species are rich in phenolic compounds which are partly responsible for the various 
biological activities.  High performance liquid chromatography was used to detect caffeic 
acid, carnosic acid, kaempferol, oleanolic acid, rosmarinic acid and ursolic acid in 17 
solvent extracts.  Compounds isolated from S. chamelaeagnea (7-O-methylepirosmanol 
and carnosol) and S. radula (betulafolientriol oxide and salvigenin) were also included to 
verify their presence in other Salvia species.  Betulafolientriol oxide was detected in all the 
investigated species.  Rosmarinic acid, carnosic acid, carnosol and oleanolic acid/ursolic 
acid were detected in relatively high levels.  The level of rosmarinic acid (percentage area) 
ranged from 3.4 (S. radula) to 52.8% (S. muirii) and was absent in S. verbenaca.  S. 
garipensis and S. radula were the only species which lacked oleanolic acid and ursolic 
acid.  Kaempferol, a compound commonly found in exotic Salvia species was not detected 
in any of the species studied.  The solvent extracts also contained other flavonoids (e.g. 
flavones).   
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5.1 Introduction 
 
Salvia is an important genus widely cultivated and used in flavouring and is a popular 
ingredient folk medicines.  They are used in traditional medicine in many parts of the 
world for the treatment of various diseases (Liu et al., 1992).  The genus has attracted great 
interest, and has been the subject of numerous phytochemical studies (Lu and Foo, 2002).  
It is a rich source of polyphenols, with an excess of 160 polyphenols having been 
identified, of which many are unique to the genus (Lu and Foo, 2002).   
 
Many Salvia species have received interest due to their ability to accumulate high levels of 
active compounds, notably flavonoids (Tanaka et al., 1989; Ulubelen et al., 2001).  These 
classes of compounds are known to exhibit a range of biological activities including; 
anticancer, antibacterial, anti-oxidant and anti-inflammatory properties (Ulubelen et al., 
2001, Cuvelier et al., 1994; Lu and Foo, 2002; Kobayashi et al., 2002).  Many Lamiaceae 
extracts are of commercial interest to the food industry as a source of natural anti-oxidants 
(Thorsen and Hildebrandt, 2003).  The quality of anti-oxidant and the price of 
commercially available species, such as Rosmarinus officinalis extracts, are highly 
correlated with the total phenolic compounds, for example the levels of carnosic acid, 
rosmarinic acid and caffeic acid (Thorsen and Hildebrandt, 2003).  A large number of 
polyphenolic compounds are constructed from the caffeic acid building block via a variety 
of condensation reactions (Lu and Foo, 2002).  As Salvia species are also rich in phenolic 
compounds, accurate identification is of great importance for commercial development.  
The identification of these compounds will also help to understand the pharmacological 
properties of species studied. 
 
High performance liquid chromatography (HPLC) of phenolic and triterpenoid compounds 
is a widely used methodology designed to separate, quantify, identify and analyse 
components in a chemical mixture (Areias et al., 2001).   
 
The objectives of this study were to: 
(i) determine the presence of some phenolic and triterpenoid compounds, 
previously identified in exotic Salvia species (caffeic acid, carnosic acid, 
kaempferol, oleanolic acid, rosmarinic acid and ursolic acid) in the solvent 
extracts of indigenous Salvia species, 
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(ii) confirm the presence of compounds isolated from S. chamelaeagnea (7-O-
methylepirosmanol and carnosol) and S. radula (betulafolientriol oxide and 
salvigenin) in the other species, and 
(iii) determine among these compounds those which  are the most common in 
indigenous Salvia species. 
 
5.2 Materials and methods 
 
5.2.1 Chemicals, reagents and standards 
 
Analytical grade acetonitrile, methanol and chloroform were purchased from Rochelle 
Chemicals, while standards of caffeic acid, carnosic acid, kaempferol, oleanolic acid, 
rosmarinic acid and ursolic acid were obtained from Sigma®.  Carnosol and 7-O-
methylepirosmanol were isolated from S. chamelaeagnea (Chapter 9), while 
betulafolientriol oxide and salvigenin [5-hydroxy-6,7-dimethoxy-2-(4-methoxyphenyl)-
4H-1-benzopyran-4-one] were isolated from S. radula (Chapter 8).   
 
5.2.2 Preparation of samples 
 
The methanol:chloroform (1:1) extracts were prepared as described in  Section 2.3.2.  The 
17 samples and standards for the analysis were prepared at a concentration of 50 mg/ml in 
methanol.  They were filtered using Whatman® No 1 filter paper, stored in vials at 4 ºC 
until analysed. 
 
5.2.3 High performance liquid chromatography  
 
The detection and identification of compounds were performed using a Waters 2695 HPLC 
system equipped with both a 2996 photodiode array (PDA) detector and a Thermabeam 
electron impact (EI) mass selective detector (TMD).  The TMD detector was operated in 
EI mode with the ionizer at 70 eV (fixed) with a gain of 10 and scanning mass range of 50-
550 amu.  Analysis was performed on a Phenomenex Aqua C18 column (250 x 2.1 mm, 5 
µm) thermostated at 40 ºC.  The flow rate of the HPLC was 0.2 ml/min and the gas flow 
through the nebulizer 30 l/h.  The nebulizer temperature was 80 ºC, the expansion region 
90 ºC and the source temperature 225 ºC.  The TMD was operated in positive ion mode 
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with no flow splitting, thereby utilizing the full HPLC eluent at a flow rate of 0.2 ml/min.  
The mobile phase started with 10% acetonitrile, 90% water containing 10 mM formic acid.  
The solvent ratio was changed through a linear gradient to 90% acetonitrile, 10% water 
(with 10 mM formic acid) at 40 minutes.  This ratio was maintained for 10 minutes where 
after the solvent ratio was changed back to the initial conditions.  Standards of caffeic acid, 
carnosic acid, kaempferol, oleanolic acid, rosmarinic acid and ursolic acid (10 µl, 50 
mg/ml) and isolated compounds (50 mg/ml) from S. chamelaeagnea (carnosol and 7-O-
methyl-epi-rosmanol) and S. radula (betulafolientriol oxide and salvigenin) were injected 
separately and co-injected with samples (10 µl) in order to identify and confirm their 
presence in the extracts.  
 
5.3 Data analysis 
 
Comparison of the MS spectra of standards and isolated compounds after fragmentation of 
the parent ion together with retention time (Rt) and ultra-violet (UV) spectra were used to 
confirm the presence/absence of these compounds in the solvent extracts using the 
Empower® software.  Flavonoids were tentatively assigned by comparing the UV 
absorption spectra of different flavonoids (Markham, 1982).  The area (%) was calculated 
from the integrated peak area.   
 
5.4 Results 
 
5.4.1 Identification of compounds 
 
The typical UV spectra (Figure 5.1) and the chromatographic data (Table 5.1) obtained for 
the standards and isolated compounds are shown below.  
 
The HPLC analysis revealed the presence of various compounds in Salvia species (Table 
5.2).  Betulafolientriol oxide, a compound isolated from S. radula was the only compound 
identified in all 17 species at relatively low levels (Table 5.2).  Rosmarinic acid, carnosic 
acid, carnosol and ursolic acid were present in the majority of the extracts in relatively high 
levels.  The percentage area of rosmarinic acid ranged from 3.41 (S. radula) to 52.82% (S. 
muirii) (Table 5.2).  S. albicaulis (35.23%), S. runcinata (38.40%) and S. muirii (52.82%) 
were particularly rich in rosmarinic acid (Table 5.2) and S. verbenaca was the only species 
 66
in which rosmarinic acid was not detected.  Carnosol and/or carnosic acid was/were 
abundant in S. aurita, S. chamelaeagnea, S. namaensis and S. stenophylla (area > 20%).  
Salvigenin (23.76%) and oleanolic acid/ursolic acid (19.85%) were abundant in S. 
disermas (Table 5.2).  
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Figure 5.1 UV spectra of standards and isolated compounds from S. radula and S. 
chamelaeagnea. The UV spectra of ursolic acid, oleanolic acid and betulafolientriol oxide 
are not reported because they are not good chromophores. 
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Table 5.1 Chromatographic data obtained for the various standards according to their 
retention times. 
Number Standards/Isolated compounds Rt (min) 
Absorption maxima  
(λmax ) in nm 
 
1 Caffeic acid 15.41 217, 239, 292, 328 
2 Rosmarinic acid 23.25 204, 328 
3 Kaempferol 30.38 266, 365 
4 7-O-Methylepirosmanol 34.39 240, 290, 373, 378 
5 Salvigenin 34.60 216, 277, 330 
6 Carnosol 34.85 284, 323, 373 
7 Carnosic acid 37.03 232, 285 
8 Oleanolic acid 41.11 - 
9 Ursolic acid 41.09 - 
10 Betulafolientriol oxide 43.28 - 
-: poor UV absorption 
 
The only other species in which 7-O-methylepirosmanol was detected was S. namaensis.  
Kaempferol reported in exotic Salvia species was absent in all the 17 Salvia species 
investigated (Table 5.2). 
 
5.4.2 Detection of other flavonoids in the solvent extracts 
 
The results of the HPLC-UV analyses of the 17 species examined showed several 
compounds exhibiting UV spectra typical of flavonoids (Markham, 1982).  The current 
investigation focused mostly on flavones.  Approximately 70% of the plants studied 
contained flavones based on UV spectra only (Table 5.3).  In S. disermas, various flavones 
were recorded, while a few were noted in S. africana-caerulea, S. aurita, S. 
chamelaeagnea, S. dolomitica, S. garipensis, S. lanceolata, S. namaensis, S. radula, S. 
repens, S. runcinata, S. schlechteri and S. stenophylla (Table 5.3).  In five species namely; 
S. africana-lutea, S. albicaulis, S. lanceolata, S. muirii and S. verbenaca, no flavones other 
than those mentioned in Table 5.2 were detected (Table 5.3).  The flavone at a retention 
time of 20.76 min was found in S. chamelaeagnea, S. dolomitica and S. garipensis (Table 
5.3).  The HPLC chromatograms of all the investigated species are presented in Figures 
5.2.   
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Table 5.2 Area (%) and identification of standards and isolated compounds in the solvent extracts of 17 indigenous Salvia species.  
 
Species 
Caffeic 
acid (1) 
Rosmarinic 
 acid (2) 
Kaemp-
ferol(3) 
7-O-Methyl- 
epirosmanol 
(4) 
Salvigenin 
(5) 
Carnosol 
(6) 
Carnosic  
acid (7) 
Oleanolic/ 
Ursolic acid 
(8 or 9) 
Betulafolien-triol 
oxide (10) 
S. africana-caerulea 5.29  22.90 - - - - 11.55 3.21 0.92 
S. africana-lutea - 23.82 - - - - 14.22 4.49 0.75 
S. albicaulis 0.58  35.23 - - - 1.10 - 10.23 1.26 
S. aurita 0.84  24.44 - - - 27.61 6.37 0.10 0.68 
S. chamelaeagnea 0.40  26.36 - 0.87 - 22.48 27.25 0.49 0.52 
S. disermas 0.25 3.62 - - 23.76 - - 19.85 2.06 
S. dolomitica 0.75 14.05 - - - - - 0.10 4.53 
S. garipensis - 29.22 - - 7.38 - - - 2.91 
S. lanceolata 3.29 10.67 - - - 2.05 - 14.28 3.83 
S. muirii 0.87  52.82 - - 0.10 4.83 11.80 0.05 1.41 
S. namaensis 0.92  15.60 - 1.19 - 30.97 20.25 0.10 1.00 
S. radula - 3.41 - - 8.52 - - - 1.94 
S. repens 0.47 23.66 - - - 13.40 13.01 0.10 2.56 
S. runcinata 0.34 38.40 - - 3.55 - 3.36 0.20 1.05 
S. schlechteri 0.33 26.58 - - - 10.88 10.38 0.10 0.80 
S. stenophylla - 22.17 - - - 23.60 25.17 0.10 1.80 
S. verbenaca - - - - 1.80 - - 2.19 2.76 
                   - : not detected 
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  Table 5.3 Compounds exhibiting a typical flavonoid spectrum in the solvent extracts of 17 Salvia species. 
 
Retention 
time 
UVλmax 
(nm) 
Sac Sal Sab Sau Sch Sdi Sdo Sga Sla Smu Sna Sra Sre Sru Ssc Sst Sve 
13.57 238, 328    +       +  +     
14.98 242, 327      +            
15.41 236, 327              +  +  
16.54 234, 327           +     +  
17.56 242, 329             +   +  
19.60 253, 348     +  +           
20.61 252, 341      +      +      
20.73 251, 269, 339               +   
20.76 256, 345     +  + +          
20.86 269, 335 +                 
22.70 250, 341      +         +   
23.63 252, 347        +          
27.83 269, 334     +  +           
28.55 265, 341      + +           
30.33 288, 329 +                 
30.64 252, 341      + +           
31.48 269, 329      +         +   
33.12 269, 337      +            
41.72 272, 324    +  +            
42.48 272, 325      +            
50.46 272, 326      +            
         Sac: S. africana-caerulea, Sal: S. africana-lutea, Aab: S. albicaulis, Sau: S. aurita, Sch: S. chamelaeagnea, Sdi: S. disermas, Sdo: S. dolomitica, Sga: S. garipensis,  
        Sla: S.  lanceolata, Smu: S. muirii, Sna: S. namaensis, Sra: S. radula, Sre: S. repens, Sru: S. runcinata, Ssc: S. schlechteri, Sst: S. stenophylla, Sve: S. verbenaca. 
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Figure 5.2 HPLC chromatograms of South African Salvia species. Rosmarinic acid (2), 
carnosol (6), carnosic acid (7), oleanolic acid (8) and ursolic acid (9).   
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Figure 5.2 Contd. HPLC chromatograms of South African Salvia species.  Rosmarinic 
acid (2); carnosol (6) and carnosic acid (7).   
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5.5 Discussion 
  
Phenolic compounds are widely distributed in Salvia species (Adzet et al., 1987; Ulubelen 
and Tuzlaci, 1990) and the flavonoids are mostly present as flavones, flavonols and their 
glycosides (Lu and Foo, 2002).  Flavones were identified in 12 species (Table 5.3), while 
in five species namely; S. africana-lutea, S. albicaulis, S. lanceolata, S. muirii and S. 
verbenaca, no flavones were detected (Table 5.3).   
 
The majority of flavonoids found in exotic  Salvia species are flavones of the apigenin and 
luteolin type and their corresponding hydroxylated derivatives, while the flavonols are 
mostly those of kaempferol and quercetin (Lu and Foo, 2002).  However, kaempferol was 
not detected in any of the investigated species (Table 5.2).   
 
The majority of the phenolic acids in Salvia species are exclusively those of caffeic acid 
derivatives.  Caffeic acid plays a central role in the biochemistry of Lamiaceae and occurs 
predominantly in the dimer form as rosmarinic acid (Gerhardt and Schroeter, 1983).  In 
many Salvia species, caffeic acid is the building block of a variety of plant metabolites, 
ranging from the simple monomers to multiple condensation products that give rise to a 
variety of oligomers (Lu and Foo, 2002).  The trimers and tetramers are also interesting 
from a therapeutic point of view as they have demonstrated various biological activities 
such as anti-oxidant, antimicrobial and anticancer activities (Lu and Foo, 2002).  The 
monomers that are frequently present in Salvia species are represented by caffeic acid 
(Qian and Li, 1992) and other monomeric derivatives including ferulic acid (Cuvelier et 
al., 1996) and isoferulic acid (Ai and Li, 1992).  The caffeic acid was present in 70% of the 
solvent extracts investigated (Table 5.2).  Caffeic acid was also identified in a dimer form 
(rosmarinic acid) in 94% of the species investigated. 
 
Before the chemical structure of rosmarinic acid was elucidated, rosmarinic acid and 
similar compounds have been known as “Labiatengerbstoffe”, a type of tannin known from 
species of the Lamiaceae (Petersen and Simmonds, 2003).  Rosmarinic acid occurs 
throughout the Boraginaceae whereas within the Lamiaceae it is restricted to the sub-
family Nepetoideae (Janicsák et al., 1999).  Rosmarinic acid is the most abundant caffeic 
dimer in Salvia species (Ai and Li, 1988; Cuvelier et al., 1994; Lu and Foo, 1999) and has 
been reported to be the major phenolic compound of Salvia samples (Cuvelier et al., 1996).  
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This was confirmed by the results obtained in this study.  Rosmarinic acid was detected in 
nerly all the species srudied and S. verbenaca was the only species lacking this compound 
(Table 5.2).  S. albicaulis (35.23%), S. runcinata (38.40%) and S. muirii (52.82%) 
contained high levels of rosmarinic acid (Table 5.2).  Phenolic and triterpenoid compounds 
reported here have certainly contributed to various biological activities of the solvent 
extracts reported in the next Chapters.  Several studies have reported on the detection and 
quantification of rosmarinic acid in various Salvia preparations (Janicsák and Máthé, 1997, 
Yaun et al., 1998; Janicsák et al., 1999; Areias et al., 2000).  The variation in levels of 
caffeic acid and rosmarinic acid in the same plant has been shown.  Janicsák et al. (1999) 
demonstrated that concentrations of caffeic acid were always much lower than those of 
rosmarinic acid.  In all the species studied where the two compounds were detected 
together, the same pattern was observed (Table 5.2).  All the compounds detected in 
southern African species investigated have previously been identified in exotic Salvia 
species (Cuvelier et al., 1996; Baricevic et al., 2001; Liu, 2005).  As phenolic and 
triterpenoid compounds are known to exhibit a range of biological activities, this prompted 
an investigation on biological activities of the solvent extracts in the subsequent Chapters. 
 
5.6 Conclusions 
 
• Salvia species are a rich source of polyphenolic flavonoids and phenolic acids, 
notably rosmarinic acid, carnosic acid, caffeic acid, carnosol and ursolic acid. 
• Betulafolientriol oxide, a compound isolated from S. radula was detected in low 
amount in all the species studied and if found in species at various locations, it may 
be used as taxonomic marker for indigenous species. 
• High level of rosmarinic acid was recorded in the majority of the species studied 
particularly in S. muirii and S. runcinata while it was absent in S. verbenaca. 
• Salvia disermas has high levels of salvigenin and oleanolic/ursolic acid. 
• Kaempferol, a compound commonly detected in exotic Salvia species was absent in 
all the species studied. 
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Chapter 6:  Anti-Oxidant Activity and Total Phenolic Content  
 
Abstract 
 
The anti-oxidant activity of 17 solvent extracts and 11 essential oils of Salvia species were 
evaluated. Anti-oxidant activity was measured using the 2,2′-azino-bis-(3-
ethylbenzothiazoline-6-sulfonic acid) (ABTS) and the 2,2,-diphenyl-1-picrylhydrazyl 
(DPPH) scavenging assays and compared to the results with the controls obtained Trolox® 
and vitamin C, respectively.  Nearly all the solvent extracts displayed anti-oxidant activity 
with IC50 values ranging from 1.61 to 74.50 μg/ml using the DPPH· radical, while the IC50 
values ranged from 11.88 to 69.26 μg/ml with the ABTS·+ radical.  The solvent extract of 
S. schlechteri, with an IC50 value of 1.61 μg/ml, was three times more active than the 
reference compound, vitamin C (IC50 value: 4.72 μg/ml).  All the essential oils displayed 
poor activity with all the IC50 values being greater than 100 μg/ml using both the DPPH· 
and ABTS·+ radicals.  Total phenolic content based on gallic acid equivalents (GAE) 
confirmed the presence of total soluble phenolics in the various extracts from 45 to 211 mg 
of GAE dry sample and showed strong association (r2 = 0.90) with anti-oxidant activity 
(DPPH assay).   
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6.1 Introduction 
 
Recent developments in biomedical science emphasise the involvement of free radicals in 
many diseases.  There is increasing evidence to suggest that many degenerative diseases 
such as brain dysfunction, cancer, heart disease and immune system decline could be the 
result of cellular damage caused by free radicals and that anti-oxidants may play an 
important role in disease prevention (Aruoma, 1998).  Anti-oxidants are compounds that 
inhibit or delay the oxidation of other molecules by inhibiting the initiation or propagation 
of oxidizing chain reactions.  The anti-oxidant activity of natural substances is based on 
their ability to donate hydrogen atoms to free radicals.  Many phenolic compounds exhibit 
a wide range of biological effects including antibacterial and anti-inflammatory activity 
(Cook and Samman, 1996).  Studies have also shown that phenolic compounds are potent 
scavengers of free radicals and as such, are potentially useful in the prevention of a number 
of diseases (Zainol et al., 2003).  Plants are a potential source of natural anti-oxidants.   
 
Plants have played a significant role in the development of new drugs and in many 
developing countries attention has been paid to exploring natural substances as substitutes 
for synthetic compounds.  In recent years, phytochemicals have appeared in the market and 
are generally regarded as safe (Wanasundara and Shahidi, 1998).  The commonly used 
anti-oxidants, butylated hydroxyanisol and butylated hydroxytolune are synthetic 
chemicals and the possible toxicity of these anti-oxidants has resulted in their reduced 
usage (Ito et al., 1985).  Due to health concerns, natural anti-oxidants have been 
extensively employed in recent years (Yen et al., 2003).   
 
The reported high anti-oxidant activity and use of Salvia in local traditional medicine 
prompted more extensive investigation in order to provide a better understanding of 
medicinal value of indigenous species.  A literature survey revealed no reference to 
previous work on the anti-oxidant activity of Salvia species found in South Africa.  Most 
studies have focused on S. officinalis (garden sage) because of its well-known and widely 
documented anti-oxidant properties (Tepe et al., 2006).   
 
 
The objectives of this study were to: 
(i) evaluate the anti-oxidant activity of South African Salvia species using the  
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  ABTS·+ and DPPH· scavenging assays,  
(ii)  determine the total phenolic content present in each species, and 
(iii)  correlate the anti-oxidant activity to the total phenolic content. 
 
6.2 Materials and methods 
 
6.2.1 Reagents, chemicals and standards 
 
Dimethyl sulfoxide (DMSO) and HPLC grade methanol were purchased from Rochelle 
Chemicals.  The 2,2-diphenyl-1-picrylhydrazyl (DPPH) and potassium persulfate (K2S2O8) 
were purchased from Fluka, while the 2,2´-azino-bis (3-ethylbenzothiazoline-6-sufonic 
acid) (ABTS), 3,4,5-trihydroxybenzoic acid commercially known as gallic acid and the 
standard 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox®) were obtained 
from Sigma®.  Sodium hydroxide (NaOH) and vitamin C were obtained from Saarchem.  
Potassium dihydrogen phosphate (KH2PO4), Folin-Ciocalteu phenol reagent, HPLC grade 
ethanol and anhydrous sodium carbonate were purchased from Merck.  Double distilled 
Millipore® (0.22 µm) water was used throughout. 
 
6.2.2 Evaluation of the anti-oxidant activity 
 
The anti-oxidant activity of volatile (essential oils) and non-volatile (solvent extracts) 
samples were evaluated using both the ABTS  and the DPPH assays.  
 
6.2.2.1 The ABTS method 
The anti-oxidant activity was determined using the method described by Villaño et al. 
(2004) with slight modifications. 
 
(i) Preparation of the ABTS·+ radical and stock solution of test samples 
The ABTS solution was prepared at a concentration of 7 mM and the potassium persulfate 
solution at a concentration of 140 mM with double distilled water.  The radical cation 
ABTS·+ was chemically generated with K2S2O8 and the ABTS solution.  Hence 88 µl of 
the K2S2O8 solution was added to 5 ml of ABTS solution, mixed well, covered with foil 
and kept at room temperature for 12-16 hours before used in the experiment.  The ABTS·+ 
radical (stable for 2-3 days) was diluted with cold ethanol and maintained on ice 
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throughout the experiment.  The experiment was performed only if the absorbance of the 
radical was 0.70 ± 0.02 at 734 nm.  Stock solutions of test samples were prepared at 
starting concentrations of 10 mg/ml in DMSO (extracts and essential oils).  
 
(ii) The ABTS assay 
From the stock solution of solvent extracts and essential oils, seven two-fold dilutions were 
prepared with DMSO.  To a sample volume of 50 µl of each concentration, in a cuvette, a 
volume of 1 ml of the ABTS·+ radical was added and kept at 30 °C in a water bath for four 
minutes before the absorbance was recorded at 734 nm.  The final concentrations ranged 
from 0.05 to 238.10 µg/ml.  Each sample was tested in duplicate.  The principle of the 
reaction is that the anti-oxidant compounds react with the ABTS·+ radical.  During the 
reaction, the solution becomes clear or decreases in colour intensity, thus decreasing the 
absorbance.  The mechanism of reaction of the ABTS·+ radical is shown below (Figure 
6.1).  The percentage of decolourisation was calculated from (Eq. 6.1) using a programme 
written on Microsoft Excel®.  The colour interference of the test sample was not taken into 
consideration because there was very little variation. 
 
% Decolourisation = 100 x (1 - Abs test sample)                                                       (Eq 6.1) 
                                          Abs control                                      
Where: Abs = absorbance at 734 nm 
 
6.2.2.2 The DPPH method 
(i) Preparation of the DPPH· radical and stock solution of test samples 
The DPPH· radical (96 µM) was prepared in HPLC grade methanol.  The radical, protected 
from light and stored at 4 °C (stable for approximately a week), has an absorbance of 0.38 
± 0.03 at 550 nm.  The stock solution of the test sample (essential oils and solvent extracts) 
was prepared at a concentration of 10 mg/ml in DMSO. 
 
(ii) The DPPH assay 
The DPPH· radical is a stable radical that can readily undergo reduction by an anti-oxidant 
(Lu and Foo, 2001).  Because of the ease and convenience of this reaction, it now has 
widespread use in the free radical-scavenging activity assessment (Sanchez-Moreno et al., 
1998; Lu and Foo, 2001; Mambro et al., 2003).  A DPPH assay (Mambro et al., 2003; 
Lourens et al., 2004) was also employed to investigate the anti-oxidant activity of different 
plant extracts and essential oils. 
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Figure 6.1 Mechanism of action of the ABTS·+ radical (Dorman et al., 2000). 
 
 From the stock solution of the test sample, a 1:20 dilution was made with DMSO followed 
by five consecutive two-fold dilutions.  For each concentration, 50 μl of the test sample 
was plated out in triplicate in a 96 well-plate with the appropriate control for the test 
sample (in order to compensate for the colour interference of the test sample).  For the 
DPPH and methanol controls, 50 μl of DMSO was added into the wells.  A volume of 200 
μl of DPPH solution was added to the test samples (including the DPPH control wells with 
only DMSO), while 200 μl of HPLC grade methanol was added to the methanol control 
wells including the methanol control wells with only DMSO).  The final concentrations of 
the test samples in the wells ranged from 3.13 to 100 μg/ml.  However, due to their high 
activity, 12 dilutions were made for the reference compound as well as for S. schlechteri.  
The plate was then shaken at 960 rpm for 2 minutes in a microtitre plate reader 
(Labsystems Multiskan RC connected to a computer equipped with Genesis® version 3.03 
software) and incubated in the dark, at room temperature, for 30 minutes.  The principle of 
the method is that anti-oxidant compounds donate electron(s) to DPPH· (Figure 6.2 and 
6.3) resulting in decolourisation that is stoichiometric with respect to the electrons captured 
by DPPH (Hristea et al., 2002). 
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The absorbance was read after incubation using a spectrophotometer (Labsystems 
Multiskan RC) equipped with Genesis® version 3.03 software at a single wavelength of 
550 nm and the percentage of decolourisation was determined using a simple programme 
written in Microsoft Excel® (Eq. 6.2).  
 
% Decolourisation = 100 x (Abs control - (Avg test Abs + Avg Abs methanol)      (Eq. 6.2)                        
                                                             Abs control   
Where: Abs = absorbance 
Avg = average 
Abs control = Average absorbance DPPH  – Average absorbance methanol 
Avg test Abs = Average absorbance obtained in the wells containing DPPH and test 
sample 
Avg Abs methanol = Average absorbance obtained in the wells containing 
methanol and test sample (no DPPH) 
 
 
  
 
 
 
 
 
 
 
 
 
Figure 6.2 Mechanism of reaction of the DPPH· radical (Brand-Williams et al., 1995):  
((FlOH: flavonoid which can donate H2; FlO: flavonoid which has donated H2 to the 
DPPH· radical). 
DPPH (purple colour) N N
N O2 
NO2
O 2N 
.
+ FlOH
O 2N NO 2 
NO2 
NN
H
+
FlO.
DPPH (reduced to yellow due to the 
presence of anti-oxidant compounds) 
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Figure 6.3 Microtitre plate showing the decolourisation of the DPPH solution in the 
presence of anti-oxidant compounds.  HC: high concentrations of test compound with 
control; LC: low concentration of test compound with control, first and last row are used 
for DPPH and methanol controls. 
 
6.2.2.3 Qualitative determination of the anti-oxidant activity of the solvent extracts 
The anti-oxidant activity of the solvent extracts was also evaluated using a TLC method.  
A 3 µl sample (5 mg/ml in methanol) was spotted on two separate TLC plates (Alugram® 
Sil G/UV254, 0.200 mm)  and eluted with ethyl acetate:toluene:acetic acid (10:5:0.01).  One 
of the TLC plates was then sprayed with 4% DPPH· radical and another sprayed with the 
ABTS·+ radical (prepared with 7 mM ABTS solution and 140 mM K2S2O8 in a ratio 3:1).   
 
6.2.3 Determination of total phenolic content 
 
6.2.3.1 Preparation of sodium carbonate and Folin-Ciocalteu reagent 
Anhydrous sodium carbonate was prepared at a concentration of 75 g/l.  The solution was 
stirred and heated until the sodium carbonate was completely dissolved before the solution 
was filtered using a Whatman® No 1 paper filter.  The Folin-Ciocalteu stock solution was 
prepared at a concentration of 0.1% (v/v) with double distilled water. 
 
6.2.3.2 Preparation of standard and test samples 
Gallic acid was used as the standard to quantify the phenolic content in the test samples.  
The stock solution and subsequent dilutions (concentration ranged from 10 to 250 mg/ml) 
HC 
LC 
Decolourisation of 
sample extract due 
 to anti-oxidant 
compounds 
LC 
Sample plated 
out in triplicate 
(test sample 
and control) 
DPPH+DMSO Methanol+DMSO 
HC 
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were prepared with DMSO.  The test samples (4 mg) were dissolved in 4 ml of DMSO and 
filtered through Whatman® No 1 filter paper.  
 
6.2.3.3 Method for determining total phenolic content 
The total phenolic content of the solvent extracts was determined by the method using 
Folin-Ciocalteu and gallic acid as standards (Slinkard and Singleton, 1977; Chandler and 
Dodds, 1983).  A 2 ml volume test sample was mixed with 10 ml of Folin-Ciocalteu 
reagent followed by the addition of 8 ml of anhydrous sodium carbonate.  After incubation 
at room temperature in the dark for 2 hours, the absorbance of the reaction mixture was 
read twice at 765 nm against a sample containing only DMSO, using a double beam 
spectrophotometer (Hitachi).  
 
6.3 Data analysis 
 
For both the ABTS and DPPH assays, the IC50 values (concentration at which 50% of 
decolourisation is obtained) were determined from the log sigmoid-dose response curves 
generated by the Enzfitter® version 1.05 software (Figure 6.4).  Gallic acid was used as a 
standard to produce the calibration curve for total phenolic content (Figure 6.5).  
 
-2 -1 0 1 2
20
40
60
80
100
S. schlechteri
S. chamelaeagnea
S. radula
S. africana-caerulea
S. lanceolata
log [Salvia extract] μg/ml
%
 D
ec
ol
ou
ri
sa
ti
on
 
Figure 6.4 Free radical scavenging activity of five Salvia species against the DPPH·. 
 82
0 50 100 150 200 250 300
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0 Y = 0.0119 X + 0.0868 r2 = 0.990
Concentration of Gallic acid (mg/ml)
A
bs
or
ba
nc
e 
at
 7
34
 n
m
 
Figure 6.5 Calibration curve of gallic acid used to estimate the total phenolic content in 
solvent extracts, plotted with a 95% confidence interval.  
 
To determine the total phenolic content, the mean of two readings was recorded and the 
quantification expressed in mg/g of gallic acid equivalent dry sample (mg/g of GAE).  The 
correlation between the anti-oxidant activity and total phenolic content was determined 
using the linear regression equation.  Trolox® and vitamin C were used as standard anti-
oxidant compounds against the ABTS and DPPH methods, respectively.  All results of the 
anti-oxidant activity were obtained from three independent experiments and given as mean 
± standard deviation (s.d.).  Experimental data were analyzed using the Student t-tests.  
with Statistica version 5.0 and Prism® version 3.0 software.  Throughout the analysis, P < 
0.05 was considered significant.   
 
6.4 Results 
 
6.4.1 Qualitative evaluation of the anti-oxidant activity of the solvent extracts 
 
The qualitative analysis of the solvent extracts showed that similar compounds are 
responsible for the anti-oxidant activity when the ABTS·+ or the DPPH· radicals were used 
(Figure 6.6).  Anti-oxidant compounds are indicated by the white spots on the green 
background (ABTS·+ radical) or purple background (DPPH· radical).  The two TLC plates 
also showed that the anti-oxidant compounds can be polar or less polar.  However, the 
majority of the white spots have relatively low Rf values implying that the anti-oxidant 
compounds were mostly polar.  
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Figure 6.6 Qualitative determination of the anti-oxidant activity of the solvent extracts: 
(A): ABTS·+ radical and (B) DPPH· radical: Sac: S. africana-caerulea, Sal: S. africana-
lutea, Aab: S. albicaulis, Sau: S. aurita, Sch: S. chamelaeagnea, Sdi: S. disermas, Sdo: S. 
dolomitica, Sga: S. garipensis, Sla: S.  lanceolata, Tro: Trolox®, Vit: Vitamin C, Smu: S. 
muirii, Sna: S. namaensis, Sra: S. radula, Sre: S. repens, Sru: S. runcinata, Ssc: S. 
schlechteri, Sst: S. stenophylla, Sve: S. verbenaca. 
 
6.4.2 The quantitative determination of the anti-oxidant activity 
 
Several solvent extracts displayed potent activity against both the ABTS·+ and the DPPH· 
radicals (Table 6.1), while all the essential oils were poorly active and were excluded from 
Table 6.1.  The IC50 values ranged from 11.88 ± 1.52 to 69.26 ± 3.22 μg/ml and from 1.61 
± 0.03 to 74.15 ± 2.85 μg/ml against the ABTS and DPPH assays, respectively.   
 
A 
B 
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Table 6.1 The anti-oxidant activity of solvent extracts determined by the ABTS and DPPH 
assays (mean ± s.d., n = 3) and the total phenol content.  
 
ABTS assay DPPH assay 
Species/Controls 
IC50 values in µg/ml 
Total phenol content 
(mg/g of GAE) 
S. africana-caerulea 39.72 ± 1.76 33.40 ± 3.73 115.06 
S. africana-lutea 30.35 ± 2.97 47.58 ± 2.61 67.83 
S. albicaulis 24.22 ± 1.28 19.85 ± 1.01 100.27 
S. aurita 22.94 ± 2.57 16.59 ± 0.22 119.09 
S. chamelaeagnea* 14.61 ± 2.25 12.75 ± 1.04 211.78 
S. disermas 33.05 ± 2.86 55.07 ± 4.01 69.01 
S. dolomitica 49.94 ± 1.17 > 100 53.04 
S. garipensis 41.66 ± 2.71 74.15 ± 2.85 45.56 
S. lanceolata 25.63 ± 0.66 68.09 ± 3.69 54.22 
S. muirii* 11.88 ± 1.52 11.06 ± 0.52 186.15 
S. namaensis 16.57 ± 2.56 10.63 ± 0.75 190.5 
S. radula 69.26 ± 3.22 > 100 55.73 
S. repens 18.24 ± 1.87 15.47 ± 1.75 178.17 
S. runcinata* 19.42 ± 2.78 19.34 ± 0.61 149.34 
S. schlechteri 17.51 ± 2.05 1.61 ± 0.03 209.18 
S. stenophylla 20.84 ± 0.86 14.92 ± 0.93 161.28 
S. verbenaca 37.47 ± 1.77 45.83 ± 2.78 73.29 
Trolox® 2.43 ± 0.07 2.51 ± 0.41 ─ 
Vitamin C ─ 4.72 ± 0.14 ─ 
* denotes no significant difference between the ABTS and the DPPH methods 
─ not determined  
 
The solvent extract of S. schlechteri displayed the most favorable activity against the 
DPPH· radical, which was statistically more active than the reference compound, vitamin C 
(P < 0.05), while the extract of  S. muirii was the most active against the ABTS·+ radical.  
The extracts of S. radula and S. dolomitica, which were poorly active (IC50 values > 100 
µg/ml) using the DPPH· radical, were moderately active against the ABTS·+ radical (IC50 
values: 69.26 ± 3.22 and 49.94 ± 1.17 µg/ml, respectively) (Figure 6.7; Table 6.1).  
Although the two methods measure the percentage decolourisation of two radicals, there is 
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a statistically significant difference in IC50 values generated by the ABTS and the DPPH 
methods (Figure 6.7) (Table 6.1).  The ABTS method in general gave lower IC50 values 
compared to the DPPH method (Table 6.1).  However, the Student t-tests did not show 
significant differences between the IC50 values of S. chamelaeagnea, S. muirii and S. 
runcinata (P > 0.05).   
 
None of the 11 essential oils tested displayed promising anti-oxidant activity with either 
the ABTS or DPPH methods.  All the IC50 values obtained were greater than 100 µg/ml.  
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Figure 6.7 Comparison between the anti-oxidant activity of the solvent extracts of Salvia 
species using the ABTS and the DPPH assays: Sac: S. africana-caerulea, Sal: S. africana-
lutea, Aab: S. albicaulis, Sau: S. aurita, Sch: S. chamelaeagnea, Sdi: S. disermas, Sdo: S. 
dolomitica, Sga: S. garipensis, Sla: S.  lanceolata, Tro: Trolox®, Vit: Vitamin C, Smu: S. 
muirii, Sna: S. namaensis, Sra: S. radula, Sre: S. repens, Sru: S. runcinata, Ssc: S. 
schlechteri, Sst: S. stenophylla, Sve: S. verbenaca. 
 
6.4.3 Total phenolic content and its relationship with the anti-oxidant activity 
 
The anti-oxidant activity exhibited by the solvent extracts depends on the type of 
compounds present.  A calibration curve used to estimate the total phenolic content is 
displayed in Figure 6.5.  The phenolic values estimated in the organic extracts of the 
various species ranged from 45.56 to 211.78 mg/g of GAE dry sample (Table 6.1).  
Species such as S. chamelaeagnea, S. muirii, S. repens, S. runcinata, S. schlechteri and S. 
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stenophylla with high phenolic content (> 150 mg of GAE) had the most promising anti-
oxidant activity (Table 6.1).  
 
After inverse transformation of IC50 values obtained (to accommodate the anti-oxidant 
capacity from low to high values on the X-axis), there was a stronger correlation between 
the total phenolic content and the anti-oxidant activity for the DPPH assay compared to the 
ABTS assay (r2 = 0.90 and 0.76, respectively) (Figure 6.8).  This implies that the phenolic 
compounds are partly, if not totally, responsible for the anti-oxidant activity observed in 
the species studied. 
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Figure 6.8 Regression analysis of the anti-oxidant activity plotted against the total 
phenolic content using the DPPH and ABTS methods.  
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6.5 Discussion 
 
The majority of solvent extracts exhibited potent anti-oxidant activity against the ABTS·+ 
and the DPPH· radicals (IC50 values < 75 µg/ml) with the exception of S. dolomitica and S. 
radula which showed weak activity in the DPPH assay (Table 6.1).  The solvent extract of 
S. schlechteri was more active than vitamin C.  In contrast, all the essential oils were 
poorly active (IC50 values > 100 µg/ml) in both assays.  The results obtained in the present 
study are in agreement with previous investigations on Salvia species.  S. tomentosa (IC50 
value: 18.7 µg/ml), S. hypageia (IC50 value: 34.6 µg/ml), S. sclarea (IC50 value: 23.4 
µg/ml) and S. caepitosa (IC50 value: 41.3 µg/ml) have been reported to display anti-oxidant 
activity against the DPPH· radical (Tepe et al., 2005, Tepe et al., 2006).  The anti-oxidant 
activity of S. officinalis has also been reported (Cuvelier et al., 1994).  However, as far as 
the literature survey has ascertained, there are no published reports on the anti-oxidant 
activity of southern African Salvia species.  Salvia dolomitica and S. radula demonstrated 
weak anti-oxidant activity against the DPPH· radical and moderate activity against the 
ABTS·+ radical.   
 
The differences obtained between the two methods indicated that the DPPH assay recorded 
lower anti-oxidant activity as compared to the ABTS assay.  A similar incongruence has 
been reported previously between the two methods (Kim et al., 2002) and these differences 
may be attributed to absorbance interference at 550 nm by other compounds in the DPPH 
assay.  In addition, the ABTS method is very sensitive, requiring a shorter reaction time 
(four minutes) compared to 30 minutes for the DPPH method.  It can be used in both 
organic and aqueous solvent systems (Lee et al., 2003).  Therefore, the ABTS assay may 
be preferable to the DPPH method for evaluating the total anti-oxidant activity of a given 
sample (Lee et al., 2003).   
 
The total phenolic content (Table 6.1) found in the species was high and varied from 45.56 
to 211.78 mg/g of GAE dry sample and a strong correlation using the DPPH method was 
obtained between the anti-oxidant activity and the total phenolic content (Figure 6.6).  It is 
well known that Salvia species contain various phenolic compounds including flavonoids, 
rosmarinic acid, caffeic acid, carnosol and carnosic acid (Lu and Foo, 2002; Tepe et al., 
2006).  The anti-oxidant activity of sage has been attributed to the phenolic compounds 
(Cuvelier et al., 1994, Cuvelier et al., 1996; Hohmann et al., 1999).  Tepe et al. (2005) 
demonstrated that S. tomentosa, which exhibited good anti-oxidant activity, also possessed 
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a high phenolic content (200 µg/mg).  Several reports have conclusively shown a close 
relationship between total phenolic content and anti-oxidant activity (Velioglu et al., 1998; 
Deighton et al., 2000).  In the present study it was found that S. chamelaeagnea and S. 
schlechteri contained a substantial amount of phenolics, that are at least partly, if not 
entirely, responsible for the anti-oxidant activity (Table 6.1).  As can be observed from the 
present data, anti-oxidant activity does not necessarily correlate with high amounts of 
phenolics as seen by the moderate correlation between the anti-oxidant activity using the 
ABTS method and the total phenolic content (Figure 6.8) (Kähkönen et al., 1999).   
 
The primary anti-oxidant activity of rosemary and sage is related to the presence of 
carnosic acid (Wenkert et al., 1964).  It was also reported that carnosic acid and carnosol 
are responsible for 90% of anti-oxidant activity of rosemary (Cuvelier et al., 1996).  
Caffeic acid, rosmarinic acid, ursolic acid, oleanolic acid, carnosic acid and carnosol are 
common in many plants and all are strong radical scavengers.  These compounds and 
derivatives have been shown to display anti-oxidant activity comparable to the reference 
compound vitamin C. Carnosol (isolated from S. chamelaeagnea, Chapter 9), standards of 
caffeic acid and rosmarinic acid also exhibited good anti-oxidant activity using the DPPH 
assay with the IC50 values 6.10 ± 0.6; 2.55 ± 0.17, 2.48 ± 0.20 µg/ml, respectively.  The 
HPLC data (Chapter 5) revealed the presence of rosmarinic acid, caffeic acid carnosol and 
derivatives (carnosic acid) in the majority of the extracts.  For example, S. aurita, S. 
chamelaeagnea, S. muirii, S. repens, S. runcinata and S. schlechteri with the presence of 
caffeic acid, carnosol, rosmarinic acid and/or carnosic acid exhibited good anti-oxidant 
activity, while those lacking these compounds were poorly active (e.g. S. dolomitica, S. 
radula and S. verbenaca).  These compounds might therefore account for the anti-oxidant 
activity obtained in most investigated species.   
 
Although the chemical composition and structures of active extract components are 
important factors governing the efficacy of natural anti-oxidants, the anti-oxidant activity 
of an extract cannot be explained based only on their phenolic content without further 
characterization (Heinonen et al., 1998).  Studies have indicated that the anti-oxidant 
activity of phenolic acids is related to their structure.  It has been reported that phenolic 
compounds with ortho- and para-dihydroxylation or a hydroxy and a methoxy group are 
more effective than simple phenolics (Frankel et al., 1995).   
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It has been reported that polar extracts exhibited stronger activity than non-polar extracts 
(Duan et al., 1998; Tepe et al., 2005; Tepe et al., 2006).  For instance, if an electron 
donating group, especially a hydroxyl group, is located on the o- or p- positions of the 
phenolic compound, it makes the compound polar and therefore anti-oxidant activity is 
increased (Duan et al., 1998).  The strong anti-oxidant activity of some Salvia species 
could be attributed to these groups that enable phenols to donate hydrogen atoms easily, 
thereby disrupting the chain-reaction of auto-oxidation.  Weng and Wang (2000) showed 
that the anti-oxidant activity of S. plebeia was concentrated in the acidic, weakly acidic and 
phenolic fractions of the extract, while the activity of neutral fractions was negligible. 
 
DPPH· and ABTS·+ radical scavenging activity of the essential oils was very low (IC50 
values > 100 µg/ml) and this was obviously related to their chemical composition.  In 
addition, essential oils have a low phenolic content (Cuvelier et al., 1994, Cuvelier et al., 
1996).  Essential oils are generally non-polar and many studies have shown that the anti-
oxidant activity is associated with polar fractions (Tepe et al., 2005; Tepe et al., 2006).  
Other members of the Lamiaceae also showed poor activity against the DPPH· radical.  For 
instance, Şahin et al. (2006) demonstrated that Origanum vulgare spp. vulgare was poorly 
active against the DPPH· radical (IC50 value > 8900 µg/ml).  In contrast, Tepe et al. (2004) 
demonstrated that S. multicaulis and S. crypthantha essential oils were more active than the 
reference anti-oxidant compounds such as vitamin C and butylated hydroxy toluene  (IC50 
values of 2.4 and 3.9 µg/ml, respectively).  The GC-MS data (Chapter 4) indicated that the 
essential oils were mostly devoid of constituents generally displaying anti-oxidant activity 
such as eugenol, thymol, carvacrol and γ-terpinene (Baratta et al., 1998; Ruberto and 
Baratta, 2000, van Zyl et al., 2006).  However, these individual components of the oils 
were generally tested at only one concentration (1000 µg/ml).  The essential oils found in 
the current study may also reveal some degree of activity at 1000 µg/ml, but this value is 
above the cut-off used to evaluate the anti-oxidant activity of samples in this study.  It was 
found that sesquiterpene hydrocarbons exerted a low, if any, anti-oxidant effect, while 
monoterpene hydrocarbons showed a significant protective effect with several variants due 
to the functional group (Ruberto and Baratta, 2000; Dorman et al., 2000).  The quantitative 
difference in their amount, as well as the antagonism in the mixture of essential oils may 
also explain why the activity was low.  Furthermore, there are various methods for anti-
oxidant activity determination of a given sample such as linoleic acid peroxidation, ferric 
thiocynate and thiobarbituric acid methods and perhaps the essential oils may display 
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greater activities using another method.  The studies reported here provide initial results on 
the anti-oxidant properties of South African indigenous Salvia species.  In order to 
investigate whether good anti-oxidant extracts can also exhibit good anti-inflammatory 
properties, the anti-inflammatory activity of Salvia species is discussed in the next Chapter. 
 
6.6 Conclusions 
 
• Indigenous Salvia species are a good source of anti-oxidants as they are rich in 
phenolic compounds.  
• The DPPH· radical was less sensitive than the ABTS·+ radical. 
• Similar compounds are responsible for the anti-oxidant activity of the solvent 
extracts against the DPPH· and ABTS·+ radicals; however the degree of activity 
varies significantly for some species 
• S. schlechteri and S. muirii were the most active solvent extracts against the DPPH· 
and ABTS·+ radicals, respectively. 
• The activity of the solvent extracts of S. schlechteri was 3 times greater than that of 
the reference compound, vitamin C. 
• Although a correlation between the anti-oxidant activity using the DPPH method 
and phenolic content has been confirmed, however the anti-oxidant activity is not 
always highly correlated to the total phenolic content. 
• Essential oils have a poor free radical scavenging capacity against the DPPH· and 
the ABTS·+ radicals. 
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Chapter 7:  Anti-inflammatory activity-Inhibition of the 5-
Lipoxygenase Enzyme  
 
Abstract 
 
5-Lipoxygenase is one of the key enzymes involved in the inflammation process.  The anti-
inflammatory activity of essential oils and solvent extracts of Salvia species was evaluated 
using the 5-lipoxygenase assay.  Essential oils exhibited better anti-inflammatory activity 
when compared to the solvent extracts.  Almost all the essential oils exhibited promising 
anti-inflammatory activity with IC50 values ranging between 22.81 and 77.32 µg/ml.  The 
essential oil of S. runcinata exhibited the most favourable activity, while S. africana-lutea 
displayed the lowest activity.  With the exception of S. radula, solvent extracts displayed 
poor ability to inhibit the enzyme with all IC50 values being greater than 100 µg/ml.  The 
components of the oils such as β-caryophyllene, trans-nerolidol, α-bisabolol, α-pinene, α-
limonene, linalool and its ester linalyl acetate, may be responsible for the anti-
inflammatory activity of the investigated essential oils.       
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7.1 Introduction 
 
Inflammation is the normal physiological response of the body that occurs when it is 
invaded by infective agents, responding to stimulation or when it is exposed to physical, 
chemical or traumatic changes (Baylac and Racine, 2003).  Inflammatory reactions may be 
initiated by a variety of mediators including eicosanoids derived from the cyclo-oxygenase 
and 5-lipoxygenase pathways (Figure 7.1).  The 5-lipoxygenase enzyme is the initiator of 
the conversion of the membrane phospholipid-derived fatty acid, arachidonic acid, into a 
number of compounds such as leukotrienes, which cause redness, pain and irritation.  
 
 
 
Figure 7.1 Inflammation process pathways (Davis et al., 2004). 
 
Leukotrienes form a group of highly potent molecules that mediate inflammatory reactions 
contributing to various diseases such as asthma, cystic fibrosis, urticaria and central 
nervous system disorders.  This important class of messengers is pro-inflammatory, 
resulting from the metabolism of arachidonic acid and which begins with oxidation by the 
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5-lipoxygenase enzyme.  The biological effects of leukotrienes can be prevented by 
suppressing leukotriene production via inhibition of the lipoxygenase pathway (Figure 
7.1).  In recent years, a large body of evidence has accumulated, demonstrating that free 
radicals are important components of inflammation (Kehrer, 1993) and anti-oxidant 
compounds have been found to display anti-inflammatory activity (Sala et al., 2003).  
Compounds such as carnosic acid and ursolic acid which have potent anti-oxidant activity, 
have also been shown to possess anti-inflammatory activity (Baricevic et al., 2001). 
 
As listed in Table 1.4 and 1.5, plants belonging to the genus Salvia have been used for 
various ailments and are reported to have anti-inflammatory properties.  Studies have 
shown that the solvent extracts or isolated compounds of Salvia also displayed anti-
inflammatory activity both in vitro and in vivo (Baricevic et al., 2001).  
 
Essential oils are low molecular weight compounds which can rapidly diffuse through the 
skin barrier and reach the underlying tissue.  They are used in many fields, such as food 
products, pharmaceuticals, cosmetics, perfumes and household items.  Furthermore, a 
number of essential oils are used in aromatherapy for their therapeutic benefits (Pauli, 
2001; Baylac and Racine, 2003).  Previous studies carried out on Salvia stenophylla 
reported the anti-inflammatory properties of its essential oil (Baylac and Racine, 2003).  
Nevertheless, South African species have not yet been fully investigated.  Together with 
the traditional uses of sage to treat body wounds (Watt and Breyer-Brandwijk, 1962), the 
potent anti-oxidant capacity and the reported anti-inflammatory activity of Salvia prompted 
this investigation on the anti-inflammatory activity of indigenous species.  
 
The objective of this study was to evaluate the effectiveness of the essential oils and 
solvent extracts to inhibit the in vitro activity of the 5-lipoxygenase enzyme. 
 
7.2 Materials and methods 
 
7.2.1 Chemicals, reagents and standard 
 
5-Lipoxygenase and nordihydroguaiaretic acid (NDGA) were obtained from Cayman 
Chemicals Company; DMSO, potassium phosphate and hydroxyl sodium from Saarchem, 
while Tween® 20 and linoleic acid were purchased from Fluka.  Double distilled 
Millipore® (0.22 µm) water was used throughout this experiment. 
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7.2.2 Preparation of solutions, enzymes and buffers 
 
The potassium phosphate buffer (pH 6.3) was prepared by mixing 50 ml of 0.1 M 
potassium dihydrogen phosphate and 9.7 ml of 0.1 M sodium hydroxyde.  The solution of 
linoleic acid was prepared at a concentration of 0.168% in ethanol (w/v).  The enzyme was 
aliquoted in eppendorfs (100 U ≈ 12 µl) and kept at -80 °C until used. 
 
7.2.3 Preparation of test samples 
 
The stock solution of the test samples (essential oils and solvent extracts) was prepared at a 
concentration of 10 mg/ml in the DMSO and Tween® 20 mixture and, if necessary, further 
dilutions were made with the same mixture.  The solution of DMSO and Tween® 20 
mixture was prepared by weighing 1.5 g of Tween® 20 and made up to 55 g with DMSO. 
 
7.2.4 The 5-lipoxygenase assay 
 
The 5-lipoxygenase assay was used as an indication of the anti-inflammatory activity.  An 
aliquot of 50 µl of the stock solution (10 mg/ml) of each test sample was placed in a 3 ml 
cuvette, followed by 2.95 ml of pre-warmed potassium phosphate buffer and 48 µl of 
linoleic acid solution.  The mixture was covered with a cap and gently shaken six times 
before the cuvette was placed back in the UV-VIS spectrophotometer in order to measure 
the absorbance reference at 234 nm.  Thereafter, 12 µl of the ice-cold buffer (potassium 
phosphate) was mixed with 100 U of the thawed enzyme (for 10 seconds to avoid its 
degradation) in order to activate the enzyme.  The mixture was then transferred to the 
cuvette and the content of the cuvette was shaken and placed back into the 
spectrophotometer (Specord Analytikjena-40 connected to Winaspect® software), before 
the absorbance was recorded at 234 nm.  It is important to note that, prior to testing 
samples; two samples were prepared as mentioned above but only with DMSO and 
Tween® 20 mixture to serve as controls (no enzyme inhibition). 
 
5-Lipoxygenase is known to catalyze oxidation of unsaturated fatty acids containing 1-4 
diene (Alitonou et al., 2006) and the modification of linoleic acid (diene 1-4 into diene 1-
3) can be detected at 234 nm.  
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7.3 Data analysis 
 
An increase in absorbance at 234 nm arising from modification of the linoleic acid (diene 
1-4 into 1-3) was measured for 10 minutes at room temperature.  The initial reaction 
determined from the slope of the linear portion (over 60 seconds) of the curve (Figure 7.2) 
and the percentage activity of the enzyme was calculated by comparison to the controls.  
The slope of the control represents 100% activity of the enzyme. 
 
Figure 7.2 Plot of the absorbance, determined over 10 minutes, of essential oil of Salvia 
runcinata at various concentrations. 
 
For samples exhibiting activity at 100 µg/ml, three 2-fold serial dilutions were prepared 
and each test sample was run once at each concentration.  The concentration inhibiting 
50% enzyme activity (IC50) was used to evaluate the test sample and the IC50 value was 
obtained by plotting the percentage activity against the log concentration using the 
Enzfitter® version 1.05 software.  NDGA was used as the reference anti-inflammatory 
compound. 
 
7.4 Results 
 
Results obtained for inhibition of the 5-lipoxygenase enzyme by the solvent extracts and 
essential oils are presented in Table 7.1.  Essential oils displayed favourable activity when 
compared to the solvent extracts.  Almost all the essential oils inhibited the 5-lipoxygenase 
enzyme with the IC50 values ranging from 22.81 ± 0.01 to 77.32 ± 6.27 µg/ml in 
comparison to the reference compound NDGA (IC50 value: 4.95 ± 0.07 µg/ml).   
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Table 7.1 Anti-inflammatory activity (IC50 ± s.e) of the essential oils and solvent extracts. 
  
Essential oils Solvent extracts 
Species / Control 
IC50 values in μg/ml 
S. africana-caerulea 73.42 ± 5.27 > 100 
S. africana-lutea 77.32 ± 6.27 > 100 
S. albicaulis 39.22 ± 3.93 > 100 
S. aurita nd > 100 
S. chamelaeagnea 48.58 ± 0.07 > 100 
S. disermas nd > 100 
S. dolomitica  64.58 ± 6.47 > 100 
S. garipensis nd > 100 
S. lanceolata 43.38 ± 3.52 > 100 
S. muirii > 100 > 100 
S. namaensis nd > 100 
S. radula > 100 78.78 ± 5.89 
S. repens 28.04 ± 4.50* > 100 
S. runcinata 22.81 ± 0.01 > 100 
S. schlechteri nd > 100 
S. stenophylla 49.17 ± 4.87 > 100 
S. verbenaca nd > 100 
NDGA  4.95 ± 0.07 
nd = not determined, essential oil not available 
* Essential oil was obtained from Lady Grey which is different from where extract was collected 
NDGA: Nordihydroguaiaretic acid 
s.e.: standard error of the estimate 
 
The essential oil of S. runcinata exhibited the most potent activity (IC50 value: 22.81 ± 
0.01 µg/ml), while S. africana-lutea displayed the lowest activity (IC50 value: 77.32 ± 6.27 
µg/ml).  The essential oils of S. muirii and S. radula displayed poor activity at a starting 
concentration of 100 µg/ml. 
 
Nearly all the solvent extracts exhibited poor anti-inflammatory activity except S. radula 
which displayed moderate activity (IC50 value: 78.78 ± 5.89 µg/ml).  The IC50 values of the 
solvent extracts were greater than 100 µg/ml against the 5-lipoxygenase enzyme.  It was 
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interesting to note that in contrast to poor activity of the essential oil of S. radula, the 
solvent extract was fractionally more potent, whilst S. muirii was found to possess no anti-
inflammatory properties in either essential oil or solvent extract (Table 7.1). 
 
7.5 Discussion 
 
Baylac and Racine (2003) found that the essential oil of S. stenophylla has the potential to 
inhibit the in vitro 5-lipoxygenase enzyme (10 < IC50 value < 30 in μg/ml).  In this study, 
S. stenophylla also displayed anti-inflammatory activity (IC50 value: 49 μg/ml).  The 
difference found between the two values reported, although the same method was used, 
may be attributed to variation in chemical composition of the two essential oils.  Many 
factors such as harvesting time, geographical location, climate and stage of development of 
the plant have been reported to affect the chemical composition of the essential oil 
(Putievsky et al., 1986).   
 
The biological activity of essential oils or plant extracts is mainly associated with their 
chemical composition.  The essential oil data given in Chapter 4 can be used to explain the 
results obtained in this study.  Essential oils are complex mixtures comprising of a 
multitude of compounds and each constituent contributes to the beneficial or adverse effect 
of the oils (Lahlou, 2004).  It is therefore difficult to determine exactly which compound(s) 
is/are responsible for the biological activity when crude essential oils are used.  
 
Aromatherapy reports on the anti-inflammatory activity of terpenes and sesquiterpenes, 
and data suggests that the presence of these compounds may account for the activity of the 
essential oils as determined by the 5-lipoxygenase in vitro enzyme.  Sesquiterpenoids and 
their derivatives are credited with various biological action including anti-asthmatic, 
antibacterial, antifungal, anti-inflammatory and antineoplastic activities (Farnworth and 
Bingel, 1977).  Structure-activity relationships to define broad categories of activities for 
the different classes of molecules found naturally in essential oils have been investigated.  
Terpenic hydrocarbons (α-pinene, 31 < IC50 value < 50 μg/ml), sesquiterpenic 
hydrocarbons (β-caryophyllene, 10 < IC50 value < 30 μg/ml), sesquiterpenic alcohols 
(trans-nerolidol, 10 < IC50 value < 30 μg/ml) and α-bisabolol, (10 < IC50 value < 30 μg/ml) 
exhibited a potential ability to inhibit the 5-lipoxygenase enzyme (Baylac and Racine 
2003).  Peana et al. (2002) demonstrated that linalool and its ester linalyl acetate (Table 
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4.1) exhibited anti-inflammatory activity.  These two compounds were found in S. 
dolomitica (16.6 and 19.6%, respectively) and may have partly contributed to the anti-
inflammatory activity.  It was reported that monoterpenes such as 1,8-cineole, α-pinene 
and limonene and sesquiterpenes such as β-caryophyllene also inhibit the in vitro 5-
lipoxygenase assay (Juergens et al., 1998; Baylac and Racine, 2003).  These compounds 
were present in the majority of species in varying concentrations (1,8-cineole: trace 
amounts to 40.5 %;  α-pinene : trace amounts to 22.3 % and limonene: 0.5 to 11.6 % 
)(Table 4.1).  All these components identified in the essential oils may have contributed to 
the anti-inflammatory activity of the essential oils.  Furthermore, α-bisabolol, which is 
widely reported to have a skin soothing action, strongly inhibited the 5-lipoxygenase 
enzyme in vitro (Baylac and Racine, 2003).  It is therefore expected that essential oils 
containing high levels of this sesquiterpenic alcohol like that of S. runcinata (65%) and S. 
stenophylla (26%), can be expected to inhibit 5-lipoxygenase enzyme as well.  Moretti et 
al. (1997) evaluated the anti-inflammatory activity (induced by carrageenin in rats) of 
essential oils of S. sclarea and found that the oil exhibited a significant anti-inflammatory 
effect.  The effect of the oil was correlated to the presence of linalool, α-terpineol and 
linalyl acetate.  They also found that these constituents produce less anti-inflammatory 
action when administered separately than the oil in toto and are less active than the 
oxygenated fractions obtained by flash chromatography of the oil.  This clearly indicated 
that the action of the essential oil might be determined by the synergistic interactions of its 
constituents. 
 
Effective anti-oxidant treatment has also been found to be effective against inflammation 
(Sala et al., 2003).  For instance, phenolic acids such as carnosic and ursolic acids, which 
are good anti-oxidants, were reported to be good anti-inflammatory compounds (Liu, 1995; 
Baricevic et al., 2001).  However, ursolic acid exhibited poor ability to inhibit the key 
enzyme of leukotriene biosynthesis, namely 5-lipoxygenase (Safayhi et al., 1997).  Only 
the solvent extract of S. radula exhibited some degree of activity, while other species were 
inactive at the starting concentration of 100 µg/ml (Table 7.1).  In addition, the anti-
inflammatory activity of the solvent extracts or isolated compounds of Salvia species is 
widely reported.  For example, Baricevic et al., (2001) investigated the topical anti-
inflammatory activity of S. officinalis leaves and found that the solvent extracts inhibited 
ear oedema in mice in a dose-dependent manner, while aethiopinone, isolated from S. 
aethiopis roots, exhibited anti-inflammatory activity (Hernández-Pèrez et al., 1995).  
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Solvent extracts of Salvia species are rich in flavonoids which possess potent anti-oxidant 
activity.  Although many pentacyclic triterpenes (ursolic acid) also bind to the 5-
lipoxygenase enzyme (Safayhi et al., 1995), the presence of an 11-keto-group and a 
hydrophilic function of the pentacyclic ring system are crucial for potent inhibition of 5-
lipoxygenase and ursolic acid turned out to be non-inhibitory (Sailer et al., 1996).  This 
compound was found in some of the solvent extracts.  This suggests that the components of 
the extract responsible for the anti-oxidant activity are not necessarily those responsible for 
the anti-inflammatory activity.  It is important to note that the ‘quasi absence’ of 5-
lipoxygenase inhibitory activity in this study does not imply that the solvent extracts do not 
possess any anti-inflammatory activity.  The activity may be observed at higher 
concentrations.  Furthermore, the biological response of any substance may be influenced 
by various factors, including variation in assay methods employed (Houghton and Raman, 
1998).  As shown in Figure 7.1, inflammation is a very complex cascade of events 
involving not only the 5-lipoxygenase pathway, but also the 12- and 15-lipoxygenases, as 
well as cyclo-oxygenase-1, cyclo-oxygenase-2, cytochrome P450 and epoxygenase 
pathways.  Further investigation involving other inflammatory routes is required in order to 
determine whether the solvent extracts do exert anti-inflammatory activity in other steps of 
the complex anti-inflammatory cascade.  
 
7.6 Conclusions 
 
• The essential oils exhibited the ability to inhibit the in vitro 5-lipoxygenase 
enzyme.  
• The solvent extracts were poorly active and only S. radula inhibited the in vitro 5-
lipoxygenase enzyme below a concentration of 100 μg/ml.  
• The uses of Salvia species by inhalation support the traditional uses of these plants 
and imply that essential oils may be responsible for the activity.  Furthermore, the 
topical use of Salvia species may be validated. 
• None of the solvent extracts or essential oils exhibited anti-inflammatory activity 
comparable to nordihydroguaiaretic acid. 
• The possibility that the solvent extracts may inhibit other enzymes or receptors 
involved in the inflammatory pathway should not be disregarded and this warrants 
further investigation. 
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Chapter 8:  The Antimalarial Activity of the Essential Oils 
and Solvent Extracts and Isolated Compounds from S. radula 
 
Abstract 
 
The resistance of Plasmodium falciparum to currently used drugs has become a serious 
problem and efforts are being directed at obtaining new drugs with different structural 
features.  One option favoured is the search for new plant-derived antimalarial drugs.  
Eleven essential oils and 17 solvent extracts of indigenous Salvia species used in 
traditional medicine against various ailments, including malaria, were subjected to 
pharmacological testing in order to evaluate their potential to inhibit the growth of 
Plasmodium falciparum FCR-3 strain.  The investigation was conducted using the [3H]-
hypoxanthine radiometric method.  The outcome showed that both the essential oils and 
the solvent extracts displayed antimalarial activity.  The IC50 values of the essential oils 
ranged from 1.20 to 13.50 µg/ml and were low compared to the solvent extracts (IC50 
values ranging from 3.91 to 26.01 µg/ml).  The essential oil of S. runcinata was the most 
active killing 50% of parasites at a concentration of 1.20 µg/ml.  Among the plants 
screened, the solvent extract of S. radula displayed the most favorable activity, while S. 
lanceolata was the least active.  The extract of S. radula was selected to determine the 
compound(s) which may be responsible for the observed antimalarial activity since it 
displayed the best activity.  Two compounds were isolated and characterised as 
betulafolientriol oxide and salvigenin.  The two compounds displayed comparable or lower  
antimalarial activity (IC50 values: 4.95 and 24.60 µg/ml, respectively) than the crude 
solvent extract.  The in vitro antimalarial activity supports the continued use of Salvia 
species in folk medicine.  
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8.1 Introduction 
 
Not considering the future implications of the AIDS pandemic, malaria is currently one of 
the most important human diseases in developing countries and is still unconquered.  It is 
the world’s leading cause of fatalities among the infectious diseases (Wanyoike et al., 
2004).  Most of the lethal cases are caused by Plasmodium falciparum, the most virulent of 
the four Plasmodium species that infect humans and which is distributed in tropical Africa, 
Asia and Latin America (Karou et al., 2003).  Despite the extensive control efforts, the 
incidence of the disease is not decreasing, especially in developing countries where malaria 
remains a major public health problem (Karou et al., 2003).  Some 3.2 billion people live 
in areas at risk of malaria transmission (WHO, 2005a).  An estimated 350-500 million 
clinical malaria episodes occur annually.  Plasmodium falciparum induced malaria causes 
more than 1 million deaths each year (WHO, 2005a).   
 
The spread of parasites resistant to agents such as chloroquine and quinine, and insecticide-
resistant mosquitoes, has led to major difficulties in the treatment and control of this 
disease and has hence triggered the search for new drugs.  One possible approach to the 
identification of new antimalarial drug candidates is to search for compounds or plants that 
reportedly cure malaria.  For many centuries, plants have formed the basis of sophisticated 
traditional medicine systems and more recently, natural products have yielded lead 
compounds, especially against infectious diseases (Schwikkard and van Heerden, 2002).  
In South Africa and in most Third World countries, the use of medicinal plants is 
widespread and there is real hope of finding an alternative to synthetic drugs.  
 
Plants are known to be the main source of drug therapy in traditional medicine (Prozesky 
et al., 2001) and the use of traditional medicinal plant preparations is transmitted verbally 
from one generation to the next, a process than runs the risk of losing essential information 
or misinformation.  The recognition and validation of traditional medical practices and the 
search for plant-derived drugs could lead to a new strategy in malaria control.  It is 
therefore necessary to obtain more scientific information concerning the efficacy and 
safety of the remedies in use, as many people already use and depend on herbal medicines 
for the treatment of malaria (Prozesky et al., 2001).  Many studies have been carried out on 
the antimalarial activity of various plant species with some encouraging results (Prozesky 
et al., 2001; van Zyl and Viljoen, 2002).  Furthermore, two of the most potent antimalarial 
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drugs have originated from plants: quinine from Cinchona trees and artemisinin from 
Artemisia annua (Gessler et al., 1994; Foley and Tiller, 1997; Olliaro et al., 2001).  
Nevertheless, only 20% of plants which are reported to have bioactivity have been 
subjected to bioassay screening (Houghton, 2001).  Malaria can occur despite taking 
antimalarial drugs and symptoms of infection usually occur within 9 to 14 days after 
exposure.  The general symptoms of malaria include headache, nausea, fever, cough, 
sweating, vomiting and flu-like symptoms.  These symptoms may differ depending on the 
type of Plasmodium that is responsible for the infection (WHO, 1998).  The life cycle of a 
malaria parasite is presented in Figure 8.1.  
 
 
 
Figure 8.1 Life cycle of the malaria parasite (National Center of Infectious Disease, 2006). 
 
The genus Salvia has been used in traditional medicine for the treatment of a variety of 
diseases, including malaria (Watt and Breyer-Brandwijk, 1962).  However, no exhaustive 
studies on the in vitro antimalarial activity of these plants have been carried out on 
indigenous species thus far.  In a continuation to verify the efficacy of traditional 
medicines against malaria, South African Salvia species were investigated.  
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The objectives of this study were to: 
(i) study the essential oils and solvent extracts of the Salvia species for  their 
potential to inhibit the in vitro growth of the malaria parasite, P. falciparum, 
(ii) isolate, identify, characterize and determine the antimalarial activity of 
isolated compound(s) from the most promising species, and 
(iii) generate reliable scientific data to validate the traditional use of these plants 
in the treatment of malaria. 
 
8.2 Materials and methods 
 
8.2.1 Chemicals, reagents and standards 
 
Roswell Park Memorial Institute media (RPMI 1640) was purchased from GibcoTM; 
quinine sulphate and the reagent anisaldehyde were obtained from Fluka.  Gentamicin 
sulphate, hypoxantine (6-hydroxypurine), NaHCO3 and the standard chloroquine 
diphospate were purchased from Sigma®, while KH2PO4, Na2HPO4.2H2O and glucose 
were obtained from Merck.  [N-(2-hydroxyethyl) piperazine-N'-(2-ethanesulfonic acid)] 
(HEPES) was obtained from Highveld Biological, while DMSO and D-sorbitol were 
obtained from Saarchem.  Sterile water was used throughout the experiments.  The [3H]-
hypoxanthine isotope was purchased from Amersham.  All other solvents and/or reagents 
were of the best available grade.  Silica gel was obtained from Macherey-Nagel. 
 
8.2.2 Preparation of different solutions 
 
8.2.2.1 Incomplete hypoxanthine negative medium and the incomplete hypoxanthine 
culture medium 
The incomplete hypoxanthine negative medium was prepared by dissolving RPMI-1640 
(10.4 g), HEPES buffer (5.9 g) and glucose (4 g) in one liter of distilled Millipore® water 
which was filtered through a Sterivex-GS 0.22 μm filter unit to sterilize the solution.   
 
The incomplete hypoxanthine culture medium was prepared in the same way as the 
hypoxanthine negative medium except that hypoxanthine (44 mg) and gentamicin (100 μl; 
50 mg/ml) were included.  Both solutions were stored at 4 °C until required. 
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8.2.2.2 Sodium bicarbonate and phosphate buffer saline  
The 5% (w/v) sodium bicarbonate was prepared by dissolving 50 g NaHCO3 into one liter 
of distilled Millipore® water and filtered.   
 
The phosphate buffer saline (PBS) (pH 7.4) was prepared with NaCl (8 g), KCl (0.3 g), 
Na2HPO4.2H2O (0.73 g) and KH2PO4 (0.2 g) in one liter of distilled Millipore® water 
which was then autoclaved  for 20 min at 120 °C and at 1.5 kgf/cm2  pressure.  These 
solutions were stored at 4 °C until required. 
 
8.2.2.3 Complete culture medium 
The complete culture medium (CCM) was prepared by supplementing the incomplete 
hypoxanthine negative medium (85.8 ml) with 10% (v/v) human plasma (10 ml) and 4.2 
ml of 5% NaHCO3.  The CCM was prepared when required and discarded when it had 
turned dark pink which indicated that it was too alkaline for use. 
 
8.2.2.4 Preparation of human plasma and blood  
The plasma pooled from healthy donors (South African Blood Transfusion Services) was 
inactivated at 56 °C in a water bath for two hours, centrifuged at 3000 rpm for 20 minutes, 
aliquoted into sterile 50 ml centrifuge tubes and stored at -20 °C until required. 
 
The whole blood collected from healthy donors (South African Blood Transfusion Service) 
was preserved in citrate phosphate dextrose adenosine-1 (CPDA-1) to prevent coagulation 
and, when required, was washed thrice with PBS at 2000 rpm for five minutes each.  The 
buffy coat was removed with each wash and the remaining erythrocytes stored in 
hypoxanthine negative medium at 4 °C until required. 
 
8.2.2.5 D-sorbitol and Giesmsa buffer 
The D-sorbitol was made at a concentration of 5% (w/v) with distilled Millipore® water, 
filtered and stored at 4 °C.  The Giesmsa buffer was prepared by dissolving 3.5 g of 
KH2PO4 and 14.5 g of Na2HPO4.12H2O in a final volume of one liter of distilled 
Millipore® water and autoclaved for 20 min at 120 °C and   at 1.5 kgf/cm2 pressure.   
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8.2.3 Plasmodium falciparum and in vitro culture maintenance 
 
The chloroquine-resistant Gambian FCR-3 strain was cultured continuously according to 
the procedure described by Trager and Jensen (1976) taking into account the modifications 
as described by van Zyl and Viljoen (2002).  The parasite culture was suspended in 
complete culture medium and maintained daily.  The culture consisted of at least a 2-6% 
parasitaemia in a 5% haematocrit of parasitised and uninfected erythrocytes in CCM 
(Section 8.2.2.3) which was gassed with 2.06% O2, 5.00% CO2, 92.94% N2 and incubated 
at 37 ºC.  Fresh uninfected human erythrocytes (less than 3 weeks old) were added when 
the parasites were predominantly in the trophozoite/schizoite stages.  In order to 
synchronise the parasites for experimental purposes, 5% (w/v) D-sorbitol was added to a 
predominantly ring-staged (Figure 8.2) the culture every second day (10-15 minutes) and 
then washed with PBS three times at 2000 rpm five minutes each.  Daily visualisation of 
parasites was done by preparing a thin smear and the observation was made under oil 
immersion objective with a light microscope (Nikon).  The percentage parasitaemia was 
then calculated using at least 10 fields counted over the length of the smear (Figure 8.2).  
 
 
Figure 8.2 A thick blood smear showing the ring form of P. falciparum in erythrocytes.  
 
8.2.4 Preparation of test samples 
 
Stock solutions of the solvent extracts (10 mg/ml) were prepared with DMSO, aliquoted 
and stored at -20 °C until required.  On the day of experimentation, seven dilutions of each 
test sample were prepared from a stock solution made with an incomplete hypoxanthine 
negative medium.  The stock solution (10 mg/ml) and dilutions of the essential oils were 
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prepared on the day of the experiment with DMSO.  A final concentration of 1% DMSO in 
the well had no effect on parasite growth. 
 
8.2.5 Assay of antimalarial activity 
 
The antimalarial activity was determined using the tritiated hypoxanthine radiometric assay 
over a single growth cycle (48 hours) (Desjardins et al., 1979; van Zyl and Viljoen, 2002).  
Before running the experiment, a thin blood film stained with diluted Giesmsa for 10-20 
minutes was microscopically examined (Figure 8.2) and the percentage parasitaemia 
calculated (Eq. 8.1).  At least 10 fields were counted over the length of the smear to obtain 
an average percentage parasitaemia.  The percentage parasitaemia normally ranged from 2 
to 6%.  To prepare a suspension to be used for the in vitro experiment, the parasite 
suspension, mainly in the ring stage, was adjusted to 0.5% parasitaemia and 1% 
haematocrit using an incomplete hypoxanthine negative medium supplemented with 10% 
human plasma and 5% NaHCO3. 
  
% Parasitaemia =  Number of infected cells  x 100                                                   (Eq. 8.1) 
         Total number of infected + uninfected cells   
 
For each dilution, 25 μl of solvent extract and isolated compounds, or 2 μl of essential oil, 
was plated out in triplicate in a 96-well culture plate (NunclonTM).  In the control wells, 25 
μl of incomplete hypoxanthine negative medium was plated out.  The hypoxanthine 
negative medium (23 μl) was added to the wells containing essential oils to ensure a total 
volume of 25 μl in each well.  Subsequently, the complete hypoxanthine negative medium 
containing 1% red blood cells (200 μl) was plated out in four wells and used as a control.  
While 200 μl of the parasitised red blood cells were added to the remaining 92 wells (each 
plate consists of four test samples and each test sample had seven dilutions).  The plate was 
placed in a humidified candle jar, relatively free of oxygen and incubated for 24 hours at 
37 ºC.  The essential oils were always assayed in separate microtitre plates and incubated 
in different candle jars due to their volatile properties. 
 
The [3H]-hypoxanthine isotope (25 μl) was then added to each well and the plate was 
incubated at 37 ºC for an additional 24 hours.  The final concentration of the solvent 
extracts in the wells ranged from 1 to 100 μg/ml, while the essential oil concentrations 
ranged from 0.05 to 50 μg/ml.  Further dilutions were prepared where necessary.  The 
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[3H]-hypoxanthine was prepared by mixing 10 μl of [3H]-hypoxanthine (5 mCi, 28.0 
Ci/mmol) with 2.7 ml of incomplete hypoxanthine negative medium.   
 
At the end of the second incubation period, parasite DNA was harvested onto Wallac® 
printed glass fiber filter mats with a 96-well semi-automated Titertek® cell harvester.  The 
glass-fiber filter mats were left to dry overnight at room temperature and transferred to a 
sample bag containing 10 ml of Wallac Betaplate® liquid scintillation fluid and heat-
sealed.  The in vitro uptake of [3H]-hypoxanthine by malaria parasites was used as an 
indicator of parasite growth.  Hypoxanthine is required by parasites for DNA synthesis and 
is only supplied by the human host, as it is not produced de novo.  The amount of 
radioactivity in counts per min (CPM) associated with the [3H]-hypoxanthine incorporated 
into the parasite DNA trapped in the mat was determined with a β-scintillation counter 
(Wallac®).  At least three independent experiments were carried out for each sample, with 
chloroquine diphosphate and quinine sulphate used as reference antimalarial drugs. 
 
8.2.6 Isolation and structural characterization procedures from S. radula 
 
S. radula was selected to isolate the compounds which may be responsible for the 
antimalarial activity because it showed the best activity compared to the other tested 
species.  Dried aerial parts (723.5 g) collected on the road to Derby (North West) were 
powdered and exhaustively extracted with methanol:chloroform (1:1, v/v).  The 
supernatant was then concentrated at 70 °C with a rotary evaporator under vacuum. 
 
8.2.6.1 Isolation by column chromatography 
The residue obtained (22.4 g) was mixed with a small amount of silica 60 (0.063-0.2 
mm/70-230 mesh ASTM), dried at 60 °C in the oven, reduced to fine powder, added to the 
top of the column (4 cm x 60 cm) and eluted with hexane:dichloromethane (9:1), 
dichloromethane:methanol (6:1) and finally with 100% methanol, respectively.  Five 
fractions (A-E) were collected and each fraction was tested for antimalarial activity. 
 
Fraction C (12.5 g) displayed the best activity and was selected for further analysis.  It was 
re-chromatographed in a smaller column (2.5 cm x 45 cm) with a solvent system of 
toluene:ethyl acetate (10:3).  This solvent system was chosen as it displayed good 
separation on a TLC plate.  A total number of 222 fractions in 3 ml test tubes were 
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collected and spotted onto a TLC plate.  The separated spots on TLC were identified under 
UV lights (254 nm and 366 nm) and also sprayed with 0.5% anisaldehyde sulfuric acid 
reagent in glacial acetic acid:methanol:sulfuric acid (10:85:5).  Fractions with similar Rf 
values were combined and concentrated to afford 7 major fractions.  Fractions 3 and 5 
were selected based on the results of their biological activity.  Fraction 3 was eluted with 
toluene:ethyl acetate (10:3) and 189 sub-fractions (in 3 ml test tubes) were collected and 
combined into two major fractions resulting in the isolation of compound 1 (29.4 mg) with 
hexane:ethyl acetate:toluene (1:1:1) as eluent.  Compound 2 (24.1 mg) was obtained after 
repeating column chromatography three times with toluene:ethyl acetate (10:2) from 
fraction 5.  The isolation procedure of the two compounds is summarized in Figure 8.3.   
 
Crude extract (22.4 g) 
 
                                                                       Silica gel 60 
                                                            Hexane:Dichloromethane (9:1) 
                                                                       Dichloromethane:Methanol (6:1) 
                                                                       Methanol (100%) 
 
                                            
                                                          Fraction C (12.5 g)  
 
                                                                       Silica gel 60 
                                                                       Toluene:Ethyl acetate (10:3) 
 
 
  
 
             
 
                       Fraction 3 (2.89 g)                                                      Fraction 5 (1.89 g) 
 
                       
                    Silica gel 60 
                   Toluene:Ethyl acetate (10:3) 
 
              Silica gel 60                                                             Silica gel 60 
              Hexane:Ethyl acetate:Toluene (1:1:1)                     Toluene:Ethyl acetate (10:2) 
 
                          Subfraction 83-95                                                      Subfraction 123-142             
                          Compound 1  (29.4 mg)                                            Compound 2 (24.1 mg)                     
 
 
Figure 8.3 Isolation procedures of the two compounds from S. radula.  (NB: Fractions 1, 
2, 4 and 6 had low activity and were not considered for further analysis). 
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The isolated compounds were structurally characterized using nuclear magnetic resonance 
(NMR) and mass spectrometry (MS) and data were compared to those found in the 
literature. 
 
8.2.6.2 Structural characterization 
(i) Nuclear magnetic resonance spectroscopy 
1H, 13C, HMBC and COSY nuclear magnetic resonance (NMR) data of compounds 1 and 2 
were recorded on a Varian Inova 2000 300 MHZ spectrometer.  All spectra were recorded 
at 25 °C in deuterated chloroform and the chemical shifts were recorded in ppm referenced 
to tetramethylsilane (TMS).  
 
(ii) Mass spectrometry 
Electron ionization MS of the isolated compounds were performed by direct inlet at 70 eV 
on the GC-MS QP 2010 gas chromatography-mass spectrometry. 
 
8.3 Data analysis 
 
The percentage inhibition of radio-activity incorporation or growth (relative to the positive 
control values of P. falciparum without test sample) was calculated based upon the mean 
radio-active contents (CPM) of the experimental wells using a simple programme written 
in Microsoft Excel® (Eq. 8.2). 
 
% parasite growth = CPM (test compound sample) – CPM ( mean of RBC control) x 100 (Eq. 8.2)                  
                                    CPM (mean of PRBC control) – CPM (mean of RBC control) 
 
Where: CPM: Counts per minute 
RBC: Red blood cells 
PRBC: Parasitised red blood cells 
 
The log sigmoid dose-response curve was then constructed using the Enzfitter® version 
1.05 and Prism® version 3.0 software and the IC50 values (the concentration required to kill 
50% parasite) calculated as a measure of the antimalarial activity of the solvent  extracts, 
isolated compounds and essential oils (Figure 8.4).  The Student t-tests and one-way 
analysis of variance (ANOVA) were used to compare data.  A linear regression was used 
in order to determine any possible relationship between the activity of the solvent extract 
and the essential oil of the same plant.  For all statistical analyses, P < 0.05 was considered 
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significant.  The IC50 values are given as the mean ± s.d. of three independent experiments.  
All the statistical analyses were performed using the Statistica® version 5.0 software.   
 
8.4 Results 
 
8.4.1 The antimalarial activity of the essential oils and solvent extracts  
 
The results of the in vitro tests of the essential oils and solvent extracts against 
chloroquine-resistant P. falciparum (FCR-3) are presented in Table 8.1.  The essential oils 
and extracts of the evaluated species were found to exhibit antimalarial activity at IC50 
values of less than 30 µg/ml.  The activity of essential oils (IC50 values) ranged from 1.20 ± 
0.08 to 13.50 ± 2.20 µg/ml.  Among the plants tested, the essential oil from S. runcinata 
was significantly the most active (IC50 value: 1.20 ± 0.08 µg/ml) (P < 0.05).   
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Figure 8.4 Antimalarial properties of the solvent extract of Salvia radula, S. runcinata and 
the essential oils of S. africana-caerulea and S. runcinata.  
 
 
An ANOVA showed that the essential oils of five species namely S. africana-caerulea, S. 
africana-lutea, S. albicaulis, S. dolomitica, S. muirii and S. stenophylla exhibited similar 
antimalarial activity (P > 0.05).  The antimalarial activity of the solvent extracts (IC50 
values) ranged from 3.91 ± 0.52 to 26.01 ± 2.95 µg/ml.  The extract of S. radula was the 
most active (IC50 value: 3.91 ± 0.52 µg/ml) (P < 0.05).   
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Table 8.1 In vitro antimalarial activity of the solvent extracts and essential oils of 
indigenous Salvia species and isolated compounds (mean ± s.d., n = 3).  
 
Essential oils Solvent extracts Species/Isolated/  
reference compounds IC50 values in μg/ml 
S. africana-caerulea* 4.76 ± 0.48 22.68 ± 2.80 
S. africana-lutea* 5.45 ± 0.35 15.86 ± 5.04 
S. albicaulis* 6.41 ± 1.97 15.83 ± 1.94 
S. aurita nd 8.92 ± 2.63 
S. chamelaeagnea** 8.63 ± 0.96 8.71 ± 1.96 
S. disermas nd 24.17 ± 4.10 
S. dolomitica * 4.81 ± 0.74 7.62 ± 1.44 
S. garipensis nd 13.95 ± 3.76 
S. lanceolata* 7.83 ± 0.98 26.01 ± 2.95 
S. muirii* 5.93 ± 1.03 11.87 ± 2.13 
S. namaensis nd 25.38 ± 2.11 
S. radula 13.50 ± 2.20 3.91 ± 0.52 
S. repens* 1.65 ± 0.26*** 8.25 ± 2.09 
S. runcinata* 1.20 ± 0.08 16.61 ± 3.33 
S. schlechteri nd 17.51 ± 2.05 
S. stenophylla* 4.13 ± 0.63 6.50 ± 1.37 
S. verbenaca nd 23.97 ± 1.10 
Compound 1 
Compound 2 
Chloroquine diphosphate 
Quinine sulphate 
4.95 ± 2.00a 
24.60 ± 1.38a 
0.06 ± .01 
0.14 ± 0.03 
*Denotes activity of the essential oil is greater than activity of the solvent extract 
* *Denotes no significant difference between the activity of the solvent extract and essential oil (P >0.05) 
*** Essential oil obtained from Lady Grey (not from the same location as the solvent extract) 
a: mean ± s.e. (n =  1) due to the small quantity of the isolated compound 
nd: Not determined, essential not available 
 
One-way analysis of variance showed that there was no difference in the antimalarial 
activity of the solvent extracts of S. aurita, S. chamelaeagnea, S. dolomitica, S. repens and 
S. stenophylla (P > 0.05).  The activity of S. africana-lutea, S. albicaulis, S. garipensis, S. 
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muirii, S. runcinata and S. schlechteri were also not different (P > 0.05).  Finally, S. 
africana-caerulea, S. disermas, S. lanceolata, S. namaensis and S. verbenaca also 
exhibited the same activity statistically (P > 0.05).  
 
Comparison of the activity of the volatile (essential oils) and non-volatile fractions showed 
significant differences with the volatile fractions generally exhibiting higher activity (P < 
0.05) (Figure 8.5).  It was interesting to note that S. radula, with the lowest activity among 
the essential oils (IC50 value: 13.50 ± 2.20), displayed the best activity of the solvent 
extracts (Figure 8.1) (Table 8.1).  In addition, there was no statistical difference between 
the activity of the solvent extract and essential oil of S. chamelaeagnea (P > 0.05).  The 
rest of the species showed significant differences between the activity of the essential oil 
and solvent extract, with the activity of the essential oil being greater than that of the 
solvent extracts (P < 0.05). 
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Figure 8.5 Comparison between the antimalarial activity of the essential oils and the 
solvent extracts of eleven Salvia species (mean ± s.d., n = 3). 
 
The activity of the essential oils and solvent extracts was low compared to the reference 
antimalarial drugs such as chloroquine and quinine (P < 0.05) (Table 8.1).  The essential 
oil of S. runcinata (IC50 value: 1.20 µg/ml) was 20 and 9 times less active than the 
reference antimalarial drugs chloroquine and quinine, respectively.  Similarly, the activity 
of S. radula (IC50 value: 3.91 µg/ml) was 65 and 28 times less active than chloroquine and 
quinine, respectively.  
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The  very poor correlation (r2 = 0.04) (Figure 8.6) between the antimalarial activity of the 
essential oils and solvent extracts implies that the compounds responsible for the activity in 
the essential oils were most probably different to those found in the solvent extracts.  
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Figure 8.6 Relationship between the antimalarial activity of the solvent extract and 
essential oil of the same plant. 
 
8.4.2 Identification and characterization of the isolated compounds 
 
The 1H-NMR and the 13C-NMR of the isolated compounds are displayed in Table 8.2 and 
Table 8.3 and were compared to the data found in the literature (Voirin, 1983; Harraz et 
al., 1995; Rouf et al., 2001).   
 
The 1H and 13C spectra of the two isolated compounds are in Appendix D.  Compound 1 
was isolated as a white anhydrous powder.  From the mass spectrum, compound 1 has a 
M+ at m/z 476 which corresponds to a molecular formula of C30H52O4.  This compound, a 
triterpene, was identified as betulafolientriol oxide.   
 
 
 
 
 
 
 
 114
Table 8.2 NMR data (in CDCl3) of compound 1 isolated from Salvia radula. 
 
Position δC δH 
1 33.6  
2 25.4  
3 76.2 3.39, br, s 
4 37.6  
5 49.6  
6 18.2  
7 34.6  
8 40.0  
9 50.3  
10 37.3  
11 31.2  
12 71.0 3.51, td, J = 10.6, 4.7 Hz 
13 49.4  
14 52.1  
15 32.6  
16 28.6  
17 47.9  
18 15.4 0.98, s 
19 16.1 0.86, s 
20 86.5  
21 27.6 1.26, s 
22 31.2  
23 25.0  
24 85.4 3.84, dd, J = 9.0, 6.7 Hz 
25 70.1  
26 26.1 1.09, s 
27 27.9 1.27, s 
28 28.3 0.93, s 
29 22.0 0.83, s 
30 18.2 0.91, s 
OH  5.58, s; 3.89, s 
          CDCl3: chloroform, s: singlet, d: doublet, dd: double of doublets, td: triple of doublets, t: triplet,  
             br: broadened, δH: proton shift, δc: carbon shift: J: coupling constant, Hz: hertz. 
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Compound 2 was isolated as a yellow anhydrous powder, and was determined to be a 
flavonoid known as hydroxy-6,7-dimethoxy-2-(4-methoxyphenyl)-4H-1-benzopyran-4-one 
(salvigenin) with a molecular formula of C18H16O6.   
 
The UV and chromatographic data of betulafolientriol oxide and salvigenin are shown in 
Figure 5.1 and Table 5.1, while the structures of the two compounds are presented in 
Figure 8.7. 
 
Table 8.3 NMR data (in CDCl3) of compound 2 isolated from Salvia radula. 
 
Position δC δH Correlations 
observed in HMBC 
2 162.6   
3 104.1 6.59, s C-1’,4 
4 182.7   
4a 106.1   
5/8a 153.2   
6 132.6   
7 158.7   
8 90.5 6.55, s, H-8 C-4,6 
8a/5 153.1   
1’ 123.6   
2’,6’ 128.0 7.85, d, J = 9.0 Hz C-2’,4’,6’ 
3’,5’ 114.5 7.02, d, J = 9.0 Hz C-1’,2,3’,5’ 
4’ 164.0   
6-OCH3 60.8 3.93, s C-6 
7-OCH3 56.3 3.97, s C-7 
4’-OCH3 55.5 3.89, s C-4’ 
5-OH  12.77, s C-4a, 5, 6 
         CDCl3: chloroform, s: singlet, d: doublet, δH: proton shift, δc: carbon shift: J: coupling constant,  
           Hz:  hertz, HMBC: heteronuclear multiple bond correlation. 
  
The two isolated compounds were tested for antimalarial activity.  Betulafolientriol oxide 
exhibited the best activity compared to the flavanoid (salvigenin) with 5 µg/ml killing 50% 
of parasites (Table 8.1).  Although statistical comparison was not possible (because the 
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isolated compounds were tested only once due to the small amount obtained through the 
isolation procedure), salvigenin was less active, while betulafolientriol oxide exhibited 
comparable activity to the crude extract of solvent S. radula.  the two compounds were less 
active than some essential oils and the reference antimalarial drugs (Table 8.1).   
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 (C30H52O4)                                         4H-1-benzopyran-4-one (C18H16O6) (Salvigenin) 
 
Figure 8.7 Structures of the isolated compounds from Salvia radula. 
 
8.5 Discussion 
 
Malaria is a worldwide problem and the increasing spread of P. falciparum strains that are 
resistant to standard treatment has initiated numerous studies aimed at identifying new 
antimalarials.  Traditional medicine seems to be a very important source of active 
molecules (Bodeker, 2000).  Indeed, at this moment, compounds from plant origin, such as 
quinine or its alkaloids and, more recently, artemisinin and its derivatives, are the most 
efficient drugs available to combat malaria (Price et al., 1998).  The essential oils and 
organic extracts from Salvia species in this study exhibited antimalarial properties against 
the P. falciparum FCR-3 strain with all IC50 values lower than 30 μg/ml.  These results 
confirm that species belonging to the genus Salvia contain metabolites with considerable 
antimalarial potential against P. falciparum.   
 
Essential oils were significantly more active than the solvent extracts (P < 0.05).  Essential 
oil constituents have low molecular weights and can easily diffuse through the cell 
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membrane.  This may partly explain why they are more active than the solvent extracts.  
The direct application of an essential oil in the treatment of malaria has not yet been 
considered.  However, the presence of potential antimalarial compounds in the essential 
oils, as well as solvent extracts, might open possibilities for further investigation in the 
field of antimalarial compounds (Valenti et al., 1995).  
 
The biological activity of the solvent extracts and essential oils depends on the type of 
compounds present in each fraction.  For instance, the antimalarial activity of essential oils 
may be attributed to their high sesquiterpene content.  Sesquiterpenoids and their 
derivatives are credited with numerous biological properties, including antimalarial 
activity.  Recently, nerolidol (an acyclic oxygenated sesquiterpene) from the leaves of 
Virola surinamensis (Rol.) Warb. was identified as an active component of an essential oil 
that displayed antimalarial activity (Lopes et al., 1999).  Furthermore, parasites treated 
with nerolidol showed decreased ability to synthesize co-enzyme Q in all intra-erythrocytic 
stages (Boyom et al., 2003).  van Zyl et al. (2006) evaluated the antimalarial activity of 
twenty individual commercial essential oil constituents (alcohols, aldehydes, esters, 
ketones, phenols and terpene hydrocarbons).  Nerolidol, linalyl acetate, pulegone and α-
pinene were amongst the most active constituents (IC50 values < 0.3 μg/ml).  α-Pinene is 
present  in the majority of essential oils (traces-22.3%), while linalyl acetate was only 
detected in S. dolomitica (19.6%) (Table 4.1).  The antimalarial activity of many essential 
oils from other plant families is well reported in literature.  The essential oils of Tetradenia 
riparia (Lamiaceae) obtained from the leaves and stems exhibited moderate antimalarial 
activity against chloroquine-sensitive D10 and the chloroquine-resistant strain FAC-8 (IC50 
values: 25.5 and 50.3 µg/ml, respectively).  Major components of the oils were α-terpineol, 
fenchone, β-fenchyl alcohol and perillyl alcohol and these oil components were absent in 
the current study and may explain the difference in the antimalarial activity (Campbell et 
al., 1997).  Valenti et al. (1995) investigated the antimalarial activity of Lippia multiflora 
(Verbenaceae) and found that the essential oils also displayed activity.  The major 
components of the oil, nerolidol (45.2%) and linalool (20.2%), were thought to be 
responsible for the activity.  Nyiligira (2004) investigated the antimalarial activity of Vitex 
species against the chloroquine-resistant FCR-3 and found that the oils were also active 
(IC50 values < 9.3 μg/ml).  Although the essential oils studied comprise a multitude of 
compounds, it can be speculated that the presence of the compounds listed above and 
identified in indigenous Salvia essential oils may have contributed to the activity observed.  
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It is important to note that not all essential oils exhibit antimalarial properties.  For 
instance, Milhau et al. (1997) studied the activity of the essential oil of S. officinalis and 
found that the activity was very poor (IC50 value > 1000 μg/ml).  This poor activity may, 
however, be attributed to the fact that a different parasite strain was used and the chemical 
composition of the oil was also different. 
 
Clarkson et al. (2004) demonstrated that S. repens displayed antimalarial activity against 
P. falciparum (IC50 value: 10.8 μg/ml).  In this study, the IC50 value of S. repens was 8.25 
± 2.09 μg/ml which is similar to that obtained by Clarkson et al. (2004).   
 
Phenolic compounds are credited with various biological activities including anticancer, 
antibacterial, anti-oxidant activities.  Oliveira et al. (2004) demonstrated that the 
antimalarial activity of Bidens pilosa (Asteraceae) was mainly correlated to its flavonoid 
content.  In Chapter 5, the HPLC analysis revealed the presence of flavonoids in the 
solvent extracts of the investigated species.  This class of compound may have also 
contributed to the antimalarial activity of the solvent extracts. 
  
Alkaloids also exhibited antimalarial activity against P. falciparum (Sanon et al., 2003).  
Alkaloids isolated from Sida acuta (Malvaceae) were also tested for antimalarial activity 
and results pointed out that they were 18 times more active than the solvent extract (Karou 
et al., 2003).  Although no research was done in this study to confirm the presence of 
alkaloids in species investigated, alkaloids have previously been identified in some 
indigenous Salvia species, such as S. chamelaeagnea, S. namaensis and S. runcinata 
(Raffauf, 1996).   
 
Salvia species are traditionally used to treat fever, cough and diarrhoea, all symptoms of 
malaria infection.  This study showed the in vitro efficacy of Salvia species against P. 
falciparum, the causative organism.  The isolated compounds from S. radula, and the 
presence of betulafolientriol oxide (IC50 value: 5 µg/ml) in all the investigated species 
(HPLC analysis, Chapter 5), may have contributed to the overall activity of the solvent 
extracts.  Betulafolientriol oxide may act alone or in combination with other compounds 
present to determine the overall activity of the solvent extract.  
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 It has also been demonstrated that methoxylated aromatic compounds, such as compound 
2, display antimalarial activity (Kraft et al., 2002).  In this study, salvigenin (compound 2) 
was not as active the crude extract or reference antimalarial drugs (Table 8.1).  
Phytochemical studies of plants used to treat the symptoms of malaria in traditional 
medicine of different countries revealed the presence of methoxylated aromatic compounds 
(Reddy et al., 2003).  Furthermore, the methoxylated flavonoids have been found to 
enhance the in vitro activity of artemisinin (Liu et al., 1989; Bilia et al., 2002). 
 
The activity of the isolated compounds was low compared to that of the crude extract 
(Table 8.1).  Williamson (2001) demonstrated that the compound known as ginkgolides, 
isolated from Ginko biloba, was less effective than the crude extract.  The activity of the 
crude extract may be the result of a multitude of compounds present in the solvent extracts 
acting in a synergistic manner rather than the effect of only one compound. 
 
 8.6 Conclusions 
 
• Salvia species exhibit antimalarial properties against P. falciparum FCR-3. 
• Generally, the activity of the volatile fraction was statistically greater than that of 
the non-volatile fractions. 
• Betulafolientriol oxide and hydroxy-6,7-dimethoxy-2-(4-methoxyphenyl)-4H-1-
benzopyran-4-one isolated from S. radula also displayed antimalarial activity,  but 
the activity of the two compounds was low compared to the antimalarial activity of 
the crude extract. 
• The essential oils and solvent extracts were less active than chloroquine 
diphosphate and quinine sulfate. 
• This preliminary study provides a scientific basis for the traditional use of Salvia 
species in treating malaria, although more thorough in vivo evaluation is required. 
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Chapter 9:  Antibacterial and Antimycobacterial Activities of 
Salvia Species and Isolated Compounds from S. 
chamelaeagnea 
  
Abstract 
 
Salvia species are commonly used in traditional medicine to treat various microbial 
infections.  Essential oils and solvent extracts of South African Salvia species were 
investigated for their antibacterial and antimycobacterial activities using the micro-dilution 
and BACTECTM 460 radiometric methods, respectively.  The micro-organisms included 
two Gram-positive (Staphylococcus aureus and Bacillus cereus), two Gram-negative 
(Escherichia coli and Klebsiella pneumoniae) bacterial strains, as well as the organism 
responsible for tuberculosis, Mycobacterium tuberculosis.  With the exception of S. radula, 
all the solvent extracts displayed moderate to good activity against all the Gram-positive 
and Gram-negative bacterial strains with the MIC values ranging from 0.03 to 8.00 mg/ml.  
In general, S. chamelaeagnea exhibited the most favorable activity.  The solvent extracts 
also exhibited promising activity against M. tuberculosis with the MIC values ranging 
between 0.10 and 0.50 mg/ml with S. dolomitica, S. radula and S. verbenaca displaying the 
best activity (MIC value: 0.10 mg/ml).  The essential oils showed moderate activity against 
B. cereus and K. pneumoniae, while negligeable activity was observed against E. coli and 
S. aureus (MIC value > 12 mg/ml).  The in vitro antibacterial activity of S. chamelaeagnea 
and Leonotis leonurus combined at various ratios showed in general synergistic interaction 
against the Gram-positive bacterial strains, while antagonistic and/or additive interactions 
were observed for the Gram-negative organisms.  The antibacterial bio-assay guided 
fractionation of S. chamelaeagnea resulted in the isolation, identification and 
characterization of four compounds, namely carnosol, 7-O-methylepirosmanol, oleanolic 
acid and its isomer ursolic acid as the active principles against S. aureus.  The in vitro 
antibacterial and antimycobacterial activities add scientific support to the use of Salvia 
species in traditional medicine against tuberculosis and a range of other bacterial 
infections. 
 121
9.1 Introduction 
 
Micro-organisms are involved in the pathogenesis of many diseases and cause 
deterioration of a variety of products.  Despite the progress in understanding the life cycle 
and control of many pathogens, nearly all the diseases affecting millions of people in 
developing countries are still caused by micro-organisms.  This is mainly due to factors 
such as inadequate sanitation, poor hygiene and overcrowded living conditions (Wagstaff, 
2002).  
 
Tuberculosis (TB), a mycobacterial infection, remains a serious health problem in many 
regions of the world.  It is estimated that a third of the world’s population is infected with 
Mycobacterium tuberculosis and approximately 1.7 million people died of TB in 2003 
(WHO, 2005b).  In 2004, TB killed half a million people in Africa, mostly young men and 
women in their most productive years.  Africa is the only continent where the TB rates are 
increasing.  In just 15 years, overall rates have doubled, tripled in HIV endemic areas, and 
quadrupled in countries worst affected by HIV and TB (WHO, 2005b).  The current threat 
to the success of TB treatment lies in the emergence of strains resistantance to the best 
antituberculosis drugs, namely isoniazid and rifampicin (Mativandlela et al., 2006) and the 
extreme drug-resistant TB strain that emerged in South Africa has drastically compromised 
the treatment programmes to eradicate TB.  Common symptoms associated with TB 
include night sweats, fatigue, chest pains, loss of appetite resulting in weight loss (WHO, 
2006a). 
 
Infections associated with bacterial pathogens are among some of the conditions treated 
using traditional remedies in South Africa (Watt and Breyer-Brandwijk, 1962).  In the past, 
the development of resistance by pathogens to many of the commonly used antimicrobial 
agents provided sufficient impetus for further attempts to search for new antimicrobial 
agents to combat infection (Grange and Davey, 1990).  Sage is a potential source for new 
antimicrobial agents since it was used prior to the discovery of antimicrobial agents as a 
common component of herbal mixtures to treat the symptoms of tuberculosis and microbial 
infections (Watt and Breyer-Brandwijk, 1962).  
 
The use of synergistic combinations is often needed in the treatment of serious infection 
and to reduce the risk of developing resistant strains.  In traditional medicine, healers 
mostly rely on a combination of plants to treat diseases (Iwu, 1994).  However, no in vitro 
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studies have as yet been reported on the effect of combining Salvia species with other 
plants against bacteria.   
A survey of the literature revealed that Salvia species were usually used by Europeans in 
the Western Cape of South Africa with Leonotis leonurus (L.)  R.Br. (Lamiaceae) to treat 
influenza, chest inflammation, pulmonary tuberculosis, skin diseases, colds and coughs 
(Watt and Breyer-Brandwijk, 1962).  This information prompted an investigation into the 
in vitro antibacterial activity of S. chamelaeagnea and L. leonurus in combination.  
 
The in vitro antibacterial and antimycobacterial screening provided the preliminary 
information for the selection of those active crude extracts of plants that were subjected to 
further chemical analysis.  
 
The objectives of this study were to: 
(i) investigate the antibacterial activity of the essential oils and solvent extracts 
of indigenous Salvia species, 
(ii) evaluate the potential of the solvent extracts in inhibiting the growth of the 
tuberculosis pathogen, 
(iii) evaluate the in vitro antibacterial activity of S. chamelaeagnea and L. 
leonurus in combination, and 
(iv) isolate, identify and characterise the compounds exhibiting antibacterial 
activity from  one of the active species. 
 
9.2 Materials and methods 
 
9.2.1 Reagents, chemicals and drugs 
 
Tryptone soya agar (TSA), Tryptone soya broth (TSB) and ciprofloxacin were purchased 
from CA Milsch, while p-iodonitrotetrazolium chloride (INT), ursolic acid, oleanolic acid 
and rifampicin were from Sigma®.  The BACTECTM 12B media was purchased from 
Becton Dickinson.  All solvents used were analytical grade from Rochelle Chemicals.  The 
blood agar was obtained from the National Heath Laboratory Services (NHLS, 
Johannesburg).  
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9.2.2 Source and maintenance of micro-organisms 
 
Four strains of bacteria were investigated and included Bacillus cereus (ATCC 11778), 
Staphylococcus aureus (ATCC 25923), Klebsiella pneumoniae (NTCC 9633) and 
Escherichia coli (ATCC 8739).  The reference stock cultures were obtained from the 
NHLS (Johannesburg) and were maintained in the microbiology laboratory of the 
Department of Pharmacy and Pharmacology, University of the Witwatersrand, 
Johannesburg, South Africa.  The maintenance was carried out using TSA prepared by 
dissolving 30 g in 750 ml of sterile water.  The agar was autoclaved for 15 minutes at 121 
ºC before use in order to sterilise the medium. 
 
Mycobacterium tuberculosis H37Ra ATCC 25177 was used for the antimycobacterial 
experiments.  The stock culture in glycerol was stored at -70 °C until experimentation.  
The stock was used to inoculate a 12B vial (Figure 9.1) and incubated at 37 °C.  The 12B 
medium is an enriched Middlebrook 7H9 broth base containing 14C-labeled palmitic acid 
for radiometric detection of mycobacterial growth.  
 
 
 
Figure 9.1 (A): BACTECTM 460 apparatus with racks containing inoculated vials; (B): the 
12B vials containing the 14C carbon substrate. 
 
If micro-organisms are viable in the test sample, they utilize the 14C-labeled substrate 
(palmitic acid) present in the medium and release 14CO2 into the head space above the 
medium.  When tested on the BACTECTM 460 instrument, the gas is aspirated from the 
vial and the 14CO2 radio-activity is measured and displayed as a growth index (GI) ranging 
from 0 to 999 (Middlebrook et al., 1977).  The daily increase in the GI is directly 
proportional to the rate and amount of growth in the medium.  
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9.2.3 Sample preparation 
 
Stock solutions of both plant extract (64 mg/ml) and essential oil (128 mg/ml) for the were 
prepared with acetone for the antibacterial study.  For the combination experiment, the 
concentration of each plant was first carried out at 64 mg/ml and various ratios using the 
stock solution prepared.  The stock solution used in the antimycobacterial activity testing 
was prepared at a concentration of 42 mg/ml with 50% methanol.  The animycobacterial 
activity of the essential oils was not performed because the quantity of oil was not 
sufficient.  
 
9.2.4 Determination of the antibacterial and antimycobacterial activities 
 
9.2.4.1 Antibacterial activity: micro-dilution method 
The in vitro antibacterial activity was evaluated by a micro-dilution assay (Eloff, 1998).  
Dilutions were prepared in a sterile, flat-bottom, 96-well microtitre plate.  In a 96-well 
plate, 100 μl of sterile water was plated out in all the wells.  In the first row, 100 μl (stock 
solution) of plant extract/essential oil was added to the well and 100 μl transferred to the 
next row after thorough mixing with the water in the 96-well microtitre plate using a 
multichannel pipette.  This dilution series is prepared from the top to the bottom of the 
plate until the last row where 100 μl from each well was discarded.  The bacterial 
suspension (100 μl), yielding an inoculum size of approximately 1 x 106 CFU/ml was 
added to all the wells.  The final concentration in the wells ranged from 16.00 to 0.13 
mg/ml (extract) and from 32.00 to 0.50 mg/ml (essential oil).  Further serial dilutions were 
made where necessary.  The plate was then sealed and incubated at 37 ºC overnight.  After 
incubation, 50 μl of 0.04% (w/v) INT was added directly into each well and the plate left at 
room temperature for six hours before the readings were taken.  The method is based on 
the principle that the colourless tetrazolium compound (INT) acts as an electron acceptor 
and is reduced to a coloured product by biologically active organisms (Eloff, 1998).  
Sterile water was used as a negative control, while ciprofloxacin was used as the positive 
antibacterial control.  The final concentration (3%) of acetone in the well did not adversely 
affect the bacterial growth. 
 
The minimum inhibitory concentration (MIC) value was determined as the lowest 
concentration of sample required to inhibit the growth of test organisms.  In the microtitre 
plate, the MIC can be seen as the lowest concentration where the clear well is observed 
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(Figure 9.2).  In some cases, the colour of the extract prevents a good visualisation of the 
bacterial growth/inhibition.  Thus, the agar plate was prepared in order to double check 
whether there was effectively no bacterial growth.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9.2 An example of the determination of the MIC value using a 96-well microtitre 
plate.  The first clear well from the bottom indicates the MIC value, i.e. the concentration 
at which no bacterial growth is obtained and the purple well indicates bacterial growth. 
 
9.2.4.2 Combination study of S. chamelaeagnea and L. leonurus 
To study the combined antibacterial activity of S. chamelaeagnea and L. leonurus 
(methanol:chloroform, 1:1 v/v), ten combinations at various ratios were prepared utilising 
extracts with an initial concentration of 64 mg/ml in acetone.  The following ratios of S. 
chamelaeagnea and L. leonurus were considered, respectively: 10:0; 9:1; 8:2; 7:3; 6:4; 5:5; 
3:7; 2:8; 1:9 and 0:10.  A volume of 100 μl of different combinations was introduced into a 
96-well microtitre plate containing 100 μl of water and the experiment was then carried out 
as described in Section 9.2.4.1. 
 
In order to analyse the outcome of the combination study, the sum of fractional inhibitory 
concentration of S. chamelaeagnea and L. leonurus (sum FICSL) was mathematically 
determined (Eq. 9.1) (Berenbaum, 1978).  All ratios were presented graphically by 
construction of isobolograms as described by Canfield et al. (1995).  The data points for 
each pathogen were obtained for various ratios by plotting the MICS in combination 
divided by the MICS alone on the X axis versus the MICL in combination divided by the  
0.25 mg/ml 0.13 mg/ml Negative control 
Decreasing concentration
16.0 mg/ml 32.0 mg/ml 
Decreasing concentration
Essential oil Extract
8.0 mg/ml 
1.0 mg/ml 
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MICL alone (on the Y axis).  Based on the sum FICSL values, values < 1 indicate 
synergistic interactions, values > 1 show antagonistic interactions, while values ≈ 1 
represent additive interactions.  On the basis of the isobolograms, data points above the 
straight line have antagonistic interactions, those below have synergistic interactions and 
those in the vicinity of the line have additive interactions. 
 
sum FICSL = MICS in combination  + MICL in combination                                     (Eq 9.1) 
                             MICS alone                 MICL alone 
Where: FICSL = Sum of the fractional inhibitory concentration of S. chamelaeagnea and  
L. leonurus. 
MICS = Minimum inhibitory concentration of S. chamelaeagnea. 
MICL = Minimum inhibitory concentration of L. leonurus. 
 
 For each analysis, samples were performed in duplicate and at least three experiments 
were carried out per test sample.  
 
9.2.4.3 Bio-assay on M. tuberculosis: BACTECTM method 
The susceptibility testing of the solvent extracts against M. tuberculosis was conducted 
using the radiometric BACTECTM technique as described by Siddiqi et al. (1981), Roberts 
et al. (1983) and Scarparo et al. (2002).  This method, despite the relatively high cost of 
the 12B culture medium, was preferred to the agar method for plant extract susceptibility 
testing because the radiometric method allows greater cell-to-drug interaction in the liquid 
medium as described by Lall and Meyer (1999). 
 
The 12B vials were inoculated with M. tuberculosis from the stock solution, incubated at 
37 °C and changes in the GI were recorded daily until a value of 999 was obtained.  The 
mycobacterial suspension was adjusted to approximately match that of a McFarland No. 1 
turbidity standard (Lall and Meyer, 1999).  Thereafter, a 12B vial was inoculated with 100 
µl of the mycobacterial suspension and incubated at 37 °C.  When the growth in this vial 
reached 400-500, the 7H9 broth culture was used undiluted to inoculate a set of 12B vials 
(100 µl per vial), yielding approximately 1 x 104-1 x 105 CFU/ml (Heifets et al., 1985).  
Before the extracts were added to the vials, each sample was filtered through a 0.22 μm 
Whatman® filter unit to prevent any contamination.  The final extract concentration of 1, 
0.5 and 0.1 mg/ml were initially prepared in 50% methanol.  Vials were incubated at 37 °C 
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and visually monitored every day for turbidity as an indicator of contamination and any 
suspected contaminants were confirmed by culturing on 2% blood agar plates (NHLS, 
Greenpoint) made with Mueller Hinton (Oxoid) and 2% blood.  Two plant extract-free 
vials were used as controls.  One vial was inoculated with the organism in the same way as 
the vial containing plant extracts and the other was inoculated with a 1:100 dilution of the 
inoculum obtained by adding 0.10 ml of inoculum to 9.90 ml of 12B medium.  A methanol 
control at 2.38%, equivalent to the maximum solvent concentration in the 12B test 
samples, had no negative impact on the normal growth of M. tuberculosis.  
 
The radiometric susceptibility method indicates that the concentration of the extract that 
results in a daily increase and final ∆GI reading lower than in the control (1:100) can be 
considered the concentration at which more than 99% of the bacterial population is 
inhibited.  Rifampicin, a standard antituberculosis drug, was used as positive control at a 
final concentration of 2.00 µg/ml.  The difference in the GI values for the last two days is 
designated as ΔGI.  The GI readings of the plant extracts were compared with the control 
vial containing 1:100 dilution of the inoculum.  Once the ΔGI of the control reached 30, 
the results were interpreted by comparing the increase with that in the test vial.  The 
following formula was used to interpret the results: ΔGI control > ΔGI drug = susceptible; 
ΔGI control < ΔGI drug = resistant and the MIC value was defined as the lowest 
concentration of drug inhibiting more than 99% of the M. tuberculosis population.  The 
final MIC value was confirmed by repeat testing.   
 
9.2.5 Isolation of antibacterial active compounds from S. chamelaeagnea 
 
S. chamelaeagnea which displayed the most favourable antibacterial activity was selected 
to isolate the active principles.  Combinations of various methods were used in isolation, 
identification and characterization procedures. 
 
9.2.5.1 Extraction  
Dried aerial parts (423.4 g) collected at the Kirstenbosch Botanical Garden were powdered 
and extracted with methanol:chloroform (1:1, v/v) and the residue was evaporated under 
reduced pressure to yield 19.6 g.  
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9.2.5.2 Column chromatography 
The residue was mixed with a small quantity of Silica gel 60 (0.063-0.200 mm/70-230 
mesh ASTM, Macherey-Nagel), dried at 60 °C in an oven, reduced to a fine powder and 
added to the top of the column.  The column (4 cm x 60 cm) was eluted successively with 
hexane:dichloromethane (9:1), then dichloromethane:methanol (6:1) followed by 100% 
methanol.  The collection of these crude fractions were based on colour change.  The 
fractions were collected in 250 ml conical flasks and similar spots on TLC were combined 
to yield five main fractions (A-E). 
 
9.2.5.3 Thin layer chromatography and bio-autographic assay 
A direct antibacterial bio-assay (Dilika and Meyer, 1996) on a TLC plate was employed 
using the agar-overlay method with S. aureus as the test organism.  S. aureus was selected 
because it is amongst the most difficult bacterial strains to combat with classic antibacterial 
agents (Tomás-Barberán et al., 1990).  Each of the five fractions (Section 9.2.5.2) were 
spotted on a TLC plate (Alugram® Sil G/UV254, 0.200 mm) developed with 
toluene:dioxan:acetic acid glacial (95:25:5) as eluent.  The dried TLC plate was then 
sterilised under UV light (254 nm) for one hour before being placed in a petri dish 
containing the solidified agar.  The UV light was used to sterilise the dried extract instead 
of autoclaving in order to avoid denaturing the active constituents (Okoli and Iroegbu, 
2004).  The plate was then overlayed with S. aureus culture (1 x 106 CFU/ml) in TSA and 
left to solidify.  After one hour at 4 °C (to allow the compounds on the TLC to diffuse), the 
plate was removed and incubated at 37 °C for 24 hours.  At the end of the incubation 
period, the TLC plate was sprayed with 0.04% (w/v) aqueous solution of INT to visualise 
the inhibition zone.  The inhibition zone was indicated by the clear zone on the purple 
background (Figure 9.3).  Only fraction D (Figure 9.3) was active and thus selected for 
further analysis.  
 
9.2.5.4 Bioactivity-guided fractionation and isolation 
Fraction D was evaporated under vacuum to yield 6.21 g. This fraction was 
rechromatographed on a small column (2.5 cm x 45 cm) using hexane:ethyl acetate: acetic 
acid (12:3:0.02) as eluent.  A total of 322 sub-fractions in 3 ml test tubes were collected.  
The fractions were spotted on the TLC plate and developed in toluene:dioxan:acetic acid 
glacial (95:25:5) and similar fractions were combined and subjected to a bio-autographic 
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assay on TLC to detect fraction(s) containing the active compound(s).  The eluted fractions 
were monitored on a TLC plate developed with the same solvent system. 
 
 
 
 
 
 
 
 
 
 
Figure 9.3 Bio-autographic assay of Salvia chamelaeagnea against Staphylococcus 
aureus:  Inhibition zones are shown by clear spots on the purple background. 
 
Pooled fractions were concentrated with a rotary evaporator and rechromatographed using 
the same column with hexane:ethyl acetate:acetic acid (12:2:0.01) as the solvent system.  
The column chromatography of the active fraction was finally carried out with 
toluene:ethyl acetate (10:3) and 293 sub-fractions were obtained.  Throughout the isolation 
procedure, crystals formed were further purified by recrystalisation from acetone.  The 
bioactivity-guided methodology is summarized in Figure 9.4. 
 
9.2.5.5 Identification and elucidation of isolated compounds 
The isolated compounds were structurally characterised using NMR and MS and data 
compared to those found in the literature [1 and 2 (Urones et al., 1998; Ahmed et al., 
2006), 3 and 4 (Mahato and Kundu, 1994)]. 
 
(i) Nuclear magnetic resonance (NMR) 
1H, 13C, HSQC, HMBC, DEPT, NOESY and COSY NMR data of compounds 1, 2, 3 and 4 
were recorded on a Varian Inova 2000 300 MHZ spectrometer.  All spectra were recorded 
at 25 °C in deuterated chloroform and the chemical shifts were recorded in ppm referenced 
to TMS. 
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(ii) Mass spectrometry  
Electron ionization MS of the isolated compounds was performed by direct inlet at 70 eV 
on the GC-MS QP 2010 GC coupled to MS. 
  
 Crude extract (19.6 g)                             
                                     
                                                            Silica gel 60 
                                                 Hexane:Dichloromethane (9:1) 
                                                            Dichloromethane:Methanol (6:1) 
                                                            Methanol (100%) 
 
                                                  Fraction D (6.21 g) 
 
                                                            Silica gel 60 
                                                            Hexane:Ethyl acetate:Acetic acid (12:3:0.02) 
 
                                                    Fractions 18-95 (0.63 g) 
    
                                                            Silica gel 60 
        
 
                                        Fractions 18-45 (0.43 g) 
                                                             
      Silica gel 
Compound 1 (120 mg)                       Hexane:Ethyl acetate:Acetic acid (12:2:0.01) 
      (Crystals) 
        Flash silica 
                                                           Toluene:Ethyl acetate (10:3) 
 
                                                    
                                                     
       
     Sub-fraction 18-25                                                                    Sub-fraction 47-54  
     Compound 2 (12 mg)                                                                Compound 3 and 4 (9 mg) 
 
Figure 9.4 Bio-assay guided fractionation for compounds isolated from S. chamelaeagnea.   
 
 
9.3 Results 
 
9.3.1 Antibacterial activity 
 
The solvent extracts and essential oils affected the test organisms to different degrees and 
the results of the antibacterial activity showed that the solvent extracts exhibited better 
antibacterial activity than the essential oils (Table 9.1).   
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Table 9.1 The MIC values (mg/ml) of the solvent extracts and essential oils of Salvia species against Gram-positive and Gram-negative  
bacteria (n = 3). 
 
nd: not determined, essrential oil insufficient or not available; EO: essential oil; Ext: solvent extract.  
E. coli (ATCC 8739) K. pneumoniae (NCTC 9633) B. cereus (ATCC 1177) S.  aureus (ATCC 25923) Species/Isolated 
compound/Controls Ext EO Ext EO Ext EO Ext EO 
S. africana-caerulea 4.00 16.00 4.67 8.00 6.00 0.75 3.00 4.0 
S. africana-lutea 3.00 > 32.00 3.00 8.00 0.75 2.33 0.75 8.00 
S. albicaulis 4.00 > 32.00 4.67 8.00 1.00 2.33 1.00 8.00 
S. aurita 4.00 nd 4.000 nd 0.25 nd 0.05 nd 
S. chamelaeagnea 1.00 > 32.00 3.0 12.00 0.03 2.00 0.06 > 32.00 
S. disermas 4.00 nd 2.00 nd 3.00 nd 0.75 nd 
S. dolomitica  3.33 > 32.00 2.00 8.00 0.75 9.33 0.03 12.00 
S. garipensis 1.88 nd 2.81 nd 0.75 nd 4.00 nd 
S. lanceolata 4.00 32.00 2.00 16.00 3.00 1.00 2.00 8.00 
S. muirii 2.00 > 32.00 3.00 6.00 0.25 9.33 0.36 > 32.00 
S. radula > 16.00 nd 4.00 nd 1.00 nd 0.06 nd 
S. repens 2.00 nd 3.00 nd 0.03 nd 0.25 nd 
S. runcinata 2.00 > 32.00 4.00 > 32.00 0.03 2.00 0.25 > 32.00 
S. schlechteri 4.00 nd 3.00 nd 0.75 nd 0.25 nd 
S. stenophylla 4.00 > 32.00 2.00 8.00 0.03 1.50 0.06 > 32.00 
S. verbenaca 8.00 nd 2.00 nd 2.00 nd 3.0 nd 
Carnosol 2.00 2.00 0.02 0.03 
Oleonolic acid 3.41 1.71 1.28 3.75 
Ursolic acid 2.50 3.75 7.32 x 10-3 0.01 
7-O-Methyl-epi-rosmanol nd nd 0.01 0.02   
Ciprofloxacin 4.00 x 10-5  1.60 x 10-4 4.10 x 10-5 3.1 x 10-4   
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Nearly all the solvent extracts evaluated for antibacterial activity were active against the 
strains used.  While essential oils exhibited moderate activity against B. cereus and K. 
pneumoniae and were almost completely inactive against E. coli and, to a certain degree, S. 
aureus (Table 9.1).  
 
Among the plants screened, only the solvent extract of S. radula failed to inhibit the 
growth of E. coli, although displaying good activity against other pathogens.  The best 
activity of the solvent extracts against B. cereus was obtained with S. chamelaeagnea, S. 
radula, S. runcinata and S. stenophylla (MIC value: 0.03 mg/ml), while S. africana-
caerulea displayed the lowest activity (MIC value: 6.00 mg/ml).  The best activity against 
S. aureus was obtained with S. dolomitica (MIC value: 0.03 mg/ml).  Five species, namely 
S. disermas, S. dolomitica, S. lanceolata, S. stenophylla and S. verbenaca were the most 
active against K. pneumoniae (MIC value: 2.00 mg/ml).  Finally, the best activity against 
the Gram-negative E. coli was obtained with the solvent extract of S. chamelaeagnea (MIC 
value: 1.00 mg/ml) and S. muirii (MIC value: 1.88 mg/ml).  It was interesting to observe 
that the essential oil of S. africana-caerulea was more active than its solvent extract 
against B. cereus. 
 
The isobolograms of S. chamelaeagnea and L. leonurus at various ratios against the four 
pathogens are shown in Figure 9.5.  Synergistic interactions were obtained against Gram-
positive bacteria for nearly all ratios.  Only the ratio 2:8 of S. chamelaeagnea and L. 
leonurus showed antagonistic interactions against S. aureus (data point corresponding to 
2.50 and 1.24, cannot be seen on the graph, but on Table 9.2 as 3.74).  Mostly antagonistic 
or additive interactions were observed with Gram-negative bacteria (Figure 9.5).  
However, ratios 5:5, 3:7 and 2:8 showed synergistic interactions against E. coli, while 
ratios 7:3 and 5:5 were also synergistic against K. pneumoniae. 
 
The sum of fractional inhibitory concentration values of S. chamelaeagnea and L. leonurus 
(sum FICSL) are displayed in Table 9.2.  It can be seen that the response of the combination 
between the two plants varied with ratios and the specific test organism.  Similarly, only 
ratio 2:8 (FICSL = 3.74) showed antagonistic interactions against the Gram-positive 
bacteria, while all the remaining ratios were synergistic (FICSL < 1). 
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Figure 9.5 Isobolograms constructed from combination study involving Salvia 
chamelaeagnea and Leonotis leonurus on four bacterial pathogens.  
 
 
The combination of S. chamelaeagnea and L. leonurus at various ratios showed synergistic 
interactions at only three ratios (5:5, 3:7 and 2:8) against E. coli, while against K. 
pneumoniae, the synergistic interactions were obtained at only two ratios (7:3 and 5:5) 
(sum FICSL < 1, Table 9.2). 
 
This study revealed that Gram-positive bacteria were more sensitive compared to Gram-
negative bacteria.  E. coli was in general the most resistant strain especially against the 
essential oils with all MIC values obtained greater than 32 mg/ml. 
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Table 9.2 The sum of the fractional inhibitory concentration (sum FICSL) values of Salvia 
chamelaeagnea and Leonotis leonurus using various combinations ratios. 
 
Pathogens 
Ratios E. coli  
(ATCC 8739) 
K. pneumoniae 
(NCTC 9633) 
B. cereus 
(ATCC 11778) 
S. aureus 
(ATCC 11778) 
10:0 1.00 1.00 1.00 1.00 
9:1 1.39 1.00 0.55 0.99 
8:2 1.10 1.00 0.50 0.87 
7:3 1.15 0.67 0.45 0.78 
6:4 1.20 1.00 0.53 0.68 
5:5 0.83 0.67 0.35 0.89 
3:7 0.81 1.00 0.66 0.81 
2:8 0.93 1.00 0.78 3.74 
1:9 1.45 1.00 0.75 0.84 
0:10 1.00 1.00 1.00 1.00 
Values < 1 denote synergism interactions; values > 1 denote antagonism interactions and values ≈ 1 denote 
additive interactions. 
 
9.3.2 Antimycobacterial activity 
 
Mycobacterium tuberculosis was sensitive to all the solvent extracts at a concentration of 
1.00 mg/ml (Table 9.3).  Three species, namely S. dolomitica, S. radula and S. verbenaca 
inhibited mycobacterial growth at a concentration of 0.10 mg/ml.  Therefore, further 
dilutions yielded a MIC value of 0.10 mg/ ml for all three extracts (Table 9.3).   
 
Since the three species exhibited the same activity, the GI was plotted at 0.10 and 0.05 
mg/ml and the results are depicted in Figure 9.6.  It is clear that S. verbenaca was the most 
active extract because its GI readings at 0.10 and 0.05 mg/ml were low compared to that of 
S. radula and S. dolomitica (Figure 9.6) when tested at the same concentration. 
 
It was noted that these three species also exhibited good antibacterial activity against S. 
aureus and B. cereus (Table 9.1). 
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Table 9.3 The effect of plant extracts on the growth of Mycobacterium tuberculosis using 
the radiometric method.   
 
∆GI values (mg/ml) 
Plant species 
1.00 0.50 0.10 
MIC values 
(mg/ml) 
S. africana-caerulea 0 (S) -3 (S) 73 (R) 0.50 
S. africana-lutea 0 (S) 0 (S) 50 (R) 0.50 
S. albicaulis 0 (S) 0 (S) 41 (R) 0.50 
S. aurita 0 (S) 4 (S) 33 (R) 0.50 
S. chamelaeagnea (S) 1 (S) 37 (R) 0.50 
S. disermas 0 (S) 18 (S) 520 (R) 0.50 
S. dolomitica 2 (S) -1 (S) 11 (S) 0.10 
S. lanceolata 0 (S) -1 (S) 40 (R) 0.50 
S. muirii 0 (S) 7 (S) 33 (R) 0.50 
S. radula -1 (S) 4 (S) 10 (S) 0.10 
S. repens 0 (S) 2 (S) 48 (R) 0.50 
S. runcinata 0 (S) 4 (S) 40 (R) 0.50 
S. schlechteri 0 (S) 19 (S) 38 (R) 0.50 
S. stenophylla 0 (S) 8 (S) 38 (R) 0.50 
S. verbenaca -2 (S) 3 (S) 5 (S) 0.10 
Rifampicin 0 (S) 0 (S) 0 (S) 0.002 
S, sensitive; R, resistant, ∆GI values of the control vials were 29, 29 and 28 at 1, 0.5 and 0.1 mg/ml, 
respectively.  For the sample to be active against M. tuberculosis, ∆GI must be less or equal to ∆GI of the 
control vial.  A rifampicin control vial (2 µg/ml) was included in each experiment. 
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Figure 9.6 Growth index of three Salvia species tested at two different concentrations 
against Mycobacterium tuberculosis. 
 
9.3.3 Elucidation and identification of the isolated compound from S. chamelaeagnea 
 
The 1H-NMR and 13C-NMR data of the four isolated compounds are presented in Table 9.4 
to Table 9.6.  The 1H, 13C spectra are shown in Appendix E.  Based on the 1H-NMR , 13C-
NMR, DEPT, COSY spectra  and comparison with the data obtained in the literature, 
compound 1 was identified as 2H-9,4a-(epoxymethano) phenanthren-12-
one,1,3,4,9,10,10a-hexahydro-5,6-dihydroxy-1,1-dimethyl-7-(1-methylmethylethyl)-
4aR,9S,10aS)-(9CI) (carnosol) and established to have a molecular formula of C20H26O4.  
Compound 2 was a diterpene identified as the 7-O-methylepirosmanol and established to 
have a molecular formula of C21H28O5.  Compound 3 and 4 (triperpenoid ) were obtained 
as co-eluting mixture and identified as [(3β)-3-hydroxyurs-12-en-28-oic acid], commonly 
known as ursolic acid and the chemical formula is (C30H48O3), while compound 4, which is 
an isomer of compound 3, was characterized as  [(3β)-3-hydroxyolean-12-en-28-oic acid] 
commonly known as oleanolic acid with the chemical formula (C30H48O3).  The UV and 
chromatographic data of the isolated compounds are shown in Figure 5.1 and Table 5.1, 
while the absolute stereochemistries of the isolated compounds are presented in Figure 9.7. 
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Table 9.4 NMR data (in CD3OD) of compound 1 isolated from Salvia chamelaeagnea. 
 
Position δC δH Correlations observed in HMBC NOESY 
1 29.0 2.82-2.88, dt C-2, 10, 20  
2 18.9 1.64, t   
3 41.0 1.58-1.62, m   
4 34.3    
5 45.9 1.74, m C-9, 10, 18, 19, 20  
6 29.7 2.25, m C-4, 7, 8, C-5  
7 78.6 5.5, s   
8 132.2    
9 121.8    
10 48.6    
11 143.6 4.90, s   
12 143.1 4.90, s   
13 134.9    
14 111.4 6.74, s C-7, 9, 12, 15 H-7 
15 26.8 3.30, m C-12, 13, 14, 16, 17  
16 22.1 1.22-1.28, m C-15, 17  
17 22.1 1.22-1.28, m C-15, 16  
18 31.0 0.80, s C-3, 4, 5, 18  
19 18.9 0.80, s C-3, 4, 5, 19  
20 178.2    
CD3OD: methanol: HMBC: heteronuclear multiple bond correlation, NOESY: nuclear overhauser effect 
spectroscopy, singlet, dt: double of triplets, t: triplet, m: multiplet, δC: carbon shift, δH: proton shift.  
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Table 9.5 NMR data (in CDCl3) of compound 2 isolated from Salvia chamelaeagnea. 
 
Carbon δC δH 
1 26.9  
2 18.8  
3 37.7  
4 31.7  
5 55.5  
6 74.2 4.35, d, J = 2.8 Hz 
7 78.0 4.85, d, J = 2.8 Hz 
8 125.7  
9 124.8  
10 47.8  
11 143.9  
12 141.2  
13 135.3  
14 119.7 6.84, s 
15 27.1  
16 22.0 1.11, d 
17 22.5 1.13, d 
18 31.5 0.91, 18 
19 21.8 0.87, 19 
20 179.4  
OMe 56.0 3.50, s 
CDCl3: chloroform: δC: carbon shift, δH: proton shift, singlet, d: doublet, J: coupling constant, Hz: hertz. 
 
 
 
 
 
 
 
 
 
 139
Table 9.6 NMR data (in CDCl3) of the mixture of two triterpenoids: oleanolic and ursolic 
acid isolated from Salvia chamelaeagnea. 
 
δC Mixture δC  Oleanolic acid (Mahato 
and Kundu, 1994) 
δC  Ursolic acid (Mahato and 
Kundu, 1994) 
180.7 (s) 181.0 (s, C-28)  
180.5 (s),  180.4 (C-28) 
143.7 (s) 143.4 (s, C-13)  
138.0 (s)  148.1 (s, C-13) 
125.3 (d)  125.5 (d, C-12) 
122.1 (d) 122.1 (d, C-12)  
78.7 (d) (2C) 78.7 (d, C-3) 78.9 (d, C-3) 
55.1 (d) (2C) 55.2 (d, C-5) 55.1 (d, C-5) 
52.7 (d)  52.7 (d, C-18) 
47.7 (s)  47.7 (s, C-17) 
47.5 (d) 47.6 (d, C-9)  
47.4 (d)  47.5 (d, C-9) 
46.2 (s) 46.6 (s, C-17)  
45.8 (t) 45.8 (t, C-19)  
41.9 (s)  42.0 (s, C-14) 
41.6 (s) 41.6 (s, C-14)  
41.0 (d) 41.3 (d, C-18)  
39.3 (s) 39.3 (d, C-8) 39.4 (d, C-8) 
39.0 (s) 38.7 (s, C-4)  
38.9 (d)  39.0 (d, C-19) 
38.7 (d)  38.6 (d, C-20) 
38.52 (t)  38.8 (t, C-1) 
38.49 (s)  38.6 (s, C-4) 
38.3 (t) 38.5 (t, C-1)  
36.8 (s) 37.0 (s, C-10)  
36.7 (s)  37.0 (s, C-10) 
36.6 (t)  36.7 (t, C-22) 
33.7 (t) 33.8 (t, C-21)  
32.8 (q) 33.1 (q, C-29)  
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δC Mixture δC  Oleanolic acid (Mahato 
and Kundu, 1994) 
δC  Ursolic acid (Mahato and 
Kundu, 1994) 
32.8 (t)  33.0 (t, C-7) 
32.6 (t) 32.8 (t, C-22)  
32.4 (t) 32.6 (t, C-7)  
30.5 (t) 30.6 (C-20) 30.6 (t, C-21) 
27.84 (q) 28.1 (q, C-23) 28.2 (q, C-23) 
27.80 (q)  28.0 (t, C-15) 
27.5 (t)  27.9 (t, C-2) 
26.7 (t) 27.7 (t, C-15)  
26.6 (t) 27.4 (t, C-2)  
25.6 (q) 26.0 (q, C-27)  
24.0 (t)  24.2 (t, C-16) 
23.3 (q) 23.6 (q, C-30)  
23.2 (t) 23.4 (t, C-16)  
23.1 (t)  23.3 (t, C-11) 
22.9 (t) 23.1 (t, C-11)  
20.9 (q)  21.1 (q, C-30) 
18.5 (t) (2C) 18.3 (t, C-6) 18.2 (t, C-6) 
16.8 (q)  16.9 (q, C-6, 27) 
16.7 (q) 16.8 (q, C-26)  
16.6 (q)  16.8 (q, C-29) 
15.40 (q)  15.7 (q, C-25) 
15.35 (q) 15.6 (q, C-24)  
15.2 (q)  15.4 (q, C-24) 
15.1 (q) 15.3 (q, C-25)  
     δH 5.21 (1H, br. s, H-12), 5.18 (1H, br. s, H-12), 3.14 (2H, t, J = 7.7 Hz, H-3). 
 
CDCL3: chloroform, s: singlet, d: doublet, t: triplet, q: quartet, δH: proton shift, J: coupling constant, Hz: 
hertz. 
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Figure 9.7 Structures of the isolated compounds with antibacterial activity from Salvia 
chamelaeagnea. 
 
9.4 Discussion 
 
The solvent extract displayed good to moderate antibacterial activity as shown by the low 
MIC values (Table 9.1).  According to Fabry et al. (1998), the solvent extracts of plants 
with MIC values around 8.00 mg/ml may have some antimicrobial activity.  The values 
obtained in this study were less than 8.00 mg/ml against all the pathogens tested and the 
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species studied can therefore be considered to display appreciable activity.  More precisely, 
species such S. dolomitica, S. radula and S. verbenaca displayed good antibacterial and 
antimycobacterial activity with MIC values less than 3 mg/ml against B. cereus and S. 
aureus and MIC values of 0.10 mg/ml against M. tuberculosis, respectively (Table 9.1 and 
9.3).  The current results are consistent with the pattern for the in vitro activity emerging 
from other studies.  The antibacterial activity of exotic Salvia species is reported in the 
literature (Lee et al., 1999; Ulubelen et al., 2001; Tepe et al., 2004) although the MIC 
values, the methodology used and pathogens differed.  Variations reported between 
antimicrobial data are frequent and this can be explained by the difficulty to cultivate 
micro-organisms under the same test conditions, due to species-specific requirements (e.g. 
incubation temperature, growth medium and atmosphere).  A further explanation for the 
differences in antibacterial activity data is the different sensitivity of strains, the mode and 
choice of solvent extraction and variation in the composition of the extracts.   
 
Indigenous Salvia species also exhibited good antimycobacterial activity with MIC values 
less than 1 mg/ml.  The ethanol extract of S. aethiopis and compounds isolated from S. 
multicaulis (eg. multiorthoquinone) have been reported to display promising activity 
against M. tuberculosis (MIC values: 50 and 2 µg/ml, respectively) (Cantrell et al., 2001; 
Tosun et al., 2004).  Seaman (2005) found that a S. africana-lutea extract exhibited 
promising activity against M. aurum and M. tuberculosis (MIC values: 2 and 1 mg/ml, 
respectively) along with moderate activity against M. smegmatis (MIC value: 8 mg/ml). 
 
Salvia species are rich in phenolic compounds and the latter are known to display a broad 
range of biological activities such as antibacterial, anti-oxidant, anticancer and anti-
inflammatory activities (Lu and Foo, 2001; Ulubelen et al., 2001; Yamazaki et al., 2004).  
The species investigated revealed high phenolic content (Chapter 5) may contribute to the 
observed activity. 
 
The essential oils showed moderate antibacterial activity, especially against B. cereus, 
while little activity was obtained against S. aureus (Table 9.1).  The essential oils of many 
Lamiaceae have been known since antiquity to display various biological activities, 
notably their antimicrobial potency (Barrata et al., 1998).  The study of biological and 
pharmacological activities of essential oils in aromatherapy is highly correlated to the 
chemical composition (Lawrence, 2000).  The results relating to the hydrocarbon and the 
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oxygenated fractions of S. officinalis essential oil showed that the hydrocarbon fractions 
did not inhibit the growth of micro-organisms, while the oxygenated fractions exhibited a 
significant dose response effect (Carta et al., 1996).  Delaquis et al. (2002) found that 
alcohols and aldehydes were particularly active against Gram-positive bacteria.  Purified 
compounds derived from essential oils, such as carvacrol, borneol, geraniol, eugenol, 
linalool, camphor, 1,8-cineole and thymol, inhibit a wide variety of micro-organisms,  
while   α-pinene (monoterpene hydrocarbon) had slight activity against a range of micro-
organisms (Hinou et al., 1989; Zakarya et al., 1993; Carta et al., 1996; Tzakou et al., 
2001).  The low potency (MIC values > 32 mg/ml) observed for some of the essential oils 
may possibly be due to the high concentration of hydrocarbon components (15-56%), 
while the moderate activity (MIC < 8 mg/ml) may be correlated to the oxygenated 
components present in the oils (22-74%) (Table 4.1).  Compounds such as p-cymene, α-
pinene and limonene have been previously been shown to exhibit low antibacterial activity 
(Chalchat et al., 1997).  The relationship between composition and biological activity 
suggests that the compounds present in the greatest proportions (e.g. linalool, linalyl 
acetate, α-bisabolol, limonene, 1,8-cineole, α-pinene) are not necessarily responsible for 
the greatest share of the total antibacterial activity.  Thus, the involvement of the less 
abundant constituents (e.g. β-caryophyllene alcohol, terpinen-4-ol) should be considered.  
Essential oils could possibly be rendered more useful if the relative concentrations of 
antimicrobial components were adjusted to levels that consistently provide the required 
potency and spectrum of inhibition (Delaquis et al., 2002), but the safety levels also need 
to be considered.  Several factors may contribute to the disparity in observations with 
reported activity of essential oils.  Variability in qualitative and quantitative estimates of 
activity has been ascribed to differences in analytical techniques (Mann and Markham, 
1998).  The volatility and poor solubility of most essential oils is problematic, particularly 
with methods that rely on dilution of the test substance in an aqueous medium (Delaquis et 
al., 2002).  Furthermore, the essential oils are volatile and one has to take into account a 
loss of the active substances, especially when the incubation period is long (Pauli, 2001).  
They are complex mixtures comprising many individual compounds and each of these 
constituents may contribute to the beneficial or adverse effects of these oils (Lahlou, 
2004).   
 
It was interesting to note in the current study that the activity of the essential oil of S. 
africana-caerulea was higher than that of the solvent extract (Table 9.1).  In many studies, 
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the antibacterial activity of solvent extracts is generally high compared to that of essential 
oils (Lourens et al., 2004; Njenga et al., 2005, van Vuuren et al., 2006).  Eriocephalus 
punctulatus and E. ericoides essential oils were also found to exhibit better activity in 
comparison to the acetone extract (Njenga et al., 2005).  Lourens et al. (2004) also 
observed that Helichrysum excisum essential oil was more active than the methanol and 
acetone extract.   
 
The Gram-positive bacteria were found to be more sensitive than the Gram-negative 
bacteria (Table 9.1) which is in agreement with other studies (Delaquis et al., 2002; 
Viljoen et al., 2003; Njenga et al., 2005).  Reasons for the resistance of many Gram-
negative bacteria will likely remain speculative until the mode of action is better 
understood.  Current hypotheses favour adverse effects on the integrity of the bacterial cell 
membrane (Delaquis et al., 2002).  Studies have reported that the sensitivity of bacteria 
was related to the morphological structure and chemical composition of bacteria 
membranes.  Gram-negative bacteria in general have an outer membrane composed mainly 
of polysaccharides which is rather impermeable, thereby preventing inhibitors from 
passing through (Nikaido and Vaara, 1985).  Given the differences in the cell envelope of 
the Gram-negative bacteria, it is plausible that access through the cell membrane is more 
restricted in Gram-negative bacteria. 
 
Infections caused by S. aureus are among the most difficult to treat with standard 
antibacterial agents (Tomás-Barberán et al., 1990).  The growth of S. aureus was inhibited 
by nearly all the extracts (Table 9.1), especially by S. aurita, S. chamelaeagnea, S. 
dolomitica, S. radula and S. stenophylla (MIC values ≤ 0.06 mg/ml).  Thus, these plants 
could yield compounds that can improve the treatment of infections caused by S. aureus in 
particular.  It was reported that many species of Salvia are used in decoctions or infusions 
in South Africa by Sotho people against possible bacterial infections such as throat 
inflammation, colds, coughs and to treat pulmonary diseases and tuberculosis (Watt and 
Breyer-Brandwijk, 1962).  The in vitro antibacterial and antimycobacterial activity 
obtained in this study strongly support the traditional medicinal uses of these plants. 
 
As a rule, a single group of compounds dominates within a given taxon with major 
compounds often accompanied by several derivatives and minor components (Wink, 
2003).  The biological activity of any plant is primarily a function of the type of 
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compounds present.  Those isolated from S. chamelaeagnea as well as some standards 
(rosmarinic acid, carnosic acid and caffeic acid) known to display antimicrobial activity 
were also present in most of the investigated Salvia species (Table 5.2) and have probably 
contributed to the observed activity.  More precisely, some of the isolated compounds 
contain phenolic hydroxyl groups which are reported to be associated with antibacterial 
activity (Tomás-Barberán et al., 1990).  The MIC values of the isolated compounds 
indicated promising activity against S. aureus and to a certain degree, against B. cereus.  
The solvent extracts are crude preparations and one should expect the activity of the 
isolated molecules to be higher than the crude extracts.  This was not observed and may 
partly be attributed to the lability of the isolated compounds.  Furthermore, it is not 
possible to quantify the antibacterial activity from bio-autographic assay where the 
inhibition spot is by nature a positive or negative response and does not reveal detail about 
the degree of activity of a specific compound.  The mechanism of many phytomedicines is 
still unknown and there are several instances of total herb extract showing a better effect 
than an equivalent dose of an isolated compound.   
 
The active isolated compounds have previously been detected in many species of the 
Lamiaceae.  Carnosol has been reported to display antibacterial activity against various 
micro-organisms including S. aureus, Bacillus subtillus, E. coli and Candida albicans 
(Collins and Charles, 1987; Dimayuga et al., 1991).  It is a common compound in Salvia 
species and was first isolated from S. carnosa (Dougl.) (White and Jenkins, 1942).  Since 
then, this compound has been detected in Rosmarinus officinalis and many other species 
belonging to the Lamiaceae family (Wu et al., 1982).  
 
A mixture of ursolic acid and its isomer, oleanolic acid, was previously isolated from 
Swertia arisanensis (Gentianaceae) (Lin et al., 1987) and the two compounds have been 
found in more than 120 plant species including the Lamiaceae family.  Medicinal plants 
containing ursolic acid have been used in folk medicine before it was known which 
constituents were responsible for their therapeutic effectiveness (Liu, 1995).  
Contemporary scientific research that led to the isolation and identification of ursolic acid 
revealed and confirmed that several pharmacological properties such as antitumour, 
hepatoprotective, anti-inflammatory, anti-ulcer, antimicrobial, antihyperlipidemic and 
antiviral activity can be attributed to this compound (Liu, 1995).  Numerous plants from 
the Lamiaceae family containing ursolic acid and its derivatives, exhibited antimicrobial 
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activity and these therapeutic effects have been confirmed by laboratory testing (Sattar et 
al., 1995).  Ursolic acid was also identified as one of the active principles in Rosmarinus 
officinalis that inhibited the growth of some food-borne pathogens (Collins and Charles, 
1987).  The isolated compounds have long been found in Salvia and other plants around 
the world.  However, this is the first investigation reporting their presence in S. 
chamelaeagnea. 
 
A major characteristic of traditional medicine that has remained constant is the use of plant 
mixtures to cure various diseases (Iwu, 1994).  The mixtures of the active compounds in 
producing desired biological effects are common practice in health care and clinical 
treatment (Liu, 2005).  Most of these phytomedicines are on the drug market as whole 
plants extracts.  Synergistic interactions between the compounds of individual or 
concoctions of various plants are a vital part of the therapeutic efficacy of the traditional 
practitioners.  The combination study involving S. chamelaeagnea and L. leonurus 
displayed synergistic or antagonistic interactions depending on the test organism (Table 
9.2; Figure 9.5).  Boik (2001) conducted a large number of combination studies using 
various natural substances and the results strongly suggest that when used in combination, 
natural substances can produce synergistic interactions in vitro.  Phenolic compounds such 
as flavonoids may have a role to play in increasing the biological activity of other 
compounds by synergistic interactions (Williamson, 2001).  The synergistic interactions 
obtained with the Gram-positive bacteria with nearly all ratios (Table 9.2; Figure 9.5) 
indicated that the combination of natural products might be an alternative approach in the 
development of new anti-infective drugs.  However, one should note that antagonistic 
actions could also occur, as can be seen with the Gram-negative bacteria.  Research on 
chemical mixtures has been difficult but it is important to fully understand the use of 
natural occurring compounds in the treatment of various diseases (Liu, 2005).  The 
antimicrobial activity of plants used alone or in combinations may involve distinct active 
principles with distinctive mechanisms of action (Okoli and Iroegbu, 2004). 
 
Although the investigations into the biological activities of chemical mixtures are difficult, 
it is important to fully understand the mechanisms by which these naturally occurring 
compounds are effective and interact in the treatment of many diseases (Liu, 2005).   
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9.5 Conclusions 
 
• The solvent extracts and the essential oils displayed varying degrees of activity 
against bacteria, with the solvent extracts being more active than essential oils. 
• Salvia dolomitica, S. radula and S. verbenaca exhibited the best activity against M. 
tuberculosis, while S. chamelaeagnea, S. muirii, S. runcinata and S. stenophylla 
displayed the most promising activity against the two Gram-positive and two 
Gram-negative bacteria.  
• The synergistic interaction between S. chamelaeagnea and L. leonurus against S. 
aureus and B. cereus, indiates that the concurrent use of these two plants may 
broaden the therapeautic indications for Salvia  species. 
• Bioassay-guided fractionation led to the isolation of four compounds with 
antibacterial activity from S. chamelaeagnea. 
• Carnosol, oleaonolic acid, ursolic acid and 7-O-methylepirosmanol inhibited the 
growth of micro-organisms to varying degrees.  
• As carnosol, ursolic acid and oleanolic acid are known to exhibit good anti-oxidant 
activity, these compounds may prove a useful substitute for some of the phenolic 
anti-oxidants in current use, whilst offering an improved inhibitory capacity to 
microbial growth. 
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Chapter 10:  In Vitro Anticancer Activity of the  
Solvent Extracts 
 
Abstract 
 
Salvia species are used in traditional medicine to treat various diseases including cancer.  
As part of an ongoing effort to verify the traditional uses of South African medicinal 
aromatic plants, 17 Salvia species were tested for in vitro anticancer activity.  The 
experiment was conducted on three human cell lines, including the breast adenocarcinoma 
(MCF-7), the colon adenocarcinoma (HT-29) and the glioblastoma (SF-268) cell lines, 
using the sulforhodamine B assay.  The results showed that the extracts inhibited cell 
proliferation of all three cell lines to varying degrees.  The concentration required to inhibit 
50% of cell growth (IC50 values) ranged between 9.69 and 43.65 µg/ml and between 8.72 
and 59.12 μg/ml against the MCF-7 and SF-268 cell lines, respectively, with S. radula and 
S. africana-caerulea being the most active.  IC50 values against the HT-29 cell line ranged 
from 17.05 to 57.00 μg/ml, with the extract from S. lanceolata being the most active.  Cell 
line specificity was observed for S. dolomitica and S. garipensis, while S. lanceolata, S. 
muirii, S. namaensis, S. repens, S. runcinata and S. verbenaca showed some degree of cell-
type selectivity.  In the search for new anticancer agents, plants that display selective 
activity against specific cell lines should be further investigated.   
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10.1 Introduction 
 
Cancer is caused by the uncontrolled growth and spread of cells that may affect almost any 
tissue of the body (WHO, 2006b).  The ability of ionising radiation to provoke the 
development of cancer has long been recognized, and the direct absorption of energy by 
DNA, resulting in damage to this molecule, may be part of the basis for radiation-induced 
carcinogenesis.  There is extensive, indirect evidence supporting the role of free radicals in 
the promotion of cancer, as many free radical-generating compounds are tumour promotors 
(Kehrer, 1993). 
 
Cancer is a worldwide public health problem, with more than 11 million people being 
diagnosed every year.  It is estimated that by 2020, there will be 16 million new cases 
annually.  It is reported that cancer causes 7 million deaths each year and results in 12.5% 
of deaths worldwide (WHO, 2006b).  Cancer produces no signs or symptoms that 
exclusively indicates the presence of the disease.  Complaints such as haemorrhoids, 
anaemia, bronchitis, sinusitis, weight loss and fever may be associated with cancer.  Some 
common symptoms of cancer include a persistent cough or blood-tinged saliva, a change in 
bowel movements, blood in the stool or urine, unexplained anaemia, breast lump or 
discharge, change in urination (frequent urination, a small amount of urine and/or weak 
urine flow), night sweats and unexpected weight loss (WHO, 2006b).  
 
A major problem with the available cancer chemotherapy is the serious deficiency of 
active drugs for curative therapy and the resistance developed by many tumours to 
treatment with standard anticancer agents (Cragg and Newman, 2005) since the majority of 
cancer chemotherapeutic agents severely affect the ‘host´s’ normal cells (Mascarenhas, 
1994).  Plants have a long history of use in the treatment of cancer.  In his review, Hartwell 
(1982) lists more than 3,000 plant species that have reportedly  been used in the treatment 
of cancer, but in many instances the “cancer” is undefined or reference is made to 
conditions such as “hard swelling”, abscesses, calluses, corns, to name a few (Cragg and 
Newman, 2005).  Such symptoms would generally apply to skin or visible conditions, but 
many of the claims for efficacy should be viewed with some skepticism because cancer, as 
a specific disease entity, is likely to be poorly defined in terms of folklore and traditional 
medicine (Cragg and Newman, 2005; Steenkamp and Gouws, 2006).  Despite these 
observations, plants have played an important role as a source of effective anticancer 
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agents and it is significant that over 60% of currently used anticancer agents are derived in 
one way or another from natural sources including plants, marine organisms and micro-
organisms (Cragg et al., 1997; Valeriote et al., 2002).  The first agents to advance into 
clinical use were the so-called vinca alkaloids, vinblastine and vincristine, isolated from 
the Madagascar periwinkle, Catharanthus roseus (Apocynaceae).  Others compounds, such 
as paclitaxel (Taxol®), topotecan and irinotecan have been isolated.  A number of 
promising new agents from plants including flavopiridol and combretastin are in clinical 
development based on selective activity against cancer-related molecular targets (Cragg 
and Newman, 2005).  In South Africa, reports on plants used for the treatment of cancer 
are rare, and can be ascribed to the fact that cancer involves a complex set of signs and 
symptoms (Steenkamp and Gouws, 2006).  With this in mind, it is recommended that when 
investigating plants for anticancer potential, ethnopharmacological properties such as 
immune and skin disorders and inflammatory diseases be taken into account when 
selecting plants used to treat cancer, since these could reflect disease states bearing 
relevance to cancer or a symptom  thereof (Cordell et al., 1991; Popoca et al., 1998).  
Plants have been a prime source of highly effective conventional drugs for the treatment of 
many forms of cancer and, while the isolated compounds from the plants may not often 
serve as the drugs, they may provide leads for the development of potential novel agents 
(Cragg and Newman 2005).  Salvia species have been used against various infectious and 
inflammatory diseases.  Furthermore, they have been used in traditional medicines in 
China, South Africa and many other countries to treat symptoms associated with cancer 
(Watt and Breyer-Brandwijk, 1962; Ulubelen et al., 1999; Shoemaker et al., 2005).   
 
There has been substantial progress in the development of anticancer drugs, but a number 
of common cancers appear to be resistant to the available drugs (e.g. Tamoxifen and 
AndriamycinTM) (Salmon, 1984; Shoemaker et al., 2005).  Furthermore, compounds were 
selected primarily on their gross cytotoxicity rather than on their selective ability to inhibit 
the growth of tumour cells (Valeriote et al., 2002).  Another reason for the search for new 
anticancer drugs is the fact that current drugs have serious adverse effects. 
 
The objectives of this study were to: 
(i) evaluate the in vitro anticancer activity of the solvent extracts (Section 
3.2.2) of Salvia species against three human cell lines using the 
sulforhodamine B assay, 
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(ii) assess any possible cell line specificity, and 
(iii) support the use of indigenous Salvia species used in traditional medicine as 
anticancer agents. 
 
10.2 Materials and methods 
 
10.2.1 Chemicals and drugs 
 
RPMI-1640 medium, Dulbecco’s Modified Eagle’s Medium (DMEM), 0.25% trypsin-
0.1% ethylene diamine tetra acetic acid (EDTA), fetal bovine serum (FBS), sodium 
pyruvate and 10 mg/ml penicillin G-sodium/streptomycin sulphate (100 x) were from 
Highveld Biological; sulforhodamine B (SRB), gentamicin sulfate and trypan blue were 
obtained from Sigma®.  Trichloro-acetic acid (TCA) and DMSO were purchased from 
Saarchem.  Tris (hydroxymethyl aminomethane) and the reference drug, 5´-fluorouracil, 
were purchased from Merck.  
 
10.2.2 Preparation of media and cell maintenance  
  
10.2.2.1 Preparation of different media and solutions 
The routine culture medium used to maintain the SF-268 and MCF-7 cells was prepared 
using 470 ml of RPMI-1640, 25 ml of FBS and 5 ml of L-glutamine, while the 
experimental medium was prepared in the same manner with the addition of 500 µl of 
0.1% gentamicin sulphate to prevent any contamination.  The DMEM used to maintain the 
HT-29 cell line was prepared with 13.53 g DMEM and 3.7 g NaHCO3 in one liter of 
distilled Millipore® water (further sterilised).  Penicillin G-sodium/streptomycin sulphate 
(1 ml), sodium pyruvate (2 ml) and FBS (25 ml) were added to DMEM (470 ml) to 
constitute the routine culture medium.   
 
The SRB solution was prepared at a concentration of 0.4% (w/v) in 1% acetic acid and the 
TCA solution made at a concentration of 50% (w/v) with distilled Millipore® water.  
Trypan blue was prepared at a concentration of 2 mg/ml in PBS (Section 8.2.2.2) and the 
solution of Tris (hydroxymethyl) aminomethane was prepared at a concentration of 10 mM 
(pH 10.5) with distilled Millipore® water.  All solutions were stored at 4 ºC until required. 
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10.2.2.2 Source and maintenance of cell lines 
Cells lines representing the most common human cancers (WHO, 2006b) were obtained 
from the National Cancer Institute (NCI).  The cell lines include the breast adenocarcinoma 
(MCF-7), the glioblastoma (SF-268) and the colon adenocarcinoma (HT-29).  They were 
chosen for the following reasons:  
 
(i) adaptability to growth in RPMI-1640 or DMEM plus FBS with glutamine,  
(ii) suitability for use in microculture, and 
(iii) mass doubling time that allows for harvesting of approximately 1.5 x 105 
cells/ml every week. 
 
The three cell lines were cultured in 200 ml flasks (NunclonTM) with the complete culture 
medium (RPMI-1640 or DMEM).  The cells were maintained at 37 ºC in a 5% CO2 
humidified incubator.  The culture medium (20 ml) was replaced three times weekly and 
the cells were trypsinised when nearly confluent.   
 
10.2.2.3 Preparation of cell suspension 
All the cells were detached from the culture flasks by addition of 1 ml of 0.25% trypsin- 
0.1% EDTA.  Trypsin was then inactivated by the addition of 10 ml of experimental 
medium (RPMI-1640 or DMEM).  Cells were separated into a single cell suspension by a 
gentle pipetting action and 1 ml of the cell suspension was returned to the culture flask 
containing 20 ml of culture medium.  The remaining cell suspension was centrifuged at 
1000 rpm (Sorvall® T6000D) for 3 minutes and the supernatant discarded.  Experimental 
medium (20 ml) was added to the cells which were then repeatedly pipetted to allow cells 
to disperse in to the medium.  An aliquot of the trypsinised cell suspension was stained 
with 2 mg/ml trypan blue (1:1 ratio) in order to obtain a more quantitative analysis of the 
cell suspension.  Trypan blue is a water-soluble dye, which is insoluble in the cell 
membrane lipids.  It will thus only cross cell membranes of dead/non-viable cells.  On 
visualisation with the light microscope (Nikon), viable cells appear transparent, while non-
viable cells are stained dark blue.  The haemocytometer was used to determine the total 
number of viable and non-viable cells by counting cells in the 25 squares (each square is 
subdivided into 16 smaller squares of 0.1 mm2) at the top and bottom of the 
haemocytometer and the average number of cells per unit volume (millimeter, ml) of 
medium calculated.  The cell suspension was adjusted with experimental medium to 
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approximately 1.5 x 105 cells/ml.  The experiment was carried out only when there was at 
least 95% cell viability. 
 
10.2.2.4 Preparation of test samples and standard 
The stock solution (10 mg/ml) of each test sample (solvent extract and standard) was 
prepared with DMSO and a further 1:50 dilution was made with appropriate experimental 
medium.  The final DMSO concentration in the well of 1% had no effect on the growth of 
the cells.  Stock samples were not filtered because DMSO has a sterilizing effect.  Stock 
solutions were stored at -20 ºC to provide consistency between tests.  The essential oils 
were not tested against cancer cell lines due to the small amount of the oils available. 
 
10.2.3 The sulforhodamine B assay  
 
The colourimetric SRB microculture assay was performed according to Monks et al. 
(1991) and Wu et al. (1993).  A volume of 100 µl cell suspension containing 150,000 
cells/ml was seeded into a 96-well microtitre plate (final count 15,000 cells/well),   except 
the blank and the test sample background colour (only sample plus experimental medium) 
wells where 100 µl of appropriate experimental medium was plated (Figure 10.1, rows A 
and H).   
 
The effect of each concentration of the solvent extract on the cell line was performed in 
triplicate wells.  For instance, sample 1 corresponds to wells B3-D3, while well A3 was 
used as its corresponding background colour control which contained test sample and 
experiemental medium (no cells) (Figure 10.1).  Wells, which contained cells with 
experimental medium in the absence of the test samples (Figure 10.1, B1-G1; B2-G2), 
were used as drug-free controls, while blank wells (A1, A2, H1 and H2) contained 
experimental medium only.   
 
The plate was incubated for 24 hours at 37 ºC, 5% CO2 and 100% relative humidity to 
allow for cell attachment prior to the addition of the test samples.  Thereafter, 100 µl of the 
different sample dilutions were added to the appropriate microtitre wells, resulting in the 
required final sample concentration.  The plate was incubated for a further 48 hours.  At 
the time of sample addition, a separate reference plate for cell growth at time zero (the time 
at which drugs were added) was also prepared as described above.   
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For each dilution, a control was also plated out (in order to take into consideration the 
absorbance resulting from the colour of extract with experimental medium alone: rows A 
and H (Figure 10.1).  The final concentration in the wells ranged from 0.34 to 100 µg/ml 
for 5´-fluorouracil (5´-FU) and from 6.125 to 100 µg/ml for the solvent extracts.  
 
At the end of the 48 hour incubation period, cells were fixed in situ by layering 50 µl of 
ice-cold TCA (50%, w/v) onto the medium in each well and incubating the plate for one 
hour at 4 ºC.  The supernatant was then discarded and the plate was rinsed at least five 
times with tap water to remove the TCA, growth medium and low-molecular weight 
metabolites, before air drying the plate at room temperature.  
 
 
 
Figure 10.1 Microtitre plate showing how extracts were plated out in the anticancer assay 
and colour change of the SRB dye as a result of cell death.  Each sample had five dilutions 
plated out in triplicate, plus one control well for measuring the colour of the sample in the 
presence of the experimental medium.  The arrow indicates the direction of increasing 
concentration of the extract: L: low and H: high.   
 
SRB is a water-soluble dye that binds to basic amino acids of cellular proteins that are only 
synthesised by viable cells (Voigt, 2005).  The colour intensity in each well thus 
corresponds to the number of viable cells and inhibitory effect of the test compounds 
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(Figure 10.1).  TCA-fixed cells were stained with 100 µl of SRB solution (0.4%, w/v).  
After 10-20 minutes at room temperature, the excess SRB solution was discarded and the 
cells washed thoroughly with 1% acetic acid to remove unbound dye.  The plate was then 
air-dried at room temperature for approximately 2 hours until no moisture was visible.  
Bound dye was solubilised with 200 µl of Tris (hydroxymethyl) aminomethane (10 mM).  
The SRB solution has a maximum absorbance at 492 nm.  The absorbance was read 
against a Tris (hydroxymethyl) aminomethane blank on an automated spectrophotometer 
plate reader (Labsystems iEMS reader MF) connected to the Ascent® version 2.4 software, 
at a single wavelength after the plate was shaken at 960 rpm for 3 minutes.  
 
10.3 Data analysis 
 
The percentage cell viability (in reference to control growth) to controls of the various 
extracts was calculated using the Microsoft Excel® programme (Eq. 10.1).  The IC50 values 
(concentration at which 50% of cells were killed) were calculated from the log sigmoid-
dose response curve using Enzfitter® version 1.05 software.  The IC50 values were 
determined only for those extracts that displayed at least 80% inhibition when tested at 100 
µg/ml.  At least three independent runs were performed for each sample.  One-way 
analysis of variance (ANOVA) and Student t-tests were used to compare data using 
Statistica version 5.0 software at a 95% confidence limit.  
 
Percentage cell viability was calculated as follows: 
% Cell viability =  Abs test sample – Abs background sample – Mean Abs blank x 100  (Eq. 10.1) 
                                            Mean Abs control – Mean Abs blank 
Where: Abs: absorbance at 492 nm 
 
10.4 Results 
 
The plant extracts exhibited anticancer activity against the HT-29, MCF-7 and SF-268 cell 
lines with the inhibitory effect increased as the concentration of the solvent extract 
increased (Figure 10.2).  This pattern was observed for all solvent extracts against all the 
cell lines tested.   
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Figure 10.2 Percentage cell viability of cancer cells tested at various concentrations for 
three Salvia species (mean ± s.d., n = 3): S. africana-caerulea (SF-268),   S. lanceolata 
(HT-29) and S. radula (MCF-7).   
 
The inhibition of tumour cell proliferation by the solvent extracts of the 17 indigenous 
Salvia species investigated are displayed in Table 10.1.  All the investigated solvent 
extracts were significantly less potent than 5´-FU (P < 0.05). 
 
The best activity against the HT-29 cell line was obtained with the extracts of S. lanceolata 
and S. stenophylla (IC50 value: 17.05 ± 3.50 µg/ml) and S. africana-lutea (IC50 value: 
20.00 ± 3.41 µg/ml), S. aurita (IC50 value: 24.58 ±6.41 µg/ml) and S. namaensis (IC50 
value: 24.39 ± 3.42 µg/ml) which showed no significant difference in their activity (P > 
0.05).  Five species, viz S. africana-caerulea, S. albicaulis, S. aurita, S. chamelaeagnea, S. 
disermas and S. namaensis, did not differ significantly from one another in the inhibitory 
effects (P > 0.05).   
 
 
S. radula exhibited the most favourable activity (IC50 value: 9.69 ± 0.92 µg/ml) (P < 0.05), 
while S. africana-lutea and S. runcinata were amongst the least active against the MCF-7 
cells (Table 10.1).  ANOVA analysis showed no significant difference in the activity 
exhibited by S. aurita, S. chamelaeagnea, S. schlechteri and S. verbenaca against the 
MCF-7 cells (P > 0.05).  Similarly, the activity against the MCF-7 cell line did not differ 
for the following species: S. africana-lutea, S. albicaulis, S. disermas, S. dolomitica, S. 
garipensis, S. muirii, S. namaensis, S. runcinata and S. verbenaca (P > 0.05).  On average, 
all of the 17 species showed an IC50 value of less than 44 µg/ml for the MCF-7 cells, 
divided as follows: four species, viz. S. aurita, S. chamelaeagnea, S. radula and S. 
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schlechteri with IC50 values less than 20 µg/ml; four species, viz S. africana-caerulea, S. 
lanceolata, S. repens and S. stenophylla had IC50 values ranging from 20 to 30 µg/ml, 
while the IC50 values of the remaining species were greater than 30 µg/ml.  Two species, S. 
dolomitica and S. garipensis, also showed a degree of cell selectivity, as they were not 
active against the HT-29 (IC50 value > 100 µg/ml) and SF-268 (IC50 value > 100 µg/ml), 
but active against the MCF-7 cell line (IC50 value: 39 ± 4 µg/ml).  None of the extracts 
were as active as 5´-FU (P < 0.05).  
 
Table 10.1 The anticancer activity (IC50 values) of the solvent extracts of Salvia species 
and reference compound obtained against three human cancer cell lines.  
 
HT-29 MCF-7 SF-268 
Species / Reference 
IC50 values in µg/ml 
S. africana-caerulea 27.10 ± 1.08 23.36 ± 4.20 8.72 ± 1.52 
S. africana-lutea 20.00 ± 3.41 43.65 ± 8.38 nc 
S. albicaulis 25.33 ± 1.11 35.25 ± 5.66 27.50 ± 0.89 
S. aurita 24.58 ± 6.41 17.28 ± 1.71 44.87 ± 2.48 
S. chamelaeagnea 29.53 ± 5.14 18.12 ± 1.67 34.98 ± 4.07 
S. disermas 26.87 ± 0.57 38.56 ± 1.28 59.12 ± 2.75 
S. dolomitica nc 37.05 ± 2.10 nc 
S. garipensis nc 39.44 ± 3.90 nc 
S. lanceolata 17.05 ± 3.50 26.15 ± 2.15 nc 
S. muirii 55.63 ± 1.30 39.07 ± 2.86 nc 
S. namaensis 24.39 ± 3.42 36.36 ± 3.07 nc 
S. radula 32.10 ± 2.93 9.69 ± 0.92 27.55 ± 4.52 
S. repens 43.62 ± 5.17 23.36 ± 2.16 nc 
S. runcinata 55.37 ± 2.10 43.42 ± 5.46 nc 
S. schlechteri 57.00 ± 11.67 18.37 ± 0.47 54.40 ± 4.42 
S. stenophylla  17.41 ± 2.65 23.74 ± 1.96 43.86 ± 3.43 
S. verbenaca 50.04 ± 5.39 31.50 ±13.70  nc 
5´-FU 7.00 ± 2.02 1.11 ± 0.31 nc 
nc: IC50 values not calculated because the percentage inhibition at 100 µg/ml was less than 80% 
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In contrast, S. africana-caerulea, with an IC50 value of 8.72 ± 1.52 µg/ml, was the most 
active extract against the SF-268 cells (P < 0.05).  The inhibition by S. africana-lutea, S. 
dolomitica, S. garipensis, S. lanceolata, S. muirii, S. namaensis, S. repens, S. runcinata and 
S. verbenaca tested at a concentration of 100 µg/ml exhibited less than 80% inhibition of 
the cell growth.  The IC50 values were thus not calculated for these species (Table 10.1).  
The IC50 values of nearly all the species were above 30 µg/ml.  No significant difference in 
the activity of S. albicaulis and S. radula against the SF-268 cells (P > 0.05) was observed.  
5´-Fluorouracil  was not active againt against the SF-268 cell line, while S. africana-
caerulea, S. albicaulis and S. radula exhibited some degree of activity (IC50 value < 30 
µg/ml) (Table 10.1).  
 
Treatments with Salvia extracts resulted in growth inhibition in the majority of cases.  For 
the three cell lines examined, MCF-7 cells were the most sensitive, as they wewre inhibited 
by all the solvent extracts, while the SF-268 cell line was the least sensitive.  About 53% 
(9/17) of samples exhibited less than 80% inhibition at 100 µg/ml (Table 10.1).   
 
In the screening of the anticancer activity of plants, species which need to be considered 
for further analysis are those that show activity against certain cell lines and are not toxic 
to others.  In this study, cell line selectivity was observed.  The solvent extracts of S. 
dolomitica, S. garipensis, S. lanceolata, S. muirii, S. namaensis, S. repens, S. runcinata and 
S. verbenaca showed some degree of activity against MCF-7, but were, however, not 
active against the SF-268 and/or HT-29 cell lines (Table 10.1).   
 
Ursolic acid and oleanolic acid were isolated from S. chamelaeagnea as an inseparable 
mixture (Chapter 9).  Ursolic acid (standard) exhibited low activity (IC50 value > 100 
µg/ml), while its isomer, oleanolic acid (standard), displayed moderate activity against the 
MCF-7 cells (IC50 value > 72.77 ± 5.23 µg/ml).  Carnosol, also isolated from S. 
chamelaeagnea, inhibited HT-29 cells with an IC50 value of 11.79 ± 0.94 µg/ml.  This 
activity was, however lower than that of 5´-FU (IC50 value: 7.00 ±  2.02 µg/ml).  
Salvigenin, a compound isolated from S. radula (Chapter 8), exhibited moderate activity 
against the MCF-7 cells (IC50 value: 67.78 ± 3.78µg/ml). 
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10.5 Discussion 
 
Some phytochemicals such as flavonoids and alkaloids, present in medicinal plants, are 
reported to possess substantial anti-oxidant, antibacterial, anti-inflammatory and 
anticarcinogenic activities.  These phytochemicals have been explored extensively for their 
potential in the treatment of cancer.  Well-known compounds like paclitaxel, a diterpenoid 
from Taxus brevifolia, and vincristine, an alkaloid from Catharanthus roseus, are used in 
chemotherapy today (Wall and Wani, 1996).  Many Salvia species have been used in 
traditional medicine in South Africa, in Chinese herbal medicine, as well as in many other 
countries for the treatment of cancer (Watt and Breyer-Brandwijk, 1962; Ryu et al., 1997).  
The in vitro anticancer activity of indigenous South African species has, however, not yet 
been fully investigated. 
 
The organic extracts of indigenous Salvia species were shown to have inhibitory effects on 
cancer cells in an apparent dose-dependent manner (Figure 10.2).  In this study, there may 
be compounds in Salvia extracts that may induce a cytotoxic action against various cancer 
cell lines and initiate cell death.  The American National Cancer Institute guidelines set the 
limit of activity for crude extracts at a 50% inhibition (IC50 value) of proliferation of less 
than 30 µg/ml (Suffiness and Pezzuto, 1990).  The extracts exhibited various responses 
depending on the cell line used.  The percentage of plant extracts with IC50 values less than 
30 µg/ml was 17%, 47% and 53% against the SF-268, MCF-7 and HT-29 cells, 
respectively.  S. africana-caerulea was the only species to exhibit anticancer activity 
against all three cell lines with an IC50 value of less than 30 µg/ml (Table 10.1). 
 
The extract of S. hypargeia has been investigated by Ulubelen et al. (1999) against a panel 
of cell lines, including the human colon cells (COL-2), breast cancer cells (BC-1) and lung 
cancer cells (LU-1).  Results indicated that the plant extracts possess anticancer activity 
(IC50 values < 20 µg/ml), which is lower than values obtained in this study, when tested 
against the breast cancer cell line.  Other members of the family Lamiaceae have also been 
shown to inhibit the in vitro or in vivo growth of cancer cells.  Ye et al. (2002) found that 
Scutellaria baicalensis (Lamiaceae) inhibited the growth of the most common human 
cancers, including  breast cancer (MCF-7), colon cancer (HCT-15) and hepato-cellular 
carcinoma (HepG-2), with IC50 values of 1.1, 0.9 and 1.5 mg/ml, respectively, when tested 
in vivo in rats.  Like most members of the Lamiaceae family, Salvia species are aromatic in 
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nature and are rich in essential oils (Chapter 4).  Foray et al. (1999) investigated the in 
vitro anticancer activity of essential oils of S. lavandulifolia, S. officinalis and S. sclarea 
against various cancer cell lines and recorded IC50 values ranged from 0.6 x 10-4 μg/ml to 
4.4 x 10-1 μg/ml.  This higher cytotoxicity of the essential oil is due to the fact that several 
essential oil compounds have highly hydrophobic character.  Their accumulation in the 
cellular membrane perturbs the membrane, resulting in increased permeability to protons 
and ions and eventually cell-death (Sikkema et al., 1995).   
 
Compounds with anticancer properties have been isolated from many Salvia species and 
include cryptotanshinone, methylenetanshiquinone and tanshindiol A from S. miltiorrhiza 
(Ryu et al., 1997).  These compounds were tested against the non-small cell lung (A549) 
and central nervous system cell lines.  The IC50 values obtained less than 0.7 μg/ml, but 
were still less potent than the reference compound used in the study (doxorubicin, IC50 
value < 0.1 μg/ml). 
 
Some of the plants investigated in this study have been studied from a chemical point of 
view.  Phytochemical research revealed that the principal secondary metabolites of Salvia 
species are mainly found to be flavonoids which are responsible for the antibacterial, anti-
oxidant, anti-inflammatory, antimalarial and anticancer activities (Ulubelen et al., 1999; 
Kobayashi et al., 2002).  Terpenoids have been isolated from many Salvia species, 
including this study (Chapter 9) and this class of compounds probably contributes to the 
anticancer activity exhibited by the extracts.  Ursolic acid and oleanolic acid isolated from 
S. chamelaeagnea are shown to have marked anti-tumour effects, with the activity of 
ursolic acid being greater than that of oleanolic acid against the human colon carcinoma 
cell line LCT-15 (Li et al., 2002).  S. chamelaeagnea was not, however, the most active 
extract.  In this study, it was found that ursolic acid (standard) exhibited low activity (IC50 
value > 100 µg/ml), while its isomer, oleanolic acid, displayed moderate activity (IC50 
value: 72.77 ± 5.23 µg/ml) against the MCF-7 cell line.  This is in agreement with the 
study conducted by Cragg and Newman (2005), which showed that ursolic and oleanolic 
acids are associated with weak anti-inflammatory and antitumour activities.  Carnosol, also 
isolated from S. chamelaeagnea (Chapter 9), inhibited the HT-29 colon adenocarcinoma 
cells with an IC50 value of 11.79 ± 0.97 µg/ml.  All the isolated compounds tested in this 
study were significantly less active (P < 0.05) than 5´-FU.  Oleanolic acid, ursolic acid acid 
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and carnosol are good anti-oxidant (Chapter 5, Cuvelier et al., 1994) and may also offer an 
improved inhibitory capacity to cancer cells.  
  
Flavonoids are biosynthesised by plants and have strong anti-oxidant activity for 
scavenging free radicals which are involved in cell damage and tumour promotion.  
Epidemiological studies suggest that flavonoids, such as the isoflavone genistein, play an 
important role in the prevention of carcinogenesis (Barnes, 1995).  Indigenous Salvia 
species also possess flavonoids (Chapter 5) and one flavonoid has been isolated from S. 
radula as part of this research (Chapter 8).  The presence of flavonoids may also contribute 
to the anticancer activity.  The flavonoid isolated from S. radula (salvigenin) was tested 
against the MCF-7 cells and it exhibited moderate activity, although not significantly 
comparable to the activity of 5´-FU (IC50 value: 67.78 ± 3.78 µg/ml).  Testing could not be 
done against the HT-29 and SF-268 cells due to the small amount of flavonoid isolated.    
  
This is the first in vitro investigation to determine the anticancer activity on indigenous 
Salvia species.  The investigated species have shown their ability to inhibit the 
proliferation of three human cancer cells.  Furthermore, the selectivity of some of the 
solvent extracts indicated that Salvia species could be considered in the search for novel 
anticancer lead compounds. 
 
10.6 Conclusions 
 
• Salvia species inhibited the growth of three different cancer cell lines in a 
dependent manner. 
• The best activity against the HT-29 cells was obtained with extracts obtained from 
S. africana-lutea, S. aurita, S. lanceolata, S. namaensis and S. stenophylla.  
• The best activity against the MCF-7 and SF-268 was obtained with extracts from S. 
radula and S. africana-caerulea, respectively. 
•  Solvent extracts of S. africana-lutea, S. dolomitica, S. garipensis, S. lanceolata, S. 
muirii, S. namaensis, S. repens, S. runcinata and S. verbenaca were active against 
the MCF-7 cell line, but not active against the SF-268 and/or the HT-29 cell line.  
• None of the solvent extracts were as effective as 5´-fluorouracil against MCF-7 and 
HT-29.  The 5´-fluorouracil did not inhibit SF-268 cells, but S. africana-caerulea, 
S. albicaulis and S. radula inhibited it with an IC50 value of less than 30 µg/ml 
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(NCI cut off) and other species were more active against the cell line that is 
resistant to the effects of 5´-fluorouracil. 
• The MCF-7 cell line was the most sensitive cell line, with 80% of cell growth being 
inhibited by a concentration of 100 µg/ml of the solvent extracts. 
• The SF-268 cell line was the least sensitive cell line as it was inhibited by only 47% 
of the extracts when tested at 100 µg/ml. 
• This study intends to further investigate Salvia species in the search for anticancer 
compounds and could help to explain their use in traditional medicine as 
chemotherapeutic or anticancer agents. 
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Chapter 11:  In Vitro Evaluation of Toxic Effects of the 
Essential Oils and Solvent Extracts  
 
Abstract 
 
The in vitro toxicity profile of 28 samples (17 solvent extracts and 11 essential oils) was 
evaluated on human kidney epithelial cells using the 3-(4,5-dimethylthiazol-2-yl)-2,5 
dimethyl tetrazolium bromide (MTT) colourimetric method.  The samples displayed some 
degree of toxicity with IC50 values ranging from 1.79 ± 0.43 to 22.9 ± 5.28 µg/ml for the 
essential oils and from 12.12 ± 2.02 to 53.34 ± 3.90 μg/ml for the solvent extracts.  The 
toxicity profile of the essential oils was significantly higher compared to the solvent 
extracts (P < 0.05).  The essential oil of S. runcinata (IC50 value: 1.79 ± 0.43 μg/ml) and 
the solvent extract of S. stenophylla (IC50 value: 12.12 ± 2.02 μg/ml) were the most toxic, 
while the S. disermas extract (IC50 value: 53.34 ± 3.90 μg/ml) and S. radula essential oil 
(IC50 value: 22.90 ± 5.28 μg/ml) were least toxic.  The essential oils and solvent extracts 
were significantly more toxic than 5´-fluorouracil (P < 0.05).   
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11.1 Introduction 
 
In recent years, there has been a worldwide trend towards the use of natural products as 
opposed to synthetic ones for medicinal purposes.  Research and identification of active 
constituents are important in the search for new biologically active compounds in the 
pharmaceutical field.  Many species of the Lamiaceae have potential therapeutic activities, 
which include anti-oxidant, anti-inflammatory, anticholinesterase, antibacterial and 
antimalarial activities (Cuvelier et al., 1996; Ulubelen et al., 2001; Hayes and Markovic, 
2002; Perry et al., 2003; Benoit-Vical et al., 2003).  Salvia species are also used 
extensively in perfumery and aromatherapy (Baylac and Racine, 2003; Kaya et al., 2003).  
The common notion among people who use Salvia to treat various conditions is that ‘ if it 
does not benefit, it would not harm’ (Gali-Muhtasib et al., 2000) and many people are not 
aware that excessive intake of sage extracts can be toxic and can lead to convulsions and 
permanent brain damage (Arnol, 1988).  The increased worldwide use of plants in 
aromatherapy and pharmaceutical fields has raised a number of concerns in relation to their 
adverse effects, which warrants further investigation (Woolf, 1999; Thompson and 
Wilkinson, 2000).  Poisoning by traditional remedies, especially by plants is well 
documented, particularly in South Africa (Joubert, 1990).  But only a few plants used in 
traditional medicine contain pharmaco-active chemicals which are toxic.  However, these 
make a significant contribution to morbidity and mortality (Steenkamp, 2000).  In order to 
verify whether the biological activities (especially the anticancer activity) exhibited by 
plants are not correlated to their general cytotoxicity, the evaluation of their toxic effects 
against a normal cell line is necessary. 
 
Plant material contains a large number of detectable and potentially active compounds, but 
only a few are responsible for the major pharmacological or adverse effects.  Such 
compounds may be expressed in the plant at different levels depending on the location, soil 
in which it is growing and the season (Steenkamp, 2000).  In addition, the toxic 
principle(s) may be located in only one part of the plant (e.g. leaves, seeds, roots or bark).  
Toxic compounds of plants are divided into various groups according to their chemical 
properties (e.g. alkaloids and glycosides) with some Salvia species having tested positive 
for alkaloids (Raffauf, 1996).  Several studies on biological activities of Salvia species 
have been published (Cuvelier et al., 1994; Ulubelen et al., 2001; Baricevic et al., 2001; 
Tepe et al., 2006), but only a few have been conducted on the toxicity of these plant 
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species and may therefore place limitations on their use in conventional medicine.  In 
phytomedicine as well as in clinical medicine, the toxicity profile of a given substance 
must always be evaluated, although plants found to be toxic in vitro may not necessarily be 
toxic in vivo because of the complexity of the human body.  The lack of information on the 
toxic profile of Salvia species and the pharmacological activities exhibited in previous 
Chapters prompted this investigation in order to determine whether they are safe for use as 
unconventional medicines. 
  
The objectives of this chapter were to: 
(i) evaluate the toxicity profile of the essential oils and the solvent extracts 
using the MTT assay, and 
(ii) verify the safety of Salvia species in traditional medicine. 
 
11.2 Materials and methods 
 
11.2.1 Chemicals, reagents and reference compound 
 
Trypsin containing EDTA, fetal calf serum (FCS) and Ham F10 were obtained from 
Highveld Biological, 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) 
was purchased from USB®.  NaHCO3, gentamicin sulfate, trypan blue and 5´-fluorouracil 
were obtained from Sigma®.  
 
11.2.2 Preparation of various media and solutions  
 
11.2.2.1 Culture medium and experimental medium 
The Ham F10 solution consisted of 9.38 g of Ham F10 medium and 1.18 g of NaHCO3 in a 
total volume of 1 liter of Millipore® water and the solution was then filtered through a 
Sterrivex-GS 0.22 μm filter unit.  The culture medium consisted of Ham F10 solution, 
gentamicin sulfate (10 mg/ml in PBS) and FCS in a proportion of 96:1:5, respectively.  
The experimental medium was prepared in the same way as the culture medium, except 
that gentamicin sulfate was not included. 
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11.2.2.2 Preparation of 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide 
solution  
The MTT solution was prepared at a concentration of 50 mg/ml with the PBS (Section 
8.2.2.2), filtered and stored at 4 °C until used.   
 
11.2.3 Cell maintenance 
 
Human kidney epithelial cells were maintained continuously in a 500 ml flask (NunclonTM) 
with 50 ml of culture medium.  The medium was changed thrice weekly or when it turned 
yellow.  The cells were maintained at 37 °C in a 5% CO2 humidified incubator and were 
trypsinised when nearly confluent.  
 
11.2.4 Cell suspension and sample preparations 
 
11.2.4.1 Single cell suspension 
The cells were detached from the flask using 4 ml of trypsin (0.25%) containing EDTA 
(0.1%) after which 6 ml of the experimental medium was added to neutralize the effects of 
the trysin.  The solution was gently agitated with a pipette until all the cells were dispersed 
into a single cell suspension.  Subsequently, 1 ml of the cell suspension was returned to the 
culture flask with 49 ml culture medium.  The remaining cell suspension was centrifuged 
at 1500 rpm for 5 minutes (Sorvall® T6000D), the supernatant-trypsin was discarded and 
20 ml experimental medium added to the cells which were again agitated with a pipette 
until a single cell suspension was obtained.  The cell density was determined using the 
trypan blue exclusion assay (Section 10.2.2.3), with 20 µl of cell suspension being stained 
with an equal volume trypan blue.  The cells were counted using the haemocytometer and 
adjusted with the experimental medium to prepare a working solution of approximately 
0.25 million cells/ml. 
 
11.2.4.2 Preparation of samples 
The stock solution of the solvent extracts and the 5´-FU were prepared with DMSO at a 
concentration of 10 mg/ml and stored at -20 ºC.  The dilutions were prepared with 
experimental medium on the day of the experiment and the concentrations of the dilutions 
used were dependent on the results obtained from the initial broad screening.  The toxicity 
profile of the isolated compounds from S. radula (salvigenin and betulafolientriol oxide) 
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and S. chamelaeagnea (carnosol); as well as the commercial standards of ursolic and 
oleanolic acid were also tested.  These samples were prepared in the same as the solvent 
extracts. 
 
The stock solution of each essential oil was prepared at a concentration of 10 mg/ml with 
DMSO and the dilutions were also prepared with DMSO on the day of the experiment.  
The final concentration of DMSO (1%) in the wells had no effect on the normal growth of 
cells.  Seven dilutions were considered for each sample.  The final concentration in the 
wells ranged from 1 to 100 μg/ml for the solvent extracts and 1 to 50 μg/ml for the 
essential oils.  Concentrations of the reference compound varied from 1 to 500 μg/ml.  
Because essential oils are volatiles, they were always tested on separate microtitre plates 
and placed in different incubators to the solvent extracts. 
 
11.2.4.3 The 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay 
The MTT colourimetric assay was performed on human kidney epithelial cells according 
to the method of Mosmann (1983) taking into consideration modifications by van Zyl and 
Viljoen (2002).   
 
For this assay, a volume of 180 μl of the cell suspension was plated out into a 96-well plate 
(Nunclon™), except for two wells which served as the blank controls to which 180 μl of 
experimental medium were added.  In order to test the effect of the solvent on the cells, 
two wells containing 1% DMSO were also included.  After six hours of incubation (to 
allow for cell attachment), 20 μl for each dilution for the solvent extracts and reference 
compound or 2 μl of the essential oils, were added in triplicate to a 96-well culture plate.  
The experimental medium (18 μl) was added to the wells containing essential oils to ensure 
a total volume of 20 μl in each well.  In the drug-free control wells (those only containing 
180 μl of cells), 20 μl of experimental medium was added.  The plate was then incubated in 
a humidified environment at 37 ºC and 5% CO2 for 44 hours.   
 
The validity of the MTT assay depends on the assumption that only viable cells reduce 
tetrazolium salts to coloured formazan which can be quantified spectrophotometrically 
(Mosmann, 1983).  After 44 hours of incubation, 40 μl of the MTT solution (50 mg/ml) 
was added to each well and the plate incubated for a further four hours.  Thereafter, 200 μl 
of the contents of each well was removed and discarded.  Subsequently, 150 μl of DMSO 
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was added to each well to stop the reaction and dissolve the formazan crystals.  The plate 
was then shaken at 1020 rpm for four minutes and the absorbance was read on an 
automated spectrophotometer plate reader (Labsystems iEMS reader MF) connected to the 
Ascent® version 2.4 software at the test wavelength of 540 nm and the reference 
wavelength of 690 nm.   
 
11.3 Data analysis 
 
The percentage cell viability was determined using a simple programme written in 
Microsoft Excel® by comparing the absorbance between the test samples and the controls 
(Eq. 11.1).  
 
% Cell viability = Abs of  test sample – (Mean Abs of control  – Mean Abs of blank) x 100     (Eq. 11.1) 
  Mean Abs of controls – Mean Abs of blank 
Where: Abs = absorbance 
Abs of test sample = Abs540 of test sample – Abs690 of test sample 
Abs of control  = Abs540 control – Abs690 control 
Abs of blank = Abs540 of blank – Abs690 of blank 
  
The IC50 values (concentration at which 50% of cell viability is obtained) were determined 
using Enzfitter® version 1.05 software.  At least three independent runs were performed for 
each sample and results are given as mean ± s.d.  An ANOVA and Student t-tests were 
used to analyse results.  A correlation between the anticancer activity and toxicity profile 
was assessed using Pearson’s correlation coefficient.  All statistical analyses were 
performed using Statistica® version 5.0 software at 95% confidence limits.  The toxicity of 
each sample was compared to that of the 5´-FU (ratio of toxicity of the 5´-FU to toxicity of 
the test sample).  For the toxicity assay, the lower the IC50 values, the more toxic the 
sample. 
 
11.4 Results 
 
The toxicity profile of the essential oils, solvent extracts and the reference compound are 
depicted in Table 11.1.  The essential oils and solvent extracts showed diverse levels of 
toxicity.  The IC50 values ranged from 1.79 ± 0.43 to 22.90 ± 5.28 μg/ml for the essential 
oils.  Of all the plants screened, the toxicity profile of the essential oil of S. africana-
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caerulea, S. runcinata and S. stenophylla were similar  (P > 0.05) and were also the most 
toxic (P < 0.05).   
 
Table 11.1 The toxicity profile of the essential oils, solvent extracts and reference 
compound.  
 
Species/Reference 
compound                        
Essential oils 
(IC50 values in 
μg/ml) 
Solvent extract 
(IC50 values in μg 
/ml) 
   Safety Index 
 
  SI1            SI2 
S. africana-caerulea 1.87 ± 0.52 14.38 ± 3.39 72.75 9.46 
S. africana-lutea 7.24 ± 0.67 25.01 ± 1.94 18.79    5.44 
S. albicaulis 2.75 ± 0.72 37.29 ± 0.58 49.47   3.64 
S. aurita nd 28.31 ± 4.94   nd    4.80 
S. chamelaeagnea 6.00 ± 0.74 24.76 ± 7.60 22.67   5.49 
S. disermas nd 53.34 ± 3.90   nd   2.55 
S. dolomitica  7.74 ± 0.27 40.26 ± 9.07 17.57   3.37 
S. garipensis nd 42.44 ± 3.03   nd   3.20 
S. lanceolata 3.66 ± 0.92 26.71 ± 6.41 37.17    5.09 
S. muirii 3.09 ± 0.53 37.00 ± 5.41 44.03    3.68 
S. namaensis nd 21.91 ± 2.89   nd       6.21 
S. radula* 22.90 ± 5.28 20.12 ± 4.02 5.94      6.76 
S. repens 6.66 ± 0.90 23.24 ± 4.72 20.42    8.85 
S. runcinata 1.79 ± 0.43 22.00 ± 3.75 76.01    6.18 
S. schlechteri nd 28.16 ± 4.69   nd       4.83 
S. stenophylla 1.98 ± 0.47 12.12 ± 2.02 68.71    11.22 
S. verbenaca nd 20.85 ± 2.59   nd       6.53 
5´-FU 136.06 ± 16.60 
 nd: not determined, essentialoil not available 
 * no significant difference between the oil and the solvent extract (P > 0.05) 
 SI1: toxicity ratio of 5´-FU over essential oil sample 
 SI2: toxicity ratio of the 5´-FU over solvent extract sample 
 
The essential oil of S. radula displayed the lowest toxicity profile (P < 0.05) (Table 11.1).  
An ANOVA showed no variation in the toxicity profile of S. albicaulis, S. lanceolata and 
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S. muirii (P > 0.05).  Similarly, S. africana-lutea, S. dolomitica, S. repens and S. 
chamelaeagnea exhibited the same toxicity profile (P > 0.05).   
 
The toxicity of the solvent extracts ranged from 12.12 ± 2.02 to 53.34 ± 3.90 μg/ml.  The 
Student t-tests showed that the solvent extracts of S. africana-caerulea and S. stenophylla 
were similar (P > 0.05) and were the most toxic, while S. disermas was the least toxic 
relative to the other extracts (P < 0.05).  An ANOVA showed that the solvent extracts of 
ten species namely S. africana-lutea, S. aurita, S. chamelaeagnea, S. lanceolata, S. 
namaensis, S. radula, S. repens, S. runcinata, S. schlechteri and S. verbenaca was not 
statistically different from each other (P > 0.05).   
 
Nearly all the essential oils were significantly more toxic than their corresponding solvent 
extracts (P < 0.05) (Figure 11.1).  However, S. radula showed no statistical difference 
between the toxicity profile of its oil and solvent extract even though the toxicity of the 
extract was slightly higher than that of the essential oil (Figure 11.1; Table 11.1).  
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Figure 11.1 Variation between the toxicity profile of the essential oil and solvent extracts 
of eleven Salvia species (mean ± s.d., n = 3).  
 
The toxicity of the essential oils and solvent extracts was compared to that of 5´-FU (safety 
index; SI1 and SI2, respectively) (Table 11.1).  The standard 5´-FU was significantly less 
toxic compared to the essential oils and solvent extracts (P < 0.05).  The solvent extracts 
were 3 to 11 times more toxic than the reference compound, whilst the essential oils were 6 
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to 76 times more toxic (Table 11.1).  More precisely, the essential oil of S. runcinata, the 
most toxic essential oil (IC50 value: 1.79 ± 0.43 μg/ml) was 76 times more toxic than 5´-FU 
and the oil of S. radula (IC50 value: 22.90 ± 0.43 μg/ml) seven times more toxic than 5´-
FU. 
 
A poor correlation was observed between the anticancer activity and the toxicity profile of 
the solvent extracts (r = 0.37 and 0.07 against the MCF-7 and HT-29 cell lines, 
respectively).  It may be assumed that compounds responsible for the inhibition or death of 
cancer cells are not necessarily those involved in the toxicity of the plants.  This can also 
be seen by the IC50 value difference of 5´-FU which is about 20 times more effective in 
inhibiting the HT-29 cancer cells.  
 
The isolated compounds, namely betulafolientriol oxide and salvigenin from S. radula 
(Chapter 8), carnosol from S. chamelaeagnea (Chapter 9) and standards of ursolic and 
oleanolic acids, exhibited poor toxicity against the human kidney epithelial cells with all 
IC50 values greater than 100 μg/ml.  
 
11.5 Discussion 
 
Plants used in traditional medicine are generally non-toxic at the administered dosage.  
However, it is known that all plants are toxic at certain concentrations (Liu, 2005).  The 
essential oils and the solvent extracts displayed some degree of toxicity, with the toxicity 
of the essential oils being greater than that of the solvent extracts (Table 11.1).  This higher 
toxicity of the essential oil is due to the fact that several essential oil compounds have 
highly hydrophobic in nature.  Their accumulation in the cellular membrane disrupts the 
membrane, resulting in increased permeability and eventually cell death (Sikkema et al., 
1995).  Salvia species are not known to be toxic (Gali-Muhtasib et al., 2000).  However, 
most of the tests done on the toxicity of these species used in vivo models (rats) rather than 
in vitro models, as is the case in the present investigation.  The solvent extracts were 
generally less toxic than the essential oils in this study.  In traditional medicine, aqueous 
extracts are used and a small amount of volatile fractions (containing generally non-polar 
compounds) would probably be extracted in hot water extracts.  However, if cold water is 
used, essential oils will not be extracted.  Furthermore, the percentage of essential oil 
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present in the plant is very low (Figure 4.2) and this will probably have little influence on 
the decoction of plant extracts as prepard traditionally.   
 
There are various types of toxic compounds in plants and these include tannins, glycosides 
and alkaloids.  The identification of tannins in Salvia species has not yet been reported in 
the literature, but alkaloids and glycosides are generally found in the genus (Lu and Foo, 
2002).  Many alkaloids are poisonous to both animals and humans.  Some of the species 
investigated, such as S. chamelaeagnea, S. namaensis and S. runcinata, tested positive for 
alkaloids (Raffauf, 1996).  The presence of these compounds was not confirmed, however 
if present, they may contribute to the toxicity of the solvent extracts. 
 
The essential oils displayed greater toxicity than the solvent extracts (Table 11.1) and the 
toxicity of the essential oils is well reported in the literature (van Zyl and Viljoen, 2003; 
Nyiligira, 2004; van Vuuren et al., 2006).  Foray et al. (1999) investigated the in vitro 
cytotoxicity of three essential oils of Salvia lavandulifolia, S. officinalis and S. sclarea 
against various cell lines.  All three essential oils were toxic with IC50 values ranging from 
6.3 x 10-5 to 4.4 x 10-1 μg/ml.  The toxicity of the essential oils found in this study is higher 
than that found in other oils such as Helichrysum picardi (IC50 value: 30 μg/ml) (De La 
Puerta et al., 1993).  However, these results are comparable to, and occasionally lower than 
essential oils from S. lavandulifolia, S. officinalis and S. sclarea (IC50 value < 0.44 μg/ml), 
cinnamon (IC50 value: 3.75 μg/ml) and clove (IC50 value: 7.31 μg/ml) (De La Puerta et al., 
1993).  It is difficult to deduce the constituent(s) of an individual oil that may contribute to 
its toxicity.  In a study of 20 essential oil constituents, van Zyl et al. (2006) demonstrated 
that limonene, nerolidol, p-cymene, α-thujene, β-thujene, δ-terpinene and α-bisabolol 
displayed some degree of toxicity (IC50 value ≤ 10 µg/ml) in comparison to chloroquine 
diphosphate and quinine sulphate (two antimalarial drugs) and the 5´-FU tested in this 
study.  Nerolidol was also found to be toxic to kidney cells (van Zyl and Viljoen, 2003).  In 
addition, camphor is known to be highly toxic if used in prolonged treatment or when 
ingested in small amounts.  A survey of literature conducted by Burkhard et al. (1999) 
showed that the essential oils of 11 plants, including Salvia were powerful anticonvulsants 
due to their terpenic and ketone contents.  The toxicity associated with the Salvia essential 
oils may be due to the presence of the above compounds, even if present in relatively small 
amounts.  The essential oil of S. runcinata was most toxic probably due to the high amount 
of α-bisabolol (65%, Table 4.1).  Some compounds are present in relatively high amounts: 
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α-thujene (4.7% in S. repens); camphor (8.3% in S. muirii) and p-cymene (9.5% in S. 
repens).  It is also possible that other compounds present even in small amount may act in 
a synergistic or additive manner to increase the toxicity of the essential oils (van Zyl, pers 
comm).    
 
Although the anticancer activity and the toxicity profile measures cell viability or 
inhibition, a poor correlation between the anticancer activity and the toxicity of the extracts 
was observed.  It was, however, interesting to note that with S. lanceolata, S. radula and S. 
stenophylla, which displayed anticancer activity, also exhibited some degree of toxicity.  In 
these cases, it could be speculated that the same compound(s) may be responsible for the 
anticancer activity and the “general” toxicity profile of the solvent extracts.  The isolated 
compounds from S. radula (betulafolientriol oxide and salvigenin, Chapter 8) and S. 
chamelaeagnea (carnosol, Chapter 9), standards of ursolic acid and oleanolic acid 
demonstrated poor toxicity towards the human kidney epithelial cells with IC50 values 
greater than 100 µg/ml.  Thus, the activity of these compounds cannot be correlated to the 
overall cytotoxic profile of the Salvia extracts. 
 
11.6 Conclusions 
 
• The essential oils and solvent extracts displayed some degree of toxicity (compared 
to the anticancer drug, 5´-fluorouracil) with the toxicity of the essential oils being 
generally greater than that of the solvent extracts. 
• The compounds responsible for the anticancer activity are not necessarily those 
responsible for the toxicity profile of the solvent extracts of Salvia. 
• Salvia species are used in traditional medicine as acqueous extracts, and water will 
extract negligeable amount of essential oils which showed some degree of toxicity.  
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Chapter 12:  Seasonal Variation in Essential Oil Composition 
and Biological Activities of Three Salvia Species  
 
Abstract 
 
Aromatic plants contain both volatile and non-volatile fractions and the chemical 
composition of these two fractions may be influenced by seasonal changes.  The essential 
oil composition of S. africana-caerulea, S. africana-lutea and S. lanceolata, collected at 
the same locality throughout the 2004/2005 growing season, was compared in terms of 
essential oil yields, chemical composition and the biological activities.  Mostly 
quantitative, rather than qualitative variation was observed in the essential oil composition 
of each species.  Major fluctuations in S. africana-caerulea oil composition include 
limonene (1.5-32.6%) and viridiflorol (1.6-22.8%).  Levels of α-pinene (0.5-11.9%), 
myrcene (2.2-11.5%) and α-eudesmol (0.1-12.9%) fluctuated seasonally in S. africana-
lutea oil.  In S. lanceolata, considerable changes were noted for β-caryophyllene (trace-
12.9%), β-caryophyllene oxide (1.4-21.2%) and ledol (trace-11.7%).  S. lanceolata 
harvested in winter was more active in winter against Gram-positive bacteria.  S. africana-
caerulea exhibited the most favourable antimalarial activity when harvested in winter (IC50 
value: 11.61 µg/ml) which contrasts with the lowest antimalarial activity of S. lanceolata 
obtained at the same period (IC50 value: 42.60 µg/ml).  The anti-oxidant activity of the 
solvent extracts also displayed variation over seasons with winter collection giving the 
most favourable anti-oxidant activity with S. africana-lutea (IC50 value: 10.05 µg/ml).  All 
the solvent extracts prepared from samples collected in winter exhibited the lowest toxicity 
profile (29.89 < IC50 value < 60.29 µg/ml), while the three essential oils obtained from 
autumn collection were more toxic (0.03 < IC50 value < 0.4 µg/ml).   
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12.1 Introduction 
 
Biological activities are correlated to the presence of chemical compounds (particularly 
secondary metabolites).  The presence of these compounds may assist in predicting some 
traditional uses of medicinal plants (Rasoanaivo and Ratsimamanga-Urverg, 1993).  Many 
plants concentrate certain secondary metabolites in specific organs resulting in the 
variation in biological activities between different parts of the same plant (e.g. barks, roots, 
leaves, stems) (Houghton, 1999).  The season and even the number of hours plants receive 
sunlight per day, may influence the phytochemistry of the plant because some compounds 
may be accumulated at a particular period to respond to environmental changes (Koenen, 
2001).  A collection of plant material made at different times of the year may contain other 
possibly novel compounds with certain bio-activities (Eloff, 1999).  This suggests that the 
biological activities should be evaluated at different times in order to determine the period 
of the year a plant exhibits its best activity. 
 
A quick and effective way to assess variations in the chemical composition of plant 
extracts is TLC (Wagner and Bladt, 1996).  While TLC can also be used to evaluate the 
variation in chemical composition of the essential oils, GC and GC-MS are preferred 
because they are not just qualitative (as with the TLC method), but also quantitative.  
Chemical data obtained by TLC, GC and GC-MS are important in addition to 
morphological features in taxonomic studies as they re-enforce the relationships of plants 
at a different level (McGaw et al., 2002). 
 
The objectives of this study were to:  
(i) determine the monthly variation in the essential oil composition of three 
randomly selected species,  
(ii) create finger-prints using TLC for the three species, which could generate 
information on the chemical constituents of the solvent extract of each plant 
over the seasons, 
(iii) evaluate the antibacterial, antimalarial and anti-oxidant activity of the 
solvent extracts over the seasons, investigate the toxicity profile of the 
essential oils and solvent extracts over seasons and determine if there is a 
correlation between the toxicity of the essential oils and their major 
compounds, and 
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(iv) recommend the best time of the year for harvesting of plants  in terms of 
essential oil yields, biological activities and toxicity profile. 
 
12.2. Materials and methods 
 
12.2.1 Plant material 
 
Three randomly selected species of Salvia, namely Salvia africana-caerulea, S. africana-
lutea and S. lanceolata, all collected from the South Western Cape (Table 2.1), were 
investigated.  The aerial parts of each species were harvested at the end of each month for 
12 consecutive months (November 2004 to October 2005) at the same location. 
 
12.2.2 Isolation of the essential oils and preparation of the solvent extracts  
 
The essential oils were isolated by hydrodistillation and the solvent extracts prepared with 
methanol:chloroform (1:1) as previously described (Section 2.3.1 and Section 2.3.2, 
respectively). 
 
12.2.2.1 Analysis of the essential oils 
The essential oils were analyzed by GC and GC-MS (Section 4.2 and Section 4.3, 
respectively). 
 
12.2.2.2 TLC fingerprint 
To evaluate the possible impact of seasonal change on the phytochemistry, 5 µl (2 mg/ml) 
of the methanol:chloroform extract was separated by TLC (Alugram® Sil G/UV254) and 
developed using ethyl acetate:toluene:acetic acid (10:5:0.01).  The separated spots on TLC 
were examined under UV light (254 and 366 nm) and also sprayed with 0.5% anisaldehyde 
sulfuric acid reagent in glacial acetic acid, methanol, concentrated sulfuric acid (10:85:5) 
and heated at 105 ºC for five minutes. 
 
12.2.3 Evaluation of the biological activities 
 
The biological activities of the solvent extracts evaluated include the antibacterial, 
antimalarial and anti-oxidant activities.  The toxicity profile was also assessed.  These 
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activities were determined at the end of each season of the year as follows: November 
(spring), February (summer), May (autumn) and August (winter).  The results of the 
biological activities corresponding to the spring samples are those reported in previous 
Chapters. 
 
12.2.3.1 The antibacterial activity 
The MIC values of the plant extracts over seasons was determined against Gram-positive 
B. cereus and S. aureus and Gram-negative E. coli and K. pneumoniae test organisms using 
the micro-dilution method (Section 9.2.4.1).  
 
12.2.3.2 The antimalarial activity 
The antimalarial activity was assessed using the [3H]-hypoxanthine radiometric method 
(Section 8.2.5). 
 
12.2.3.3 The anti-oxidant activity  
The effect of seasonal change on the anti-oxidant activity of the three species was 
evaluated using the DPPH method as previously described (Section 6.2.2.2).  
 
12.2.3.4 The toxicity profile 
The effect of seasonal variations on the toxicity profile of the solvent extracts and essential 
oils was performed on human kidney epithelial cells using the MTT proliferation 
colourimetric method (Section 11.2.4.3). 
 
12.3. Data analysis 
 
The identity of the components of each oil was assigned by comparison of their retention 
indices, relative to C8-C17 n-alkanes and GC-MS spectra with corresponding data of 
components of reference oils, laboratory-synthesized components and commercially 
available standards from a home-made library.  Comparison of biological activities 
between seasons was determined using ANOVA.  The IC50 values are given as a mean ± 
s.d. of at least three replicate experiments.  Pearson’s correlation coefficient was used to 
determine any correlation between the toxicity profile and major components of each 
essential oil. 
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12.4 Results 
 
12.4.1 Variation in yield and essential oil composition 
 
The essential oil yield of each species varied with the respective seasons.  The highest 
yield was obtained from plants collected in late winter for S. africana-caerulea (August), 
spring for S. africana-lutea and S. lanceolata (October and September, respectively) 
(Figure 12.1).  All three species demonstrated the lowest essential oil yield in early or mid- 
winter (July for S. africana-caerulea and S. africana-lutea and June for S. lanceolata). 
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Figure 12.1 Variation in essential oil yields of three Salvia species over a one year period. 
 
The components of essential oil found in each species at different seasons are those 
reported in Table 4.1.  However, quantitative variation in the components of individual oil 
was noted (Appendix F).  Only components of the oils greater than 4% of the total oil at 
least in one month are reported here.  Major fluctuations in components of S. africana-
caerulea includes α-pinene (trace-8.2%), limonene (1.50-32.6%), terpinen-4-ol (0.50-
8.3%), trans-calamenene (0.2-8.9%) and viridiflorol (1.60-22.8%) (Figure 12.2).  In the 
November sample of S. africana-caerulea, spathulenol and β-caryophyllene oxide were 
present in high amounts but were totally absent during the rest of the year.  The 
components reported represent up to 60% of the total oil in January and only 20% of the 
total oil in December (Figure 12.2).  The identified compounds of S. africana-lutea over a 
one year period are displayed in Appendix F (Table F-1). 
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Figure 12.2 Variation of major components of Salvia africana-caerulea essential oil over 
a one year period. 
 
The major variations in S. africana-lutea essential oil includes α-pinene (0.5-11.9%), 
myrcene (2.2-11.5%), o-cymene (0.4-10.3%), spathulenol (1.9-10.9%) and α-eudesmol 
(0.1-12.90) (Figure 12.3).  These five components of S. africana-lutea oil represent up to 
45% of the total oil in May and just below 20% in November (Figure 12.3).  The identified 
compounds of S. africana-lutea over a one year period are displayed in Appendix F (Table 
F2). 
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Figure 12.3 Variation of major components of Salvia africana-lutea essential oil over a 
one year period. 
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The major components in S. lanceolata showing considerable changes include β-
caryophyllene (trace-12.90%), α-humulene (0.1-10.0%), spathulenol (0.7-10.6), β-
caryophyllene oxide (1.4-21.2%) and ledol (0.9-11.70) (Figure 12.4).  The components of 
S. lanceolata oil reported here represent close to 50% of the total oil in April and only 15% 
in December (Figure 12.4).  The identified compounds of S. africana-lutea over a one year 
period are displayed in Appendix F (Table F-3). 
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Figure 12.4 Variation of major components of Salvia lanceolata essential oil over a one 
year period. 
 
12.4.2 TLC finger print of the solvent extracts over seasons 
 
Like the essential oil composition, the TLC chromatograms of the solvent extracts showed 
a similar range of compounds for each extract prepared from plant material collected in 
different seasons of the year (Figure 12.5).  The sample collected in the spring, however 
showed less compounds.  Some compounds which cannot be seen in the spring sample 
include A, B and C (S. africana-caerulea), compound D (S. africana-lutea) and compound 
E and F (S. lanceolata).  
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      S. africana-caerulea                  S. africana-lutea                           S. lanceolata 
     
 
Figure 12.5 TLC chromatograms of the solvent extracts of three Salvia species collected at 
various seasons of the year: compounds A, B, C, D, E and F are those absent in the 
samples collected during spring. 
 
12.4.3 Seasonal variation in biological activities  
 
12.4.3.1 The antibacterial activity 
The MIC values of each plant across seasons are given in Figure 12.6.  The best activity 
against Gram-negative bacteria was obtained from the spring sample (November), with the 
exception of S. africana-caerulea against K. pneumoniae.  With the Gram-positive 
bacteria, the best activity was exhibited against B. cereus from the sample harvested in 
spring and S. aureus from the collection done in autumn, respectively for S. africana-lutea.  
The solvent extract of the winter collection of S. lanceolata was more active (S. aureus) 
and the same activity was obtained against B. cereus in the collection done in summer and 
winter.  S. africana-caerulea exhibited its best activity against B. cereus in winter and S. 
aureus in summer (Figure 12.6). 
     Summer  Autumn Winter Spring Summer Autumn  Winter Spring Summer Autumn  Winter   Spring 
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Figure 12.6 Antibacterial activity of the solvent extracts of three Salvia species obtained 
across four seasons of the year (n = 3). 
 
12.4.3.2 The antimalarial activity of the solvent extracts 
The variations in antimalarial activity of Salvia africana-caerulea, S. africana-lutea and S. 
lanceolata as influenced by the seasons are displayed in Figure 12.7.  An ANOVA showed 
significant variation between the antimalarial activities of samples collected at different 
seasons (P < 0.05).  The multiple comparison tests (Tukey test) showed that the activity of 
S. africana-caerulea from the sample collected in winter was the most favourable (IC50 
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value: 11. 61 ± 4.53 µg/ml), whilst the autumn sample exhibited the lowest activity (IC50 
value: 26.41 ± 3.17 µg/ml) (Figure 12.7).  The activity of S. africana-lutea also varied over 
seasons with the spring sample giving the most favourable activity (IC50 value: 15.86 ± 
5.04 µg/ml) and winter the lowest activity (IC50 value: 32.86 ± 2.01 µg/ml).  In contrast to 
S. africana-caerulea, which exhibited its best activity with sample collected in winter, the 
lowest activity of S. lanceolata was obtained with plant harvested in winter (IC50 value: 
42.60 ± 6.34 µg/ml), while no variation was observed between the antimalarial activity of 
S. lanceolata in spring, summer and autumn (P > 0.05) (Figure 12.7).  
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Figure 12.7 Antimalarial activity of three Salvia species obtained at different seasons of 
the year (mean ± s.d., n = 3). 
 
12.4.3.3 The anti-oxidant activity of the solvent extracts 
The anti-oxidant activity of the three species over four seasons is presented in Figure 12.8.  
An ANOVA showed significant variation in the anti-oxidant activity of each species across 
seasons (P < 0.05).  The multiple comparison tests (Tukey test) showed that the activity of 
S. africana-caerulea obtained in autumn was statistically higher compared to the activity 
obtained in other seasons (P < 0.05).  S. africana-lutea exhibited its best activity with the 
extract harvested in winter, which was statistically higher than that of other seasons (P < 
0.05).  In contrast, the best activity of S. lanceolata was obtained in summer (P < 0.05) 
with the spring extract yielding the lowest activity (Figure 12.8).  
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Figure 12.8 Anti-oxidant activity of three Salvia species obtained at different seasons of 
the year (mean ± s.d., n = 3). 
 
 
12.4.3.4 Seasonal variation in the toxicity profile of the solvent extracts and their 
essential oils 
The toxicity of the essential oils and solvent extracts was evaluated against human kidney 
epithelial cells.  The analysis of variance showed variation in the toxicity over the four 
seasons, both for the solvent extracts and essential oils (P < 0.05) (Figure 12.9 and 12.10).  
The solvent extracts exhibited the lowest toxicity for all three species with sample 
harvested in winter (higher IC50 values) (Figure 12.9), while the highest toxicity profile 
(lower IC50 values) was obtained with  spring sample for S. africana-caerulea and summer 
samples for S. africana-lutea and S. lanceolata.   
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Figure 12.9 Toxicity profile of the solvent extracts of three South African Salvia species 
across seasons (mean ± s.d., n = 3). 
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Figure 12.10 Toxicity profile of the essential oils of three South African Salvia species 
across seasons (mean ± s.d., n = 3). 
 
The oils samples of the three species collected during autumn were significantly more 
toxic compared to other seasons.  The lowest toxicity of the essential oil was obtained with 
samples collected during spring for S. africana-caerulea and S. africana-lutea, and sample 
harvested in summer for S. lanceolata (Figure 12.10).  
 
12.5 Discussion 
 
The essential oil yields varied greatly for the same species collected at different periods of 
the year (Figure 12.1).  However, a continuous increase in the yield was noted for all 
species during summer (December to February, with exception of S. africana-caerulea).  
Pitarevic et al. (1984) recorded variation in essential oil yield of S. officinalis collected in 
Yugoslavia in various seasons, with July (flowering period) giving the highest yield.  The 
essential oils yield varied from 0.07% (July) to 0.19% (August) for S. africana-caerulea.  
In S. africana-lutea, the highest yield (0.18%) was obtained in September while July gave 
the lowest yield (0.09%).  Finally, in S. lanceolata, the lowest yield was obtained in June 
and July (0.03%) with September giving the highest yield (0.11%).  The higher essential 
oil yield obtained in early spring, may be explained by the fact the plants remain in flower 
from August to January, a period of full vegetation.  During this period, plants might 
produce substantial amounts of essential oils in order to attract more pollinators (Palá-paúl 
et al., 2001).  The yield of S. africana-caerulea and S. africana-lutea decreased from May 
to July which corresponds to dry season and the period of latent vegetation.   
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Quantitative seasonal variation in chemical composition was found in the essential oil of 
each species and those showing remarkable fluctuations include α-pinene, viridiflorol, 
limonene, terpinen-4-ol and trans-calamanene in S. africana-caerulea.  Two compounds 
namely, β-caryophyllene oxide and spathulenol were detected in the November sample of 
S. africana-caerulea; however were absent during the rest of the year (Figure 12.2).  α-
Pinene, myrcene, o-cymene, spathulenol and α-eudesmol showed fluctuations in S. 
africana-lutea between seasons (Figure 12.3), while β-caryophyllene, α-humulene, 
spathulenol, β-caryophyllene oxide and ledol showed major variations in S. lanceolata 
(Figure 12.4).  Although no pattern in the fluctuation of the components of an individual 
oil component was observed, the most conspicuous variation was recorded for β-
caryophyllene and β-caryophyllene oxide in S. lanceolata.  The variation of these two 
compounds was inversely related: a rise in the β-caryophyllene oxide content was 
accompanied by a decrease in the content of β-caryophyllene (Figure 12.11).  The content 
of β-caryophyllene oxide started to increase from January and reached its maximum in 
April when the content of β-caryophyllene was at its lowest level (Figure 12.11).   
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Figure 12.11 Variation in β-caryophyllene and β-caryophyllene oxide contents in S. 
lanceolata over seasons. 
 
Researchers have reported seasonal variation in essential oil yields and composition for 
many species.  Pitarevic et al. (1984) also noted variation in essential oil composition of S. 
officinalis collected at various seasons of the year.  The components of the oil with 
significant variation included 1,8-cineole (5.8-13.2%), α-thujene (10.9-23.1%), β-thujene 
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(25.0-40.1%) and camphor (7.1-16.4%).  The qualitative variation in essential oil 
composition of S. libanotica was also demonstrated (Farhat et al., 2001).  The major 
components of the oil including 1,8-cineole (47.7-57.4%) and camphor (7.7-12.3%) 
fluctuated from one season to another.  The seasonal variation in the composition of the 
essential oil of Crithmum maritimum L. (Umbelliferae) also showed a great degree of 
variation in the essential oil composition of the main components, namely sabinene (7-
42%) and γ-terpinene (26-55%) (Barroso et al., 1992), but the essential oil yield of this 
species did not show remarkable change.  This study has demonstrated that the essential oil 
yield and change in the amount of each component varied from one season to another.  It is 
known that many factors affect the essential oil yield and composition such as season, 
temperature and reproductive stage (Putievsky et al., 1986).   
 
 
The biological activities of the same plant collected at different periods of the year showed 
significant variation, which could be attributed to changes in the amounts of the active 
compounds present in each plant in different months.  Changes in chemical composition 
could be explained in terms of a thermoregulatory action of the hydrophobic compounds 
which could protect the plant from desiccation.  Furthermore, polar solids (triterpenes, 
flavonoids, diterpene acids) present in the plants might act as a physical barrier to prevent 
water permeation and dehydration (Harbone et al., 1975).  
 
Many studies have reported differences in the biological activity of the same plant 
collected in different seasons.  McGaw et al. (2002) investigated the variation in 
antibacterial activity of Schotia species and noted slight fluctuations.  They also noted 
small variations in the chromatograms obtained from one season to another.  Maréchal et 
al. (2004) also demonstrated seasonal variation in antibacterial activity of solvent extracts 
of Bifurcaria bifurcata (Cystoseiraceae) with the highest level of activity obtained from 
spring to summer.  In the current study, major fluctuations in the antibacterial activity of 
the three Salvia species investigated were observed.  Furthermore, the variation obtained in 
the antibacterial activity depended on both the plant species and the test organism 
involved.  Variation in the anti-oxidant activity and toxicity profile of the three species 
across seasons was exhibited.  Farhat et al. (2001) investigated the essential oil of S. 
libanotica across four seasons of the year and found that the winter sample was the most 
toxic, while the spring sample was the least toxic.  The toxicity of the solvent extracts of 
all three species was low during winter (Figure 12.9), while the three essential oils were 
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significantly (4 to 142 times) more toxic during autumn (Figure 12.10).  An attempt to find 
a relationship between the amount of major components of each essential oil and the 
toxicity profile was not successful.  Thus it can be assumed that the concentration of the 
essential oil components is not directly involved in the toxicity of the essential oils.  To 
account for this, two possibilities can be proposed: either the toxicity profile was due to 
other minor components or there was a synergistic effect between the major components of 
the essential oils and other molecules.  A negative correlation was observed between the 
toxicity and the major components [Pearson’s correlation coefficient r = -0.98, P < 0.05, 
(S. africana-lutea); r = - 0.97, P < 0.05, (S. lanceolata)] denoting that an increase in the 
amounts of the major components of the essential oil are accompanied by an increase in 
the toxicity.  However, S. africana-caerulea showed no significant correlation (r = 0.45, P 
> 0.05) between the toxicity of the oil and its major components.  This suggests that both 
major and minor components of the essential oil may interact to contribute to the toxicity 
of the oil.  This investigation has demonstrated the importance of seasonal changes on 
biological activity and essential oil yield.   
 
12.6 Conclusions 
 
• Quatitative variation in the essential oil composition and yields exists over seasons 
and this also depends on the species studied. 
• Variation in the chemical profile of the solvent extracts was observed on the TLC 
plates as for the various seasons.  
• Seasonal/climatic changes play an important role in the biological activities and the 
toxicity of the plants. 
• The best activity of the solvent extract of S. africana-caerulea was obtained in 
summer (Gram-positive), winter (antimalarial activity) and autumn (anti-oxidant 
activity). 
• The best activity of S. africana-lutea was obtained in spring (antibacterial activity), 
spring (antimalarial activity) and winter (anti-oxidant activity). 
• S. lanceolata exhibited the best activity in winter (against Gram-positive bacteria), 
spring (against Gram-negative bacteria), winter (antimalarial activity) and summer 
(anti-oxidant activity).  
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• The solvent extracts of all three species exhibited the lowest toxicity in winter, 
while the essential oils of the three species were less toxic in spring.  The toxicity 
of the essential oils is not always related to presence of the major components, but 
the influence of minor components to act synergistically with other components 
needs to be evaluated to understand the overall toxicity of the essential oils.  
• It is difficult to determine which season will give the best activity because this 
varies with the species involved as well as the biological activity studied.  
However, it is important to use more plants in order to have a good pattern.   
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Chapter 13: The Influence of Essential Oils on the Biological 
Activities of Solvent Extracts 
 
Abstract 
 
The solvent extracts of aromatic plants contain both the volatile (essential oils) and non-
volatile compounds.  The biological activities of the solvent extracts of three Salvia species 
(Salvia africana-caerulea, S. africana-lutea and S. lanceolata) were evaluated in the 
presence and absence of essential oils.  The biological activities assessed included the 
antibacterial, anti-oxidant, antimalarial and anticancer activity.  In addition, the toxicity 
profile was also investigated.  The solvent extract of S. africana-caerulea without essential 
oil exhibited the best activity against Gram-positive bacteria (MIC value: 0.1 mg/ml), 
while the solvent extract containing essential oil of S. africana-lutea was the most active 
against Gram-negative bacteria (MIC value: 3 mg/ml).  No significant difference was 
obtained in the antimalarial activity for the two extracts of S. africana-caerulea and S. 
lanceolata, while the activity of the solvent extract without essential oil was significantly 
higher than that of the solvent extract containing essential oil in S. africana-lutea (P < 
0.05).  The toxicity profile of all three species was significantly higher (P < 0.05) with the 
solvent extracts containing essential oils.   
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13.1 Introduction 
 
Aromatic plants have traditionally been used in folk medicine as well as to extend the shelf 
life of foods.  In the previous Chapters, it was observed that the essential oils and the 
solvent extracts of indigenous Salvia species exhibited a broad range of biological 
activities including anti-oxidant (Chapter 6), anti-inflammatory (Chapter 7), antimalarial 
(Chapter 8), antibacterial (Chapter 9) and anticancer (Chapter 10) activity.  The essential 
oils and solvent extracts also displayed various levels of toxicity against normal cells with 
the toxicity of the essential oil being greater than that of the solvent extracts (Chapter 11).  
The solvent extracts contain both the essential oils (volatiles) and non-volatile compounds 
(e.g. phenolics).  In order to investigate whether the removal of essential oils could reduce 
the toxicity of the solvent extract without affecting the biological properties, the 
investigation of the solvent extracts in the presence and absence of the essential oils was 
conducted. 
 
The objective of this study was to evaluate the antibacterial, anti-oxidant, anticancer and 
antimalarial activities of two solvent extracts (with and without essential oils) of three 
Salvia species and to compare the toxicity of these solvent extracts. 
 
13.2 Materials and methods 
 
13.2.1 Plant material 
 
Three randomly selected species namely Salvia africana-caerulea, S. africana-lutea and S. 
lanceolata, all collected from the South Western Cape (Table 2.1) were investigated.   
 
13.2.2 Isolation of the essential oils and preparation of the solvent extracts  
The essential oils were isolated by hydrodistillation as previously described in Section 
2.3.1.  In order to investigate the effect of the essential oils on selected biological activities, 
the residue of the plant material in the Clevenger apparatus (with water) was air-dried at 
room temperature and then extracted as described in Section 2.3.2.  To provide a better 
understanding of the terminology used in this Chapter, the plant collected from the field 
and air-dried is referred to ‘as the solvent extracts containing essential oils or solvent 
extracts with essential oils’.  The plant material remaining in the Clevenger apparatus, 
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which was then air-dried and also extracted with methanol:chloroform, are referred to as 
‘the solvent extracts without the essential oils or solvent extracts in the absence of the 
essential oils’.  The same plant material was used and three-quarters of fresh plant material 
of each species was hydrodistilled and the remaining one-quarter air-dried at room 
temperature to constitute the extracts without essential oils and the extracts containing 
essential oils, respectively. 
 
13.2.3 Comparison of the TLC plates of the solvent extract with and without essential 
oils 
 
In order to verify whether the high temperature used to isolate the essential oils would 
affect the plant extract, a TLC plate representing the solvent extract with essential oil and 
solvent extract without essential oil were prepared.  Hence, 5 µl (2 mg/ml) of each 
methanol:chloroform extract from S. africana-caerulea, S. africana-lutea and S. lanceolata 
were separated by TLC (Alugram® Sil G/UV254) and developed using ethyl 
acetate:toluene:acetic acid (10:5:0.01).  The separated spots were examined under UV light 
(254 and 366 nm) and also visualised by spraying the plates with 0.5% anisaldehyde 
sulfuric acid reagent in glacial acetic acid, methanol, concentrated sulfuric acid (10:85:5) 
and heated at 105 ºC for five minutes. 
    
13.2.4 Evaluation of the biological activities  
 
The biological activities evaluated included the antibacterial, anticancer, antimalarial and 
anti-oxidant activities, as well as the toxicity profile being determined for the extracts.   
 
13.2.4.1 The antibacterial activity 
The MIC values of the solvent extracts with and without the essential oils were determined 
against Gram-positive B. cereus and S. aureus and Gram-negative E. coli and K. 
pneumoniae test organisms using the micro-dilution method (Section 9.2.4.1) and 
compared to activity of the essential oils alone (Table 9.1). 
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13.2.4.2 The anticancer activity 
The anticancer activity of the solvent extracts in the presence and absence of the essential 
oils was determined using the SRB method (Section 10.2.3) against the HT-29 and MCF-7 
cells.  
 
13.2.4.3 The antimalarial activity 
The antimalarial activity of the solvent extracts with and without essential oils was 
assessed using the [3H]-hypoxanthine radiometric method (Section 8.2.5) and compared to 
activity of the essential oils alone (Table 8.1). 
 
13.2.4.4 The anti-oxidant activity  
The effect of the essential oils on the anti-oxidant activity of the two solvent extracts was 
determined using the DPPH method as previously described (Section 6.2.2.2) and 
compared to activity of the essential oils alone (Table 6.1). 
 
13.2.4.5 The toxicity profile 
The toxicity profile of the two solvent extracts was determined using the MTT 
proliferation colourimetric method on human kidney epithelial cells (Section 11.2.4.3) and 
compared to activity of the essential oils alone (Table 11.1). 
 
13.3 Data analysis 
 
The IC50 values are given as a mean ± s.d. of three replicate experiments.  The difference 
between the activity of the solvent extracts with and without essential oils was determined 
using the paired sample t-tests.  All statistical analyses were performed using Statistica® 
version 5.0 software and P < 0.05 was considered significant. 
 
13.4. Results 
 
13.4.1 Comparison of the TLC plates of the solvent extracts with and without the 
essential oils  
 
There was not obvious variation in the chromatographic profiles in the solvent extracts of 
the three species studied in the presence or absence of the essential oils (Figure 13.1).  
 194
Similar compounds were noted and it appeared that the high temperature did not alter the 
composition of the phenolic compounds based on TLC plate results. 
  
 
                               SacW   SacWT   SalW    SalWT   SlaW   SlaWT 
Figure 13.1 TLC chromatogram of the solvent extracts of three Salvia species obtained in 
the presence and absence of the essential oils.  SacW: solvent extract of S. africana-
caerulea with essential oils; SacWT: solvent extract of S. africana-caerulea without 
essential oils, SalW: solvent extract of S. africana-lutea with essential oils; SalWT: solvent 
extract of S. africana-lutea without essential oils; SlaW: solvent extract of S. lanceolata 
with essential oils; SlaWT: solvent extract of S. lanceolata without essential oils.  
 
13.4.2 The antibacterial activity 
 
A comparison between the activity of the solvent extracts containing essential oils and the 
solvent extracts without essential oils is displayed in Figure 13.2.  The best activity against 
Gram-positive bacteria for all three species was obtained with the solvent extracts without 
essential oils.  In contrast, the best activity against Gram-negative bacteria was obtained 
with the solvent extracts containing essential oils with the exception of S. africana-
caerulea against K. pneumoniae (Figure 13.2). 
 195
E. 
co
li
K. 
pn
eu
mo
nia
e
B. 
cer
eus
S. 
au
reu
s
0
8
16
24
32
 Extracts containing essential oils
 Extracts in the absence of essential oils
Essential oils
S. africana-caerulea
> 32
M
IC
 v
al
ue
s 
(m
g/
m
l)
E. 
co
li
K. 
pn
eu
mo
nia
e
B. 
cer
eu
s
S. 
au
reu
s
0
8
16
24
32 > 32
M
IC
 v
al
ue
s 
(m
g/
m
l)
S. africana-lutea
E. 
col
i
K. 
pn
eu
mo
nia
e
B. 
cer
eus
S. 
au
reu
s
0
8
16
24
32
S. lanceolata
> 32
M
IC
 v
al
ue
s 
(m
g/
m
l)
 
Figure 13.2 Antibacterial activity of the solvent extracts with and without essential oils of 
three Salvia species (n = 3). 
 
13.4.3 The anticancer activity 
 
The results of the anticancer activity of the two solvent extracts (with and without essential 
oils) against two cancer cell lines are displayed in Figure 13.3.  A paired sample t-test 
showed no difference between the solvent extracts containing essential oil and the solvent 
extract without essential oil against the HT-29 cell line (P > 0.05).  In S. africana-lutea, the 
solvent extract containing essential oil was significantly less active than the solvent extract 
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without essential oil against the MCF-7.  In contrast, S. africana-caerulea exhibited the 
most favourable activity with the solvent extract containing essential oil, while in S. 
lanceolata there was no difference between the two solvent extracts against the MCF-7 cell 
line. 
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Figure 13.3 Anticancer activity of the solvent extracts of three Salvia species evaluated in 
the presence and in the absence of the essential oils (mean ± s.d., n = 3). 
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13.4.4 The antimalarial activity 
 
The antimalarial activity of the two solvent extracts against the chloroquine-resistant P. 
falciparum strain is depicted in Figure 13.4.  A paired sample t-test showed no variation in 
the antimalarial activity of S. africana-caerulea and S. lanceolata using the extracts with 
and without the essential oils (P > 0.05).  The solvent extract of S. africana-lutea without 
essential oils exhibited higher activity (P < 0.05) compared to the solvent extract with 
essential oils (Figure 13.4).  In all cases, the antimalarial activity of the solvent extracts 
(with and without essential oils) was significantly lower than the activity of the essential 
oils (Figure 13.4). 
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Figure 13.4 Variation in the antimalarial activity of the solvent extracts with and without 
their respective essential oils of three Salvia species (mean ± s.d., n = 3). 
 
13.4.5 The anti-oxidant activity  
 
The anti-oxidant activity of the two solvent extracts is depicted in Figure 13.5.  A paired 
sample t-test showed that the activity of the solvent extracts containing essential oils was 
significantly lower (P < 0.05) compared to the activity of the solvent extracts without 
essential oils for all three species.  This suggests that the essential oils contributed little to 
the anti-oxidant activity of the solvent extracts.  
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Figure 13.5 Anti-oxidant activity of the solvent extracts with and without their respective 
essential oils of three Salvia species (mean ± s.d., n = 3). 
 
13.4.6 The toxicity profile  
 
The outcome of the toxicity profile of the two solvent extracts is displayed in Figure 13.6.  
A paired sample t-test indicated that the toxicity of the solvent extracts was significantly 
lower in the absence of the essential oils (P < 0.05) implying that the essential oils have 
contributed significantly to the toxicity of the solvent extracts of  these three species.  The 
toxicity of the essential oil was always higher than that of the two solvent extracts (with 
and without essential oils).  In order to determine whether there is a direct correlation 
between the toxicity of the oil and solvent extract of the same plant, a regression analysis 
was performed.  A poor relationship (r2 = 0.25) between the activity of the essential oil and 
the solvent extract of the same plant was observed.  This suggests that the high toxicity of 
an essential oil does not imply that its solvent extract is also highly toxic.   
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Figure 13.6 Toxicity profile of the solvent extracts of three Salvia species with and 
without essential oils (mean ± s.d., n = 3). 
 
13.5 Discussion 
 
There is a variation in the in vitro biological activities of the solvent extracts when tested 
with and without the essential oils.  The essential oils seem to have beneficial or adverse 
effects depending on the biological activities implicated.  In this study, it was found that 
the essential oils do not have a negative influence on the activity of the solvent extracts 
against Gram-positive bacteria, while they increase the activity of the solvent extracts 
against Gram-negative bacteria.  The essential oils also slightly increase the activity of the 
solvent extracts against cancer cells.  The toxicity of the solvent extracts was significantly 
decreased when the essential oils were removed implying that the essential oils contribute 
to the toxicity of the solvent extracts.  A poor relationship obtained between the toxicity of 
the essential oils and the solvent extracts may be due to the fact that essential oils were 
present in relatively small amounts in the solvent extracts (Figure 4.2).   
 
Although the mechanism of action of the essential oil is not clearly understood, the 
hydrophobic compounds present in essential oils are proposed to disrupt cell membranes 
resulting in increased permeability to ions which will cause cell death (Sikkema et al., 
1995; Cowan, 1999).   
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Although the activity of the essential oils was generally greater than that of the solvent 
extracts, this study has demonstrated that the removal of the essential oils did not 
significantly reduce the antimalarial activity of the solvent extract (for S. africana-caerulea 
and S. africana-lutea) as one may have assumed.  Solvent extracts contain both volatile 
and non-volatile fractions.  In Chapter 6 it was shown that the essential oils possessed poor 
anti-oxidant activity (IC50 values > 100 µg/ml), thus it could be expected that the removal 
of essential oils would not affect the anti-oxidant activity of the solvent extracts.  This 
assumption was correct as the solvent extracts still exhibited favourable anti-oxidant 
activity once the essential oil had been removed (Figure 13.5).  It is known that there is a 
direct relationship between the anti-oxidant activity and the total phenolic content (Chapter 
6; Cuvelier et al., 1994, Cuvelier et al., 1996; Hohmann et al., 1999).  The dilution of total 
phenolic content after the removal of the essential oils affects the anti-oxidant capacity, as 
well as other biological activities, of the solvent extracts.   
 
13.6 Conclusions  
 
• The solvent extracts have varying degrees of activities, and depend on the presence 
or absence of essential oils. 
• The solvent extracts without the essential oils exhibited the best activity against 
Gram-positive bacteria, while those containing essential oils displayed the most 
favourable activity against Gram-negative bacteria.  The hydrophobic essential oil 
compounds may therefore be important to disrupt the cell membrane and increasing 
the activity of the solvent extracts. 
• The presence of the essential oils in the solvent extracts may have antagonistic, 
synergistic or additive interactions depending on the biological activity 
investigated. 
• The presence of essential oils in the solvent extracts reduces the concentrations of 
phenolic compounds which are the main contributors of the anti-oxidant activity of 
the solvent extracts. 
•  S. africana-caerulea and S. lanceolata showed no significant variation in 
antimalarial activity between the two extracts.  However, the solvent extract of S. 
africana-lutea containing essential oil was lower than that of the solvent extract 
without essential oil. 
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• The solvent extract containing essential oils was more toxic to “normal cells” 
compared to the solvent extracts without essential oils. 
• The essential oils contribute to the toxicity of the solvent extracts.   
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Chapter 14:  General Conclusions and Recommendations 
 
14.1 General conclusions 
 
The aims of the study were to evaluate the biological activities of the solvent extracts and 
essential oils of indigenous Salvia species, to isolate and identify compounds which may 
be responsible for the biological activities and to determine any possible relationship 
between the species investigated using the essential oil composition and the leaf trichomes 
type data.  In addition, the effect of seasons on the chemical composition of essential oil 
was studied as well as the influence of the essential oils on the biological activities of the 
solvent extracts.  The aims of the study were achieved and the major findings are listed 
below. 
 
14.1.1 Leaf trichome types and essential oil composition 
 
• Both glandular (peltate and capitate) and non-glandular trichomes were observed in 
all the investigated species. 
• The peltate trichome consists of eight to sixteen cells in the head arranged in one or 
two concentric circles. 
• Four types of capitate trichomes were recorded based on the number of cells in the 
head and the length of the stalk cell and this helped to divide the investigated 
species into four groups. 
• Three species namely S. aurita, S. chamelaeagnea and S. repens have multiple cells 
at the base of the non-glandular trichomes, while others only have one cell at the 
base. 
• The essential oil yield of the eleven species studied was low (0.004-0.5%) and 
varied between species with S. muirii and S. radula having the highest and the 
lowest yield, respectively. 
• Quantitative and qualitative variations in essential oil were recorded for the 
essential oils investigated. 
• Ninety-three components composed mainly of monoterpene and sesquiterpene 
hydrocarbons, oxygen-containing monoterpenes and oxygen-containing 
sesquiterpenes were recorded. 
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• Major components identified include α-pinene, 1,8-cineole, linalool, limonene, 
myrcene, β-caryophyllene, spathulenol, β-caryophyllene oxide, viridiflorol, δ-3-
carene and α-bisabolol. 
• S. runcinata was found to particularly rich in α-bisabolol (65% of the total oil) and 
may therefore be considered as a natural source of α-bisabolol. 
• Cluster analysis data revealed that the essential oils of S. africana-caerulea and S. 
lanceolata were highly correlated due to their high amount of spathulenol and β-
caryophyllene oxide, which supports the morphological resemblance of the two 
species.  The correlation between the essential oil of S. dolomitica and the rest of 
the species was very low.  
 
14.1.2 Identification of phenolic compounds in the solvent extracts 
 
• Indigenous Salvia species contain various phenolic compounds such as rosmarinic 
acid, carnosol, ursolic acid, oleanolic acid, salvigenin, 7-O-methylepirosmanol, 
betulafolientriol oxide, caffeic acid and carnosic acid. 
• Betulafolientriol oxide isolated from S. radula was detected in all the 17 species 
investigated.  Various populations need to be investigated in order to determine 
whether this compound could be used as taxonomic marker for indigenous Salvia 
species.  
• Rosmarinic acid was detected in all the indigenous species, except S. verbenaca. 
• S. muirii, S. runcinata and S. albicaulis have high levels of rosmarinic acid (> 
35%), while the levels of carnosol and/or carnosic acid are high in S. aurita, S. 
chamelaeagnea, S. namaensis and S. stenophylla (> 20%). 
 
14.1.3 Biological activities and isolated compounds from two Salvia species 
 
• The solvent extracts of indigenous Salvia species are good anti-oxidant but 
exhibited poor anti-inflammatory activity. 
• In contrast, the essential oils possessed favourable anti-inflammatory activity, but 
poor anti-oxidant activity. 
• Qualitative analysis by TLC indicated that the same compounds possessed the 
ability to scavenge the ABTS·+ and DPPH· radicals. 
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• The anti-oxidant capacity of the S. schlechteri extract was higher than that of the 
reference compound, vitamin C which indicates that this plant may be used as 
Natural anti-oxidant. 
• The solvent extracts and essential oils inhibited the in vitro growth of P. falciparum 
and in most of cases the activity of the essential oils was greater than that of its 
counterpart solvent extract. 
• Betulfolientriol oxide and salvigenin isolated from S. radula exhibited comparable 
or lower activity than the crude extract and chloroquine and quinine.  This suggests 
that the activity of the crude extract is determined by the combination of various 
compounds. 
• The solvent extracts and/or essential oils displayed varing degrees of activity 
against bacterial, human cancer cells and human kidney epithelial kidney cells. 
• The solvent extracts of S. chamelaeagnea, S. disermas, S. dolomitica and S. muirii 
exhibited good activities in various assays, while their toxicity to human epithelial 
cells were low in comparison to other solvent extracts. 
• S. africana-caerulea was the only species displaying anticancer activity on all three 
human cancer cell lines with an IC50 less than 30 µg/ml.  
• The antibacterial and anticancer activities of the essential oils and/or solvent 
extracts against the test patogens provide a scientific rationale of the use of the taxa 
in traditional herbal remedies for the treatment of respiratory ailments, dermal 
infections, tuberculosis and some cardio-vascular diseases. 
• The in vitro combination of S. chamelaeagnea and L. leonurus demonstrated a 
synergistic interactions against B. cereus and S. aureus, providing support for the 
co-administration use of these two species. 
•  Carnosol, ursolic acid/oleanolic acid, 7-O-methylepirosmanol were isolated from 
S. chamelaeagnea and tested against bacterial pathogens.  Their activities were in 
most cases higher than that of the crude extract, but less active than ciprofloxacin. 
• No direct correlation could be observed between the chemical composition of the 
essential oils and the solvent extracts and the biological activities.  Hence, the 
activity of the essential oil or solvent extract is most likely the result of the 
combination between the major and minor compounds. 
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14.1.4 Seasonal variation in essential oil composition and biological activities and the 
influence of the essential oil in the biological activities of the solvent extracts 
 
• Seasonal variation is an important factor that has an influence on essential oil 
yield.  In addition, the chemical profile of the solvent extracts and essential oils 
were found to vary between seasons. 
• It is difficult to determine a specific time of the year when the solvent extract 
and essential oil provide optimal biological activity as the activity varies with 
the species involved, as well as the biological activity.  However, it was noted 
that, collection and preparationsof the solvent extracts in winter and essential 
oils in spring were generally less toxic than plants collected during other 
seasons. 
• The presence of essential oils in the solvent extract had a variable effect on the 
the activity of the solvent extract and was dependent on the biological activity 
investigated. 
• The solvent extracts containing essential oils were more toxic to human kidney 
epithelial cells than the solvent extracts devoid of essential oils. 
• The results of the in vitro pharmacological activities justify why Salvia species 
in general are considered as a ‘panacea’ in traditional medicine. 
 
14.2 Recommendations  
 
• The collection of the same species from different localities is important in order 
to determine chemotypic variation for each species. 
• The leaf trichome types, biological activity and phytochemistry of indigenous 
Salvia species not included in this study should be completed. 
• Investigate the mechanisms by which the solvent extracts and essential oils 
exert their anti-inflammatory and anti-oxidant activities. 
• Isolate the active compounds from the most promising plant which displayed 
anticancer, antimycobacterial and anti-oxidant activity. 
• Further research should consider testing various fractions of the solvent extracts 
for different biological activities and disregard the fraction with highly toxic 
effects. 
• Perform in vivo tests with those plants that exhibited specific activity in vitro. 
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Appendix B:  Abstracts of conferences/presentations 
 
Appendix B1: (South African Association of Botanists, Durban 2004) 
 
Biological activities and essential oil composition of Salvia repens, S. 
runcinata and S. stenophylla 
 
G.P.P. KAMATOU1, A.B. GONO-BWALYA1, A.M. VILJOEN1, A. LOURENS, Y. 
FRUM, R.L. VAN ZYL1, S.F. VAN VUUREN1, K.H.C. BAŞER2 
 
1Department of Pharmacy and Pharmacology, University of the Witwatersrand, 7 York 
Road, Parktown 2193, Johannesburg, South Africa 
2Department of Pharmacognosy, Faculty of Pharmacy, Anadolu University, 26470 
Eskişehir, Turkey 
 
Salvia species have been used medicinally throughout the word.  There are about 900 
Salvia species of which 26 are found in South Africa.  The methanol extracts and essential 
oils from S. stenophylla, S. repens and S. runcinata were investigated for anti-oxidant (α,α-
diphenyl-β-picrylhydrazyl), anti-inflammatory (5-lipoxygenase), antimalarial (tritiated 
hypoxanthine incorporation), antimicrobial (disc diffusion and microplate methods) and 
toxicity properties (MTT assay).  The results indicated that some extracts and/or essential 
oils were active with the anti-oxidant IC50 values ranging from 8.98 to 15.07 ppm 
(methanol extracts) and anti-inflammatory activity from 22.84 to 30.24 ppm (essential 
oils).  Essential oils and extracts of plants possessed antimalarial properties but are 
potentially toxic.  S. stenophylla exhibited the highest activity with the MIC values ranging 
from 0.10 mg/ml (S. aureus) to 3.13 mg/ml (S. epidermidis).  Essential oils have shown 
little antimicrobial activity against all tested organisms. Analytical techniques (GC-MS, 
HPLC) were employed to complete chromatographic profiles for the essential oils and 
methanol extracts, respectively.  HPLC results indicate the presence of rosmarinic acid and 
carnosic acid derivatives.  Using bioassay guided fractionation the antimicrobial activity is 
ascribed to carnosic acid.  The results of the study gave the evidence of the traditional use 
of the members of the S. stenophylla species complex to treat different ailments in some 
regions of South Africa.     
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Appendix B2 (Indigenous Plant Use Forum, Grahamstown 2005) 
 
Biological activities of solvent extracts and essential oils of four related 
Salvia species 
 
 
G.P.P. KAMATOU1, A.M. VILJOEN1, R.L. VAN ZYL1, S.F. VAN VUUREN1, D.H. 
DAVIDS1, F.R. VAN HEERDEN2, T. SEAMAN3 
 
1Department of Pharmacy and Pharmacology, University of the Witwatersrand, 7 York 
Road, Parktown 2193, Johannesburg, South Africa 
2School of Chemistry, University of KwaZulu-Natal, Private Bag X01, Scottsville, 3209, 
Pietermaritzburg, South Africa 
3Division of Pharmacology, Faculty of Health Sciences, University of Cape Town, 
observatory, 7925, cape Town, South Africa 
 
Salvia species (sage) are widely used in traditional medicine throughout the world to treat 
various ailments.  In South Africa, they have been used to treat microbial infections, 
malaria, sore throat and cancer.  The solvent extracts and essential oils of four related 
species; S. africana-lutea, S. africana-caerulea, S. lanceolata and S. chamelaeagnea were 
investigated for antibacterial, antimalarial, anti-inflammatory, anticancer and anti-oxidant 
activities.  The essential oils were obtained by hydrodistillation of the fresh aerial plant 
parts.  The solvent extract (methanol:chloroform) displayed antibacterial activity against 
Gram-positive and Gram-negative bacteria with MIC values ranging from 0.03 to 4.67 
mg/ml.  The extracts also exhibited good anti-oxidant (12.75 ± 1.04 < IC50 < 68.09 ± 3.69 
μg/ml.), antimalarial (15.86 ± 5.04 < IC50 < 28.68 ± 2.80 μg/ml) and anticancer activities 
(8.72 ± 1.52 < IC50 < 54.40 ± 4.42 μg/ml) but poor anti-inflammatory activity (IC50 > 100 
μg/ml).  The essential oils exhibited better antimalarial activity (4.76 ± 0.48 < IC50 < 8.63 ± 
0.95 μg/ml) and anti-inflammatory activity (43.38 ± 0.48 < IC50 < 77.2 ± 6.27 μg/ml), 
antibacterial and poor anti-oxidant activity.  The in vitro assessment of the toxicity against 
human kidney epithelium cells indicated that both essential oils and solvent extracts 
displayed some degree of toxicity with essential oils being more toxic than the solvent 
extracts.  However, the toxicity of the solvent extract was reduced when tested after 
extraction of the essential oil.  A study of S. chamelaeagnea and Leonotis leonurus in 
combination showed that when the two plants are used in combination (as reported in the 
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ethnobotanical literature) they have synergistic effects against Gram-positive bacteria and 
additive or antagonistic effects against Gram-negative bacteria.  The bio-autographic-
guided fractionation method was employed to isolate the active compound from S. 
chamelaeagnea against Staphylococcus aureus; and was identified by NMR to be carnosol.  
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Appendix B3 (University of Johannesburg Symposium, 2005) 
 
Trichome morphology and the role of leaf essential oils in the 
pharmacological activity recorded for indigenous Salvia species 
 
G.P.P. KAMATOU1, A.M VILJOEN2, P.M. TILNEY3, S.F. VAN VUUREN1, R.L. VAN 
ZYL1 
 
1Department of Pharmacy and Pharmacology, Faculty of Health Sciences, University of 
the Witwatersrand, 7 York Road, Parktown 2193 
2School of Pharmacy, Tshwane University of Technology, Private Bag X680, Pretoria, 
0001 
3Department of Botany, University of Johannesburg, PO Box 524, Auckland Park, 2006 
 
South Africa is home to 26 Salvia species of which many are used in traditional medicine 
to treat various ailments.  We investigated the leaf trichome morphology of four related 
species; S africana-caerulea, S. africana-lutea, S. chamelaeagnea and S. lanceolata.  The 
SEM and the LM show both glandular and non-glandular trichomes.  Glandular trichomes 
are single- or multi-celled with short to medium stalk (1-3 cells) and present in all four 
species.  The non-glandular trichomes are unbranched with at least two stalk cells.  The 
leaf trichome morphology cannot be used to set up boundaries among the four species 
studied.  The present work also investigated the in vitro biological activities of extracts in 
the presence and absence of essential oil to establish the role of the essential oil fraction in 
the pharmacological activity.  The MIC values for the antibacterial activity were best after 
removal of essential oils against Gram-positive bacteria while the opposite results were 
obtained for the Gram-negative bacteria.  Superior anti-oxidant activity (lower IC50 values) 
and lower toxicity (high IC50 values) were obtained after the essential oils were removed 
from the plants.  The total phenolic content was also high after removal of the essential oil 
fraction.  The results suggest that essential oils may play an important role (antagonistic or 
synergistic) in the biological activity of medicinal aromatic plants.  This work forms part 
of a greater project to summarise the chemistry, trichome morphology and biological 
activity of indigenous aromatic plants in monograph format.   
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Appendix B4 (South African Association of Botanists, Port Elizabeth, 
2006) 
 
Biological activities, essential oils composition and leaf trichome 
morphology of four selected Salvia species indigenous to southern Africa 
 
G.P.P. KAMATOU1, A.M. VILJOEN2, P.M. TILNEY3, R.L. VAN ZYL1, D.H. 
DAVIDS1, T. SEAMAN4, A.C. FIGUEIREDO5 
 
1Department of Pharmacy and Pharmacology, Faculty of Health Sciences, University of 
the Witwatersrand, 7 York Road, Parktown 2193 
2School of Pharmacy, Tshwane University of Technology, Private Bag X680, Pretoria, 
0001 
3Department of Botany, University of Johannesburg, PO Box 524, Auckland Park, 2006 
4Division of Pharmacology, Faculty of Health Sciences, University of Cape Town, 
Observatory, 7925, Cape Town, South Africa 
5Universidade de Lisboa, Faculdade de Ciências de Lisboa, Departamento de Biologia 
Vegetal, Centro de Biotechnologia Vegetal, C2, Campo Grande, 1749-016 Lisbon, 
Portugal 
 
Salvia species are widely used in traditional medicine to treat various ailments.  Twenty-
three species are indigenous to southern Africa and have been poorly investigated.  The 
biological activities of the essential oils and the solvent extracts of four related species 
namely S. africaca-caerulea, S. africana-lutea, S. chamelaeagnea and S. lanceolata were 
studied.  The essential oils were extracted by hydrodistillation and analyzed by GC and 
GC/MS.  The essential oils displayed good antimalarial (IC50 < 8. 6 µg/ml) and promising 
anti-inflammatory properties (IC50 < 77 µg/ml) in comparison to respective controls.  The 
solvent extracts also exhibited potent antimalarial (IC50 < 26 µg/ml), anticancer (IC50 < 50 
µg/ml), antituberculosis (MIC ≤ 0.5 mg/ml) activities but poor anti-inflammatory 
properties (IC50 > 100 µg/ml).  The toxicity of the essential oils was higher compared to 
that of solvent extracts (P < 0.05) with the IC50 values ranging from 1.87 to 7.24 µg/ml and 
from 14.38 to 25.01 µg/ml respectively.  The analysis of the leaf trichome morphology 
with SEM and LM revealed the presence of the non-glandular and glandular trichomes in 
all four species.  The non-glandular trichome, unbranched, composed of 2 to 3 stalk cells 
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was common to all the species investigated.  The glandular trichomes, were single or 
multicelled in the head, 2-4 short/medium stalk cells were also common to the four species.  
The composition of the essential oils analysis is also reported and the taxonomical 
relationship using the essential oils data discussed.  
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Appendix B5 (4th International Conference on Pharmaceutical and 
Pharmacological Sciences, Gauteng, 2006) 
 
The Antimalarial Activity and Cytotoxic Effects of Solvent Extracts of 
South African Salvia Species and Isolated Compounds from S. radula 
 
G.P.P. KAMATOU1, R.L. VAN ZYL1, A.M. VILJOEN2, H. DAVIDS1,  
F.R. VAN HEERDEN3 
 
1Department of Pharmacy and Pharmacology, University of the Witwatersrand, 7 York 
Road, Parktown 2193, Johannesburg, South Africa. 
2School of Pharmacy, Tshwane University of Technology, Private Bag X680, Pretoria, 
0001 
3School of Chemistry, University of KwaZulu-Natal, Private Bag X01, Scottsville, 3209, 
Pietermaritzburg, South Africa 
 
Purpose: 
About 80% of the population in developing countries, including South Africa rely 
on traditional medicine for their primary care needs.  The objectives of this paper are to 
investigate the in vitro antimalarial and cytotoxic effects of Salvia species which are 
currently used in traditional medicine in South Africa and to isolate the compounds 
responsible for the antimalarial activity from the most active species. 
Method: 
         The hypoxanthine radioisotope and the sulforhodamine B methods used to 
investigate the antimalarial and anticancer activity respectively.  The cytotoxicity of the 
extracts (methanol:chloroform) were tested on a human kidney epithelium cell line using 
the 3-(4,5-dimethylthiazol-2-yl)-2,5 dimethyl tetrazolium bromide (MTT) method and on 
three human cancer cell lines (SF-268, MCF-7 and HT-29).  The active compounds were 
isolated using a combination of TLC and column chromatography and their 
characterization was done using NMR and mass spectrometry. 
Results: 
Solvent extracts displayed antimalarial activity with the IC50 values ranging from 
3.91 ± 0.52 to 26.01 ± 2.95 µg/ml.  Among the plants screened, S. radula displayed the 
most favorable activity, while S. lanceolata was the least active.  Since the most active 
 243
extract was that obtained from S. radula, this species was selected to isolate the 
compound(s) which may account for the observed biological activity.  Two compounds 
were isolated, identified and characterized as; 5-hydroxy-6,7-dimethoxy-2-(4-
methoxyphenyl)-4H-1-benzopyran-4-one and betulafolientriol oxide and tested for 
antimalarial activity.  The plant extracts also exhibited the ability to inhibit cell 
proliferation against the human kidney epithelial cells (12.12 ± 2.02 < IC50 < 53.34 ± 3.90 
μg/ml) and three human cancer cell lines.  The concentration required to inhibit 50% of 
cell growth (IC50 values) ranged between 9.69 ± 0.92 and 43.65 ± 8.38 and between 8.72 ± 
1.52 and 54.40 ± 4.20 μg/ml against the MCF-7 and SF-268 cell lines, respectively.  
Against the HT-29 cell line, the IC50 values ranged from 17.05 ± 3.50 to 57.00 ± 11.67 
μg/ml; with S. lanceolata being the most active plant.  S. africana-caerulea was the most 
active against SF-268 and S. radula showed the best activity against the MCF-7 cell line.  
Results obtained in this in vitro study may support the traditional use of indigenous Salvia 
species as coveted ingredient in traditional headlining.  
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Appendix C:  Monographs of Salvia species investigated  
 
A monograph of all the investigated species are presented in alphabetical order and 
includes: 
(i)  a brief description,  
(ii)  the geographical distribution,  
(iii) the traditional uses, 
(iv) the main components of the essential oil,  
(v) the phenolic compounds identified in each solvent extract,  
(vi) the biological activities of the essential oils and solvent extracts,  
(vii) the leaf trichome types, and  
(viii) the HPLC profile of the solvent extract (only peak with percentage area 
greater than 3% is recorded).  
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C1. Salvia africana-caerulea L.  
Synonyms: S. africana L., S. lanuginose Burm.f., S. integerrima Mill., S. barbata Lm. 
Common names: ‘Bloublomsalie’, wild sage. 
Botanical description:  Shrub up to 2 m tall, often branching at the base with several 
erect, usually sparingly branched stems.  Stems are gland-dotted and occasionally with 
glandular hairs.  Leaves are petiolated, blade simple, obovate-ellicptic to broadly obovate.  
The calyx is somewhat funnel-shapped, glandular-villous and the corolla is light blue to 
bluish purple or pinkish, the lower lip usually with a paler blue margin and white to 
yellowish in the centre (Codd, 1985).   
Distribution:  This plant is distributed from the Vanrhynsdorp district to Cape Town and 
eastwards to Montagu and Caledon with an old record from Peddi district in the Eastern 
Cape Province, common in coastal fynbos and rocky slopes (Codd, 1985). 
  
Petiolate and obovate leaves and flowers         Distribution of S. africana-caerulea. 
of S. africana-caerulea. 
Traditional uses: The infusion or decoction is used as a remedy for coughs, colds, chest 
problems, urine troubles, kidney infections, stomach ailments (Watt and Breyer-Brandwijk 
1962; Hutchings et al.,1996; van Wyk et al. (1997). 
Leaf trichome types: Both non-glandular and glandular trichomes are present on the leaf.  
The glandular trichomes are either peltate or capitate. 
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Scanning electron microscopy and light microscopy micrographs of S. africana-caerulea. 
Essential oil composition: The essential oil yield of this plant collected in the South 
Western Cape was 0.12% (w/w, wet biomass) and the major components of this oil include 
spathulenol (29.1%), β-caryophyllene oxide (14.6%) and ledol (6.5%). 
 
 
 
 
 
          Spathulenol                                   β-Caryophyllene oxide                      Ledol 
HPLC analysis of the solvent extract: Caffeic acid, rosmarinic acid, 7-O-
methylepirosmanol, salvigenin, carnosol, carnosic acid, ursolic acid and betulafolientriol 
oxide were detected.  The HPLC chromatogram and the tentative of identification are 
displayed in below, while the retention time, the absorption maxima and the percentage 
area of the major peaks are depicted in the table below. 
 
HPLC chromatogram of the solvent extract of S.  africana-caerulea.  
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A summary of the HPLC-UV data of the methanol:chloroform extract of S. africana-
caerulea. 
 
Biological activities and total phenolic content: The IC50 values (in µg/ml) of the in vitro 
biological activities of the solvent extract (SE) and the essential oil (EO), as well as the 
total phenolic content are given below. 
AC AI AM AO TO TP  
SF-268 MCF-7 HT-29 5-LOX 3[H]-hyp ABTS·+ DPPH· MTT FCM 
SE 8.72 23.36 27.10 > 100.0 22.68 39.72 33.40 14.38 
EO nd nd nd 73.47 4.76 > 100.0 > 100.0 1.87 
115.06 
- 
AC: anticancer activity; AI: anti-inflammatory activity; AM: antimalarial activity; AO: anti-oxidant activity; 
TO: toxicity profile: TP: total phenolic content; 5-LOX: 5-lipoxygenase assay; [3H]-hyp; hypoxanthine 
isotope method; MTT: 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay; FCM: Folin-
Ciocalteu method; nd: not determined.  NB: the anticancer activity was determined using the SRB assay, 
while the anti-oxidant activity was investigated using the ABTS and the DPPH methods.   
 
The MIC values (mg/ml) of the solvent extract (SE) and essential oil (EO) against bacteria 
are displayed below. 
Pathogens  
E. coli K. pneumoniae B. cereus S. aureus M. tuberculosis 
SE 4.00 4.67 6.00 3.00 0.50 
EO 16.00 8.00 0.75 4.00 nd 
     nd: not determined 
References 
Codd, L.E.W. 1985.  Lamiaceae: Flora of Southern Africa. 28, Botanical Research 
Institute, Pretoria. 
Hutchings, A., Scott, A.H., Lewis, G., Cunningham, A. 1996.  Zulu Medicinal Plants – an 
Inventory.  University of Natal Press.  Pietermaritzburg. 
van Wyk, B.E., van Oudtshoorn, B., Gericke, N. 1997.  Medicinal Plants of South Africa. 
Briza, Pretoria.  
Watt, J.M., Breyer-Brandwijk, B.N. 1962.  Medicinal and Poisonous Plants of Southern 
and Eastern Africa.  2nd edition.  E. and S. Livingstone, Edinburg, UK.  
Peak number 
Retention time 
(min) 
λmax (nm) 
Tentative 
identification 
Area (%) 
1 15.55  218, 324  Caffeic acid 5.29 
2 23.27  329  Rosmarinic acid 22.90 
3 37.08 204, 283  11.55 
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C2. Salvia africana-lutea L.  
Synonyms: S. aurea L., S. colorata L., S. eckloniana Benth. 
Common names: ‘Bruinsalie’, ‘beach Salvia’, ‘Dune Salvia’, ‘golden Salvia’ 
Botanical description: Branched shrub up to 2 m tall; stems are densely leafy.  Leaves are 
petiolate; blade simple, grey-tomentosed, gland dotted, apex rounded to obtuse.  The calyx 
is purplish and membranous with short spreading glandular and non-glandular hairs dotted 
with orange-red gland-dots.  The corolla is golden brown, reddish brown khaki or 
sometimes purplish.  The flowering begins in early spring and the bright yellow flowers 
soon fade to rusty-orange and then reddish brown (Codd, 1985).   
Distribution:  The distribution of S. africana-lutea extends from the coast of 
Namaqualand to the Cape Peninsula and eastwards from there to Port Alfred.  In its natural 
state, it grows not far from the sea and is often a common constituent of the vegetation on 
coastal sand dunes (Codd, 1985). 
                              
Golden brown flowers of S. africana-lutea.      Distribution of S. africana-lutea. 
Traditional uses: An infusion of the plant is used for coughs, colds and female ailments 
(Watt and Breyer-Brandwijk, 1962). 
Leaf trichome types: Both non-glandular and glandular trichomes are present on the leaf.  
The glandular trichomes are either peltate or capitate. 
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Scanning electron microscopy and light microscopy micrographs of S. africana-lutea. 
Essential oil composition: The essential oil yield of this plant collected in the South 
Western Cape was 0.15% (w/w, wet biomass) and the major components in the oil include 
myrcene (11.5%), p-cymene (7.6%) and α-pinene (6.0%).  
 
 
                      Myrcene                                 p-Cymene                           α-Pinene 
 
HPLC analysis of the solvent extract: Rosmarinic acid, carnosic acid, ursolic acid and 
betulafolientriol oxide were identified.  The HPLC chromatogram is displayed below, 
while the retention time, the absorption maxima and the percentage area of the major peaks 
are depicted in the table below. 
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HPLC chromatogram of the solvent extract of S. africana-lutea.   
 
A summary of the HPLC-UV data of the methanol:chloroform extract of S. africana-lutea. 
Peak number 
Retention time 
(min) 
λmax (nm) 
Tentative 
identification 
Area (%) 
1 10.81 281, 374  3.47 
2 16.03 202, 281, 391  3.12 
3 19.79 273  3.51 
4 21.30 255, 283, 345  8.58 
5 23.21 311, 326 Rosmarinic acid 23.82 
6 24.28 286, 310  3.10 
7 30.31 202, 285, 328  9.20 
8 35.68 205, 282  7.46 
9 36.53 284, 391  3.2 
10 37.05 208, 283 Carnosic acid 14.22 
11 41.17 245, 277, 374  4.49 
 
Biological activities and total phenolic content: The IC50 values (in µg/ml) of the in vitro 
biological activities of the solvent extract (SE) and the essential oil (EO), as well as the 
total phenolic content are given in the table below. 
AC AI AM AO TO TP  
SF-268 MCF-7 HT-29 5-LOX 3[H]-hyp ABTS·+ DPPH· MTT FCM 
SE > 100.0 43.65 20.00 > 100.0 15.86 30.35 47.58 25.01 
EO nd nd nd 77.32 5.45 > 100.0 > 100.0 7.24 
67.83 
- 
AC: anticancer activity; AI: anti-inflammatory activity; AM: antimalarial activity; AO: anti-oxidant activity; 
TO: toxicity profile: TP: total phenolic content; 5-LOX: 5-lipoxygenase assay; [3H]-hyp; hypoxanthine 
isotope method; MTT: 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay; FCM: Folin-
Ciocalteu method; nd: not determined.  NB: the anticancer activity was determined using the SRB assay, 
while the anti-oxidant activity was investigated using the ABTS and the DPPH methods.   
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The MIC values (mg/ml) of the solvent extract (SE) and essential oil (EO) against bacteria 
are displayed in the table below. 
Pathogens  
E. coli K. pneumoniae B. cereus S. aureus M. tuberculosis 
SE 3.00 3.00 0.75 0.75 0.50 
EO > 32.00 8.00 2.33 8.00 nd 
   nd: not determined 
References 
Codd, L.E.W. 1985.  Lamiaceae: Flora of Southern Africa. 28, Botanical Research 
Institute, Pretoria. 
Watt, J.M., Breyer-Brandwijk, B.N. 1962.  Medicinal and Poisonous Plants of Southern 
and Eastern Africa.  2nd edition.  E. and S. Livingstone, Edinburg, UK.  
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C3. Salvia albicaulis Benth.  
Synonym: S. dregeana Benth. 
Botanical description: Shrub or woody herb up to 0.3-0.6 m tall and branched from the 
base.  Stems erect, densely and shortly tomentose with occasional multicelular hairs.  
Leaves are petiolated, blade simple and coriaceous.  The inflorescence is a panicle.  Calyx 
is densely villous with long white hairs mainly along the nerves and the corolla is purplish 
(Codd, 1985).  Flowering time is November to May.   
Distribution: This species is distributed from Clanwilliam southwards to Ceres and 
Wellington districts, common in fynbos on rocky slopes (Codd, 1985). 
 
                                                        Distribution of S. albicaulis 
Leaf trichome types: Both non-glandular and glandular trichomes are present on the leaf.  
The glandular trichomes are either peltate or capitate. 
  
Scanning electron microscopy and light microscopy micrographs of S. albicaulis. 
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Essential oil composition: The essential oil yield of this plant collected at the 
Kirstenbosch Botanical Garden was 0.06% (w/w, wet biomass) and the major components 
include viridiflorol (24.5%), 1,8-cineole (9.4%), limonene (9.4%), ledol (6.6%) and  β-
caryophyllene oxide (5.6%). 
 
 
 Viridiflorol                   1,8-Cineole      Limonene           Ledol         β-Caryophyllene oxide         
HPLC analysis of the solvent extract: Caffeic acid, rosmarinic acid, salvigenin, carnosol, 
ursolic acid and betulafolientriol oxide were identified.  The HPLC chromatogram is 
displayed in the figure below, while the retention time, the absorption maxima and the 
percentage area of the major peaks are depicted in the table which follows. 
 
HPLC chromatogram of the solvent extract of S. albicaulis.   
 
A summary of the HPLC-UV data of the methanol:chloroform extract of S. albicaulis. 
Peak number 
Retention time 
(min) 
λmax (nm) 
Tentative 
identification 
Area (%) 
1 10.67 282, 327, 357  9.54 
2 22.48 228, 284, 327  6.36 
3 23.24 330 Rosmarinic acid 35.23 
4 24.25 230, 256, 286  14.58 
5 41.08 373  10.23 
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Biological activities and total phenolic content: The IC50 values (in µg/ml) of the in vitro 
biological activities of the solvent extract (SE) and the essential oil (EO), as well as the 
total phenolic content are given in the table, which follows. 
AC AI AM AO TO TP  
SF-268 MCF-7 HT-29 5-LOX 3[H]-hyp ABTS·+ DPPH· MTT FCM 
SE 27.50 35.25 25.33 > 100.0 15.83 24.22 19.85 37.29 
EO nd nd nd 39.22 6.41 > 100.0 > 100.0 2.75 
100.27 
- 
AC: anticancer activity; AI: anti-inflammatory activity; AM: antimalarial activity; AO: anti-oxidant activity; 
TO: toxicity profile: TP: total phenolic content; 5-LOX: 5-lipoxygenase assay; [3H]-hyp; hypoxanthine 
isotope method; MTT: 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay; FCM: Folin-
Ciocalteu method, nd: not determined.  NB: the anticancer activity was determined using the SRB assay, 
while the anti-oxidant activity was investigated using the ABTS and the DPPH methods.   
 
The MIC values (mg/ml) of the solvent extract (SE) and essential oil (EO) against bacteria 
are depicted in the table below. 
Pathogens  
E. coli K. pneumoniae B. cereus S. aureus M. tuberculosis 
SE 4.00 4.67 1.00 1.00 0.50 
EO > 32.00 8.00 2.33 8.00 nd 
   nd: not determined 
Reference 
Codd, L.E.W. 1985.  Lamiaceae: Flora of Southern Africa.  28, Botanical Research 
Institute, Pretoria. 
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C4. Salvia aurita L. f.  
Synonyms: S. sylvicola Burch., S. lasiostachys Benth., S. peglerae Skan 
Botanical description: Perennial herb with few to several stems from a subwoody base, 
stems ascending or straggling, pilose, usually with longish multicelular hairs, sometimes 
dense, or short and dense and occasionally with capitate glandular hairs.  Leaves are 
petiolated, blade simple to lyrate or runcinate and variable in shape.  Apex obtuse to 
rounded, base truncate to auriculate.  Calyx pilose, tubular campanulate, corolla pale blue, 
lilac or white pinkish (Codd, 1985).   
Distribution:  This plant is distributed from the southern and south Eastern and KwaZulu-
Natal to the Southpansberg in Gauteng, on grassy slopes, stream banks and wooded places 
(Codd, 1985). 
 
 
Pilose stem and petiolate leaves of S. aurita.             Distribution of S. aurita.                                               
Leaf trichome types: Both non-glandular and glandular trichomes are present on the leaf.  
The glandular trichomes are either peltate or capitate. 
 
 Scanning electron microscopy and light microscopy micrographs of S. aurita. 
HPLC analysis of the solvent extract: Caffeic acid, rosmarinic acid, carnosol, carnosic 
acid, ursolic acid and betulafolientriol oxide were identified.  The HPLC chromatogram is 
displayed in the figure below, while the retention time, the absorption maxima and the 
percentage area of the major peaks are given in the table. 
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HPLC chromatogram of the solvent extract of S. aurita.   
 
A summary of the HPLC-UV data of the methanol:chloroform extract of S. aurita. 
Peak number 
Retention time 
(min) 
λmax (nm) 
Tentative 
identification 
Area (%) 
1 10.67 282, 341, 355  5.63 
2 23.29 330 Rosmarinic acid 24.44 
3 32.44 235, 285, 333  3.06 
4 34.90 206, 284, 319 Carnosol 27.61 
5 37.05 285 Carnosic acid 6.37 
6 37.74 205, 283  20.74 
 
Biological activities and total phenolic content: The IC50 values (in µg/ml) of the in vitro 
biological activities of the solvent extract (SE) and the total phenolic content are given in 
table, which follows. 
AC AI AM AO TO TP  
SF-268 MCF-7 HT-29 5-LOX 3[H]-hyp ABTS·+ DPPH· MTT FCM 
SE 44.87 17.28 24.58 > 100.0 8.92 22.94 16.59 28.31 119.09 
AC: anticancer activity; AI: anti-inflammatory activity; AM: antimalarial activity; AO: anti-oxidant activity; 
TO: toxicity profile: TP: total phenolic content; 5-LOX: 5-lipoxygenase assay; [3H]-hyp; hypoxanthine 
isotope method; MTT: 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay; FCM: Folin-
Ciocalteu method; nd: not determined.  NB: the anticancer activity was determined using the SRB assay, 
while the anti-oxidant activity was investigated using the ABTS and the DPPH methods.   
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The MIC values (mg/ml) of the solvent extract against various bacteria are given in the 
table below. 
Pathogens  
E. coli K. pneumoniae B. cereus S. aureus M. tuberculosis 
SE 4.00 4.00 0.20 0.05 0.50 
 
Reference 
Codd, L.E.W. 1985.  Lamiaceae: Flora of Southern Africa. 28, Botanical Research 
Institute, Pretoria. 
 
 258
C5. Salvia chamelaeagnea Berg. 
Synonym: S. paniculata L. 
Common name: ‘Afrikaansesalie’ 
Botanical description: Salvia chamelaeagnea forms a dense shrub, growing almost 2 
meters high.  The stems are square-shaped, a typical feature of the Lamiaceae.  The leaves 
are dotted with glands which emit a very strong scent.  The large calyx is usually an 
attractive reddish-purple colour.  The corolla usually called the flower varies in colour 
from blue, mauve, pink to pure white.  Flowers with a dark blue top lip and white lower lip 
are the most common (Codd, 1985).  Flowering time is from October to May.   
Distribution:  This plant is distributed from Clanwilliam to Cape Town and eastwards to 
Ladismith and Riversdale districts, but also found in fynbos along watercourses, in sandy 
soil among rocks and along roadsides (Codd, 1985). 
 
Petiolate and elliptical leaves of    Large panicle inflorescence      Distribution of S. 
 S. chamelaeagnea.                        of S. chamelaeagnea.                 chamelaeagnea. 
 
 
Traditional uses: Like many of the other sages, Salvia chamelaeagnea is used to treat a 
wide variety of ailments such as coughs, symptoms associated with cancer, colds, 
diarrhoea, colic, heartburn and flatulence.  A tea, to be sipped slowly a few times a day, is 
usually made from the fresh or dried leaves and flowers (Watt and Breyer-Brandwijk, 
1962).  
Leaf trichome types: Both non-glandular and glandular trichomes are present on the leaf.  
The glandular trichomes are either peltate or capitate. 
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Scanning electron microscopy and light microscopy micrographs of S. chamelaeagnea. 
Essential oil composition: The essential oil yield of the plant collected at the Kirstenbosch 
Botanical Garden was 0.39% (w/w, wet biomass) and the major components for the oil 
include 1,8-cineole (40.5%) followed by α-pinene (10.4%) and limonene (9.7%). 
 
                    1,8-Cineole                            α-Pinene                                  Limonene                                      
HPLC analysis of the solvent extract: Caffeic acid, rosmarinic acid, oleanolic acid, 7-O-
methylepirosmanol, carnosol, carnosic acid, ursolic acid and betulafolientriol oxide were 
identified.  The HPLC chromatogram is displayed in the figure below, while the retention 
time, the absorption maxima and the percentage area of the major peaks are depicted in the 
 table which follows. 
 
HPLC chromatogram of the solvent extract of S. chamelaeagnea.   
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A summary of the HPLC-UV data of the methanol:chloroform extract of S. 
chamelaeagnea. 
Peak number 
Retention time 
(min) 
λmax (nm) 
Tentative 
identification 
Area (%) 
1 10.63 282, 339, 354  4.71 
2 23.23 330 Rosmarinic acid 26.36 
3 34.81 206, 284, 324 Carnosol 22.48 
4 36.95 203, 285 Carnosic acid 27.25 
 
Biological activities and total phenolic content: The IC50 values (in µg/ml) of the in vitro 
biological activities of the solvent extract (SE) and the essential oil (EO), as well as the 
total phenolic content are given in the table below. 
AC AI AM AO TO TP  
SF-268 MCF-7 HT-29 5-LOX 3[H]-hyp ABTS·+ DPPH· MTT FCM 
SE 34.98 18.12 29.53 > 100.0 8.71 14.61 12.75 24.76 
EO nd nd nd 48.58 8.63 > 100.0 > 100.0 6.00 
211.78 
- 
AC: anticancer activity; AI: anti-inflammatory activity; AM: antimalarial activity; AO: anti-oxidant activity; 
TO: toxicity profile: TP: total phenolic content; 5-LOX: 5-lipoxygenase assay; [3H]-hyp; hypoxanthine 
isotope method; MTT: 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay; FCM: Folin-
Ciocalteu method; nd: not determined.  NB: the anticancer activity was determined using the SRB assay, 
while the anti-oxidant activity was investigated using the ABTS and the DPPH methods.   
 
The MIC values (mg/ml) of the solvent extract (SE) and essential oil (EO) against various 
bacteria are depicted in the table below. 
Pathogens  
E. coli K. pneumoniae B. cereus S. aureus M. tuberculosis 
SE 1.00 3.00 0.03 0.06 0.50 
EO > 32.00 12.00 2.00 > 32.00 nd 
   nd: not determined 
References 
Codd, L.E.W. 1985.  Lamiaceae: Flora of Southern Africa. 28, Botanical Research 
Institute, Pretoria. 
Watt, J.M., Breyer-Brandwijk, B.N. 1962.  Medicinal and Poisonous Plants of Southern 
and Eastern Africa.  2nd edition.  E. and S. Livingstone, Edinburg, UK. 
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C6. Salvia disermas L. 
Synonyms: S. rugosa Ait., S. fleckii Gurke, S. fleckii Gürke  
Common name: Grootblousalie. 
Botanical description: Herbaceous perennial shrub, up to 1.2 m tall with one or more 
stems from a woody rootstock.  Leaves are often crowded and larger near the base of the 
plant and petiolated.  The inflorescence is composed of 15 or more verticils.  The calyx is 
glandular-hispid to villous, while the corolla is whitish, pale blue or mauve (Codd, 1985).  
The flowering time is from August to May.   
Distribution:  This plant is distributed in the south-west of Gauteng and Northern Cape 
through the western Free State and Namaqualand (Codd, 1985)  
 
 
Glandular stems and inflorescence of S. disermas.           Distribution of S. disermas. 
Traditional uses: Treatment of heart problems, high blood pressure, rheumatism and 
sores; used as a tea (Watt and  Breyer-Brandwijk, 1962).  
Leaf trichome types: Both non-glandular and glandular trichomes are present on the leaf.  
The glandular trichomes are either peltate or capitate. 
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     Scanning electron microscopy and light microscopy micrographs of S. disermas. 
HPLC analysis of the solvent extract: Caffeic acid, rosmarinic acid, salvigenin, ursolic 
acid and betulafolientriol oxide were identified.  Various unidentified flavonoids were 
detected in the solvent extract.  The HPLC chromatogram is displayed in the figure below, 
while the retention time, the absorption maxima and the percentage area of the major peaks 
are depicted in the table which follows. 
 
HPLC chromatogram of the solvent extract of S. disermas.   
 
A summary of the HPLC-UV data of the methanol:chloroform extract of S. disermas. 
Peak number 
Retention time 
(min) 
λmax (nm) 
Tentative 
identification 
Area (%) 
1 23.24 330  Rosmarinic acid 3.62 
2 32.40 284, 332  3.35 
3 34.58 218, 277, 330 Salvigenin 23.76 
4 40.40 271  19.85 
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Biological activities and total phenolic content: The IC50 values (in µg/ml) of the in vitro 
biological activities of the solvent extract (SE) and the total phenolic content are given in 
the table below. 
AC AI AM AO TO TP  
SF-268 MCF-7 HT-29 5-LOX 3[H]-hyp ABTS·+ DPPH· MTT FCM 
SE 59.12 38.56 26.87 > 100.0 24.17 33.05 55.07 53.34 69.01 
AC: anticancer activity; AI: anti-inflammatory activity; AM: antimalarial activity; AO: anti-oxidant activity; 
TO: toxicity profile: TP: total phenolic content; 5-LOX: 5-lipoxygenase assay; [3H]-hyp; hypoxanthine 
isotope method; MTT: 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay; FCM: Folin-
Ciocalteu method; nd: not determined.  NB: the anticancer activity was determined using the SRB assay, 
while the anti-oxidant activity was investigated using the ABTS and the DPPH methods.   
 
The MIC values (mg/ml) of the solvent extract (SE) against various bacteria are given in 
the table below. 
Pathogens  
E. coli K. pneumoniae B. cereus S. aureus M. tuberculosis 
SE 4.00 2.00 3.00 0.75 0.50 
 
References  
Codd, L.E.W. 1985.  Lamiaceae: Flora of Southern Africa. 28, Botanical Research 
Institute, Pretoria. 
Watt, J.M., Breyer-Brandwijk, B.N. 1962.  Medicinal and Poisonous Plants of Southern 
and Eastern Africa.  2nd edition.  E. and S. Livingstone, Edinburg, UK.  
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C7. Salvia dolomitica Codd  
Common name: ‘Kruipsalie’ 
Botanical description: It is a shrub that may reach 2 m in height and branched from the 
base.  Leaves are petiolated, blade simple, elliptic to obovate densely greyish and gland-
dotted.  The inflorescence is compact.  The calyx is broadly campanulate, often purple-
tinged, glandular hirsute.  The corolla is light pink or lilac with cream or yellow markings 
on the lower lip (Codd, 1985).   
Distribution: The plant is restricted to Gauteng, between 1000 and 1500 m altitude (Codd, 
1985). 
 
Leaves and flowers of S. dolomitica.            Distribution of S. dolomitica. 
Leaf trichome types: Both non-glandular and glandular trichomes are present on the leaf.  
The glandular trichomes are either peltate or capitate. 
 
 
Essential oil composition: The essential oil yield obtained from the plant collected at the 
Kirstenbosch Botanical Garden was 0.34% (w/w, wet biomass) and the major components 
for the oil include geraniol (19.6%), linalyl acetate (19.6%), linalool (16.6%) and α-
terpineol (6.2%). 
  Scanning electron microscopy and light microscopy micrographs of S. dolomitica.                    
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  Geraniol                       Linalyl acetate                        Linalool                           α-Terpineol          
HPLC analysis of the solvent extract: Caffeic acid, rosmarinic acid, ursolic acid and 
betulafolientriol oxide were identified.  The HPLC chromatogram is displayed in the figure 
below, while the retention time, the absorption maxima and the percentage area of the 
major peaks are depicted in the table which follows. 
 
  HPLC chromatogram of the solvent extract of S. dolomitica.   
 
A summary of the HPLC-UV data of the methanol:chloroform extract of S. dolomitica. 
Peak number 
Retention time 
(min) 
λmax (nm) 
Tentative 
identification 
Area (%) 
 1  23.23 231 Rosmarinic acid 14.05 
2 30.62 252, 268, 341  4.48 
3 33.36 252, 269, 344  3.44 
4 34.53 237, 276, 329  9.16 
5 35.23 242, 326, 373  4.36 
6 43.27 249, 273, 355  5.08 
 
Biological activities and total phenolic content: The IC50 values (in µg/ml) of the in vitro 
biological activities of the solvent extract (SE) and the essential oil (EO), as well as the 
total phenolic content are given in table below. 
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AC AI AM AO TO TP  
SF-268 MCF-7 HT-29 5-LOX 3[H]-hyp ABTS·+ DPPH· MTT FCM 
SE > 100.0 37.05 > 100.0 > 100.0 7.62 49.94 > 100.0 40.26 
EO nd nd nd 64.58 4.81 > 100.0 > 100.0 7.74 
53.04 
- 
AC: anticancer activity; AI: anti-inflammatory activity; AM: antimalarial activity; AO: anti-oxidant activity; 
TO: toxicity profile: TP: total phenolic content; 5-LOX: 5-lipoxygenase assay; [3H]-hyp; hypoxanthine 
isotope method; MTT: 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay; FCM: Folin-
Ciocalteu method; nd: not determined.  NB: the anticancer activity was determined using the SRB assay 
while the anti-oxidant activity was investigated using the ABTS and the DPPH methods.   
 
The MIC values (mg/ml) of the solvent extract (SE) and essential oil (EO) against bacteria 
are given in table below. 
Pathogens  
E. coli K. pneumoniae B. cereus S. aureus M. tuberculosis 
SE 3.33 2.00 0.75 0.03 0.10 
EO > 32.00 8.00 9.33 12.00 nd 
   nd: not determined 
 
References 
Codd, L.E.W. 1985.  Lamiaceae: Flora of Southern Africa. 28, Botanical Research 
Institute, Pretoria. 
Watt, J.M., Breyer-Brandwijk, B.N. 1962.  Medicinal and Poisonous Plants of Southern 
and Eastern Africa.  2nd edition.  E. and S. Livingstone, Edinburg, UK. 
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C8. Salvia garipensis E. Mey. ex Benth. 
Synonyms: S. steingroeveri Briq., S. dinteri Briq. 
Botanical description: Shrub mostly branched up to 1.2 m tall.  Stems are glandular-
pubescents with longish non-glandular hairs.  Leaves are green, glandular-hispid and 
glandular-dotted.  The leaves vary considerably in size, degree of crenation.  The calyx is 
glandular-pubescent and the corolla is white or pale blue to mauve (Codd, 1985).   
Distribution: This species is distributed from the southern half of Namibia to the 
adjoining Northern Cape Province (Codd, 1985). 
     
 
 Flowers of S. garipensis.                               Distribution of S. garipensis. 
Leaf trichome types: Both non-glandular and glandular trichomes are present on the leaf.  
The glandular trichomes are either peltate or capitate. 
  
   Scanning electron microscopy and light microscopy micrographs of S. garipensis. 
HPLC analysis of the solvent extract: Rosmarinic acid, salvigenin and betulafolientriol 
oxide were identified.  The HPLC chromatogram is displayed in the figure below, while 
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the retention time, the absorption maxima and the percentage area of the major peaks are 
depicted in the table below. 
 
HPLC chromatogram of the solvent extract of S. garipensis.   
 
A summary of the HPLC-UV data of the methanol:chloroform extract of S. garipensis. 
Peak number 
Retention time 
(min) 
λmax (nm) 
Tentative 
identification 
Area (%) 
1 23.24 331 Rosmarinic acid 29.22 
2 23.63 252, 347  Flavone 4.76 
3 34.57 277, 332 Salvigenin 7.38 
4 37.02 273, 400  14.09 
 
Biological activities and total phenolic content: The IC50 values (in µg/ml) of the in vitro 
biological activities of the solvent extract (SE) and the total phenolic content are given in 
the table which follows. 
AC AI AM AO TO TP  
SF-268 MCF-7 HT-29 5-LOX 3[H]-hyp ABTS·+ DPPH· MTT FCM 
SE > 100.0 39.44 > 100.0 > 100.0 13.95 41.66 74.15 42.44 45.56 
AC: anticancer activity; AI: anti-inflammatory activity; AM: antimalarial activity; AO: anti-oxidant activity; 
TO: toxicity profile: TP: total phenolic content; 5-LOX: 5-lipoxygenase assay; [3H]-hyp; hypoxanthine 
isotope method; MTT: 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay; FCM: Folin-
Ciocalteu method.  NB: the anticancer activity was determined using the SRB assay, while the anti-oxidant 
activity was investigated using the ABTS and the DPPH methods.   
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The MIC values (mg/ml) of the solvent extract (SE) against bacteria are given in the table 
below. 
Pathogens  
E. coli K. pneumoniae B. cereus S. aureus M. tuberculosis 
SE 1.88 2.81 0.75 4.00 nd 
   nd: not determined 
Reference 
Codd, L.E.W. 1985.  Lamiaceae: Flora of Southern Africa. 28, Botanical Research 
Institute, Pretoria. 
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C9. Salvia lanceolata Lam.  
Synonyms: S. nivea Thunb., S. hastifolia Benth., S. diversifolia Benth.  
Botanical description: Branched shrub up to 2 m tall, stems glabrescent often reddish 
brown.  Leaves petiolate, blade simple, linear elliptic to ovate-oblong or oblanceolate with 
a short dense greywish tomentum or with a sparse indumentum of short broad hairs mainly 
on the veins and leaf margin, gland-doted, apex acute.  Inflorescence usually branched.  
Calyx fairly densely glandular-hispid.  Corolla dull rose to brownish crimson or grey-blue 
(Codd, 1985).  Flowering time September to November.   
Distribution: This plant is distributed from Namaqualand to the Cape Peninsula and 
eastwards to Montagu.  Found mainly in coastal sandveld or arid fynbos, on sandy soil and 
rocky hillsides at altitudes of about 300 m (Codd, 1985). 
  
Linear-elliptic leaves, inflorescence and distribution map of S. lanceolata 
Leaf trichome types: Both non-glandular and glandular trichomes are present on the leaf.  
The glandular trichomes are either peltate or capitate. 
  
 
Scanning electron microscopy and light microscopy micrographs of S. lanceolata.                                 
 271
Essential oil composition: The essential oil yield for this plant collected in the South 
Western Cape was 0.10% (w/w, wet biomass) and the major components include 
spathulenol (18.3%), β-caryophyllene oxide (14.3%), β-caryophyllene (5.7%) and ledol 
(5.2%). 
 
 
Spathulenol                 β-Caryophyllene-oxide                 β-Caryophyllene              Ledol 
 
HPLC analysis of the solvent extract: Caffeic acid, rosmarinic acid, carnosol, ursolic 
acid and betulafolientriol oxide were identified.  The HPLC chromatogram is displayed in 
the figure below, while the retention time, the absorption maxima and the percentage area 
of the major peaks are depicted in the table below. 
 
HPLC chromatogram of the solvent extract of S. lanceolata.   
 
A summary of the HPLC-UV data of the methanol:chloroform extract of S. lanceolata.  
Peak number 
Retention time 
(min) 
λmax (nm) 
Tentative 
identification 
Area (%) 
 1  11.66 279, 329, 355  20.58 
2 12.22 229, 278, 329  3.35 
3 15.44 242, 298, 324 Caffeic acid 3.29 
4 20.20 226, 282, 376  3.70 
5 22.49 233, 284, 329  3.77 
6 23.26 235, 329  Rosmarinic acid 10.67 
7 30.66 244, 269, 340  7.57 
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Peak number 
Retention time 
(min) 
λmax (nm) 
Tentative 
identification 
Area (%) 
8 32.37 239, 284, 332  6.34 
9 41.09 273, 374 Ursolic acid 14.28 
10 43.26 248, 373, 374  3.83 
 
Biological activities and total phenolic content: The IC50 values (in µg/ml) of the in vitro 
biological activities of the solvent extract (SE) and the essential oil (EO), as well as the 
total phenolic content are given in the table which follows. 
AC AI AM AO TO TP  
SF-268 MCF-7 HT-29 5-LOX 3[H]-hyp ABTS·+ DPPH· MTT FCM 
SE > 100.0 26.15 17.05 > 100.0 26.01 25.63 68.09 26.71 
EO nd nd nd 43.38 7.83 > 100.0 >100.0 3.66 
54.22 
- 
AC: anticancer activity; AI: anti-inflammatory activity; AM: antimalarial activity; AO: anti-oxidant activity; 
TO: toxicity profile: TP: total phenolic content; 5-LOX: 5-lipoxygenase assay; [3H]-hyp; hypoxanthine 
isotope method; MTT: 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay; FCM: Folin-
Ciocalteu method; nd: not determined.  NB: the anticancer activity was determined using the SRB assay 
,while the anti-oxidant activity was investigated using the ABTS and the DPPH methods.   
 
The MIC values (mg/ml) of the solvent extract (SE) and essential oil (EO) against bacteria 
are displayed  below. 
Pathogens  
E. coli K. pneumoniae B. cereus S. aureus M. tuberculosis 
SE 4.00 2.00 3.00 2.00 0.50 
EO 32.00 16.00 1.00 8.00 nd 
   nd: not determined 
Reference 
Codd, L.E.W. 1985.  Lamiaceae: Flora of Southern Africa. 28, Botanical Research 
Institute, Pretoria. 
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C10. Salvia muirii L. Bol.  
Synonym: S. muirii var. gradiflora L. Bol. 
Common names: ‘Wild sage’, ‘wildesalie’. 
Botanical description: Salvia muirii is a small, twiggy, evergreen shrub that grows only 
about 30 cm high.  The leaves are leathery, oval in shape and light green to almost grey in 
colour.  When crushed, they are slightly sticky and release a light scent that is reminiscent 
of Vicks.  The calyx is densely and shortly antrose pubescent, dotted with orange-red 
glands (Codd, 1985).   
Distribution: This species is found in the Langberg in the Riversdale district to Great Brak 
River in the Mossel Bay district (Codd, 1985). 
 
Oval leaves and flowers of S. muirii.                 Distribution of S. muirii 
Leaf trichome types: Both non-glandular and glandular trichomes are present on the leaf.  
The glandular trichomes are either peltate or capitate. 
 
 Scanning electron microscopy and light microscopy micrographs of S. muirii.                                             
Essential oil composition: The essential oil yield of this plant collected at the 
Kirstenbosch Botanical  Garden was 0.50% (w/w, wet biomass) and the major components 
include 1,8-cineole (23.2%), α-pinene (22.3%) followed by limonene (11.6%) and 
camphene (7.6%). 
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1,8-Cineole                     α-Pinene                              Limonene                            Camphene 
HPLC analysis of the solvent extract: Caffeic acid, rosmarinic acid, salvigenin, carnosol, 
carnosic acid, ursolic acid and betulafolientriol oxide were identified.  The HPLC 
chromatogram is displayed in the figure below, while the retention time, the absorption 
maxima and the percentage area of the major peaks are depicted in the table which 
follows.
 
HPLC chromatogram of the solvent extract of S. muirii.   
 
A summary of the HPLC-UV data of the methanol:chloroform extract of S. muirii. 
Peak number 
Retention time 
(min) 
λmax (nm) 
Tentative 
identification 
Area (%) 
1 23.23 330 Rosmarinic acid 52.82 
2 34.82 232, 284, 327 Carnosol 4.83 
3 36.98 285, 327, 371 Carnosic acid 11.80 
 
Biological activities and total phenolic content: The IC50 values (in µg/ml) of the in vitro 
biological activities of the solvent extract (SE) and the essential oil (EO), as well as the 
total phenolic content are displayed in the table below. 
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AC AI AM AO TO TP  
SF-268 MCF-7 HT-29 5-LOX 3[H]-hyp ABTS·+ DPPH· MTT FCM 
SE > 100.0 39.07 55.63 > 100.0 11.87 11.88 11.06 37.00 
EO nd nd nd > 100.0 5.93 > 100.0 > 100.0 3.09 
186.15 
- 
AC: anticancer activity; AI: anti-inflammatory activity; AM: antimalarial activity; AO: anti-oxidant activity; 
TO: toxicity profile: TP: total phenolic content; 5-LOX: 5-lipoxygenase assay; [3H]-hyp; hypoxanthine 
isotope method; MTT: 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay; FCM: Folin-
Ciocalteu method; nd: not determined.  NB: the anticancer activity was determined using the SRB assay, 
while the anti-oxidant activity was investigated using the ABTS and the DPPH methods.   
 
The MIC values (mg/ml) of the solvent extract (SE) and essential oil (EO) against bacteria 
are given below. 
Pathogens  
E. coli K. pneumoniae B. cereus S. aureus M. tuberculosis 
SE 2.00 3.00 0.25 0.36 0.50 
EO > 32.00 6.00 9.33 > 32.00 nd 
   nd: not determined 
Reference 
Codd, L.E.W. 1985.  Lamiaceae: Flora of Southern Africa. 28, Botanical Research 
Institute, Pretoria. 
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C11. Salvia namaensis Schinz 
Synonym: S. burchellii N.E.Br.  
Botanical description: Shrub or bushy shrub up to 1.2 m tall, often herbaceous above and 
woody below.  Leaves are shortly petiolate, blade irregular.  The inflorescence is simple, of 
up to 14 verticils.  The calyx and glandular-hispidulous and the corolla is white, mauve or 
blue (Codd, 1985). 
Distribution: This species is found in the in the Northern Cape and in the Free Sate on 
rocky slopes (Codd, 1985). 
 
Leaves and flowers of S. namaensis.                  Distribution of S. namaensis. 
HPLC analysis of the solvent extract: Caffeic acid, rosmarinic acid, 7-O-
methylepirosmanol, carnosol, carnosic acid, ursolic acid and betulafolientriol oxide were 
identified.  The HPLC chromatogram is displayed in the figure below, while the retention 
time, the absorption maxima and the percentage area of the major peaks are depicted in the 
table below. 
 
HPLC chromatogram of the solvent extract of S.  namaensis.   
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A summary of the HPLC/UV data of the methanol:chloroform extract of S.  namaensis. 
Peak number 
Retention time 
(min) 
λmax (nm) 
Tentative 
identification 
Area (%) 
1 23.21 330 Rosmarinic acid 15.60 
2 31.46 206, 289  9.99 
3 34.29 288, 326  4.66 
4 34.84 206, 284, 332 Carnosol 30.97 
5 36.98 206, 285 Carnosic acid 20.25 
 
Biological activities and total phenolic content: The IC50 values (in µg/ml) of the in vitro 
biological activities of the solvent extract (SE) and the total phenolic content are given in 
table which follows. 
AC AI AM AO TO TP  
SF-268 MCF-7 HT-29 5-LOX 3[H]-hyp ABTS·+ DPPH· MTT FCM 
SE > 100.0 36.36 24.39 > 100.0 25.38 16.57 10.63 21.91 190.5 
AC: anticancer activity; AI: anti-inflammatory activity; AM: antimalarial activity; AO: anti-oxidant activity; 
TO: toxicity profile: TP: total phenolic content; 5-LOX: 5-lipoxygenase assay; [3H]-hyp; hypoxanthine 
isotope method; MTT: 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay; FCM: Folin-
Ciocalteu method.  NB: the anticancer activity was determined using the SRB assay, while the anti-oxidant 
activity was investigated using the ABTS and the DPPH methods.   
Reference 
Codd, L.E.W. 1985.  Lamiaceae: Flora of Southern Africa. 28, Botanical Research 
Institute, Pretoria. 
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C12. Salvia radula Benth. 
Botanical description: Perennial herb with one or more erect stems from a woody 
rootstock and can reach up to 1 m in height or more.  Leaves are often crowded and larger 
near the base of the plant.  The calyx is gland-dotted and the corolla is white or pale mauve 
to blue.  This plant is closely related to S. disermas but can usually be distinguished by its 
denser lanate indumentum on lower stems and the undersides of the leaves (Codd, 1985).   
Distribution: This species is found in Gauteng and North-West Province aided by road 
building and overgrazing of veld (Codd, 1985). 
 
Glandular stem and flowers of S. radula.                 Distribution of S. radula 
Essential oil composition: The essential oil yield of this plant collected in North-West 
was 0.004% (w/w, wet biomass) and the major components include β-caryophyllene oxide 
(22.6%), humulene epoxide (12.6%) followed by isocaryophyllene (8.6%) and spathulenol 
(7.7%). 
 
β-Caryophyllene oxide    Humulene epoxide           Isocaryophyllene                 Spathulenol 
HPLC analysis of the solvent extract: Rosmarinic acid, salvigenin and betulafolientriol 
oxide were identified.  The HPLC chromatogram is displayed in the figure below, while 
the retention time, the absorption maxima and the percentage area of the major peaks are 
depicted in the table below. 
R
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HPLC chromatogram of the solvent extract of S. radula.   
 
A summary of the HPLC-UV data of the methanol:chloroform extract of S. radula is 
displayed below.   
Peak number 
Retention time 
(min) 
λmax (nm) 
Tentative 
identification 
Area (%) 
1 23.26 238, 329  Rosmarinic acid 3.36 
2 32.40 269, 338  Flavone 5.65 
3 34.56 235, 277, 329 Salvigenin 8.52 
4 36.36 272, 338  4.84 
5 40.38 271, 373, 392  20.67 
 
Biological activities and total phenolic content: The IC50 values (in µg/ml) of the in vitro 
biological activities of the solvent extract (SE) and the essential oil (EO), as well as the 
total phenolic content are given in table below. 
AC AI AM AO TO TP  
SF-268 MCF-7 HT-29 5-LOX 3[H]-hyp ABTS·+ DPPH· MTT FCM 
SE 27.55 9.69 32.10 78.78 13.50 69.26 > 100.0 20.12 
EO nd nd nd > 100.0 3.91 > 100.0 > 100.0 22.90 
55.73 
- 
AC: anticancer activity; AI: anti-inflammatory activity; AM: antimalarial activity; AO: anti-oxidant activity; 
TO: toxicity profile: TP: total phenolic content; 5-LOX: 5-lipoxygenase assay; [3H]-hyp; hypoxanthine 
isotope method; MTT: 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay; FCM: Folin-
Ciocalteu method; nd: not determined.  NB: the anticancer activity was determined using the SRB assay, 
while the anti-oxidant activity was investigated using the ABTS and the DPPH methods.   
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The MIC values (mg/ml) of the solvent extract (SE) against bacteria are depicted in the 
table below. 
Pathogens  
E. coli K. pneumoniae B. cereus S. aureus M. tuberculosis 
SE  > 16.00 4.00 1.00 0.06 0.10 
 
Reference 
Codd, L.E.W. 1985.  Lamiaceae: Flora of Southern Africa.  28, Botanical Research 
Institute, Pretoria. 
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C13. Salvia repens Burch. ex Benth.  
Synonyms: S. rudis Benth., S. incisa Benth., S. natalensis Benth., S. cooperi Skan, S. 
subssillis Benth.  
Common name: ‘Kruipsalie’. 
Botanical description: An easy and fast-growing herb, Salvia repens has rhizomes, which 
spread to form small clumps of soft; hairy stems about 400 mm tall.  Simple or branched, 
the stems are square (typical of Salvia) and the leaves are formed opposite each other along 
the stem.  The small, two-lipped flowers vary in colour from pure white to pale blue, 
mauve and purple (Codd, 1985).  The main flowering season is during the summer from 
about October to March.   
Distribution: Salvia repens is widespread in eastern part of South Africa.  It is most 
common in the grasslands of the highveld and in open woodland (Codd, 1985).  
 
Large leaves and flowers of S. repens.              Distribution of S. repens. 
Traditional uses: The leaves have been added to the bath for treating sores, and a 
decoction of the root has been used for both humans and cattle for treating stomachache 
and diarrhoea.  Smoke from burning the plant can be used as a fumigant (Watt and Breyer-
Brandwijk, 1962). 
Leaf trichome types: Both non-glandular and glandular trichomes are present on the leaf.  
The glandular trichomes are either peltate or capitate. 
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Scanning electron microscopy and light microscopy micrographs of S. repens.                                             
Essential oil composition: The essential oil yield of this plant collected from Lady Grey  
was 0.13% (w/w, wet biomass) and the oil has a predominance of 1,8-cineole (12.8%), p-
cymene (9.5%) followed by isocaryphyllene (8.6%) and terpinen-4-ol (7.1 %) 
 
1,8-Cineole                    p-Cymene                        Isocaryphyllene                 Terpinen-4-ol  
HPLC analysis of the solvent extract: Caffeic acid, rosmarinic acid, carnosol, carnosic 
acid, ursolic acid and betulafolientriol oxide were identified.  The HPLC chromatogram is 
displayed in the figure below, while the retention time, the absorption maxima and the 
percentage area of the major peaks are depicted in the table below. 
 
HPLC chromatogram of the solvent extract of S. repens.   
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A summary of the HPLC-UV data of the methanol:chloroform extract of S. repens. 
Peak number 
Retention time 
(min) 
λmax (nm) 
Tentative 
identification 
Area (%) 
1 23.24 329 Rosmarinic acid 23.66 
2 26.50 328  13.29 
3 32.40 240, 285, 331 Flavone 3.10 
4 34.86 206, 284, 321 Carnosol 13.40 
5 37.02 285, 372 Carnosic acid 13.01 
 
Biological activities and total phenolic content: The IC50 values (in µg/ml) of the in vitro 
biological activities of the solvent extract (SE) and the essential oil (EO), as well as the 
total phenolic content are given in table, which follows. 
AC AI AM AO TO TP  
SF-268 MCF-7 HT-29 5-LOX 3[H]-hyp ABTS·+ DPPH· MTT FCM 
SE > 100.0 23.36 43.62 > 100.0 8.25 18.24 15.47 23.24 
EO nd nd nd 28.04 1.65 > 100.0 > 100.0 6.66 
178.17 
- 
AC: anticancer activity; AI: anti-inflammatory activity; AM: antimalarial activity; AO: anti-oxidant activity; 
TO: toxicity profile: TP: total phenolic content; 5-LOX: 5-lipoxygenase assay; [3H]-hyp; hypoxanthine 
isotope method; MTT: 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay; FCM: Folin-
Ciocalteu method; nd: not determined.  NB: the anticancer activity was determined using the SRB assay, 
while the anti-oxidant activity was investigated using the ABTS and the DPPH methods.   
 
The MIC values (mg/ml) of the solvent extract (SE) against bacteria are displayed in the 
table below. 
Pathogens  
E. coli K. pneumoniae B. cereus S. aureus M. tuberculosis 
SE 2.00 3.00 0.03 0.25 0.50 
 
References 
Codd, L.E.W. 1985.  Lamiaceae: Flora of Southern Africa. 28, Botanical Research 
Institute, Pretoria. 
Watt, J.M., Breyer-Brandwijk, B.N. 1962.  Medicinal and Poisonous Plants of Southern 
and Eastern Africa.  2nd edition.  E. and S. Livingstone, Edinburg, UK. 
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C14. Salvia runcinata L.f.  
Synonyms: S. scabra Benth., S. monticola Benth.  
Botanical description: Perennial erect herb up to 0.7 m tall with one to several stems from 
a taproot.  Leaves, shortly petiolate or the upper ones sessile, blade runcinate-pinnatipartite 
to lyrate.  The inflorescence has several verticils.  The calyx is hispid-scabrid, gland-dotted 
and the corolla is white or pale blue to mauve or purplish (Codd, 1985).   
Distribution: Distributed to the Free State and Eastern Cape as far south as Bredasdorp 
district, rare in the Eastern Cape, KwaZulu-Natal and Lesotho, but also found in Gauteng 
and North-West Province (Codd, 1985). 
 
  
Runcinate-pinnatipartite leaves and pale-blue    Distribution of S. runcinata. 
 flowers of S. runcinata. 
Essential oil composition: The essential oil yield of this plant collected at the Klerkskraal 
Dam was 0.20% (w/w, wet biomass) and this oil was largely dominated by α-bisabolol 
(65.5%) and β-caryophyllene (10.5%).  
 
                                        
 
 
HPLC analysis of the solvent extract: Caffeic acid, rosmarinic acid, salvigenin, carnosic 
acid, ursolic acid and betulafolientriol oxide were identified.  The HPLC chromatogram is 
H
H
OH
                                   α-Bisabolol                                     β-Caryophyllene  
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displayed in the figure below, while the retention time, the absorption maxima and the 
percentage area of the major peaks are depicted in the table below. 
 
HPLC chromatogram of the solvent extract of S. runcinata.   
 
A summary of the HPLC-UV data of the methanol:chloroform extract of S. runcinata. 
Peak number 
Retention time 
(min) 
λmax (nm) 
Tentative 
identification 
Area (%) 
1 23.29 329 Rosmarinic acid 38.40 
2 35.25 237, 288, 373  3.55 
3 37.10 236, 283, 328 Carnosic acid 3.36 
4 37.83 244, 282  14.34 
 
Biological activities and total phenolic content: The IC50 values (in µg/ml) of the in vitro  
biological activities of the solvent extract (SE) and the essential oil (EO), as well as the 
total phenolic content are given in the table below. 
AC AI AM AO TO TP  
SF-268 MCF-7 HT-29 5-LOX 3[H]-hyp ABTS·+ DPPH· MTT FCM 
SE > 100.0 43.42 55.37 > 100.0 16.61 19.42 19.34 22.00 
EO nd nd nd 22.81 1.20 > 100.0 > 100.0 1.79 
149.34 
- 
AC: anticancer activity; AI: anti-inflammatory activity; AM: antimalarial activity; AO: anti-oxidant activity; 
TO: toxicity profile: TP: total phenolic content; 5-LOX: 5-lipoxygenase assay; [3H]-hyp; hypoxanthine 
isotope method; MTT: 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay; FCM: Folin-
Ciocalteu method; nd: not determined.  NB: the anticancer activity was determined using the SRB assay, 
while the anti-oxidant activity was investigated using the ABTS and the DPPH methods.   
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The MIC values (mg/ml) of the solvent extract (SE) and essential oil (EO) against bacteria 
are depicted in the table below. 
Pathogens  
E. coli K. pneumoniae B. cereus S. aureus M. tuberculosis 
SE 2.00 4.00 0.03 0.25 0.50 
EO > 32.00 > 32.00 2.00 > 32.00 nd 
   nd: not determined 
Reference 
Codd, L.E.W. 1985.  Lamiaceae: Flora of Southern Africa.  28, Botanical Research 
Institute, Pretoria. 
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C15. Salvia schlechteri Briq. 
Synonym: S. monticola Benth. 
Botanical description: Herbaceous or perennial herb up to 0.3 m tall usually branched 
from a woody base.  Leaves are sessile or subsessile, pinnatisect or pinnatifid and 
relatively large.  The inflorescence is composed of several to many verticils.  Calyx is 
gland-dotted and the corolla, wide-throated is pale blue and white (Codd, 1985).  The 
flowering time starts in January and ends in March.   
Distribution: This species is generally found in disturbed area and well drained soil, and 
narrow endemic to Eastern Cape (Codd, 1985).  
 
Pinnatifid or pinnatisect leaves and flowers       Distribution of S. schlechteri. 
of S. schlechteri.    
Leaf trichome types: Both non-glandular and glandular trichomes are present on the leaf.  
The glandular trichomes are either peltate or capitate. 
 
Scanning electron microscopy and light microscopy micrographs of S. schlechteri.  
HPLC analysis of the solvent extract: Caffeic acid, rosmarinic acid, carnosol, carnosic 
acid, ursolic acid and betulafolientriol oxide were identified.  The HPLC chromatogram is 
displayed in the figure below, while the retention time, the absorption maxima and the 
percentage area of the major peaks are depicted in the table below. 
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HPLC chromatogram of the solvent extract of S. schlechteri.   
 
A summary of the HPLC-UV data of the methanol:chloroform extract of S.  schlechteri. 
Peak number 
Retention time 
(min) 
λmax (nm) 
Tentative 
identification 
Area (%) 
1 20.75 269, 341  Flavone 3.75 
2 23.24 330 Rosmarinic acid 26.58 
3 26.19 329  31.09 
4 34.87 206, 284, 321 Carnosol 10.88 
5 37.02 206, 285 Carnosic acid 10.38 
 
Biological activities and total phenolic content: The IC50 values (in µg/ml) of the in vitro 
biological activities of the solvent extract (SE) and the total phenolic content are given in 
the table which follows. 
AC AI AM AO TO TP  
SF-268 MCF-7 HT-29 5-LOX 3[H]-hyp ABTS·+ DPPH· MTT FCM 
SE 54.40 18.37 57.00 > 100.0 17.51 17.51 1.61 28.16 209.18 
AC: anticancer activity; AI: anti-inflammatory activity; AM: antimalarial activity; AO: anti-oxidant activity; 
TO: toxicity profile: TP: total phenolic content; 5-LOX: 5-lipoxygenase assay; [3H]-hyp; hypoxanthine 
isotope method; MTT: 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay; FCM: Folin-
Ciocalteu method.  NB: the anticancer activity was determined using the SRB assay, while the anti-oxidant 
activity was investigated using the ABTS and the DPPH methods.   
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The MIC values (mg/ml) of the solvent extract (SE) against bacteria are depicted in the 
table below. 
Pathogens  
E. coli K. pneumoniae B. cereus S. aureus M. tuberculosis 
SE 4.00 3.00 0.75 0.25 0.50 
 
Reference 
Codd, L.E.W. 1985.  Lamiaceae: Flora of Southern Africa. 28, Botanical Research 
Institute, Pretoria. 
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C16. Salvia stenophylla Burch. ex Benth. 
Synonyms: S. xerobia Briq., S. chlorophylla Briq, S. pallida Dinter 
Botanical description: It is a perennial erect herb that can reach 0.6 m tall and usually 
much branched from a woody taproot.  The leaves are shortly petiolated, linear oblong to 
oblong-lanceolate.  The calyx is hispidulous, gland dotted and the corolla is pale blue or 
mauve (Codd, 1985).   
Distribution: The plant is common in Gauteng, Free State and rarely found in KwaZulu- 
Natal (Codd, 1985). 
   
Pinnatifid or pinnatisect  leaves of S. stenophylla.      Distribution of S. stenophylla. 
Essential oil composition: The essential oil yield of this plant collected at the East of 
Clarens was 0.25% (w/w, wet biomass) and the major components of this oil were α-
bisabolol (26.1%) and δ-3-carene (22.6%). 
 
 
                               α-Bisabolol                                       δ-3-Carene 
HPLC analysis of the solvent extract: Rosmarinic acid, carnosol, carnosic acid, ursolic 
acid and betulafolientriol oxide were identified.  The HPLC chromatogram is displayed in 
the figure below, while the retention time, the absorption maxima and the percentage area 
of the major peaks are depicted in the table below. 
 
 
OH
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HPLC chromatogram of the solvent extract of S. stenophylla.   
 
A summary of the HPLC-UV data of the methanol:chloroform extract of S. stenophylla. 
Peak number 
Retention time 
(min) 
λmax (nm) 
Tentative 
identification 
Area (%) 
1 10.65 282, 316, 344  5.31 
2 23.22 330 Rosmarinic acid 22.17 
3 24.23 287, 254, 310  4.10 
4 34.86 206, 284, 323 Carnosol 23.60 
5 37.00 203, 285 Carnosic acid 25.17 
6 37.77 282  6.33 
 
Biological activities and total phenolic content: The IC50 values (in µg/ml) of the in vitro 
biological activities of the solvent extract (SE) and the essential oil (EO), as well as the 
total phenolic content are given in the table below. 
AC AI AM AO TO TP  
SF-268 MCF-7 HT-29 5-LOX 3[H]-hyp ABTS·+ DPPH· MTT FCM 
SE 43.86 23.74 17.41 > 100.0 6.50 20.84 14.92 12.12 
EO nd nd nd 49.17 4.13 > 100.0 > 100.0 1.98 
161.28 
- 
AC: anticancer activity; AI: anti-inflammatory activity; AM: antimalarial activity; AO: anti-oxidant activity; 
TO: toxicity profile: TP: total phenolic content; 5-LOX: 5-lipoxygenase assay; [3H]-hyp; hypoxanthine 
isotope method; MTT: 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay; FCM: Folin-
Ciocalteu method; nd: not determined.  NB: the anticancer activity was determined using the SRB assay, 
while the anti-oxidant activity was investigated using the ABTS and the DPPH methods.   
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The MIC values (mg/ml) of the solvent extract and the essential oil against bacteria are 
given in the table below. 
Pathogens  
E. coli K. pneumoniae B. cereus S. aureus M. tuberculosis 
SE 4.00 2.00 0.03 0.06 0.50 
EO > 32.00 8.00 1.50 > 32.00 nd 
   nd: not determined 
Reference 
Codd, L.E.W. 1985.  Lamiaceae: Flora of Southern Africa. 28, Botanical Research 
Institute, Pretoria. 
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C17. S. verbenaca L.,  
Synonyms: Horminum verbenaca (L.) Mill., S. cladestina L., S. controversa Ten., S. 
cleistogama De Bary and Paul 
Botanical description: It is a perennial short-lived plant with stems arising from woody 
taproot.  The leaves form a dense basal rosette, shortly petiolate to subsessile.  The 
inflorescence is usually branched with many verticils.  The calyx is pilose and gland-
dotted.  The corolla is light blue to purple.  Its nearest affinity is with S. disermas and S. 
radula.   
Distribution: This plant is distributed in the central and Western Cape Province and it also 
occurs in the Free State (Codd, 1985).  
 
Rosette leaves, inflorescence and glandular stem of S.           Distribution of S. verbenaca. 
 verbenaca. 
HPLC analysis of the solvent extract: Salvigenin, ursolic acid and betulafolientriol oxide 
were identified.  S. verbenaca was the only species devoid of rosmarinic acid.  The HPLC 
chromatogram is displayed in the figure below, while the retention time, the UV spectra 
and the percentage area of the major peaks are depicted in the table below. 
 
HPLC chromatogram of the solvent extract of S. verbenaca.   
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A summary of the HPLC-UV data of the methanol:chloroform extract of S. verbenaca. 
Peak number 
Retention time 
(min) 
λmax (nm) 
Tentative 
identification 
Area (%) 
1 32.41 220, 285, 332  7.46 
2 36.77 272, 333  8.17 
3 49.82 272, 327  3.09 
 
Biological activities and total phenolic content: The IC50 values (in µg/ml) of the in vitro 
biological activities of the solvent extract (SE) and the total phenolic content are given in 
the table which follows. 
AC AI AM AO TO TP  
SF-268 MCF-7 HT-29 5-LOX 3[H]-hyp ABTS·+ DPPH· MTT FCM 
SE > 100.0 31.50 50.04 > 100.0 23.97 37.47 45.83 20.85 73.29 
AC: anticancer activity; AI: anti-inflammatory activity; AM: antimalarial activity; AO: anti-oxidant activity; 
TO: toxicity profile: TP: total phenolic content; 5-LOX: 5-lipoxygenase assay; [3H]-hyp; hypoxanthine 
isotope method; MTT: 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay; FCM: Folin-
Ciocalteu method.  NB: the anticancer activity was determined using the SRB assay, while the anti-oxidant 
activity was investigated using the ABTS and the DPPH methods.   
 
The MIC values (mg/ml) of the solvent extract (SE) against bacteria are displayed in the 
table below. 
Pathogens  
E. coli K. pneumoniae B. cereus S. aureus M. tuberculosis 
SE 8.00 2.00 2.00 3.00 0.10 
 
Reference 
Codd, L.E.W. 1985.  Lamiaceae: Flora of Southern Africa.  28, Botanical Research 
Institute, Pretoria. 
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Appendix D: 1H and 13C spectra of compounds isolated from 
Salvia radula 
 
 
 
 
Figure D1  1H spectrum of betulafolientriol oxide. 
 
 
 
 
 
Figure D2  13C spectrum of betulafolientriol oxide. 
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Figure D3   1H spectrum of salvigenin. 
 
 
 
 
 
 
 
 
Figure D4   13C spectrum of salvigenin. 
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Appendix E: 1H and 13C spectra of compounds isolated from Salvia 
chamelaeagnea 
 
 
 
 
Figure E1  1H spectrum of carnosol.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure E2  13C spectrum of carnosol. 
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Figure E3   1H spectrum of 7-O-methylepirosmanol. 
 
 
v
 
Figure E4  13C spectrum of 7-O-methylepirosmanol. 
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Figure E5  1H spectrum of ursolic/oleanolic acid. 
 
 
 
 
Figure E6  13C spectrum of ursolic/oleanolic acid. 
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Appendix F:  Seasonal variation in essential oil composition of Salvia africana-caerulea,  
S. africana-lutea and S. lanceolata  
 
 
 
Table F-1 Percentage of the components identified in the essential oil of Salvia africana-caerulea over a one year period. 
 
 
Components RI Jan Feb Mar Apr May Jun Jul Aug Sept Oct Nov Dec 
α-Thujene 924 tr 0.1 1.6 0.1 0.1 tr 1.2 0.3 0.1 0.4 0.1 0.1 
Benzaldehyde 927 tr tr tr tr tr tr tr tr tr tr tr tr 
α-Pinene 930 1.7 4.2 tr 3.4 4.0 2.6 tr 3.9 3.7 8.2 4.1 4.7 
Camphene 938 0.7 0.1 0.1 0.1 0.1 tr 0.1 0.1 0.1 0.1 0.1 0.1 
Sabinene 958 0.2 0.2 tr 0.3 0.4 0.2 tr 0.2 0.3 0.1 tr 0.4 
1-Octen-3-ol 961 0.2 0.2 tr 0.3 0.4 0.2 0.2 0.2 tr 0.1 tr 0.4 
β-Pinene 963 tr 0.3 tr tr tr tr 0.2 0.3 1.0 2.9 1.3 tr 
Myrcene 975 0.6 0.8 0.6 0.7 0.6 0.6 tr 0.8 0.6 10.7 0.2 0.8 
α-Phellandrene 995 0.6 0.5 0.4 0.5 0.5 0.3 0.3 0.3 0.2 0.8 - 0.6 
p-Cymene 1003 tr 0.1 0.1 0.1 tr 0.2 0.1 0.6 0.2 0.2 1.5 0.2 
ο−Cymene  0.2 0.4 0.7 0.4 tr 0.2 0.1 0.3 0.2 0.2 - 0.6 
1,8-Cineole 1005 tr tr tr tr tr tr tr tr tr tr 0.5 tr 
β-Phellandrene 1005 0.4 0.8 tr 0.4 1.0 0.4 tr 0.1 1.2 7.8 - 0.8 
Limonene 1009 24.9 31.4 23.4 27.3 28.5 21.4 10.2 29.2 31.5 5.8 1.5 32.6 
cis-β-Ocimene 1017 0.1 0.1 0.1 0.2 tr 0.1 tr 0.3 0.2 3.1 tr 0.2 
trans-β-Ocimene 1027 0.3 tr tr 0.1 tr tr tr 0.1 0.2 1.0 tr tr 
γ-Terpinene 1035 tr 0.1 tr 0.1 0.1 0.1 tr 0.1 0.1 0.2 - 0.1 
trans-Sabinene hydrate 1037 tr 0.1 tr 0.1 0.1 0.1 tr 0.1 0.2 0.2 tr 0.1 
cis-Sabinene hydrate 1066 tr tr tr tr tr tr tr tr tr tr 0.1 tr 
Linalol 1074 1.5 0.4 1.6 0.6 0.4 0.3 0.4 0.4 0.4 0.3 0.3 0.4 
trans-p-2-Menthen-1-ol 1074 tr tr tr tr tr tr tr tr tr tr 0.6 tr 
Camphor 1095 0.4 0.2 0.1 0.3 0.2 0.3 0.5 tr tr 0.3 - 0.2 
δ-Terpineol 1134 - - - - - - - - - - tr - 
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Components RI Jan Feb Mar Apr May Jun Jul Aug Sept Oct Nov Dec 
Terpinen-4-ol 1148 8.3 1.4 0.3 0.4 3.2 2.2 7.3 1.7 1.1 1.1 0.5 1.1 
α-Terpineol 1159 1.2 0.4 1.5 1.1 0.4 0.2 1.4 0.2 0.1 0.5 0.7 0.4 
trans-Carveol 1189 tr tr tr tr tr tr tr tr tr tr tr tr 
Carvone 1206 tr tr tr tr tr tr tr tr tr tr tr tr 
cis-Jasmone 1372 tr tr tr tr tr tr tr tr tr tr tr tr 
α−Gurjunene 1400 tr tr tr tr tr tr tr tr tr tr tr tr 
β-Caryophyllene 1414 0.7 0.4 0.5 0.4 0.5 0.2 0.7 0.3 0.4 0.3 1.9 0.4 
β-Gurjunene* 1426 6.1 1.4 1.3 2.3 3.8 3.9 6.7 2.0 1.3 4.3 0.7 1.0 
Aromadendrene 1428 tr 0.5 0.7 tr tr tr 2.2 tr tr tr 0.9 0.6 
Eudesmadiene* 1435 tr tr tr tr tr tr tr tr tr tr 0.8 tr 
α-Humulene 1447 tr 0.3 0.6 1.4 tr 0.9 tr 1.3 0.5 1.8 1.2 0.4 
allo-Aromadendrene 1456 1.5 0.9 0.7 0.1 2.5 0.7 1.3 0.2 1.4 0.5 tr 0.9 
Viridiflorene 1487 0.1 1.1 2.2 1.3 1.0 1.8 2.3 1.0 1.5 1.1 0.2 1.2 
α−Muurolene 1494 1.0 0.4 1.4 0.6 2.2 2.8 1.1 0.4 0.5 1.1 - 0.4 
γ−Cadinene 1500 0.6 1.0 0.9 1.2 0.9 0.9 tr 2.4 1.3 0.3 1.5 2.0 
trans-Calamenene 1505 0.2 0.8 2.8 3.4 4.4 8.9 tr 0.7 0.3 3.4 0.3 1.0 
trans-Nerolidol 1549 1.2 1.9 2.2 2.3 2.5 2.4 2.0 2.4 2.3 0.7 1.4 1.9 
β-Caryophyllene alcohol 1550 1.8 2.3 2.9 3.0 2.6 3.1 1.6 4.0 3.6 1.4 1.4 2.2 
Spathulenol 1551 - - - - - - - - - - 29.1 - 
β-Caryophyllene oxide 1561 - - - - - - - - - - 14.6 - 
Globulol 1566 - - - - - - - - - - tr - 
Viridiflorol 1569 11.1 21.0 24.4 22.8 18.9 20.1 14.2 22.8 21.2 1.6 6.5 20.6 
Ledol 1580 6.4 2.6 3.7 3.7 3.7 5.6 7.5 3.4 3.1 1.9 tr 2.2 
epi-Cubenol 1600 1.3 0.8 1.3 1.3 1.4 2.0 1.1 1.2 1.2 0.8 tr 0.8 
T- Cadinol 1616 0.7 3.4 2.5 3.8 3.4 3.4 2.5 3.9 3.5 1.3 3.0 3.3 
β-Eudesmol 1620 0.4 0.8 3.2 1.0 0.8 0.7 0.7 0.5 0.6 3.8 0.7 0.8 
α−Eudesmol 1634 1.4 1.4 3.0 2.3 2.2 2.3 2.7 1.5 1.4 7.7 2.0 1.5 
              
% Identification  75.8 82.8 84.8 87.4 90.8 89.1 68.6 87.2 85.4 76.0 78.0 85.0 
                                         RI: Relative retention indices calculated against n-alkanes. - : not present, tr: trace (< 0.05 %); *: determined by mass spectra only. 
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Table F-2 Percentage of the components identified in the essential oil of Salvia africana-lutea over a one year period. 
 
 
Components RI Jan Feb Mar Apr May Jun Jul Aug Sept Oct Nov Dec 
α-Thujene 924 0.5 0.1 0.4 0.4 0.3 0.3 0.5 0.4 0.2 0.2 0.6 0.1 
α-Pinene 930 11.0 0.5 7.1 8.6 11.6 5.0 11.9 9.8 4.6 3.2 6 1.1 
Camphene 938 tr 0.1 tr tr 0.1 tr 0.1 0.1 0.1 0.1 0 0.1 
Sabinene 958 tr 0.3 1.4 1.9 3.9 2.7 0.9 0.1 0.1 0.7 0.9 0.1 
1-Octen-3-ol 961 tr 0.3 1.4 1.9 3.8 2.7 0.9 0.1 0.1 0.7 0.9 0.1 
β-Pinene 963 3.4 0.2 tr tr tr 1.8 2.9 3.8 1.9 tr 0.2 0.9 
Myrcene 975 10.7 3.7 5.0 2.6 4.3 5.9 5.3 8.4 2.7 5.4 11.5 2.2 
α-Phellandrene 995 0.6 0.2 0.8 0.4 0.9 1.1 1.0 0.8 0.8 0.7 -  0.6 
δ−3−Carene 1000 1.9 3.9 1.1 7.8 1.5 8.3 8.0 3.5 4.4 0.1 -  6.8 
ο−Cymene 1000 10.3 0.4 8.1 3.0 7.1 0.6 3.4 0.7 0.5 0.3 -  1.1 
p-Cymene 1003 2.6 0.2 1.3 0.7 0.4 0.3 0.4 0.2 0.2 0.1 7.6 0.3 
1,8-Cineole 1005 5.3 0.5 3.2 2.6 2.4 4.0 4.9 3.5 2.4 2.5 1.9 3.3 
β-Phellandrene 1005 5.3 0.5 3.2 2.6 2.4 4.0 4.9 3.5 2.4 2.5 -  3.3 
Limonene 1009 tr 3.4 tr 2.8 tr 6.0 3.7 5.4 3.7 3.3 1.6 5.3 
cis-β-Ocimene 1017 1.4 3.0 1.3 tr 0.5 0.5 0.5 1.7 0.2 2.1 5.4 0.2 
trans-β-Ocimene 1027 0.5 1.1 0.6 tr 0.1 0.2 0.1 0.6 0.2 0.7 1.8 0.1 
γ-Terpinene 1035 tr 0.4 0.1 tr 0.1 0.2 0.2 0.1 0.2 0.1 -  0.1 
trans-Sabinene hydrate 1037 tr 0.4 0.1 tr 0.1 0.2 0.2 0.1 0.2 0.1 0 4.7 
Linalol 1074 0.6 0.2 0.3 0.2 tr tr tr 0.4 0.7 0.4 0.8 0.8 
Camphor 1095 0.2 0.4 0.5 0.4 tr tr tr 0.3 0.2 0.4 0.2 0.3 
Terpinen-4-ol 1148 1.3 0.1 0.5 0.7 tr tr tr 0.2 0.2 tr 0.6 1.6 
α-Terpineol 1159 tr 0.3 0.1 tr tr tr tr tr 0.2 tr 0.8 0.3 
1-Decanol 1259 0.8 tr 0.4 0.4 0.4 0.6 0.6 0.8 0.5 0.5 -  1.4 
Bornyl acetate 1265 0.5 tr tr 0.6 tr tr tr tr 0.1 tr -  0.2 
α−Gurjunene 1400 0.5 0.6 4.7 5.0 4.6 4.3 2.5 0.7 0.8 0.4 1.1 0.9 
β-Caryophyllene 1414 2.7 2.0 2.4 1.5 1.1 0.8 0.9 2.1 4.3 2.6 3.4 3.4 
β-Gurjunene* 1426 1.0 3.3 tr tr 0.2 tr 0.2 2.8 1.5 1.0 0.3 1.2 
Aromadendrene 1428 1.0 1.1 1.2 0.7 1.4 0.6 0.8 1.4 1.4 0.9 2.7 0.6 
α-Humulene 1447 1.1 1.1 2.4 2.4 1.3 1.8 1.8 1.1 1.9 1.5 1.9 1.7 
trans-β-Farnesene 1455 tr 0.4 tr tr 0.7 tr 0.4 0.9 0.2 0.4 tr 0.1 
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Components RI Jan Feb Mar Apr May Jun Jul Aug Sept Oct Nov Dec 
allo-Aromadendrene 1456 tr 0.4 tr tr 0.7 tr 0.4 0.9 0.2 0.4 1.3 0.1 
Germacrene-D 1474 0.5 0.9 1.4 0.5 0.4 0.3 0.7 0.5 0.6 1.0 tr 0.8 
Bicyclogermacrene 1487 2.2 2.3 1.0 0.8 0.4 0.5 0.2 0.1 0.2 0.5 -  0.4 
Viridiflorene 1487 - tr  tr  tr  tr    -  -  -  -  1.3 -  
β-Bisabolene 1495 0.5 1.8 0.9 0.5 0.5 0.4 0.5 0.5 0.8 3.4 1.3 0.8 
δ−Cadinene 1505 0.4 2.3 0.6 0.5 0.5 0.4 0.4 0.5 0.6 0.4 4.7 0.5 
trans-Calamenene 1505 tr  tr  tr  tr  tr  tr  tr  tr  tr  tr  0.9 tr  
Elemol 1530 1.6 0.9 1.2 1.3 0.6 0.7 0.8 0.7 1.4 1.8 3.5 2.2 
trans-Nerolidol 1549 0.2 0.7 0.7 0.3 0.5 0.2 0.5 0.7 0.6 0.6 2.0 0.3 
β-Caryophyllene  
  alcohol 1550 0.2 0.7 0.4 0.3 0.5 0.2 0.5 0.7 0.6 0.6 2.0 0.3 
Spathulenol 1551 3.3 2.8 6.3 5.6 10.9 2.3 4.3 6.8 6.7 3.8 1.9 3.1 
β-Caryophyllene 
  oxide 1561 2.3 2.7 4.1 2.8 2.4 1.9 1.9 2.8 3.5 3.9 0.8 2.6 
Humulene epoxide* 1579 0.5 2.6 0.8 0.9 0.4 0.7 0.7   tr 1.3 3.3 0.7 
epi-Cubenol 1600 -  -  -  -  -  -  -  -  -  -  1.8 -  
T- Cadinol 1616 1.3 2.2 1.7 2.7 2.3 3.2 1.8 1.5 2.3 2.2 1.9 1.9 
γ-Eudesmol   0.9 4.0 2.4 1.5 2.6 2.9 2.8 2.4 2.2 3.3 -  3.6 
β-Eudesmol 1620 3.2 8.9 2.1 4.6 4.7 1.4 5.3 1.8 9.9 2.1 1.7 12.7 
α−Eudesmol 1634 5.0 10.6 8.1 9.5 10.4 10.9 9.3 8.5 12.6 9.1 tr 12.9 
                          
% Identification   85.3 72.5 79.3 79.0 87.1 77.9 87.1 81.9 79.1 65.3 78.6 85.8 
                                  RI: Relative retention indices calculated against n-alkanes. - : not present, tr: trace (< 0.05 %); *: determined by mass spectra only. 
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Table F-3 Percentage of the components identified in the essential oil of Salvia lanceolata over a one year period. 
 
Components RI Jan Mar Apr May Jun July Aug Sep Oct Nov Dec 
Tricyclene 921            
α-Thujene 924 0.4 0.5 0.5 0.4 0.1 0.1 0.2 0.4 0.4 - 0.2 
Benzaldehyde 927 - - - - - - - - - 0.5 - 
α-Pinene 930 3.8 tr tr 0.3 1.2 0.8 1.4 0.5 2.7  0.3 
Camphene 938 0.1 tr tr tr tr 1.1 tr tr 0.1 2.6 0.1 
Sabinene 958 1.9 0.3 0.3 0.2 0.3 0.7 0.8 0.1 1.9 tr 0.1 
1-Octen-3-ol 961 1.9 0.3 0.3 0.2 0.3 0.7 0.8 0.1 1.9  0.1 
β-Pinene 963 1.8 tr tr 0.6 0.8 0.8 2.2 0.7 1.3 1.4 0.1 
Myrcene 975 3.9 0.7 0.1 1.6 1.0 3.0 1.5 2.0 6.1 - 0.1 
α-Phellandrene 995 0.1 tr 0.1 tr 0.2 0.3 0.2 tr 0.1 - 0.1 
δ−3−Carene 1000 0.1 tr tr 0.1 0.2 0.1 0.5 0.1 0.1 - 0.4 
ο−Cymene  0.9 tr tr tr 0.5 0.8 0.3 tr 1.0 - tr 
p-Cymene 1003 1.1 1.0 0.4 0.9 0.5 0.2 0.7 1.4 0.5 - 0.2 
1,8-Cineole 1005 0.7 1.0 0.5 1.3 1.2 1.0 0.5 1.0 1.0 1.1 0.6 
β-Phellandrene 1005 0.7 1.0 0.5 0.7 1.2 1.0 1.4 1.0 1.0 1.8 0.6 
Limonene 1009 3.6 tr tr tr tr 1.6 2.1 tr 1.9  tr 
cis-β-Ocimene 1017 0.8 0.1 tr 1.1 1.5 1.9 3.1 1.6 2.5 1.8 tr 
trans-β-Ocimene 1027 0.4 tr tr 0.7 1.0 1.3 1.6 1.5 1.9 tr tr 
γ-Terpinene 1035 tr tr tr tr 0.6 tr 0.1 0.1 0.1 tr tr 
trans-Sabinene hydrate 1037 tr tr tr tr 0.4 tr 0.2 0.1 0.1 - tr 
Linalol 1074 0.6 tr 0.3 0.8 0.7 0.3 0.2 tr 1.1 tr 0.2 
Camphor 1095 0.4 tr 0.1 0.4 0.7 0.3 0.2 0.3 tr - 0.4 
Terpinen-4-ol 1148 0.2 1.0 0.7 0.5 0.6 0.6 0.8 0.7 0.8 - 0.4 
α-Terpineol 1159 tr 0.2 0.5 0.1 0.4 0.5 0.9 0.1 0.2 1.0 0.3 
Bornyl acetate 1265 tr tr 1.1 tr tr 0.5 tr tr tr - tr 
β-Bourbonene 1373 0.3 1.5 1.1 0.8 2.1 1.2 1.2 1.0 1.3 - 0.8 
β−Elemene 1388 0.7 2.0 1.3 2.2 1.8 1.0 1.1 2.6 0.9 - 0.6 
α−Gurjunene 1400 0.3 0.4 0.9 0.2 0.3 tr tr 0.2 0.3 - 0.9 
β-Caryophyllene 1414 12.9 13.1 3.1 19.2 18.6 17.8 17.0 18.4 12.7 - 0.7 
β-Gurjunene* 1426 1.6 1.8 1.1 1.5 1.2 2.3 1.4 1.5 0.7 5.7 1.8 
Aromadendrene 1428 - 2.9 0.5 3.2 0.2   1.0 0.4 0.1 0.6 
γ-Elemene* 1430 0.5 2.0 0.9 0.6 2.0 1.0 1.3 1.2 3.4 - 0.6 
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Components RI Jan Mar Apr May Jun July Aug Sep Oct Nov Dec 
Geranyl acetone 1434 0.4 0.8 1.9 0.6 2.0 tr 0.9 5.2 5.2 - - 
α-trans-Bergamotene 1434 - - - - - - - - - 0.8 - 
α-Humulene 1447 5.9 8.4 2.7 1tr 9.7 8.5 8.6 8.5 5.5 tr 1.6 
trans-β-Farnesene 1455 - - - - - - - - - 4.7 - 
allo-Aromadendrene 1456 0.9 0.5 0.5 0.8 0.9 1.0 1.1 0.9 0.6 - 0.6 
Germacrene-D 1474 2.2 1.4 0.3 2.7 2.2 1.9 4.3 1.2 3.0 - 1.2 
ar-Curcumene 1475 - - - - - - - - - 2.4 - 
Bicyclogermacrene 1487 4.8 1.3 1.0 3.4 6.0 5.4 7.9 2.5 4.7 - 1.8 
β-Bisabolene 1495 0.9 1.3 0.3 0.9 0.8 1.0 0.9 0.9 0.8 0.2 0.6 
γ−Cadinene 1500 1.1 0.7 0.6 1.0 0.8 1.0 1.1 0.6 0.8 - 0.3 
trans-Nerolidol 1549 0.7 0.9 0.8 0.8 0.7 3.1 0.9 4.6 0.8 - 0.8 
Spathulenol 1551 6.5 4.3 10.6 3.1 2.6 2.8 4.0 1.9 2.4 2.2 0.7 
β-Caryophyllene oxide 1561 3.4 7.1 21.2 3.3 2.2 2.0 1.8 2.4 1.4 18.3 10.3 
Globulol 1566 - - - - - - - - - 14.3 - 
Viridiflorol 1569 - - - - - - - - - 0.6 - 
Ledol 1580 - 4.1 2.9 11.7 4.5 3.6 3.7 4.1 4.3 5.9 - 
Humulene epoxide* 1579 2.8 6.7 3.6 4.6 4.5 4.4 4.0 4.3 6.5 5.2 10.8 
epi-Cubenol 1600 0.8 1.4 0.4 0.9 0.7 0.8 tr 1.0 tr  0.8 
T- Cadinol 1616 0.7 0.8 1.3 0.6 0.7 0.9 1.6 0.2 tr 0.6 1.4 
δ-Cadinol 1618 - - - - - - - - - 1.9 - 
β-Eudesmol 1620 0.9 1.3 tr 1.1 1.0 0.8 3.4 0.2 3.9 tr 1.7 
Cubenol 1624 - - - - - - - - - 1.3 - 
α−Eudesmol 1634 1.2 3.8 1.3 3.3 3.4 2.7 tr 3.3 tr - 1.0 
α−Bisabolol 1656 - - - - - - - - - 0.4 - 
             
% Identification  77.0 73.4 72.5 79.2 81.4 80.9 86.3 79.6 87.9 69.8 44.7 
                                    RI: Relative retention indices calculated against n-alkanes. - : not present, tr: trace (< 0.05 %); *: determined by mass spectra only. 
                                    NB: Sample from February collection was not done due to the lack of plant material.  
 
 
